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Abstract 
 
The first two chapters of this thesis deals with the synthesis of 6H-benzo[d]-naphtho[ 1,2-
b]pyran-6-one motif found in gilvocarcin as well as related aromatic compounds containing 
the aromatic pyranone moiety. The synthesis was undertaken by employing the Suzuki-
Miyaura cross coupling reaction and a novel N-bromosuccinimide induced ring cyclization 
reaction to afford the pyranone. It was established that the treatment of both [2-(1,4-
dimethoxynaphthalen-2-yl)phenyl]methanol and (2',5'-dimethoxy-[1,1'-biphenyl]-2-
yl)methanol separately with N-bromosuccinimide results in the unexpected synthesis of a 
naphthopyranone ring system in the form of 12-methoxy-6H-dibenzo[c,h]chromen-6-one and 
2-methoxy-6H-benzo[c]chromen-6-one respectively. Application of the same methodology 
for the attempted synthesis of related compounds namely, 1-hydroxy-12-methoxy-6H-
dibenzo[c,h]chromen-6-one and 8-fluoro-12-methoxy-6H-dibenzo[c,h]chromen-6-one 
unfortunately did not generate the desired results. Attempts were made to elucidate the 
mechanism of this reaction. The most apparent mechanism indicates that N-
bromosuccinimide, in the presence of air, oxidizes the benzylic alcohol to an aldehyde which 
is then converted to an acid bromide allowing for the ring closure with the adjacent aromatic 
ether to afford the desired pyranone. 
 
In Chapter 3 and 4 of this thesis we dealt with the synthesis of benzo[b]phenanthridine-7,12-
dione motif, the backbone of biologically important secondary metabolite jadomycin B. 
Again, a key step involves employing the Suzuki-Miyaura cross coupling reaction. The 
synthetic methodology also sheds some light on the dynamics of the ring closure of benzylic 
amines onto naphthoquinones resulting in the synthesis of benzo[i]phenanthridine-11,12-
dione, 12-methoxybenzo[i]phenanthridine and 1-hydroxybenzo[i]phenanthridine-11,12-dione. 
 
The synthesis of benzo fused phenanthridines has been undertaken in Chapter 5 and 6 by 
employing Suzuki-Miyaura cross coupling reaction and a potassium t-butoxide and light 
mediated cyclization reaction as the key steps. The synthesis of 5-
phenylbenzo[i]phenanthridine was undertaken successfully but attempts to execute the 
same methodology to form a compound library of related benzo-fused phenanthridines was 
unsuccessful. 
 
The same methodology employing a Suzuki-Miyura cross coupling reaction and potassium t-
butoxide and light mediated cyclization reaction was applied in Chapter 7 and 8 of the thesis 
directed towards the synthesis of 13H-indolo[3,2-c]acridine and 3-methoxy-13H-indolo[3,2-
c]acridine. The successful synthesis of the 13H-indolo[3,2-c]acridine is reported using this 
methodology. 
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Chapter 1: Introduction, Literature Review and Aims: The Gilvocarcins 
 
1.1 The Naphthopyranone Derivatives 
 
Aromatic polyketides featuring an oxygenated benzo-fused naphthopyranone motif form one 
of the major families of secondary metabolites found in nature and they are a major source 
of novel chemotherapeutics. These compounds are particularly known for their anti-bacterial, 
anti-viral, anti-tumour and enzyme inhibitory activity.1,2 As a result of their unique structural 
complexities and profound biological importance this class of compounds is of considerable 
interest to synthetic organic chemists. A few representatives of the class of oxygenated 
benzo-fused naphthopyranones are chartreusin 1, chrymutasin A 2, arnottin 1 3, 
hayumicinone 4 and gilvocarcins 5 as shown in Figure 1.1,2 
 
 
 
Chartreusin 1         Chrymutasin A 2       Arnottin 1 3 
            (R = 2-O-α-digitaloxy-β-D-fucosyl) 
 
 
 
       Hayumicinone 4              Gilvocarcins 5 
 
Representatives of the class of oxygenated benzo-fused naphthopyranone 
 
Figure 1 
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Chartreusin 1, a naphthopyranone derivative with an aromatic polyketide glycoside structure, 
was first isolated in 1959 from the cultures of Streptomyces chartreusis.2 It is known for its 
potent anti-tumor activity against various cell lines such as murine P388 and L1210 leukemia 
cell lines, and B16 melanoma cells along with significant antibacterial activity. Unfortunately, 
there have been some setbacks in the development of chartreusin 1 as a drug due to its 
unfavorable pharmacokinetics caused by its rapid biliary excretion and slow gastrointestinal 
absorption.3 
 
Chrymutasin A 2, is a glycosidic antibiotic produced by the fermentation of a mutant strain of 
Streptomyces chartreusis obtained by NTG (N-methyl-N'-nitro-N-nitrosoguanidine) 
treatment. The mutant strain produces chrymutasin, which differs in the aglycone moiety 
from chartreusin 1, and related compounds.4  The anti-tumor activity of chrymutasin A 2 has 
been found to be better in vivo than that of chartreusin 1, the cytotoxic activity against cell 
lines in vitro is equivalent, and the antimicrobial spectrum is narrower.4 
 
Arnottin I 3 is a dibenzo[c,h]chromen-6-one derivative and was isolated from the bark of 
Xanthoxylum arnottianum by Ishikawa and co-workers in 1977 and no biological activity to-
date has been reported.5  
 
Hayumicinone 4 and related compounds are isolated from the culture of a strain of 
Actinomadura sp., ATCC 55432. These compounds are known for their anti-tumour as well 
and antibacterial activity.6 
 
Gilvocarcins 5 are a family of polyketide metabolites isolated from Streptomyces sp. 
Members of this family are known to exhibit exceptionally high antimicrobial and anti-tumour 
activities and very low toxicity.7 The gilvocarcins 5 are discussed in more detail in the 
following sections of this Chapter. 
 
1.1.1 The Gilvocarcin Family 
 
This distinctive class of potent anticancer antibiotics often referred to as gilvocarcin-type 
aryl-C-glycosides exhibit low toxicity and have been shown to be especially resistant to 
enzymatic and acidic hydrolysis. The gilvocarcins 5 and structurally related compounds are 
polyketide glycosides which are the metabolites of a variety of Streptomyces sp. and 
constitute a novel class of aryl C-glycoside antibiotics or glycosylarenes. These compounds 
share a common tetracyclic aromatic nucleus, the 6H-dibenzo[c,h]chromen-6-one 6, to 
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which a carbohydrate moiety is attached at C-4, an alkyl group at C-8, two methoxyl groups 
at C-10 and C-12 and a phenolic group is present at C-1, 7 as shown in Figure 2. 7,8,9 
 
 
 
 
R = carbohydrate 
R’ = an alkyl or alkenyl group 
 
6H-Dibenzo[c,h]chromen-6-one 6  Substituted 6H-dibenzo[c,h]chromen-6-one 7 
 
Figure 2 
 
1.1.2 Members of the Gilvocarcin Family 
 
In 1980, Hatano et al. published a report describing the isolation of an antibiotic (antibiotic B-
21085), which he first presented at the Annual Meeting of the Agricultural Chemical Society 
of Japan in 1971, as yellow crystals from the mycelium of the culture broth of Streptomyces 
sp. No. B-21085 and named it toromycin.10 Toromycin was found to be active against gram-
positive bacteria, mycobacteria, mycoplasma, DNA viruses (vaccinia virus and Herpes 
Simplex virus) and some bacteriophages.10 Later the same year Horii et al. elucidated the 
structure of toromycin aglycone 8, describing it as 6-oxo-6H-benzo[d]naphtho[1,2-b]pyran 
skeleton with a C-glycosyl group at C-4, a vinyl group at C-8 and two methoxy groups at C-
10 and C-12 (Figure 3). 11 
 
 
Toromycin aglycone 8 
 
Figure 3 
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In the same year, Sehgal et al. isolated an antibiotic from the fermentation broth of 
Streptomyces ravidus and named it ravidomycin 9. It was found to exert strong inhibitory 
effect on gram positive bacteria and displayed potent anti-tumour activity (Figure 4).12 
 
The following year, in 1981, Findlay et al. proposed the structure for ravidomycin 9 based on 
the results of chemical and spectroscopic studies and found it to be consisting of a 6-oxo-
6H-benzo[d]naphtho[1,2-b]pyran skeleton with an amino sugar at C-4, a vinyl group at C-8, 
two methoxy groups at C-10 and C-12 and a phenolic hydroxyl group at C-1 (Figure 4)13,14 
 
 
 
Ravidomycin 9 
 
Figure 4 
 
Nakano et al. reported the isolation of two related compounds in 1981, gilvocarcin V 10 and 
gilvocarcin M 11 (Figure 5). These compounds were discovered in culture broths of 
Actinomycete DO-38, which was subsequently recognized to be a new species and was 
named Streptomyces gilvotanareus (NRRL 11382). Both gilvocarcin V 10 and M 11 were 
isolated from the ethyl acetate extract and by using silica gel chromatography. These 
compounds were found to exhibit activity against gram-positive bacteria and experimental 
tumours such as mouse sarcoma 180 and mouse leukemia P388.15 
 
The same year, Takahashi et al. also described gilvocarcin V 10 and M 11, isolated from 
Streptomyces gilvotanareus, and established the structure and stereochemistry by means of 
X-ray crystallographic analysis. Gilvocarcin M 11 contains a methyl group at C-8 while 
gilvocarcin V 10 analogue contains a vinyl substituent at the same position. Other features 
were found to be similar in both the molecules with a fucose (in furanosyl form) present at C-
4, two methoxy groups each at C-10 and C-12 and a phenolic hydroxyl group at C-1 was 
observed (Figure 5).16 
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   Gilvocarcin V 10    Gilvocarcin M 11 
 
Structures of Gilvocarcin V 10 and M 11 
 
Figure 5 
 
Later the same year, Balitz and co-workers, isolated and elucidated the structure of another 
gilvocarcin: gilvocarcin E 12 along with gilvocarcin V 10 and M 11 from a culture of 
Streptomyces anandii subsp. araffinosus strain C-22437 (ATCC-31431). Gilvocarcin E 12 
was found to have similar structural features to gilvocarcin V 10 and M 11 with the only 
difference being in the presence of an ethyl group at C-8 (Figure 6).17 
 
 
 
Gilvocarcin E 11 
 
Figure 6 
 
Two years later, Jain et al. isolated toromycin 13 from a strain of Streptomyces species 
(AAC-324) and from chemical and spectroscopic studies inferred its structure and 
stereochemistry. From these studies, it was realised that toromycin 13 and gilvocarcin V 10 
are the same compounds (Figure 7), though the name gilvocarcin V 10 is more widely 
accepted.18 
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            Toromycin 13          Gilvocarcin V 10 
 
            Toromycin 13 and gilvocarcin V 10 are structurally identical 
 
Figure 7 
 
In 1989, Weiss et al. identified the components of the yellow antibiotic chrysomycin, which 
was first reported in 1955 by Strelitz et al. , as chrysomycin A 14 and chrysomycin B 15 as 
depicted in Figure 8.19, 20 These differed only by the substituent at C-8, which is a vinyl group 
in chrysomycin A 14 and a methyl group in chrysomycin B 15. Structural elucidation of 
chrysomycins A 14 and B 15 revealed a very close similarity with gilvocarcin V 10 and M 11 
respectively. The only difference being in the C-glycosidic side-chain, which is a 
methylpentose in the gilvocarcins 5 and a 3,5-dimethylpentose in the chrysomycins (14 and 
15).20 The same year, Matson et al. illustrated the effectiveness of chrysomycins A 13 and B 
14 in inhibiting three mouse tumours and P388 lymphatic leukemia.21 
 
 
 
Chrysomycin A 14    Chrysomycin B 15 
 
Figure 8 
 
Recently, a new antimicrobial polyketide glycoside – Gilvocarcin HE 16 (Figure 9) has been 
isolated along with three known compounds, gilvocarcins E 12, V 10 and M 11 from the ethyl 
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acetate extract of Streptomyces sp., QD01-2. The structure has been established by 
spectroscopic analysis, X-ray single crystal diffraction and CD spectra. The new compound 
showed potent antimicrobial activities against Staphylococcus aureus, Bacillus subtilis, 
Escherichia coli and Candida albicans, and showed weak cytotoxicity against the MCF-7, 
K562 and P388 cancer cell lines.7 
 
 
 
     Gilvocarcin HE 16 
 
Figure 9 
 
In this section we have discussed a variety of gilvocarcin-type polyketide glycosides. As 
observed from their structural features they all contain a 6H-dibenzo[c,h]chromen-6-one 6 
skeleton with two methoxy groups at C-10 and C-12 and a phenolic hydroxyl group at C-1 
(Figure 2). They only differ in the presence of different carbohydrate moieties present at C-4 
as well as a variety of different substituents at C-8 such as vinyl, methyl or alkyl. Structurally, 
this group of naturally occurring polyketide antibiotics are known as gilvocarcin-type 
polyketide glycosides as the gilvocarcins 5 are the prototypes of this class.7 We will focus 
further discussion on the aglycones of gilvocarcins, since the intercalation of aglycones is 
known to be the main source of free energy of binding in any intercalated drug–DNA 
complex.22 Furthermore, the focus of this PhD is on the 6H-dibenzo[c,h]chromen-6-one 6 
(Figure 2) skeleton, rather than the carbohydrate moiety. 
 
1.2 Biological Importance of Gilvocarcins and Mechanism of Action 
 
As has already been mentioned, gilvocarcins 5 are known for their remarkable antitumour 
activity and exceptionally low toxicity. Wei et al., Tomita et al. and Shishido et al. have in 
separate studies suggested that Gilvocarcin V 10 interacts with double-stranded DNA by 
intercalation.23, 24, 25 They are known to be DNA targeting agents with potent intercalating 
ability, leading to covalent binding or strand breaking upon photoirradiation. The presence of 
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the vinyl group as present in Gilvocarcin V 10 is known to enhance anti-tumour activity under 
irradiation with low-energy UV or visible light. Recent studies have proven that it undergoes 
photoactivated [2+2]-cycloaddition with thymine residues of DNA under irradiation with low 
energy UV or visible light.26, 27 The carbohydrate moiety seems to be essential for the 
observed gilvocarcin-mediated cross-linking of histone H3 or heat shock protein GRP78 with 
DNA resulting in the disruption of DNA replication and transcription.28 
 
Gilvocarcins 5 are also known to exhibit strong antibacterial and antiviral properties however, 
the characteristic poor solubility of these molecules seems to be a major obstacle in their 
development as antibiotics.27 
 
1.3 Biosynthesis of Gilvocarcins  
 
Initial biosynthetic studies started with the addition of various 13C labelled acetate and 
propionate substrates to the fermentation broth of Streptomyces gilvotanareus to elucidate 
the biosynthetic origin of carbon atoms in the unique 6H-dibenzo[c,h]chromen-6-one 6 
skeleton of the gilvocarcins 5 (Figure 2).27 Genetic and biochemical analysis of gilvocarcin V 
10 gave way to the biosynthesis which started with the isolation and sequence analysis of its 
biosynthetic gene cluster from Streptomyces griseoflavus Go 3592.99 The gilvocarcin gene 
(gil) cluster was found to consist of twenty seven open reading frames (ORFs), including 
genes encoding the polyketide synthase (PKS) as well as several post-PKS tailoring and 
deoxysugar biosynthetic genes. Biosynthetically, the polyketide-derived backbone of the 
gilvocarcins 5 is produced from acetate, propionate, and malonate subunits by the action of 
a type-II polyketide synthase (PKS). It has been proven that the early biosynthetic steps 
generate an angucyclinone intermediate (e.g., prejadomycin 17 and dehydrorabelomycin 18) 
that subsequently undergoes a complex structural rearrangement via an oxidative C5−C6 
bond cleavage to form the benzonaphthopyranone skeleton of the gilvocarcins 5 (Scheme 1 
and 2).29, 30, 31, 32  
 
 
Scheme 1: Biosynthesis of gilvocarcins 5.29 
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Scheme 2: Biosynthesis of gilvocarcin M aglycone 19.29  
  
1.4 Selected Synthetic Approaches Towards Gilvocarcin Aglycones 
 
As a result of the biological activity of these compounds and their interesting structures, 
many attempts at the synthesis of these compounds have been made. In this section a few 
selected syntheses will be highlighted. 
 
1.4.1 Jung and Jung Approach Towards the Synthesis of O-Benzyl-Gilvocarcin M 
Aglycon 20.33 
 
Jung and Jung in 1988, demonstrated a short and efficient synthesis of the 1-benzylated 
aglycone of gilvocarcin M 20 as presented in Scheme 3. The key step of the synthesis is a 
Suzuki-Miyaura cross coupling reaction between [5-(benzyloxy)-1,4-dimethoxynaphthalen-2-
yl]boronic acid 22 and 22. The desired boronic acid 21 was prepared starting from 1.5-
diacetoxynaphthalene 23 which was converted into 2-bromo-5-hydroxynaphthoquinone 24 in 
two steps. Benzylation of the free naphthol group 25 followed and subsequent reduction of 
the quinone followed by dimethylation gave the boronic acid precursor 26. The second 
fragment, a substituted aryl iodide 22 was synthesized from 3-hydroxy-5-methylbenzoic acid 
10 
 
27. Methylation followed by reduction of 3-hydroxy-5-methylbenzoic acid 27 afforded the 
alcohol 28 which on treatment with nbutyllithium followed by the addition of iodine and 
oxidation to the ester gave the desired iodide 22. A Suzuki coupling reaction between these 
two synthesized fragments gave a biaryl compound 29 which was subjected to ceric 
ammonium nitrate oxidation to obtain a mixture of two products 30 and 31. Treatment of the 
mixture of 30 and 31 to zinc in acetic acid gave the desired hydroxylactone 32. Methylation 
of the free phenol yielded the desired benzyl protected aglycone of gilvocarcin M 20. The 
synthetic scheme presents an efficient approach towards the generation of the benzyl 
protected aglycone of gilvocarcin M 20 but if the same approach could be used for the total 
synthesis of gilvocarcin M 11 is still doubtful. Though, this synthetic methodology could also 
be applied to the synthesis of aglycone of gilvocarcin V 33 (Figure 10). 
 
 
 
Aglycone of gilvocarcin V 33 
 
Figure 10 
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Scheme 3: Reagents and conditions: A) 1) NBS, AcOH; 2) H2O, H2SO4, EtOH, 91%; B) 
Ag2O, BnBr, 85%; C) Na2S2O4, K2CO3, Me2SO4, 87%; D) nBuLi/THF, -100°C, B(OMe)3, -78 
°C-25 °C, H+; E) MeI, K2CO3, acetone, LiAlH4, 89%; F) 1) nBuLi, I2, hexane, Et2O(10:1), -
78°C, 59%; 2) PCC, MnO2/HOAc, NaCN/MeOH, 91%; G) Na2CO3/EtOH, Pd(PPh3)4, 61%; H) 
CAN, CH3CN, H2O; I) Zn, HOAc, 52% 29 and 37% 30; J) 1) Me2SO4, K2CO3, acetone, 
100%; 2) H2, Pd/C Ac2O, Pyr/DMAP, 80%.
33 
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1.4.2 Hart’s Approach Towards the Synthesis of Defucogilvocarcin M 19.34  
 
The key step in the synthesis described by Hart involved the methyl aluminium bis-(2,6-di-t-
butyl-4-methylphenoxide) (MAD)-mediated conjugate addition of an aryllithium derived from 
oxazoline 34 to the naphthoquinone monoketal 35 (Scheme 4). The oxazoline derivative 34 
was prepared in four steps starting from 3,5-dichloroanisole 36. Treatment of the starting 
material 36 with Rieke magnesium and dimethyl sulfate gave 37 followed by another 
reaction with Rieke magnesium which afforded ester 38 on exposure to ethyl chloroformate. 
Subsequent saponification gave the carboxylic acid 39. Finally, sequential treatment of 39 
with thionyl chloride, 2-amino-2-methylpropanol and thionyl chloride yielded oxazoline 34. 
On the other hand, the napthoquinone ketal 35 was prepared in four steps starting from 
juglone, which was first converted to benzyl ether 40, followed by reduction and methylation 
of the least hindered hydroxyl group to yield 40. The naphthol obtained was converted to 
monoketal 35 using an electrochemical procedure. The coupling of naphthoquinone 
monoketal 35 and oxazoline 34 was performed using methyl aluminium bis-(2,6-di-t-butyl-4-
methylphenoxide) (MAD) as a key reagent to give 42. Ketal and oxazoline hydrolysis, 
aromatization, and intramolecular lactone formation afforded 43. Subsequent methylation 
yielded 20 and hydrogenolysis of the resulting benzyl ether afforded defucogilvocarcin M 19. 
This synthetic approach employed by Hart towards the synthesis of the aglycone of 
gilvocarcin M 19 was efficient and high yielding.  
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Scheme 4: Reagents and conditions: A) 1) Rieke Mg, THF, rt; 2) Me2SO4, THF, rt, 53%; B) 
Rieke Mg, CICO2Et; C) KOH, MeOH-H2O (3:1), heat, 71%; D) SOCl2, PhH, heat; 
HOCH2C(Me)2NH2, DCM; SOCl2, 87%; E) Na2S2O4, H2O, Et2O, Me2SO4, K2CO3, acetone, 
heat, 64%; F) anodic oxidation, MeOH, 2% LiClO4, 88%; G) nBuLi, THF, MAD, PhMe, -78 
°C, 72%; H) HCI, THF, H2, heat, 95%; I) Me2SO4, K2CO3, DCM, heat, 98%; J) H2, Pd/C, 
THF, 82%.34 
 
1.4.3 Deshpande’s Approach Towards the Synthesis of Gilvocarcin Aglycones.35 
 
As illustrated in Scheme 5, Deshpande and co-workers were also able to synthesize 
gilvocarcin aglycone but the strategy involved the making of the ester that was to become 
part of the lactone of the final product as the first step. Starting from benzylated juglone 40, 
8-(benzyloxy)-4-acetoxynaphthalen-1-ol 44 was obtained over three steps by utilizing 
14 
 
reduction and selective acetylation. This was followed by methylation 45 and deacetylation 
which yielded 46. A DCC-mediated esterification of the resulting product with O-
bromobenzoic acid 47 afforded benzoate 48 which on treatment with 
bis(triphenylphosphine)palladium(II)dichloride (Pd(PPh3)2Cl2) promoted the desired 
cyclization and gave 1-(benzyloxy)-12-methoxy-6H-dibenzo[c,h]chromen-6-one 49 skeleton 
albeit in low yield. The same methodology was then used to synthesize the aglycones of 
gilvocarcin M 19, V 33 and E 50. 
 
 
Scheme 5: Reagents and conditions: A) Zn, Ac2O, Py/CHCl3, heat, 80%; B) MeI, K2CO3, 
acetone, heat, 96%; C) KOH, MeOH, 60%; D) DCC, DMAP, DCM, 51%; E) Pd(PPh3)2Cl2, 
NaOAc, DMA, 130 °C, 2 hrs, 40%.35 
 
1.4.4 Snieckus Approach Towards the Synthesis of Aglycones of Gilvocarcin V 33, M 
19 and E 50.36, 37 
 
James and Snieckus in 1997 and later in 2009 reported the total synthesis of 
defucogilvocarcin V 32, M 18 and E 49 as depicted in Scheme 6. 36, 37 The key step 
employed in this case was the remote anionic Fries rearrangement. To carry out the 
synthesis, a differentially protected trioxygenated naphthalene species 51 was iodinated and 
the resulting compound 52 was utilized in a Suzuki-Miyaura cross coupling reaction with a 
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MOM protected arylboronic acid 53 to furnish the biaryl compound 54. Cyclization to the 
desired lactone 55 was achieved by using lithium diisopropylamide. Deprotection of the 
MOM group was carried out under acidic conditions to give 56, followed by conversion of the 
free phenolic hydroxyl group into the required triflate 57. Treatment of 57 with vinyltributyltin 
under modified Stille conditions (2 mol% Pd2(dba)/LiCl/(2-furyl)3P/NMP) yielded 58. Negishi 
coupling using MeZnBr (5 mol% NiCl2dppp/THF) and Suzuki–Miyaura coupling with BEt3(5 
mol% PdCl2dppf/K2PO4/THF) yielded the methyl 59 and ethyl 60 analogues respectively. 
Finally, selective deprotection afforded defucogilvocarcin V 33, M 19 and E 50 respectively. 
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Scheme 6: Reagents and conditions: A) 1) sBuLi/TMEDA/THF/-78°C; 2) I2, 94%; B) Pd(0), 
95%; C) LDA/THF, reflux, H+; D) 1) 50% aq. HOAc, 70%; E) Tf2O/Et3N/DCM, -78 °C, 81%; 
F) For R = CH=CH2 57, CH2=CHSn[CH3(CH2)3]3, 2 mol% Pd2(dba)3/LiCl/(2-furyl)3P/NMP, rt, 
5 hrs, 69%; For R = CH3 58, MeZnBr (5 mol% NiCl2dppp, THF, rt, 12 hrs, 75%; For R = C2H5 
59, BEt3(5mol% PdCl2dppf, K3PO4, THF, reflux, 1 hr, 59%; G) BCI3, DCM, 0°C, 10 mins, For 
R = CH=CH2 32, 90%, For, R = CH3 18, 83%, For R = C2H5 49, 86%.
36 
 
1.4.5 Qabaja and Jones’ Approach.38 
 
In their synthesis of the benzo[b]fluorene skeleton, Qabaja and Jones devised a synthesis of 
the methoxy derivative of gilvocarcin M aglycone 61. This product was isolated as an 
intermediate in their synthesis of benzo[b]fluorene. The synthesis of the 
benzonaphthopyranone was carried out by the reaction of 5-methoxy hydroquinone 62 with 
2-iodo-3-methoxybenzoyl chloride 63 which resulted in the generation of an ester 64. The 
ester intermediate obtained was first methylated and then subjected to a palladium catalysed 
intramolecular ring closure reaction to generate O-methoxy gilvocarcin M aglycone 61 as 
shown in Scheme 7. 
 
 
 
Scheme 7: Reagents and conditions: A) DMAP, i-Pr2NEt, THF, 71%; B) 1) Me2SO4, K2CO3, 
acetone; 2) PdCl2(PPh3)2, NaOAc, DMA, 75%.
38 
 
Using the same methodology, the authors also demonstrated the synthesis of 12-methoxy-
6H-dibenzo[c,h]chromen-6-one 65, as depicted in Scheme 8, a framework which is native to 
all the members of the gilvocarcin family. 
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Scheme 8: Reagents and conditions: A) DMAP, i-Pr2NEt, THF; 88%; B) 1) Me2SO4, K2CO3, 
acetone; 2) PdCl2(PPh3)2, NaOAc, DMA, 58%.
38 
 
1.4.6 Patra’s Approach Towards the Synthesis of Defucogilvocarcin M.39 
 
In 2005, Patra et al. reported the synthesis of 1-methoxydefucogilvocarcin M 61 employing 
the Hauser annulation as a key step. A styryl sulfone 66 which was used as an acceptor in 
the annulation reaction was prepared in four steps from 2-Methoxy-4-methylpivalanilide 67 
using a Heck-coupling with vinyl sulfone 68. Following a reaction with cyanophthalide 69 this 
afforded the tetracyclic gilvocarcin skeleton 70. Subsequent radical initiated desulfonation 
and an aromatization reaction led to the synthesis of 1-methoxy defucogilvocarcin M 61 as 
illustrated in Scheme 9. 
 
 
 
Scheme 9: Reagents and conditions: A) 1) nBuLi, CO2, THF, HCl; 2) MeOH, reflux; 3) 
SOCl2, MeOH, reflux, 62%; B) HBF4, NaNO2, H2O, MeOH, Pd(OAc)2, reflux, 88%; C) tBuOLi, 
THF, -60 °C, 93-98%; D) 1) Bu3SnCl, NaBH3CN, AIBN, tBuOH, 1 hr, 94%; 2) Me2SO4, 
K2CO3, acetone, 88%.
39 
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1.4.7 Cortezano-Arellano’s Approach Towards Defucogilvocarcin M 19.40  
 
The synthesis described by Cortezano-Arellano started with the generation of the radical 
precursor 71 from 2-hydroxyacetophenone 72 over three steps. This was followed by the 
addition of vinyl pivalate 72 along with dilauroyl peroxide (DLP) to afford adduct 74. Another 
reaction with DLP facilitated the ring closure to form the desired α-tetralone 75. 
Subsequently, the aromatization of the α-tetralone 75 was accomplished by performing a 
bromination followed by the elimination of hydrobromic acid to give 76. Methylation of the 
free phenol provided 77. The reduction of the pivaloyl ester followed by the treatment of the 
crude naphthol with substituted aromatic acid chloride 78 afforded compound 79. Finally, a 
palladium-catalyzed cyclization of 79, followed by hydrogenolysis of the benzyl ether, gave 
the aglycone of gilvocarcin M 19. This generalised synthetic scheme could be used for the 
synthesis of other aglycones of the gilvocarcin family.  
 
 
 
Scheme 10: Reagents and conditions: A) 1) BnBr, K2CO3, DMF, rt; 2) Br2, Et2O, 0 ºC-rt; 3) 
KSC(S)OEt, acetone, 0 ºC-rt, 90%; B) DLP, 1,2-DCE, reflux, 80%; C) DLP, 1,2-DCE, reflux, 
42%; D) 1) NBS/Et2O, CH3CN, 0 ºC; 2) DBU, DCM, rt, 87%; E) MeI, K2CO3, DMF, 80-90 ºC, 
68%; F) DIBAL, DCM, -78 ºC, 81%; G) 1) PdCl2(PPh3)2, AcONa, DMA, 65%; 2) H2, Pd/C, 
THF, 80%.40 
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1.5 Comparative Analysis of the Synthetic Approaches Towards the Gilvocarcin 
Aglycones 
 
A few selected examples of synthetic approaches towards the synthesis of the aglycones of 
gilvocarcin antibiotics have been discussed in the previous sections. In this section an 
analysis of the methodology used will be outlined. 
 
From one of the earliest synthesis described by Jung et al. in 1988 it was clear that a key 
step of the synthetic methodology would be the Suzuki-Miyaura cross coupling reaction to 
generate biaryl axis between ring B and D as shown in Scheme 11.33 
 
 21    22      29 
 
Scheme 11: Reagents and conditions: Na2CO3/EtOH, Pd(PPh3)4, 61%. 
 
The work done by Jung et al. laid the foundation for the use of Suzuki-Miyaura cross 
coupling reaction to generate biaryl axis for the synthesis of gilvocarcin tetracyclic 
framework.33 The use of this methodology featured in later syntheses of the same class of 
compound.  
 
For example, later, in the year 1997 and again in 2009, James and Snieckus also employed 
palladium catalysed Suzuki-Miyaura cross coupling reaction to form the biaryl axis for the 
synthesis of aglycones to form linkage between rings B and D of the tetracyclic system as 
illustrated in Scheme 12.36,37 
 
 
 
Scheme 12: Reagents and conditions: Pd(PPh3)4, Na2CO3, DME/H2O, 48 hrs, 95% 
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Other related synthetic approaches employed used towards the generation of 
benzonaphthopyranone skeleton of gilvocarcin family, include the palladium-catalysed 
intramolecular aryl coupling for ring closure to generate the ring C. This kind of approach 
was first used by Bringmann et al.in 1986 and was used for the synthesis of aglycones of 
gilvocarcins by Deshpande et al., Qabaja et al. and Cortezano et al. as discussed in the 
previous Sections 1.4.3, 1.4.5 and 1.4.7.35,38,40,41 One general example of palladium 
mediated ring closure to generate ring C of the gilvocarcin framework is depicted in Scheme 
15. 
 
 
 
Scheme 15  
 
The Meyers coupling reaction also appears to be a common approach for the construction of 
the desired biaryl axis as shown for example by Hart et al. where the authors managed to 
synthesize aglycone of gilvocarcin V 33 by coupling an appropriately functionalized Grignard 
precursor of naphthalene 80 with the protected and substituted derivative of benzoic acid 81 
via the Meyers nucleophilic aromatic substitution reaction which led to the generation of 
biaryl coupled product 82 as illustrated in Scheme 13.34 
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Scheme 13: Reagents and conditions: Reagents and conditions: 1) Mg, I2, dry THF, reflux, 
0.25 hrs; 2) rt, 15 hrs, 81% 
 
Patten et al. have also employed the Meyers coupling reaction between 83 and 84 to 
generate 85 which could later be converted to aglycone of gilvocarcin V 33 to synthesize the 
aglycone of gilvocarcin V 33 as shown in Scheme 14.42,43 
 
 
 
Scheme 14  
 
Thus, the use of the Meyers coupling reaction proved to be a versatile and applicable 
methodology for the synthesis of aglycones of gilvocarcins. 
 
Perhaps not surprisingly the Hauser-Kraus annulation reaction is used extensively for the 
synthesis of this class of heterocycle. In this thesis only one example is shown but others are 
evident in the literature. In the example shown Patra et al. managed to synthesize aglycone 
of gilvocarcin M 19 by employing Hauser-Kraus annulation followed by an in-situ lactone 
generation as illustrated in Scheme 9.39 The authors suggested that the route could be 
applied towards the synthesis of other polycyclic aromatic natural products like the 
phenanthrovirdins, and a review published in 2007 outlines the utility of this reaction.44   
 
Analyzing the methods that have been used for the synthesis of the benzonaphthopyranone 
framework, we realized that the Suzuki-Miyaura cross coupling reaction, that has been used 
extensively in our laboratories could be applied towards the synthesis of 6H-
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dibenzo[c,h]chromen-6-one 6 frameworks as seen in gilvocarcin as will be described in the 
following sections. 
 
In order to continue our on-going research in the field of heteropolyaromatics, we wanted to 
try and develop new methodology for the synthesis of 12-methoxy-6H-dibenzo[c,h]chromen-
6-one 65 motif which is a general framework of all the molecules of the gilvocarcin family 
(Figure 12). Later, we hope to extend the methodology to the synthesis of more complex 
counterparts and finally, various gilvocarcin aglycones. 
 
 
 
12-Methoxy-6H-dibenzo[c,h]chromen-6-one 65 
 
Figure 12 
 
1.6 Related Work Done Previously at Wits University on the Synthesis of Chromen-6-
ones 
 
During the work carried out by Ms Reynolds for her MSc research project, an unexpected 
and interesting observation was made. It was noted that the treatment of biaryl alcohol 86 
with N-bromosuccinimide led to an unexpected ring closure, which resulted in the synthesis 
of 12-methoxy-6H-dibenzo[c,h]chromen-6-one 65 instead of resulting in bromination of the 
electron rich naphthalene ring to afford 87 (Scheme 12).45 
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Scheme 16 
 
As a part of this PhD research project, we wanted to investigate this unprecedented reaction 
resulting in an intramolecular ring closure carried out by N-bromosuccinimide and determine 
the exact mechanism of the reaction as well as subject other substrates to these conditions 
to ascertain if this was a general reaction. To synthesize the substrates required for the 
reaction, a key Suzuki-Miyaura cross coupling reaction between a brominated and protected 
substituted naphthoquinone moiety and a substituted formylphenyl boronic acid would be 
used. We would then be in a position to test the N-bromosuccinimide induced intramolecular 
ring closure reaction as described in general terms in Scheme 17. The next section will 
introduce the key Suzuki-Miyaura cross-coupling reaction. 
 
 
 
Scheme 17 
 
1.7 Palladium Catalyzed Suzuki-Miyaura Cross-Coupling Reaction 
 
Carbon-carbon (C-C) bond formation is one of the most important aspects of organic 
chemistry. Suzuki, Miyaura and Yamada laid the foundation for one of the most useful 
palladium-catalyzed C-C bond formation reactions which is now commonly known as the 
Suzuki-Miyaura cross coupling reaction. The work was first published in 1979 and reported 
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coupling reactions of alkenyl boronates with alkenyl bromides in the presence catalytic 
amount of tetrakis(triphenylphosphine)palladium(0) and a base as shown in Scheme 18.46 
 
 
 
Scheme 18 
 
Since then, vast and extensive research has been carried out by Miyaura, Yamada, and 
Suzuki and a number of other groups which has led to vast improvements in this 
methodology. Developments have been made in the way of reaction scope, ability to 
conduct couplings at very low catalyst loadings, using less harsh reaction conditions and 
also recently with the use of microwave irradiation, which dramatically reduces the time 
taken for completion of the reaction.47,48 Furthermore, it is now possible to cross-couple 
hindered substrates, and even asymmetric molecules could be coupled.47,49 A large variety 
of substrates apart from boronic acids, including potassium trifluoroborates, organoborates 
and boronate esters and triflates could also be used.47 For this extensive work in palladium-
catalyzed cross coupling reactions, Richard F. Heck and Eiichi Negishi along with Akira 
Suzuki won the Nobel Prize in Chemistry in 2012. 
 
1.7.1 Mechanism of Suzuki-Miyaura Cross Coupling Reaction 
 
The major advantage of this reaction is that it can be carried out under relatively mild 
conditions and with a wide variety of boronic acids, both commercially available and unique 
substrates could be used. Most boronic acids are less toxic than other organometallic 
compounds.50 The reaction uses a palladium(0) complex as catalyst and the most commonly 
used catalyst is tetrakis(triphenylphosphine)palladium(0) which could be synthesized 
previously or made in situ.50 One major drawback of this reaction is that all oxygen must be 
excluded from the reaction system to keep the catalyst active by preventing catalyst 
oxidation.50 
 
The mechanism of the Suzuki-Miyaura cross coupling reaction could be explained through a 
general catalytic cycle which involves the oxidative addition-transmetalation-reductive 
elimination sequences as outlined in Scheme 14.51,52 
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Scheme 19 
 
The first step involves the oxidative addition of the carbon electrophile 88 to the palladium(0) 
species 89 to obtain organo-palladium intermediate 90. This intermediate reacts with a base 
(in this case sodium hydroxide) to give rise to the key intermediate R1-Pd
2-OH 91.53 Here, 
the base comes into play by offering the counter-ion to the halide, which forms a salt, and 
prevents the reverse reaction.51 The following step is the transmetallation of the nucleophilic 
carbon from the boron complex 92 to the organo-palladium species to generate intermediate 
R1-Pd
2-R2 93. Base also plays an important role in this transmetallation step.
53 As organo-
boron compounds are weakly electrophilic in nature, the coordination of the negatively 
charged base to the boron atom helps in improving the nucleopilicity of the organic group to 
be transferred. The last step in the catalytic cycle is the reductive elimination of the cross-
coupling product 94 and regeneration of the palladium(0) species 89.53  
 
The Suzuki-Miyaura cross coupling reaction has been used extensively in this PhD as it is 
one of the most versatile synthetic procedures for the generation of biaryl compounds.48 
However, most of the classical procedures are associated with relatively long reaction 
times.48 In 2007, Sharma et al. reported an efficient method for conducting this coupling 
reaction under microwave irradiation, with the advantage of improved reaction rates and 
reduced reaction times (Scheme 20).48 This is the methodology that we often used during 
the course of this PhD. 
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Scheme 20 
 
1.7.2 Atropisomerism in molecules with biryl axis 
 
Today, the Suzuki–Miyaura coupling reaction is certainly one of the most widely used 
method for the construction of the biaryl axis due to its great versatility and relatively 
environmental friendly nature. One important aspect of this reaction is that if the biaryl axis 
formed is restricted in rotation axial chirality can result otherwise known as atropisomerism. 
Atropisomerism or also referred to as helical chirality, is a type of stereoisomerism that 
arises from the hindered rotation about the sp2-sp2 (aryl-aryl) carbon-carbon single bond in 
axially chiral biaryls.54 This phenomenon arises due to the presence of at least two bulky 
substituents in the ortho position to the biaryl bond.56 as shown in Scheme 21.56 
 
 
 
Scheme 21 
 
These axially chiral biaryl compounds have attracted significant attention because of the 
growing number of known biologically active natural products that contain the biaryl motif for 
example, vancomycin, steganone, and a class of compounds known as the michellamines.54 
The rigid biaryl unit is also a key feature in the sartan family of drugs for high blood pressure: 
losartan, valsartan, irbesartan, or candesartan.54 The stereogenic axis also affords rigid 
molecular frameworks to design highly efficient tools in asymmetric synthesis, for example 
chiral ligands like BINAP.57 
 
In reference to the examples discussed previously, intermediate 29 depicted in the paper by 
Jung using Suzuki-Miyaura cross coupling reaction as shown in Scheme 3, could offer 
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hindered rotation across the biaryl axis as all the ortho positions across the biaryl axis are 
occupied this is as an example of atropisomerism (Figure 13).33 
 
 
 
Figure 13 
 
Having discussed in detail about the gilvocarcin family of antibiotics and studied the various 
methodologies undertaken in the past to synthesize their benzonaphthopyranone skeletons, 
we planned to undertake the synthesis of benzonaphthopyranone motif based on the 
Suzuki-Miyaura cross coupling reaction and N-bromosuccinimide ring closure reaction as 
undertaken in the past in the organic chemistry laboratories of the University of the 
Witwatersrand. 
 
In the following Chapter, an approach to the synthesis of the gilvocarcin skeleton using 
Suzuki-Miyaura cross coupling reaction and the N-bromosuccinimide ring closure reaction as 
key steps will be described. 
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Chapter 2: Results and Discussion: Synthetic Approaches to the 6H-
dibenzo[c,h]chromen-6-one Analogues as found in Gilvocarcins 
 
2.1 Introduction 
 
As has been outlined in the previous Chapter, gilvocarcins 5 and closely related polyketide 
metabolites represent a small but major class of novel C-glycoside antibiotics isolated from 
Streptomyces sp. which are known for their high anti-tumour and antibacterial activity and 
exceptionally low toxicity. All these compounds share a common tetracyclic anti-tumour 
nucleus, 6H-dibenzo[c,h]chromen-6-one 6, with gilvocarcin V 10 being the most prominent 
member of this class. The importance of these glycoside antibiotics engendered our interest 
towards the synthesis of the gilvocarcin backbone, namely the 12-methoxy-6H-
dibenzo[c,h]chromen-6-one 65 nucleus (Figure 14). Only a few syntheses have been 
reported for the synthesis of gilvocarcin V 10 and its aglycone 33. Most of these approaches 
employ harsh conditions, use expensive chemicals or are highly time consuming. In this 
section, we will discuss the synthesis of the 12-methoxy-6H-dibenzo[c,h]chromen-6-one 65 
motif using a novel N-bromosuccinimide induced ring closure reaction which was discovered 
in our laboratories. This unusual reaction in the presence of N-bromosuccinimide and air 
leads to generation of the benzonaphthopyranone skeleton from suitable substituted biaryl 
precursors. In this PhD we have also attempted to elucidate a possible mechanism of this 
reaction and additionally address the applicability of this methodology to the synthesis of 
gilvocarcin V 10 and related molecules in the future. 
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      Gilvocarcin V 10 
 
 
6H-dibenzo[c,h]chromen-6-one 6 12-methoxy-6H-dibenzo[c,h]chromen-6-
one 65  
 
Figure 14 
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2.2 Synthesis of 12-Methoxy-6H-dibenzo[c,h]chromen-6-one 65 
 
 
 
Scheme 22: Proposed synthetic strategy for the synthesis of 12-methoxy-6H-
dibenzo[c,h]chromen-6-one 65: Reagents and conditions: A) Na2S2O4, DEE, H2O, rt; 2) 
K2CO3, Me2SO4, acetone; B) NBS, DCM, rt; C) 2-formylphenyl boronic acid, Pd(PPh3)4, CsF, 
DMF, microwave irradiation; D) LiAlH4, dry THF; E) NBS, DCM, atmospheric conditions. 
 
The scheme shown above illustrates our initial synthetic plans to achieve the synthesis of 
12-methoxy-6H-dibenzo[c,h]chromen-6-one 65. Starting with the commercially available 1,4-
naphthoquinone 95 we planned to reduce the quinone followed by subsequent protection to 
obtain 1,4-dimethoxynaphthalene 96, (which is also commercially available). Mono-
bromination at the ortho position would lead to the formation of a substrate 97 for Suzuki-
Miyaura cross coupling reaction with 2-formylphenyl boronic acid 98 to eventually afford the 
compound 99 containing a biaryl axis. Reduction of the carbonyl group of 99 would produce 
the benzylic alcohol 86, our substrate for the novel N-bromosuccinimide-mediated ring 
closure to afford the desired backbone 65. 
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2.2.1 Synthesis of 1,4-Dimethoxynaphthalene 96 
 
 
 
Scheme 23: Reagents and Conditions: A) Na2S2O4, DEE, H2O, rt, 1 hr; B) K2CO3, Me2SO4, 
acetone, reflux, 18 hrs, 85% 
 
The starting point of the synthetic scheme was the reduction and then protection of the 
commercially available 1,4-naphthoquinone 95 as 1,4-dimethoxynaphthalene 96, which was 
achieved using a procedure available in literature.58 Sodium dithionite, a reducing agent, 
reduces 1,4-naphthoquinone 95 to naphthalene-1,4-diol 100. The dark brown colour of 1,4-
naphthoquinone 95 disappeared during the course of reaction and the mixture changed in 
colour to produce a clear solution confirming completion of the reduction. The product so 
obtained was immediately used in the next step owing to its inherent instability and tendency 
to oxidize back to naphthoquinone in the presence of air. Subsequent to the work up and the 
removal of solvent, the intermediate product 100 was immediately dissolved in dry acetone 
and potassium carbonate was again added to it under inert conditions assisted with vigorous 
stirring. Potassium carbonate being a base abstracts a proton from the diol 100, leaving a 
nucleophile capable of reacting with the electrophilic methyl group from the dimethyl sulfate 
which was added to the reaction mixture after fifteen minutes. The reaction progress could 
also be confirmed by a change in colour as the diol, which is being light brown in acetone 
turned to dark brown after addition of the base, indicating the formation of a resonance 
stabilized anion. Upon addition of dimethyl sulfate to this anion, the dark colour disappeared 
after some time which indicated that the anion was being quenched. The reaction was stirred 
under reflux for a further eighteen hours and was collected as a white crystalline solid after 
work up and column chromatography in 85% yield. The product 96 so obtained was 
characterized by 1H and 13C NMR spectroscopy and the spectroscopic data correlated well 
with the values reported in the literature.58  
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2.2.2 Synthesis of 2-Bromo-1,4-dimethoxynaphthalene 97 
 
 
 
Scheme 24: Reagents and Conditions: NBS, DCM/acetone, rt, 18 hrs, 84% 
 
Having successfully synthesized 1,4-dimethoxynaphthalene 96, we now wished to brominate 
it at the position ortho to the methoxy group to obtain a substrate for the Suzuki-Miyaura 
cross-coupling reaction. The desired product was obtained by dissolving 1,4-
dimethoxynaphthalene 96 in dichloromethane and allowing it to react with N-
bromosuccinimide at room temperature. The yield of the reaction was not very high as N-
bromosuccinimide is not readily soluble in dichloromethane. Heating under reflux did not 
improve the yield, but resulted in decomposition, which was seen through thin layer 
chromatography. However, the addition of acetone, which acts as co-solvent and aids in 
dissolution N-bromosuccinimide helped improving the yield of reaction. When the reaction 
was tested in acetone as solvent, the starting material 96 was consumed but with a low yield 
of product 97. Thus the best solvent system for the reaction was dichloromethane containing 
a few milliliters of acetone. Subsequent to work-up and column chromatography, the product 
97 was obtained in 84% yield as a light pink oil which solidified on standing. Spectroscopic 
analysis of the product was in agreement with that in the literature.59 
 
2.2.3 Synthesis of 2-(1,4-Dimethoxynaphthalen-2-yl)benzaldehyde 99 
 
 
 
Scheme 25: Reagents and Conditions: 2-Formylphenyl boronic acid, Pd(PPh3)4, CsF, DME, 
microwave irradiation, 150 ºC, 150 W, 30 mins, 76% 
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We were now in a position to test the key Suzuki-Miyaura cross coupling reaction step to 
obtain the desired biaryl compound 99 as shown in Scheme 25. The reaction was easily 
carried out in the microwave reactor. All the reagents and starting material were dissolved in 
previously degassed dimethoxyethane and the resulting solution was subjected to 
microwave conditions (150 ºC and 150 W), for thirty minutes. It was soon realized that a 
concentrated reaction solution helped in improving the yield of the reaction. The progress of 
the reaction was followed by thin layer chromatography and subsequent to work-up and 
column chromatography product 99 was obtained as an off-white solid in 76% yield. 
 
The synthesis of the desired product was confirmed by the presence 
of the characteristic peak for the carbonyl proton of the aldehyde: a 
singlet at 9.90 ppm in the 1H NMR spectrum and a signal at 192.42 
ppm in the 13C NMR spectrum. Also, two peaks for the two methoxy 
groups could be seen at 4.01 and 3.40 ppm in the 1H NMR spectrum 
and at 60.94 and 55.80 ppm in the 13C NMR spectrum. This confirmed that the Suzuki-
Miyaura coupling was successful. A singlet upfield at 6.74 ppm in the 1H NMR spectrum 
integrating for one proton denotes a single proton H-3’, on the electron rich naphthalene ring. 
A characteristic signal at 1726 cm-1 in the FTIR spectrum also confirmed the presence of the 
aldehyde group. Furthermore, the HRMS indicated the correct exact mass of the expected 
product, which was calculated for C19H17O3 (M
++ H) as 293.1178.  
 
Suzuki-Miyaura cross coupling reaction is being widely used for the synthesis of related 
compounds having biaryl axis as present in compound 99. For example, Koyama et al. in 
1998 managed to synthesize 101 by coupling 102 and 103 employing Suzuki-Miyaura cross 
coupling reaction as illustrated in Scheme 26.60 
 
 
 
Scheme 26: Reagents and Conditions: Pd(PPh3)4, Na2CO3, DME, reflux, 100%. 
 
A very similar compound 104 was synthesized using similar Suzuki-Miyaura cross coupling 
reaction by Kimura et al. in 2011 by coupling 102 and 105 as shown in Scheme 27.61 
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Scheme 27: Reagents and Conditions: Pd(PPh3)4, Na2CO3, DME, 90 °C, 48 hrs, 97%. 
 
de Koning and co-workers have also employed the Suzuki-Miyaura cross coupling strategy 
to generate a range of compounds having biaryl axis as shown in Scheme 28.62 
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Scheme 28: Reagents and Conditions: Pd(PPh3)4, Na2CO3, DME–EtOH, 46 hrs, 106 = 88%; 
107 = 100%; 108 = 58%; 109 = 72%. 
 
2.2.4 Synthesis of (2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanol 86 
 
 
 
Scheme 29: Reagents and Conditions: LiAlH4, dry THF, 0 ºC-rt, 1 hr, 96%. 
 
The next step in our synthesis was the reduction of the aldehyde in 2-(1,4-
dimethoxynaphthalen-2-yl)benzaldehyde 99 to the benzylic alcohol 86. The reaction was 
carried out by dissolving the starting material 99 in freshly distilled and dry tetrahydrofuran. 
Lithium aluminium hydride was added in portions to the reaction mixture at 0 ºC. The 
reaction was then allowed to stir at room temperature under inert conditions for an hour and 
the progress of the reaction was monitored by thin layer chromatography. After conversion of 
all of the starting material 99, the excess lithium aluminium hydride was quenched followed 
by work-up and column chromatography to afford the product 86 as a white solid in 96% 
yield. 
 
In the 1H NMR spectrum, a broad singlet at 3.60 ppm clearly 
indicated the presence of the hydroxyl group. The two benzylic 
protons were seen at 4.43 ppm and 4.37 ppm as two doublets (J = 
11.7 Hz), with a corresponding peak at 64.0 ppm in the 13C NMR 
spectrum for the benzylic carbon. The absence of the aldehydic 
proton and carbonyl carbon in both the 1H and 13C NMR spectra clearly confirms the 
reduction of the aldehyde 99 into the alcohol 86. Both FTIR and HRMS analysis further 
confirmed this, with the disappearance of the aldehyde peak, which was present at 1726 cm-
1 and the appearance of a broad signal at 3442 cm-1 in the FTIR spectrum. 
 
One important point which needs to be mentioned here is that the biaryl aixs of compound 
86 displays restricted rotation. The two benzylic protons around the biaryl axis, appears as 
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two doublets because it is an AB system resulting from non-equivalence of the two benzylic 
hydrogens arising from the restricted rotation (atropisomerism) about the biaryl axis. This 
could be seen in the Figure 15 where part of the 1H NMR spectrum is displayed. 
 
 
 
Figure 15 
 
In order to examine the phenomenon of atropisomerism in this particular case we decided to 
conduct further 1H NMR spectroscopy experiments. We performed 1H NMR spectroscopy on 
86 at the elevated temperatures of 40 °C and later at 50 °C and as expected we observed 
that the two doublets coalesced into two broad signals at 40  C (Figure 16) and then into 
one singlet (Figure 17) at 50 °C. The reason for this observation could be attributed to the 
fact that as the temperatures increased the rotation around the biaryl axis became 
unhindered and the two benzylic protons became equivalent. 
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Figure 16 
 
 
Figure 17 
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2.2.5 Synthesis of 12-Methoxy-6H-dibenzo[c,h]chromen-6-one 65 
 
 
 
Scheme 30: Reagents and Conditions: NBS, DCM, rt, atmospheric conditions, 8 hrs, 53%. 
 
As we had successfully prepared (2-(1,4-dimethoxynaphthalen-2-yl)phenyl)methanol 86, we 
now wanted to attempt our ring closure reaction induced by N-bromosuccinimide to afford 
the lactone 65. To carry out the reaction, we dissolved our starting material 86 and N-
bromosuccinimide in dichloromethane under inert conditions and stirred the reaction for 
twenty four hours over which time the reaction mixture turned bright red in colour. 
Unfortunately, analysis by thin layer chromatography showed decomposition of the starting 
material 86. NMR spectroscopy did not show any signals for the product expected 65 or the 
starting material 86. We then attempted the reaction a number of times varying the 
temperature and other factors like concentration of the reactants and equivalents of N-
bromosuccinimide added, but to our frustration none of these modifications afforded the 
desired product 65. 
 
Finally when we tested the reaction at room temperature, with one equivalent of N-
bromosuccinimide in dichloromethane and left the reaction exposed to air, and under these 
conditions we obtained our desired product 65. The reaction goes from a clear solution to 
red in colour and at that point thin layer chromatography shows the formation of a major spot 
of different Rf. After isolation and purification by column chromatography 65 was obtained as 
light tan solid in 53% yield. From this observation we deduced that oxygen from air is 
essential for this reaction. When the reaction is conducted under nitrogen or argon, these 
inert conditions resulted in eventual decomposition of the starting material 86 without giving 
the desired product 65. 
 
Our spectroscopic data agreed with that of Qabaja and Jones which 
confirmed that we had synthesized 12-methoxy-6H-
dibenzo[c,h]chromen-6-one 65.38 The 1H NMR spectrum showed 
one peak integrating for three methoxy hydrogens at 4.10 ppm 
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compared to the two signals for methoxy protons present in the starting material 86. The 
peak for the methoxy carbon appeared at 55.79 ppm in the 13C NMR spectrum. A carbonyl 
signal in the 13C NMR spectrum was also seen at 161.37 ppm. The signal for the benzylic 
protons and carbons and the primary hydroxyl group of the starting material were no longer 
present. The final confirmation came from the single crystal X-ray structure. As shown in 
Figure 18. 
 
 
 
Single crystal X-ray structure: 12-methoxy-6H-dibenzo[c,h]chromen-6-one 65 
 
Figure 18 
 
There have been reports suggesting that N-bromosuccinimide could be used as an oxidizing 
agent where it converts aldehydes into esters.63 Here in this particular case, N-
bromosuccinimide could be oxidizing the alcohol functional group into an aldehyde, which 
could be converted into an acid bromide, which would facilitate ring closure. We carried out 
further experiments as discussed in the following sections to determine a possible 
mechanism for this reaction. We also tried to perform this N-bromosuccinimide ring closure 
reaction on a variety of substrates to prove the generality of the reaction and this is also 
described in the following sections. 
 
2.3 Synthesis of Related Naphthopyranone Scaffolds to Prove Wider Application of 
the Methodology 
 
Having successfully synthesized 12-methoxy-6H-dibenzo[c,h]chromen-6-one 65 using our 
novel N-bromosuccinimide induced ring closure reaction, we wanted to extend our 
40 
 
methodology to the synthesis of a variety of other naphthopyranone scaffolds to establish 
the application of the methodology on a range of substrates. 
 
2.3.1 Synthesis of 2-Methoxy-6H-benzo[c]chromen-6-one 110 
 
We first decided to ascertain if simpler commercially available starting materials like 1,4-
dimethoxybenzene 111 could be elaborated to afford possible substrates for our novel N-
bromosuccinimide-mediated ring closure reaction as shown in Scheme 30.  
 
 
Scheme 30 
 
2.3.1.1 Synthesis of 2-Bromo-1,4-dimethoxybenzene 112 
 
 
 
Scheme 31: Reagents and conditions: NBS, DCM, reflux, 72 hrs, 90%. 
 
The first step in our synthetic scheme was the bromination of commercially available 1,4-
dimethoxybenzene 111. 1,4-Dimethoxybenzene 111 was dissolved in freshly distilled dry 
dichloromethane and N-bromosuccinimide was added. The brominated product 112 has a 
slightly higher Rf when checked by thin layer chromatography than the starting material 111. 
On completion of the reaction, a saturated solution of sodium sulfite was added followed by 
isolation and column chromatography to yield the product 112 as clear oil in 90% yield. Care 
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was taken to use exactly one equivalent of N-bromosuccinimide, as excess N-
bromosuccinimide results in the formation of the di-brominated product 1,3-dibromo-2,5-
dimethoxybenzene 113 as shown in Figure 19. 
 
 
 
1,3-dibromo-2,5-dimethoxybenzene 113 
 
Figure 19 
 
Characterization of the product 112 was achieved by 1H and 13C NMR spectroscopy and was 
found to be in agreement with the data in the literature.59  
 
2.3.1.2 Synthesis of 2',5'-Dimethoxybiphenyl-2-carbaldehyde 114 
 
 
 
Scheme 32: Reagents and conditions: 2-Formylphenyl boronic acid, Pd(PPh3)4, CsF, DMF, 
microwave irradiation, 150 ºC, 150 W, 30 mins, 88% 
 
Having successfully synthesized 2-bromo-1,4-dimethoxybenzene 112, the next step in our 
synthesis was the generation of a biaryl axis utilizing the Suzuki-Miyaura cross coupling 
reaction. The reaction was carried out using the same standard microwave procedure as 
employed previously which involves transfer of all reagents along with the starting material 
112 to the microwave vial and addition of the freshly degassed solvent. The reaction mixture 
was then subjected to microwave irradiations under the above mentioned conditions 
(Scheme 32). Upon completion of the reaction, work up and column chromatography were 
done to isolate pure product 114 as a white solid in 88% yield which was then characterized 
by NMR spectroscopy. Spectroscopic results were found in accordance with literature.64 
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A singlet at 9.79 ppm in the 1H NMR spectrum which integrates for one 
proton indicates the presence of an aldehyde functional group with the 
corresponding peak in the 13C NMR spectrum at 192.58 ppm. Two 
singlets in the 1H NMR spectrum at 3.81 and 3.67 ppm are very distinct 
for six protons each representing two methoxy groups with peaks in the 
13C NMR spectrum visible at 55.92 and 55.81 ppm. Signals in the region 8.01-6.87 ppm in 
the 1H NMR spectrum accounts for the correct number of aromatic protons present in the 
molecule and also it confirms that we have obtained the product from the Suzuki-Miyaura 
cross coupling reaction. There are a total of twelve aromatic carbons giving signals in the 
aromatic region of 153.77 to 111.78 ppm in the 13C NMR spectrum, which accounts for the 
number of non-equivalent carbons expected in the molecule. 
 
2.3.1.3 Synthesis of (2',5'-Dimethoxybiphenyl-2-yl)methanol 115 
 
 
 
Scheme 33: Reagents and conditions: LiAlH4, dry THF, 0 ºC-rt, 1 hr, 100% 
 
Following the successful synthesis of 2',5'-dimethoxybiphenyl-2-carbaldehyde 114, the next 
step was the reduction of the aldehyde group to a benzylic alcohol which was achieved 
easily using lithium aluminium hydride as the reducing agent in dry tetrahydrofuran. The 
additions were done at 0 ºC. The product 115 was obtained as white solid in 100% yield 
after isolation and purification. The identification of the obtained product was done by NMR 
spectroscopy. 
 
Examination of the NMR spectroscopic data, showed that the peak for 
the aldehyde proton in the 1H NMR spectrum and respective carbon in 
the 13C NMR spectrum were no longer present. The peak for the 
hydroxyl proton could be seen as a broad singlet upfield at 2.41 ppm in 
the 1H NMR spectrum. The two benzylic protons could be seen at 4.44 
ppm and 4.40 ppm as doublet of doublet and the corresponding peak in the 13C NMR 
spectrum could be seen at 63.81 ppm. Apart from these characteristic signals all other 
expected peaks could also be seen, including the two methoxy groups at 3.79 and 3.68 ppm; 
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and at 56.70 and 55.73 ppm in the 1H NMR and 13C NMR spectra respectively. The FTIR 
spectrum showed a stretching band at 3422 cm-1 characteristic of the hydroxyl group. HRMS 
analysis also gave the correct exact mass of the product. 
 
2.3.1.4 Synthesis of 2-Methoxy-6H-benzo[c]chromen-6-one 110 
 
 
 
Scheme 34: Reagents and conditions: NBS, AIBN, carbon tetrachloride, reflux, atmospheric 
conditions, 18 hrs, 49%.  
 
Having successfully synthesized the precursor needed to attempt the N-bromosuccinimide 
mediated reaction, (2',5'-dimethoxybiphenyl-2-yl)methanol 115 was subjected to N-
bromosuccinimide and air in order to obtain the naphthopyranone 2-methoxy-6H-
benzo[c]chromen-6-one 110. To begin with, we dissolved the starting material 115 in 
dichloromethane and added N-bromosuccinimide and left the reaction mixture to stir at room 
temperature under atmospheric conditions. However, no change was seen by thin layer 
chromatography, we then heated the mixture to reflux for some days but still no change was 
observed. Addition of the radical initiator azobisisobutyronitrile (AIBN) also had no effect. We 
then decided to use carbon tetrachloride as this solvent can provide a higher boiling point for 
the reaction as compared to dichloromethane. Dissolving the starting material 115 in carbon 
tetrachloride, we added N-bromosuccinimide along with AIBN and heated the reaction under 
reflux for eighteen hours. By thin layer chromatography, we observed that all of the starting 
material 115 had been consumed and a spot appeared at a higher Rf, than starting material 
115 appeared. After isolation and purification by column chromatography our desired 
product 110 was obtained in a mediocre yield of 49%. 
  
The disappearance of one methoxy substituent and the benzlyic protons 
in the NMR spectra was an indication that we had converted (2',5'-
dimethoxybiphenyl-2-yl)methanol 115 into 2-methoxy-6H-
benzo[c]chromen-6-one 110 . A quaternary peak at 161.27 ppm in the 13C 
NMR spectrum is characteristic of the aromatic lactone C-6. In addition, 
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the number of protons and carbons expected in the product corresponded exactly to that in 
the 1H NMR and 13C NMR spectra. The FTIR spectrum showed a stretching band at 1722 
cm-1 characteristic to the carbonyl group and exact mass was confirmed from the HRMS 
results where there a molecular ion for C14H11O3 (M
++H) was found at 227.0701 for the 
calculated value of 227.0709. Finally confirmation came from a single crystal X-ray structure 
of the compound 110 as shown in Figure 20. 
 
 
 
Single crystal X-ray structure: 2-methoxy-6H-benzo[c]chromen-6-one 110 
 
Figure 20 
 
2.4 Mechanistic Studies to Elucidate Lactone Ring Formation Induced by NBS and Air 
 
As a result of these findings we were interested in investigating the mechanistic aspects of 
this unusual ring closure reaction we discovered induced by N-bromosuccinimide and air. 
There is literature precedent to show that N-bromosuccinimide can oxidize aldehydes into 
the corresponding acid bromide and further leading to the generation of esters.63 We 
anticipated that a similar process could be occurring in our reaction. Unfortunately as acid 
bromides are unstable intermediates that could not be isolated. We hoped to assess whether 
the alcohol 115 or the aldehyde 114 would lead to the synthesis of 2-methoxy-6H-
benzo[c]chromen-6-one 110 via the acid bromide 116, as shown in Scheme 35. 
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Scheme 35 
 
2.4.1 Synthesis of 12-Methoxy-6H-dibenzo[c,h]chromen-6-one 65 Using Aldehyde 
Intermediate. 
 
One proposed mechanism for the synthesis of 12-methoxy-6H-dibenzo[c,h]chromen-6-one 
65 is, as mentioned previously, that it proceeds via an aldehyde intermediate. As N-
bromosuccinimide is an oxidizing agent, it oxidizes the benzylic alcolol 86 into an aldehyde 
intermediate leading to the release of radicals into the solution affording 117. N-
Bromosuccinimide could then also oxidize the aldehydes into an acid bromide 118 under 
these radical conditions, which is a known process. After the generation of the activated and 
unstable acid bromide 118, the carbonyl carbon is attacked by the nucleophilic methoxy 
group and bromine leaves leading to the ring closure to afford the lactone 119 and in the last 
step methyl group is removed by another bromine radical leading to the generation of 
lactone 65 (Scheme 36). It is also observed during the course of reaction that in the 
absence of air, the reaction fails to deliver any product and the reaction mixture 
decomposes. The importance of air in the reaction could be attributed to the fact that oxygen 
in the air aids in the oxidation reaction of the alcohol 86 to the aldehyde 99. 
 
46 
 
 
 
Scheme 36 
 
Hence, we carried out a number of reactions in order to determine whether the proposed 
mechanism is actually feasible, where the alcohol is initially oxidized into the aldehyde and 
then converted to the very activated and unstable acid bromide leading to the ring closed 
product 65 To test the theory, we took previously synthesized aldehyde, 2-(1,4-
dimethoxynaphthalen-2-yl)benzaldehyde 99 and dissolved it in dichloromethane. This 
solution was then charged with N-bromosuccinimide and the reaction was allowed to stir at 
room temperature and under atmospheric conditions for eighteen hours. The reaction was 
monitored by thin layer chromatography, where major spot was observed having much lower 
Rf than the starting material 120. On completion of the reaction, unreacted N-
bromosuccinimide was quenched followed by work-up and column chromatography to 
isolate the major product of the reaction. On spectroscopic analysis of the product obtained 
we found that the desired ring closure reaction had taken place to yield 120 in 57% yield as 
shown in Scheme 37. 
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Scheme 37: Reagents and conditions: NBS, DCM, rt, atmospheric conditions, 18 hrs, 57%.  
 
In this case, the product 120 contained a phenolic alcohol rather than a methoxy group as 
was present in compound 65. This could be attributed to the presence of hydrogen bromide 
in the reaction mixture which could have resulted in the cleavage of the methyl group 
allowing for the generation of the alcohol 120. 
 
Initially, we were surprised to see no signal for a methoxy group in 
the 1H and 13C NMR spectra. Rather a singlet at 9.95 ppm in the 1H 
NMR spectrum was present as a result of the phenolic proton in the 
1H NMR spectrum with the corresponding peak at 150.90 ppm in the 
13C NMR spectrum. Unfortunately due to the instability of the product 
we were unable to obtain HRMS data or single crystal X-ray structure data. 
 
2.4.2 Synthesis of 4'-Bromo-2',5'-dimethoxybiphenyl-2-carbaldehyde 121 from (2',5'-
Dimethoxybiphenyl-2-yl)methanol 115 
 
Further indicators about the mechanism of the N-bromosuccinimide ring closure reaction 
came from the synthesis of 4'-bromo-2',5'-dimethoxybiphenyl-2-carbaldehyde 121 In our 
various attempts to obtain the product 2-methoxy-6H-benzo[c]chromen-6-one 110, we had to 
test a number of chlorinated solvents in order to allow for the reaction to succeed. When 
dichloromethane failed to give us the desired result, we tested the reaction with chloroform 
and finally carbon tetrachloride. For the reaction in chloroform, the starting material (2',5'-
dimethoxybiphenyl-2-yl)methanol 115, was dissolved in the solvent and N-bromosuccinimide 
and AIBN were added to it. The reaction was heated at reflux for eighteen hours under 
atmospheric conditions, after which time reaction solution turned orange in colour. Thin layer 
chromatography showed that all of the starting material 115 had been consumed and a 
major spot was seen at higher Rf than starting material 115. After work up and column 
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chromatography a white solid was isolated in 63% which, when analyzed by NMR 
spectroscopy, did not look like the product we were expecting. 
 
In the 1H NMR spectrum at 9.78 ppm, observed a singlet integrating for 
one proton, characteristic of an aldehydic proton, which suggested that 
we had isolated an aldehyde from the alcohol 115. Also we were 
expecting signals integrating for seven aromatic protons and the 
integration of the aromatic region of the 1H NMR spectrum we obtained 
six aromatic protons, two of them giving rise to singlets. N-bromosuccinimide is a known 
brominating agent, and is also known to oxidize alcohols into aldehydes. In this reaction, 
when we wanted to convert (2',5'-dimethoxybiphenyl-2-yl)methanol 115 to 2-methoxy-6H-
benzo[c]chromen-6-one 110, we obtained an intermediate 4'-bromo-2',5'-dimethoxybiphenyl-
2-carbaldehyde 121. All three positions ortho to the two methoxy groups could undergo 
bromination, however, bromination took place at C-4’, ortho to the methoxy group and para 
to the biaryl axis. This could easily be seen in the 1H NMR spectrum by the presence of two 
singlets at 6.86 and 7.18 ppm in the aromatic region, for the protons at C-2’ and C-5’ 
respectively. Two singlets at 3.88 and 3.69 ppm in the 1H NMR spectrum each integrating for 
three protons accounted for the two methoxy groups. In the 13C NMR spectrum, we could 
clearly see a peak at 192.09 ppm representing a carbonyl carbon. Two peaks at 150.83 and 
150.40 ppm represent the aromatic carbons attached to the two methoxy groups, C-3’ and 
C-6’. There are two peaks at 56.99 and 56.20 ppm for the two methoxy groups. There are a 
total of six quaternary peaks in the 13C NMR spectrum as expected from the structure of the 
molecule. 
 
Hence, we had isolated 4'-bromo-2',5'-dimethoxybiphenyl-2-carbaldehyde 121 when trying to 
do the N-bromosuccinimide mediated ring cyclization reaction of (2',5'-dimethoxybiphenyl-2-
yl)methanol 115.  
 
An interesting observation was made here as both the conversions, 115 to 110 and 115 to 
121 were carried out the same way, the only difference being in the solvent used, carbon 
tetrachloride in the previous case and chloroform in the later, which resulted in the 
generation of the two different products 110 and 121 as illustrated in Scheme 38.  
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Scheme 38 
 
The only tentative explanation for this difference must be related to the different boiling 
points of the two solvents. Carbon tetrachloride with a boiling point of 76.7 °C provides more 
energy to the reaction as compared to chloroform, which has a boiling point of 61.2 °C.  
 
We propose that this unusual result could shed some light on the possible mechanism of this 
novel reaction suggesting that the reaction could proceed via the aldehyde intermediate 121. 
 
 
 
Scheme 39 
 
Ms Reynolds in her MSc research project obtained 3-bromo-2-methoxy-6H-
benzo[c]chromen-6-one 122 from (2',5'-dimethoxybiphenyl-2-yl)methanol 115, using N-
bromosuccinimide with chloroform as a solvent however she allowed the reaction to proceed 
for thirty six hours.45  
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2.4.3 Synthesis of 12-Methoxy-6H-dibenzo[c,h]chromen-6-one 65 Using Benzylic 
Alcohol Intermediate 
 
Another proposal for the mechanism of the reaction we wished to explore is the initial 
formation of the benzylic bromide 123 from benzylic alcohol 124 under the radical conditions 
of the reaction. This benzylic bromide 123 could in turn be converted to the acid bromide 118 
under the influence of N-bromosuccinimide and oxygen, thereby leading to the desired ring 
closed product 65 as shown in Scheme 40.  
 
 
Scheme 40 
 
To test this hypothesis we would first have to synthesize the benzyl bromide intermediate 
123 from the alcohol 86 and then subject it to N-bromosuccinimide in a suitable solvent. 
 
2.4.4 Synthesis of 2-(2-(Bromomethyl)phenyl)-1,4-dimethoxynaphthalene 123 
 
 
 
Scheme 41: Reagents and conditions: PPh3, CBr4, DCM, rt, 3 hrs, 67%. 
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To carry out the reaction, (2-(1,4-dimethoxynaphthalen-2-yl)phenyl)methanol 86 was 
dissolved in freshly distilled dry dichloromethane in a flame dried flask. Triphenylphosphine 
and carbon tetrabromide were added to the reaction mass and the solution was allowed to 
stir at room temperature for three hours, over which time the reaction mixture was seen to 
turn orange in colour. This was followed by work-up and column chromatography and the 
product 123 was obtained in 67% yield as a pale yellow oil which solidified on standing. 
 
Formation of the product was seen clearly from 1H and 13C NMR 
spectroscopy. The disappearance of the proton of the hydroxyl group 
in the 1H NMR spectrum was observed. An upfield shift of the 
benzylic carbon to 32.46 ppm in the 13C NMR spectrum from 64.1 
ppm in the starting material in the 13C NMR spectrum further 
corroborated our findings.  
 
After the successful synthesis of the benzylic bromide 123, we continued our efforts to 
elucidate the reaction mechanism by subjecting this intermediate to the conditions of our N-
bromosuccinimide ring closure reaction.  
 
2.4.5 Attempted Synthesis of 12-Methoxy-6H-dibenzo[c,h]chromen-6-one 65 from 2-(2-
(Bromomethyl)phenyl)-1,4-dimethoxynaphthalene 123 
 
 
 
Scheme 42: Reagents and conditions: NBS, AIBN, DCM, rt, atmospheric conditions, 72 hrs. 
 
2-(2-(Bromomethyl)phenyl)-1,4-dimethoxynaphthalene 123 was dissolved in 
dichloromethane, treated with N-bromosuccinimide, and the reaction mixture was allowed to 
stir for twenty four hours at room temperature and under atmospheric air conditions. Analysis 
by thin layer chromatography showed no change after this time. AIBN was then added to the 
reaction, and the mixture was allowed to stir for another forty eight hours under the same 
conditions, during which time the solution turned yellow in colour. Thin layer chromatography 
showed that all the starting material 123 had been consumed, and four new spot appeared 
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all at a much higher Rf than the starting material 123. When each of these spots were 
isolated and analyzed by NMR spectroscopy it was found that none of them was our desired 
product 65. Rather, it looked as though we had isolated mixtures of dibrominated products 
where bromination had taken place at the aromatic positions of 2-(2-(bromomethyl)phenyl)-
1,4-dimethoxynaphthalene 123. The failure of this reaction led us to the conclusion that the 
benzylic bromide is not a likely intermediate in our novel N-bromosuccinimide mediated ring 
cyclization reaction. 
 
In conclusion we propose that this novel N-bromosuccinimide and air induced ring closure 
reaction to form fused 3,4-dihydro-2H-pyran-2-ones proceeds through the aldehyde 
intermediate 121 rather than the benzylic bromide intermediate 123. This hypothesis is also 
supported by reports of N-bromosuccinimide to oxidizing aldehydes to acid bromides under 
radical conditions.63 One major and crucial factor controlling this oxidative lactonisation 
reaction is air or oxygen and the reaction seems to decompose when performed under inert 
conditions.  
 
2.4.6 Role of Oxygen in N-Bromosuccinimide Mediated Oxidation Reactions  
 
The role of oxygen together with N-bromosuccinimide or another bromine source is evident 
in a few examples in the literature. For example, Minisci et al. has shown that the oxidation 
of primary benzylic 125 alcohols into the corresponding aromatic aldehydes 126 in the 
presence of nitric acid and oxygen, catalyzed by bromine can take place as illustrated in 
Scheme 43.65 
 
 
Scheme 43: Reagents and conditions: HNO3, O2, Br2 
 
Kuwabra et al. has also showed the importance of molecular oxygen directly in the presence 
of catalytic amount of N-bromosuccinimide and irradiation through high pressure mercury 
lamp leads to the oxidation of benzylic alcohol 127 into carboxylic acid 128 as shown in 
Scheme 44.66 
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Scheme 44: Reagents and conditions: O2, NBS 
 
The authors demonstrated that when the reaction was performed under argon atmosphere, 
the yield of the product decreased substantially. The authors also postulated a radical 
mechanism indicating the role of N-bromosuccinimide and oxygen for this kind of oxidation 
reaction.66 
 
So far, happy with these results of N-bromosuccinimide and oxygen mediated ring closure 
reaction, we wanted to probe the generality of this reaction by testing the methodology on 
structurally similar substrates in order to generate a library of lactone-containing aromatic 
compounds. The first choice that came to mind was to start our synthesis from commercially 
available juglone 129 which would, if successful, yield 1-hydroxy-12-methoxy-6H-
dibenzo[c,h]chromen-6-one 130 as the final product. The reason for using this starting 
material was that the product formed would contain the core features of the natural product 
gilvocarcin 5, and the methodology could be applied to the synthesis of the natural product in 
the future. 
 
 
Scheme 45 
 
2.5 Synthesis of 1-Hydroxy-12-methoxy-6H-dibenzo[c,h]chromen-6-one 130 
 
Commencing from commercially available juglone 129, it was envisioned that the free 
naphthol of juglone 129 could be protected with a benzyl group to afford 40 and then a 
bromine could be introduced at the 2-position of the molecule to give 25, using literature 
procedures.67 After that, the quinone could be reduced and then protected to furnish 5-
(benzyloxy)-2-bromo-1,4-dimethoxynaphthalene 26. 5-(Benzyloxy)-2-bromo-1,4-
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dimethoxynaphthalene 26 would act as a substrate for our Suzuki–Miyaura cross coupling 
reaction to synthesize biaryl compound 131 using 2-formylphenyl boronic acid 98 as shown 
in Scheme 46. The aldehyde in the product could then be reduced to a benzylic alcohol 132 
and this compound 132 could then be subjected to N-bromosuccinimide and air to obtain the 
desired final ring closed product 49. A final deprotection step would afford 1-hydroxy-12-
methoxy-6H-dibenzo[c,h]chromen-6-one 130. 
 
 
 
Scheme 46 
 
2.5.1 Synthesis of 5-(Benzyloxy)naphthalene-1,4-dione 40 
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Scheme 47: Reagents and conditions: BnBr, Ag2O, CCl4, reflux, 72 hrs, 88%. 
 
The first step in our synthetic scheme was the protection of the free naphthol of juglone 129. 
Our choice of protecting group was a benzyl protecting group as there is literature precedent 
for accomplishing this reaction, and it can be easily removed at a later stage of the 
synthesis. The reaction was carried out by dissolving the starting material 129 in carbon 
tetrachloride and adding silver(I)oxide and benzyl bromide, and heating the reaction mixture 
under reflux for seventy two hours. On completion of the reaction, the mixture was filtered to 
remove the solid silver salt. Column chromatography afforded the product 40 as a bright 
yellow solid in 88% yields. 
 
When we initially attempted this reaction, we struggled with low yields of product and 
incomplete conversion of the starting material 129. This was frustrating as this was the first 
step in our synthetic scheme. Fortunately by changing the solvent from chloroform to carbon 
tetrachloride, and adding additional equivalents of silver(I)oxide at regular intervals of twelve 
hours ensured complete conversion of the starting material 129 and resulted in good yields 
of 5-(benzyloxy)naphthalene-1,4-dione 40. 
 
The spectroscopic result was found to be in agreement with that of the 
literature.68 The spectroscopic data clearly indicated the formation of 5-
benzyl protected juglone 40. There was no peak visible for the proton of 
the free hydroxyl group of juglone 129 and there were signals from five 
extra protons in the aromatic region of the 1H NMR spectrum due to the 
protons of the benzyl group. The most prominent indication came from 
the presence of a signal due to the two benzylic protons in the 1H NMR 
spectrum which appeared as a singlet at a chemical shift of 5.30 ppm with the corresponding 
carbon signal at a chemical shift of 70.9 ppm in the 13C NMR spectrum. 
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2.5.2 Synthesis of 5-(Benzyloxy)-2-bromonaphthalene-1,4-dione 25 
 
 
 
Scheme 48: Reagents and conditions: 1) Bromine, DCM, 0 ºC, inert conditions, 15 mins. 2) 
10% Acetic acid, ethanol, reflux, 15 mins, 74%. 
 
Following the successful protection of the free hydroxyl group of juglone, the following step 
was the bromination at the 2-position of 5-(benzyloxy)naphthalene-1,4-dione 40. After trying 
quite a few literature procedures that met with failure, we tried the procedure for bromination 
published in 1979 by Hannan et al.67 The procedure worked well and gave the product in 
good yield when care was taken to use only one equivalent of bromine to prevent the 
generation of by-products. To carry out the reaction, starting material 40 was dissolved in 
dichloromethane under inert conditions and the temperature of the solution was maintained 
at 0 ºC. To this stirred solution was added bromine dissolved in dichloromethane and 
maintained at 0 ºC. The reaction mixture was allowed to stir under the same conditions for 
fifteen minutes. Following this, the solvent was removed under reduced pressure, and the 
residue was treated with 10% aqueous acetic acid and the thick slurry obtained was again 
subjected to reduced pressure for five minutes and then the ethanol was added. The solution 
was then refluxed for fifteen minutes, followed by work-up and column chromatography to 
yield the product 25 as orange needles in 74% yield. The product was characterized by NMR 
spectroscopy, and the results were found to be in agreement with the literature.69 
 
The 1H NMR spectrum of 5-(benzyloxy)-2-bromonaphthalene-1,4-dione 
25, showed one less proton than observed in the starting material 40 
which indicated that aromatic quinone proton had been substituted with 
a bromine atom. The benzylic protons were observed as a singlet at 
5.31 ppm in the 1H NMR spectrum with the benzylic carbon giving rise 
to a signal at 70.99 ppm in the 13C NMR spectrum. Two carbonyl 
carbons of the quinone carbons, C-1 and C-4 could be seen at 181.26 
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and 178.26 ppm in the 13C NMR spectrum. At 158.83 ppm in 13C NMR a signal due to C-5 
was observed. 
 
2.5.3 Synthesis of 5-(Benzyloxy)-2-bromo-1,4-dimethoxynaphthalene 26 
 
 
 
Scheme 49: Reagents and conditions: 1) Na2S2O4, DEE, H2O, rt, 1 hr. 2) K2CO3, Me2SO4, 
acetone, reflux, 24 hrs, 74%. 
 
Reduction of the quinone and the subsequent protection of the hydroquinone as methyl 
ether was done the same way as in the of synthesis of 1,4-dimethoxy naphthalene 96. The 
reaction was accomplished in two steps, with the first step being the reduction of the quinone 
to obtain a 1,4-diol intermediate. This reduction was achieved by stirring a solution of starting 
material 25 in diethyl ether with a solution of sodium dithionite in water. After work up, the 
intermediate hydroquinone was dissolved in acetone and potassium carbonate and dimethyl 
sulfate were added. Subsequently, work-up and column chromatography facilitated the 
isolation of the product 26 as a white solid in 74% yield. The product was characterized by 
NMR spectroscopy and the spectroscopic data was found to be in agreement with that 
reported in the literature.70 
 
Most notably, the appearance of two singlets at 3.91 and 3.89 ppm in 
the 1H NMR spectrum indicated the presence of the two methoxy 
groups, with the corresponding carbon peaks visible at 61.24 and 56.60 
ppm in the 13C NMR spectrum. Three peaks at 156.57, 154.04 and 
146.64 ppm represent three carbons attached to oxygen C-1, C-4 and 
C-5 in the 13C NMR spectrum. Conclusive C-Br peak in the 13C NMR 
spectrum could be identified at 137.32 ppm. 
 
 
 
58 
 
2.5.4 Synthesis of 2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 131 
 
 
 
Scheme 50: Reagents and conditions: 2-formylphenyl boronic acid, Pd(PPh3)4, CsF, DMF, 
microwave irradiation, 150 ºC, 150 W, 30 mins, 93%. 
 
2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 131 was prepared by the 
standard microwave method for the Suzuki-Miyaura cross coupling reaction we had used 
previously in the synthesis of 2-(1,4-dimethoxynaphthalen-2-yl)benzaldehyde 99. 5-
(Benzyloxy)-2-bromo-1,4-dimethoxynaphthalene 26 and all the other reagents were added to 
dry and freshly degassed dimethoxyethane in a microwave reaction vial. This reaction 
mixture was subjected to microwave irradiation under the above mentioned conditions. This 
was followed by work-up and column chromatography and the product 131 was obtained as 
a yellow solid in a 93% yield.  
 
Analysis of the product 131 was done by NMR spectroscopy and 
the results were found to be as expected. Signals from both the 
starting materials, 5-(benzyloxy)-2-bromo-1,4-
dimethoxynaphthalene 26 and 2-formylphenylboronic acid 98 
were evident. At 9.90 ppm in the 1H NMR spectrum a singlet 
could be seen integrating for one proton, which is characteristic 
of an aldehyde functional group. The corresponding carbonyl 
carbon could be seen at 192.37 ppm in the 13C NMR spectrum. 
At 5.25 ppm a signal integrating for two protons due to the benzylic protons was visible in the 
1H NMR spectrum and the corresponding carbon signal was observed at 71.54 ppm in the 
13C NMR spectrum. 
 
Having results from previous reactions that the N-bromosuccinimide reaction could proceed 
through an aldehyde intermediate we planned to subject 2-(5-(benzyloxy)-1,4-
dimethoxynaphthalen-2-yl)benzaldehyde 108 to N-bromosuccinimide in a chlorinated solvent 
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(both dichlormethane and chloroform were used) in order to obtain 1-(benzyloxy)-12-
methoxy-6H-dibenzo[c,h]chromen-6-one 48. When we proceeded with this reaction we were 
unable to isolate any of the desired product 48. Within a few seconds, when monitored by 
thin layer chromatography the reaction gave rise to multiple faint spots on thin layer 
chromatography plate which were difficult to purify and isolate.. We therefore planned to 
reduce 2-(5-(benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 108 to (2-(5-
(benzyloxy)-1,4-dimethoxynaphthalen-2-yl)phenyl)methanol 109 and then attempt the ring 
cyclization. 
 
2.5.5 Synthesis of (2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)phenyl)methanol 
132 
 
 
 
Scheme 51: Reagents and conditions: NaBH4, Dry THF, rt, 12 hrs, 99%. 
 
Proceeding further with our synthesis, we were now in a position to reduce the aldehyde 
functionality of the 131 into the benzylic alcohol 132 to obtain our substrate required for the 
N-bromosuccinimide mediated ring closure reaction. In our initial attempts to obtain the 
product 132 we used lithium aluminium hydride as the reducing agent in tetrahydrofuran. 
Thin layer chromatography of the reaction mixture showed that all of the starting material 
had been consumed and two spots of almost equal intensity appeared at much lower Rf than 
the starting material 131. As we were expecting our product to be more polar than the 
starting material 132 because of the presence of the hydroxyl group, we thought that one of 
these spots would be our desired product. However, we were unable to separate these 
products by column chromatography as they always eluted as a mixture. We therefore 
decided to change our reducing agent to milder conditions and sodium borohydride was our 
next choice. The starting material 131 was therefore dissolved in dry and freshly distilled 
tetrahydrofuran, sodium borohydride was added and the mixture was stirred for twelve 
hours. After work up of the reaction and column chromatography of the mixture our desired 
product 132 was isolated in 99%. 
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In both the 1H and 13C NMR spectra, peaks for the aldehyde 
functional group were absent. At 4.41 ppm and 4.39 ppm in 
the 1H NMR spectrum, a doublet of doublet for the two 
benzylic protons (CH2OH) were seen with the corresponding 
peak in 13C NMR spectrum observed at 56.55 ppm.  
 
 
 
 
2.5.6 Attempted Synthesis of 1-(benzyloxy)-12-methoxy-6H-dibenzo[c,h]chromen-6-
one 49 
 
 
 
Scheme 52: Reagents and conditions: NBS, DCM, rt, atmospheric conditions, 5 mins. 
 
The next step was to try our ring closing reaction using N-bromosuccinimide on the substrate 
(2-(5-(benzyloxy)-1,4-dimethoxynaphthalen-2 yl)phenyl)methanol 132. To the stirred solution 
of the starting material 132 dissolved in dichloromethane, N-bromosuccinimide was added. It 
was observed that the reaction mixture turned dark red in colour in a few seconds on 
addition of N-bromosuccinimide, and thin layer chromatography showed that starting 
material 132 had been consumed and four new faint spots had formed. The products were 
separated by preparative thin layer chromatography and all the fractions obtained were 
analyzed by NMR spectroscopy. Unfortunately, none of them were found to be our expected 
product 49. It appeared that the reaction was too fast to be controlled at room temperature, 
and possibly the intermediates and/or product were unstable, so we decided to try this 
reaction at lower temperatures. A range of temperatures were tested, ranging from 0 oC to -
80 ºC without success. At this stage we speculated that the presence of a O-benzyl 
protecting substituent might be interfering with the reaction and preventing the desired ring 
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closure from occurring. We therefore decided to test the reaction on a similar system, but 
using a different protecting group, where a methyl group was used instead. 
 
In order to proceed with a methyl protecting group instead of the benzyl protecting, the first 
thing we attempted was to perform a debenzylation reaction on 132 and then protect the free 
naphthol 133 with methyl protecting group to isolate (2-(1,4,5-trimethoxynaphthalen-2-
yl)phenyl)methanol 134 as shown in Scheme 53. 
 
 
 
Scheme 53 
 
On  attempting the O-debenzylation reaction for the conversion of 132 to 133, by subjecting 
132 to hydrogenation in presence of palladium on carbon and dichloromethane as the 
solvent, we isolated the toluene derivative, 5,8-dimethoxy-6-o-tolylnaphthalen-1-ol 135 rather 
than 133. 
 
 
 
5,8-dimethoxy-6-o-tolylnaphthalen-1-ol 135 
 
Figure 21 
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As, a result of this unfavorable product obtained we decided to abandon this approach and 
synthesize the desired substrate 134 form juglone 129. 
 
2.6 Synthesis of 1,12-Dimethoxy-6H-dibenzo[c,h]chromen-6-one 136 
 
As before our prospective plan to synthesize 1,12-dimethoxy-6H-dibenzo[c,h]chromen-6-one 
136 would begin with protecting the free hydroxyl group of juglone 129 with a methyl group 
to give 137, followed by bromination at the 2-position of this compound to yield 2-bromo-5-
methoxynaphthalene-1,4-dione 138. The quinone would then be reduced and protected as 
methyl ether to give 80, the substrate 80 for our Suzuki Miyaura cross coupling reaction with 
2-formyl phenyl boronic acid 98. The resulting biaryl compound 139 could be reduced to the 
benzylic alcohol 134, which we would be able to try our N-bromosuccinimide induced ring 
closure reaction on. Ideally, this should afford the product 136 as shown in Scheme 54. 
 
 
Scheme 54 
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2.6.1 Synthesis of 5-Methoxynaphthalene-1,4-dione 137 
 
 
 
Scheme 55: Reagents and conditions: MeI, Ag2O, DCM, rt, inert conditions, 48 hrs, 73% 
 
To begin our synthesis, commercially available juglone 129 was methylated using methyl 
iodide as the methyl source. Juglone 129 was dissolved in dichloromethane and 
silver(I)oxide and methyl iodide were added to it. Progress of the reaction was monitored by 
thin layer chromatography and to our surprise it was observed that the product formed had 
lower Rf compared to the starting material 129. This could be attributed to the fact that the 
free naphthol forms a hydrogen bond in juglone 129. On completion of the reaction the silver 
salt was filtered off and the residue was purified by column chromatography to afford the 
product 137 as a bright yellow solid in 73%. The structure of the product 137 obtained was 
confirmed by NMR spectroscopy and was found to be in agreement with that of the 
literature.71 
 
2.6.2 Synthesis of 2-Bromo-5-methoxynaphthalene-1,4-dione 138 
 
 
 
Scheme 56: Reagents and conditions: 1) Br2, DCM, 0 ºC, inert conditions, 15 mins; 2) 10% 
Acetic acid, ethanol, reflux, 15 mins, 73%. 
 
After methyl protection of the phenolic substituent in juglone our next step in the synthesis 
was bromination at the 2-position of 5-methoxynaphthalene-1,4-dione 137. This was 
achieved by dissolving the starting material 137 in dichloromethane and reducing the 
temperature of the solution to 0 ºC. Bromine dissolved in dichloromethane at 0 ºC was 
added drop-wise to the stirred solution of our starting material 137 and the reaction was 
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allowed to stir for fifteen minutes at the same temperature and under inert conditions. This 
was followed by work-up and purification by column chromatography, the product 138 was 
obtained as orange needles in 73% yield.  
 
Identification of the product 138 was done by NMR spectroscopy. Spectral 
data was in agreement with the data found in the literature.67 In particular 
what was notable was that on conversion from 5-methoxynaphthalene-1,4-
dione 137 to 2-bromo-5-methoxynaphthalene-1,4-dione 138, there was 
one less proton signal observed in the 1H NMR spectrum of the product 138.  
 
Although this bromination reaction worked well in terms of the yields extreme care was taken 
to prevent large quantities of other by-products forming during the reaction, such as 2-
bromo-8-methoxynaphthalene-1,4-dione 140 and 2,3-dibromo-5-methoxynaphthalene-1,4-
dione 141 as shown in Figure 22. 
 
 
 
Figure 22 
 
Unfortunately even a slight excess of bromine led to the formation of these by-products (140 
and 141), along with the expected product 138. In addition, even when strictly one 
equivalent of bromine was added, the starting material 137 was not consumed during the 
course of the reaction due to by-product formation. As all of these compounds had very 
close Rf values, with almost equal intensity on the thin layer chromatography plate and 
hence purification of the product was difficult.  
 
Owing to the cost of buying commercially available juglone 129, we considered synthesizing 
the required brominated analogue by an alternative route starting from 1,5-dihydroxy 
naphthalene 118. 
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2.6.3 Synthesis of 2-Bromo-5-methoxynaphthalene-1,4-dione 138 From 1,5-Dihydroxy 
naphthalene 142 – Method 1 
 
 
Scheme 57: Reagents and conditions: A) K2CO3 Me2SO4, acetone, reflux, 12 hrs, 86%; B) 
POCl3, DMF, toluene, 0 ºC-rt- reflux, 3.5 hrs, 79%; C) H2O2, H2SO4, methanol, 0 ºC-rt, 12 
hrs, 80%; D) CAN, CH3CN: H2O (1:1), rt, atmospheric conditions, 5 mins, 99%; E) 1) 
Bromine, DCM, 0 ºC, inert conditions, 15 mins; 2) 10% Acetic acid, ethanol, reflux, 15 mins, 
73%. 
 
To this end, 1,5-dihydroxynaphthalene 142 was methylated to afford 1,5-
dimethoxynaphthalene 143. The reaction was carried out by dissolving the starting material 
142 in acetone and adding potassium carbonate to the solution. On completion of the 
reaction the desired product 143 precipitated out of the solution by the addition of aqueous 
ammonia. The product was isolated by filtration and dried. NMR spectroscopic analysis 
confirmed the formation of the desired product 143 which was also found to be in agreement 
with literature.72 
 
Having protected the hydroxyl groups, the next step was to generate the desired 
naphthoquinone. This was achieved by initially formylating 1,5-dimethoxynaphthalene 143 
using the classical Vilsmeier-Haack formylation reaction with phosphorus oxychloride and 
dimethylformamide and employing toluene as the solvent. To carry out the reaction, starting 
material 143 was dissolved in dimethylformamide and toluene to obtain a thick slurry. The 
temperature was maintained at 0 ºC and phosphorus oxychloride was added slowly. The 
reaction was allowed to stir at the same temperature for thirty minutes before warming it up 
to room temperature and then was heated under reflux for another two hours. Over this time 
the reaction mixture changes colour from dark brown to dark red. After work-up with sodium 
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hydroxide and purification by column chromatography, the product 144 was obtained as a 
yellow solid in 79% yield. 
 
The product 4,8-dimethoxy-1-naphthaldehyde 144 was characterized by 
NMR spectroscopy and was found to be in accordance with literature.73 The 
characteristic peak for the aldehydic proton was observed at 11.04 ppm in 
the 1H NMR spectrum and the corresponding carbonyl carbon was seen at 
194.60 ppm in the 13C NMR spectrum. Two methoxy peaks were observed 
at 4.05 and 4.00 ppm in the 1H NMR spectrum and at 55.90 and 55.62 in the 13C NMR 
spectrum. 
 
After introduction of the formyl group at the 4-position of the naphthalene nucleus, we were 
now in a position to oxidize this system to produce methoxy protected juglone 137.  
 
To carry out the reaction, we dissolved the starting material 144 in methanol and both 
hydrogen peroxide and sulfuric acid were added dropwise at 0 ºC. The reaction was then 
allowed to stir at room temperature for twelve hours, while monitoring the progress of the 
reaction by thin layer chromatography. On completion, a basic work-up was done and the 
crude product was purified by column chromatography. Close inspection of the 
spectroscopic data showed that we had in fact isolated the intermediate 4,8-
dimethoxynaphthalen-1-ol 145. We were not unhappy with this result as we anticipated that 
it would be easy to oxidize to the desired product 137. The spectroscopic result was found to 
be in agreement with the data found in literature.74  
 
After identification of the intermediate 4,8-dimethoxynaphthalen-1-ol 145, we next attempted 
the oxidation of this compound to obtain 5-methoxynaphthalene-1,4-dione 137. Ceric 
ammonium nitrate was used as the oxidizing agent for this step. The reaction was carried 
out by dissolving the starting material 145 in a mixture of acetonitrile and water, and ceric 
ammonium nitrate was added to the stirred solution. The reaction was allowed to stir at room 
temperature and exposed to air for twelve hours. After work-up and purification by column 
chromatography, the desired product 137 was obtained as orange needles in 99% yield. 
Analysis of the product by NMR spectroscopy was found to be in agreement with that 
reported in the literature.67 The methoxy protected juglone 137 that we had synthesized over 
four steps was further brominated using the same procedure as discussed previously 
(Scheme 57). This gave 2-bromo-5-methoxynaphthalene-1,4-dione 138, which was 
characterized by NMR spectroscopy. 
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Although the product 138 was easily prepared by this route (Scheme 57), we were still 
unhappy with the outcome of the last step, bromination of 5-methoxynaphthalene-1,4-dione 
137. As discussed previously, this reaction was unpredictable and it was difficult to isolate 
pure product 138 from the complex mixture of by-products (116 and 117) and starting 
material 110. In addition, the by-products (140 and 141) formed in the reaction were reactive 
in the following steps of the synthesis, making purification at this step crucial. 
 
We therefore sought alternative route for the preparation of 2-bromo-5-methoxynaphthalene-
1,4-dione 138 During our literature search we came across a paper, where the problems 
arising from the bromination step could be overcome by carrying out the bromination at a 
earlier stage in the synthesis.75 
 
2.6.4 Synthesis of 2-Bromo-5-methoxynaphthalene-1,4-dione 138 from 1,5-Dihydroxy 
naphthalene 142 – Method – 2 
 
In this method for the synthesis of 2-bromo-5-methoxynaphthalene-1,4-dione 111, we 
avoided two major problems that were arising in our previous two synthetic schemes: 
protection of the juglone 106 and bromination of the resulting product. Also, the synthesis 
appeared to be both time and cost efficient. 
 
 
Scheme 58: Reagents and conditions: A) Acetic anhydride, pyridine, rt, 12 hrs, 98%; B) 
NBS, CH3COOH, H2O, 45 mins, 60 ºC, 45 mins, inert conditions, 79%; C) 3 N H2SO4, 
ethanol, reflux, 90 mins, 98%; D) MeI, Ag2O, CHCl3, 48 hrs, rt, inert conditions, 87%. 
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The first step in the synthesis as shown in Scheme 58, was acetyl protection of the phenolic 
groups of 1,5-dihydroxynaphthalene 142. The reaction was carried out by dissolving the 
starting 142 material in pyridine, and treating this with acetic anhydride, which is an acetyl 
source. The stirred mixture 142 was then left at room temperature for twelve hours under 
inert conditions. The product 23 was then isolated by precipitating from the mixture with 
water and drying in 98% yield. Identification of the product was easily done through NMR 
spectroscopy and the results were found to be in accordance with the literature.75 
 
The next step in the synthetic sequence was a one pot oxidation and bromination of 
naphthalene-1,5-diyl diacetate 23 to afford the brominated quinone 146. 
 
The reaction was conducted by the dropwise addition of a warm solution of our starting 
material 23 in acetic acid to a stirred solution of N-bromosuccinimide in a mixture of water 
and acetic acid and allowing this reaction mixture to stir for further forty five minutes at 60 ºC 
under inert conditions. On completion of the reaction, the mixture was quenched with water 
and the product was extracted in to chloroform and was precipitated from the solution by 
addition of ethanol. This gave the desired product 146 as orange needles in 79% yield. The 
product 146 was characterized by NMR spectroscopy and the results were found to be in 
agreement with the literature.75 
 
In the 1H NMR spectrum, a peak for only one acetyl group could be seen 
in the product 146 at 2.52 ppm in the 1H NMR spectrum, with the 
corresponding signal in the 13C NMR spectrum at 21.64 ppm. A signal for 
the carbonyl carbon could be seen at 148.78 ppm, while two carbonyls of 
the quinone system, C-1 and C-4 could be seen at 174.89 ppm and 
167.92 ppm in the 13C NMR spectrum. A singlet integrating for one proton at 7.96 ppm in the 
1H NMR spectrum corresponded to the proton at H-3 and the corresponding signal at 134.01 
ppm in the 13C NMR spectrum, confirms bromination. 
 
Having synthesized the brominated quinone 6-bromo-5,8-dioxo-5,8-dihydronaphthalen-1-yl 
acetate 146, the next step in our synthesis was the removal of the acetyl group from 146 to 
obtain free hydroxyl group which could be re-protected with a more robust protecting group. 
The deprotection reaction was carried out by refluxing the mixture of starting material 146 in 
ethanol with a 3 N sulfuric acid solution for ninety minutes. The product was isolated and 
purified by column chromatography to afford an orange solid in 98% yield and characterized 
by NMR spectroscopy. The results were found to be in agreement with literature.70 
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In the NMR spectra of the product 24, there were no signals from the 
acetyl protecting group as expected. Instead, a singlet was visible at 11.81 
ppm in the 1H NMR spectrum due to the proton of the hydroxyl group with 
a signal for the phenolic carbon C-5 at 147.11 ppm in the 13C NMR 
spectrum. 
 
The last step in the synthesis of the intermediate 2-bromo-5-methoxynaphthalene-1,4-dione 
138 was the protection of the free hydroxyl group of 2-bromo-5-hydroxynaphthalene-1,4-
dione 24. This was achieved by dissolving the starting material 24 in dichloromethane and 
treating the solution with silver(I)oxide and methyl iodide which acts as a methyl source. 
Upon completion of the reaction, the product was isolated and purified by column 
chromatography followed by isolation of the product in 87% yield as a yellow solid. The 
product 138 obtained was analyzed by NMR spectroscopy and the data was found to 
correspond to the results obtained previously, (Section 2.6.2) and also with the data in the 
literature.70 
 
2.6.5 Synthesis of 2-Bromo-1,4,5-Trimethoxynaphthalene 80 
 
 
 
Scheme 59: Reagents and conditions:  Na2S2O4, AIBN, KOH, Me2SO4, THF, rt, 18 hrs, 76%. 
 
Initially we attempted the reduction of the quinone 138 using the conventional procedure by 
stirring the starting material 138 in diethyl ether with sodium dithionite in water for thirty 
minutes. After this time, the solvent was removed and the unstable intermediate 147 
obtained was immediately dissolved in dry acetone and treated with potassium bicarbonate 
and dimethyl sulphate, to afford the product 80. 
 
We also tested an alternate procedure for the synthesis of 80 from 138. In this procedure, 
the starting material 138 was dissolved in dry tetrahydrofuran under inert conditions and 
treated with aqueous sodium dithionite and AIBN to reduce the quinone. This could be 
observed as the reaction mixture changes colour from dark brown to almost pale yellow. 
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After ten minutes, an aqueous solution of potassium hydroxide was added to the reaction 
mixture, which abstracts protons from the newly formed methoxynaphthalene-1,4-diol 147, 
with a colour change from pale yellow to very dark brown. To this solution, dimethyl sulfate 
was then added, giving rise to our desired product 80. Progress of the reaction was carried 
out by thin layer chromatography. After work-up and purification by column chromatography, 
the pure product 80 was isolated as a white solid in 76% yield.  
 
This procedure provided a convenient way to synthesize 2-bromo-1,4,5-
trimethoxynaphthalene 80 from 2-bromo-5-methoxynaphthalene-1,4-dione 138, in one pot, 
with shorter reaction time and using very mild conditions when compared with our previous 
procedure. 
 
2.6.6 Synthesis of 2-(1,4,5-Trimethoxynaphthalen-2-yl)benzaldehyde 139 
 
 
 
Scheme 60: Reagents and conditions: 2-Formylphenyl boronic acid, Pd(PPh3)4, CsF, DMF, 
microwave irradiation, 150 ºC, 150 W, 30 mins, 64%. 
 
We were finally in a position to test the Suzuki-Miyaura cross coupling reaction on 80 to 
produce the desired biaryl compound 139. The reaction was carried out in a microwave 
reactor using the same standard procedure used previously. The product 139 was isolated 
as an off-white solid in 64% yield. 
 
Characterization of the product by NMR spectroscopy showed the 
correct number of protons and carbons in the respective NMR 
spectra expected for the biaryl compound 139. A singlet at 9.89 ppm 
was visible in the 1H NMR spectrum characteristic for the aldehyde 
proton, and the corresponding carbonyl carbon, gave signal at 
192.36 ppm in the 13C NMR spectrum. In addition to this new peak, all other characteristic 
peaks were visible. There were three peaks due to the methoxy groups in both the 1H and 
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13C NMR spectra at 4.01, 3.98 and 3.37 ppm in the 1H NMR spectrum and at 60.72, 56.93 
and 56.57 ppm in the 13C NMR spectrum. 
 
2.6.7 Synthesis of (2-(1,4,5-Trimethoxynaphthalen-2-yl)phenyl)methanol 
 
 
 
Scheme 61: Reagents and conditions:  NaBH4, dry THF, rt, 12 hrs, 100% 
 
Reduction of the aldehyde 139 to alcohol 134 to afford the substrate for our novel ring 
closing reaction was readily carried out. The same procedure was employed as previously 
done for the reduction of 2-(5-(benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 131 
to (2-(5-(benzyloxy)-1,4-dimethoxynaphthalen-2-yl)phenyl)methanol 132 as discussed in 
Section 2.5.5. 2-(1,4,5-Trimethoxynaphthalen-2-yl)benzaldehyde 139 was dissolved in dry 
freshly distilled tetrahydrofuran and sodium borohydride was added to this solution under 
inert conditions and at room temperature. Isolation of the product 134 and purification gave 
the product as a white solid in 100% yield. 
 
The 1H NMR spectrum confirmed that the reduction of the aldehyde 
to an alcohol had taken place as the signal for the aldehyde proton 
at 9.89 ppm in the 1H NMR spectrum was missing. A new doublet of 
doublet appeared in the 1H NMR spectrum: due to two benzylic 
protons at 4.31 ppm and 4.33 ppm, which appeared as a doublet 
and integrated for two protons and a broad multiplet at 0.85 – 0.71 ppm due to the proton of 
the hydroxyl group. A peak at 3384 cm-1 in the FTIR spectrum also clearly indicated the 
presence of an alcohol functional group. 
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2.6.8 Attempted Synthesis of 1,12-Dimethoxy-6H-dibenzo[c,h]chromen-6-one 136 
 
 
 
Scheme 62: Reagents and conditions: NBS, DCM, rt, atmospheric conditions, 5 mins. 
 
The final N-bromosuccinimide induced ring closure reaction was carried out the same way 
as described for the conversion of (2-(5-(benzyloxy)-1,4-dimethoxynaphthalen-2-
yl)phenyl)methanol 132 to 1-(benzyloxy)-12-methoxy-6H-dibenzo[c,h]chromen-6-one 49 
(Section 2.5.6), but unfortunately it did not afford the desired product 136 in this case. 
Immediately upon addition of N-bromosuccinimide to the stirred solution of (2-(1,4,5-
trimethoxynaphthalen-2-yl)phenyl)methanol 134 in dichloromethane at room temperature 
and under inert conditions, the reaction mixture turned dark red. Thin layer chromatography 
of the reaction mixture showed that all the starting material 134 had been consumed and 
four new spots appeared which were isolated employing column chromatography but none 
of them showed signals of the desired product 136, as shown by  NMR spectroscopy. Also 
substrate: 2-(1,4,5-trimethoxynaphthalen-2-yl)benzaldehyde 139, which, is a possible 
intermediate in the reaction, also failed to produce the desired product.  
 
We were very disappointed with this result, but had to conclude that the reaction was not 
successful when a slightly more electron rich substrate is used. One possibility that could be 
tested is the use of an electron withdrawing protecting group such as p-nitrobenzoyl chloride, 
in the last step. This will help in decreasing electron density from the ring system, and may 
result in the formation of the desired product as shown in Scheme 63. 
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Scheme 63 
 
Unfortunately, due to time constraints this alternative strategy was not tested, however, it will 
be considered for the future work. 
 
The other possibility to synthesize the desired lactone framework 65 could be by converting 
aldehyde into a carboxylic acid and then trying the oxidative lactonization reaction. There are 
several examples in the literature where this kind of approach has been employed to 
synthesize related lactones, but this would not fall in the ambit of the N-bromosuccinimide-
mediated reactions that we were studying. 
 
For example, Koch et al. in 2005 demonstrated the synthesis of alternariol 148 where 
Suzuki-Miyaura cross coupling reaction was employed to form a biaryl axis 149 between the 
substituted boronic acid 150 with a brominated resorcylic aldehyde 151.76 Later the aldehyde 
in 149 was oxidized to the carboxylic acid 152 which was followed by a lactone ring forming 
reaction in the presence of boron tribromide to afford alternariol 148 as shown in Scheme 
64.  
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Scheme 64: Reagents and conditions: A) K2CO3, Pd(PPh3)4, DMF, 100 °C, 4 hrs, 78%; B) 
NaH2PO4, NaClO4, 2-methyl-2-butene, tBuOH/H2O (5:1), 2 hrs, 85; C) BBr3, DCM, 0 °C, 24 
hrs, 73%. 
 
Schmidt et al. also synthesized benzo fused pyranone framework by performing 
lactonization reaction between a carboxylic acid and methoxy group across the biaryl axis of 
153 to afford 154 as shown in Scheme 65.77 
 
 
 
Scheme 65: Reagents and conditions: SOCl2, AlCl3, DCM, rt, 90% 
 
Nguyen et al also in 2005, demonstrated the synthesis of similar benzo-fused pyranone 
frameworks by subjecting the substrate having a biaryl axis 155 with methoxy and ester 
substituents on the ortho position of each ring. Such molecule was subjected to boron 
tribromide to afford lactonization to generate 156 as shown in Scheme 66.78 
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Scheme 66: Reagents and conditions: BBr3, DCM, 0-20 °C, 18 hrs; 2) KOBut, H2O, 15 mins, 
20 °C, 71%.  
 
2.7 Synthesis of Halogenated Naphthopyranones 
 
Still continuing with our novel N-bromosuccinimide and air induced ring closure reaction, we 
wanted to check its applicability on other similar substrates. This time we wanted to see if we 
could synthesize some halogenated naphthopyranones, and in particular 
fluoronaphthopyranones. 
 
In our quest to synthesize fluorine containing naphthopyranones, we envisioned that if we 
could synthesize 1,4-dimethoxynaphthalen-2-ylboronic acid 157 from previously synthesized 
2-bromo-1,4-dimethoxynaphthalene 97 we could then perform a Suzuki Miyaura reaction 
with 2-bromo-5-fluorobenzaldehyde 158. We anticipated that the Suzuki Miyaura coupling 
would take place between the bromine end of the boronic acid 158 rather than on fluorine 
substituent of 158 as bromine is a better leaving group.79 If we were able to prepare the 
biaryl compound 159 we could then subject this molecule to the conditions of the N-
bromosuccinimide-mediated reaction to obtain the ring closed product, or we could reduce 
the aldehyde functional group to an alcohol and then subject the resulting product to these 
conditions. As we have already seen that the reaction proceeds via an aldehyde 
intermediate we decided to initially test the N-bromosuccinimide ring closure reaction on 
aldehyde intermediate 159. 
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Scheme 67 
 
 
2.7.1 Synthesis of 1,4-Dimethoxynaphthalen-2-ylboronic acid 157 
 
 
 
Scheme 68: Reagents and conditions: nBuLi, triisopropylborate, dry THF, 78 °C-rt. 
 
From previously prepared 2-bromo-1,4-dimethoxynaphthalene 97, we synthesized 1,4-
dimethoxynaphthalen-2-ylboronic acid 157, using a reported procedure for the synthesis of 
boronic acids.62 - 80 Before carrying out the reaction, triisopropyl borate and tetrahydrofuran 
were distilled and the molarity of the nbutyllithium was calculated by titration. 2-Bromo-1,4-
dimethoxynaphthalene 97 then dissolved in tetrahydrofuran under inert conditions, cooled to 
78 °C and treated with nbutyllithium. The reaction mixture was stirred under the same 
conditions for one hour before the addition of triisopropyl borate, and then allowed to slowly 
warm to room temperature for two hours. After acidic work up the organic phase was 
collected and the solvent was removed under reduced pressure. The product 157 was 
isolated by precipitation from acetone at 0 °C The product 157 was obtained as a white solid 
and was used immediately in the next step without further characterization due to possible 
instability. 
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2.7.2 Synthesis of 2-(1,4-Dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 159 
 
 
 
Scheme 69: Reagents and conditions: 2-bromo-5-fluorobenzaldehyde, Pd(PPh3)4, CsF, 
DMF, microwave irradiation, 150 ºC, 150 W, 30 mins, 62%. 
 
Boronic acid intermediate 154 was immediately subjected to a Suzuki-Miyaura cross 
coupling reaction with 2-bromo-5-fluorobenzaldehyde 159 under microwave conditions. The 
pure product was obtained after isolation and purification by column chromatography as a 
yellow solid in 62%. 
 
Product formation was confirmed by NMR spectroscopy. There 
were signals seen from both the fragments used in the reaction in 
the spectra of the product obtained. There was a characteristic 
aldehyde peak at 9.83 ppm in the 1H NMR spectrum which 
appeared as a doublet. The corresponding peak for the carbonylic 
carbon was seen at 191.08 ppm in the 13C NMR spectrum. Two methoxy peaks were seen 
as singlets in the 1H NMR spectrum at 4.01 and 3.40 ppm. The corresponding methoxy were 
seen at 60.92 and 55.81 ppm in the 13C NMR spectrum. One aromatic proton at H-3’ gave 
rise to a singlet upfield at 6.71 ppm in the 1H NMR spectrum.  
 
2.7.3 Attempted Synthesis of 8-Fluoro-12-methoxy-6H-dibenzo[c,h]chromen-6-one 160 
 
 
 
Scheme 70: Reagents and conditions: NBS, DCM, rt, 18 hrs, atmospheric conditions. 
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After having successfully synthesized the biaryl compound 126, we next wanted to try our N-
bromosuccinimide induced ring closure reaction on this substrate. The starting material 159 
was dissolved in dichloromethane and N-bromosuccinimide was added. The reaction was 
allowed to stir at room temperature and under atmospheric conditions for eighteen hours. 
During this time the reaction progress was monitored by thin layer chromatography. A new 
spot of higher Rf was visible just above the starting material 159 on the thin layer 
chromatography plate. The product was isolated and characterized by NMR spectroscopy. 
However, this showed that we had not synthesized the expected product 160. In this case, 
N-bromosuccinimide acted as a bromine source and brominated position C-3’ instead of 
facilitating the desired cyclization. N-bromosuccinimide is known to brominate ortho to 
aromatic methoxy groups, and this system acted as the perfect substrate for ortho 
bromination, affording 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 161 
as shown in Figure 23. 
 
 
 
2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 161 
 
Figure 23 
 
Confirmation of the identity of the product came from the 
disappearance of the singlet in the 1H NMR spectrum due the 
proton H-3’, which indicated that a substitution reaction has taken 
place. Also, the existence of peaks for the two methoxy groups and 
an aldehyde confirmed that the cyclization reaction had not taken 
place. 
 
2.8 Conclusion 
 
In our quest towards the synthetic approaches to 6H-dibenzo[c,h]chromen-6-one analogues 
65, as found in gilvocarcins 5, we successfully managed to synthesize 12-methoxy-6H-
dibenzo[c,h]chromen-6-one 65 and 2-methoxy-6H-benzo[c]chromen-6-one 110 using our 
novel N-bromosuccinimide induced ring closure reaction. We also managed to elucidate the 
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probable mechanism of the reaction, which we believe proceeds via an aldehyde 
intermediate. Unfortunately, when we tried to extend our methodology towards the synthesis 
of 1-hydroxy-12-methoxy-6H-dibenzo[c,h]chromen-6-one 130 and later halogenated 
naphthopyranones as 8-fluoro-12-methoxy-6H-dibenzo[c,h]chromen-6-one 160, we failed to 
execute the methodology to allow for the formation of the desired products. There are 
literature precedents where lactonization could be achieved by using carboxylic acid 
intermediate instead of aldehyde intermediate. However, these processes did not 
demonstrate the use of N-bromosuccinimide and oxygen on aldehydes or alcohols for the 
lactonization process.77 Factors like, substituents on C-1 of this benzonaphthopyranone 
system plays an important role here and this aspect could be considered in the future. 
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Chapter 3: Introduction, Literature Reviews and Aims: The Jadomycins 
 
3.1 Introduction 
 
Nature is an abundant source of medicinally beneficial biologically active molecules. A large 
amount of research is being carried out to identify such molecules that can either be used in 
their native forms or derivatized to modify their activities in order to achieve higher specificity 
and selectivity against a particular target, with lower toxicity. In fact, more than half of the 
drugs on the market today are derived from natural products.81, 82 The requirement to identify 
and develop new and potent therapeutic agents to address a wide array of disease and 
health-related conditions, has encouraged scientists to discover versatile and efficient routes 
for the biosynthesis and synthesis of new biologically active natural products.  
 
Jadomycins are a unique class of novel angucycline polyketide natural products produced by 
soil-borne gram positive Streptomyces venezuelae ISP5230 (ATCC10712) bacteria under 
stress and nutrient limitation conditions like heat shock, phase infection, or exposure to toxic 
concentrations of ethanol.29 These natural products contain an unusual 
benzo[b]phenanthridine-7,12-dione 162 (Figure 23) backbone with variously fused nitrogen 
and oxygen-containing heterocycles (e.g., oxazolidine, pyrimidine, oxazinone) and 
carbohydrate attached to the nucleus. 
 
 
 
Benzo[b]phenanthridine-7,12-dione 162 
 
Figure 23 
 
Some well-known examples of the jadomycins are jadomycin A 163, B 164, N 165, ala 166 
and dalomycin 167 (Figure 24). With the exception of jadomycin A 163 all the jadomycins 
are glycosylated with a L-digitoxose carbohydrate unit. Their unique structural complexity 
and commendable biological activities have stimulated extensive study of their biological 
activity, biosynthesis and synthesis.83 The following section covers some reported 
developments in the study of the jadomycin class of antibiotics. 
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Jadomycin A 163        Jadomycin B 164        Jadomycin N 165 
 
 
 
   Jadomycin ala 166    Dalomycin 167 
 
Figure 24 
 
Ayer et al. isolated jadomicyn A 163 for the first time in 1991 followed by the isolation of 
jadomycin B 164 in 1993, both from Streptomyces venezuelae.84, 85 This was later followed 
by isolation and identification of other jadomycins. Interestingly, a year before the isolation of 
jadomycin A 163, Fendrich et al. reported the isolation of the first naturally occurring 
benzo[b]phenanthridine ring systems, phenanthrovirdin 168 and its aglycone 169 as shown 
in Figure 25, both from Streptomyces viridiochromgenes (DSM3972) and both these 
compounds were found to be active against the lung carcinoma MBA9812 in mice.86 
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Phenanthrovirdin 168   Phenanthrovirdin aglycone 169 
 
Figure 25 
 
It is clearly evident that all these molecules have a characteristic benzo[b]phenanthridine-
7,12-dione 129 ring system as their skeleton 
 
3.2 Biological Importance 
 
Jadomycins are known for their commendable range of biological activities ranging from anti-
bacterial properties to activity against both gram positive and gram negative bacterial strains, 
anti-yeast activity and effectiveness against some drug resistant cancer cell lines.87, 88 More 
than 250 structurally defined angucycline compounds have been reported, with a large 
number of them showing anti-tumour activity although, the mode of action is still not fully 
understood. 89, 90 It has been suggested that jadomycin B 164 and its related analogues may 
act as selective protein kinase B (PKB) inhibitors, owing to their structural resemblance to 
lactoquinomycin A 170, where the mechanism of action involves the opening of a lactone 
ring to form the methide that reacts with the thiol functionality in the regulatory region of the 
PKB.91 Structural similarities between jadomycin, lactoquinomycin A 170 and doxorubicin 
171 (Figure 26) further implicate thiol-reactive intermediates that may inhibit DNA-gyrase 
and topoisomerase, which is another possible possibility for the cytotoxic behavior of 
jadomycins.91 
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     Lactoquinomycin A 170     Doxorubicin 171 
 
Figure 26 
 
The presence of a quinone system could also be the reason for the potent biological activity 
of jadomycins. In a system of rapidly dividing cells and/or bacteria, an oxygen deficient area 
is generated due to constant and rapid consumption of oxygen. Quinones undergo reduction 
to hydroquinones under this reductive, hypoxic conditions in-vivo and consequently act as 
bisalkylating agents which interact with the DNA of rapidly dividing cells responsible for the 
reductive system.92 
 
Four human tumour cell lines were used to evaluate the cytotoxicity of these jadomycin 
derivatives including HepG2 (human hepatocellular carcinoma) ATCC HB-8065, IM-9 
(human lymphoblast, immunoglobulin-secreting cell line derived from a multiple myeloma) 
ATCC CCL159, IM-9 subline IM-9/Bcl-2 and H460 (non-small-cell lung cancer). All the 
jadomycin derivatives tested suppressed the proliferation of tumour cells in vitro.87  
 
To assess the antimicrobial activity of this class of compounds the jadomycins were 
evaluated against several microbial strains including Streptomyces aureus, Streptomyces. 
epidermidis, Pseudomonas aeruginosa, Enterococcus faecalis and Bacillus subtilis strains. 
In general, the jadomycins were observed to be more active against gram-positive 
microorganisms than gram-negative ones when erythromycin control was used.93  
 
3.3 Biosynthesis of Jadomycin  
 
The distinctive structure of the jadomycins has inspired extensive study of their biosynthesis 
with jadomycin B 164 being the prototype. The polyketide synthase (PKS) genes which are 
accountable for jadomycin B 164 biosynthesis in Streptomyces venezuelae ISP5230 
(ATCC10712) were first cloned and characterized in 1994.94 Thereafter, more detailed 
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studies of the gene clusters were performed by Yang and co-workers.95 The genome 
sequence of Streptomyces venezuelae ISP5230 (ATCC10712) has recently been reported 
which assisted in the better understanding of the biosynthetic pathway of jadomycins.96  
 
Stressful conditions on Streptomyces venezuelae leading to induction of jadomycin 
production is quite unique, which suggests the presence of some sort of control 
mechanism.97 Evidence for this control mechanism can be found in the genetic code for 
jadomycin A 163. 196 Amino acid sequence (jadR2) is known to be encoded by an Open 
Reading Frame (ORF) upstream of type-II PKS, which resembles identified proteins like 
MtrR, AcrR, TetC, and TcmR. This jadR2 repressor gene in Streptomyces venezuelae 
regulates the resistance to xenobiotic exposure. When its nucleotide sequence was 
disrupted, jadomycin B 164 was formed, and overproduction was seen on exposed to 
ethanol stress.98 This outcomes leads to the conclusion that jadR2 negatively regulates the 
expression of biosynthetic genes coding for jadomycin B 164 in Streptomyces venezuelae. 97 
 
Studies conducted by Vining et al. in 2001 suggested a second regulatory gene (jadR1) 
encoding for 234 amino acids and found immediately upstream of the repressor gene 
(jadR2) may play a role.99 The mutants produced by disruption or deletion of jadR1 did not 
lead to the production of jadomycin B 164, suggesting that the gene acts as a positive 
regulator in the antibiotic biosynthesis. When a disrupted chromosomal copy of jadR1 was 
complemented with a cloned gene, recovery of the wildtype phenotype was observed. In 
addition, a negative effect on the growth of Streptomyces venezuelae occurred upon 
increasing the copy number of jadR1 in the plasmid. This investigation led to the conclusion 
that both jadR1 and jadR2 form an interacting stress-responsive regulatory system for the 
biosynthesis of jadomycin B 164.99 
 
Apart from the ORF responsible for encoding jadR1 and jadR2, there is complete ORF6 and 
two incomplete ORFs (ORF4 and ORF7). The amino acid sequences for ORF6 and ORF7 
resemble those of oxygenases. Transformation of Streptomyces venezuelae with an ORF6 
disruption vector gave a mutant that blocked jadomycin B 164 biosynthesis. Instead, the 
mutant accumulated a non-nitrogenous secondary metabolite rabelomycin 172, which is also 
produced by Streptomyces olivaceus.100 This suggested that rabelomycin 172 is an 
intermediate in the biosynthesis of jadomycin, where ORF4, ORF6, and ORF7 encode for 
oxygenases that are involved in the oxidative cleavage of the B ring in the angucycline to 
afford an aldehyde.101,102 Other steps in the biosynthesis of jadomycin B 164 are A 163 ring 
include dehydration/aromatization, isoleucine incorporation, oxazoline ring formation, and 
glycosylation. However, the specific order of these sequences is still in doubt. (Scheme 71). 
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First reported biosynthetic pathway of Jadomycin B 164 
 
Scheme 71 
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3.4 Approaches Towards the Total Synthesis of Jadomycins 
 
So far, there have been only two reported syntheses focused on the total synthesis of 
jadomycins. The first report came in 2010 by Ishikawa et al. where the synthesis of dimethyl 
protected jadomycin A 173 was accomplished.98 Later the same year O’Doherty et al. 
reported an efficient synthesis of jadomycin A 163 and the carbasugar analogue of 
jadomycin B 174. 69  
 
 
Dimethyl jadomycin A 173  Carbasugar analogue of jadomycin B 174 
 
Figure 27 
 
3.4.1 Ishikawa’s Approach98 
 
The approach described by Ishikawa utilizes an α-spirolactonedihydroquinone 175 as the 
key intermediate for building the jadomycin ring system as shown in Scheme 72. The route 
started with a palladium-catalyzed coupling of 5-methoxytetralone 176 with O-
bromobenzoate 177 leading to an enol-lactone intermediate 178 which after dihydroxylation 
and rearrangement led to spiro[lactone-tetralone]-type molecule 179. This molecule was 
subjected to bromination at the benzylic position, SN
2 displacement and later an allylic 
oxidation led to the generation of the key intermediate α-spirolactonedihydroquinone 175. 
This intermediate 175 was reduced with borane-tetrahydrofuran complex and the isoleucine 
methyl ester was hydrolyzed with lithium hydroxide to afford naphthoquinone derivative 180. 
Oxidation of this molecule to an aldehyde with manganese dioxide facilitated condensation 
of the aldehyde with the secondary amine to form an iminium system which was immediately 
trapped by carboxylate to form the dimethylated jadomycin A 173.98 Ishikawa described the 
first synthesis of dimethylated jadomycin A 173 using α-spirolactonedihydroquinone 175 as 
the key intermediate. It is not clear if this approach could be used for the synthesis of 
jadomycin. 
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Scheme 72: Reagents and conditions: A) Pd2(dba)3, xantphos, K3PO4, Na2S2O5, o-xylene, 
130 ºC, 5 hrs, 56%; B) OsO4/NMO, Acetone, rt, 7 d, 95%; C) 1) NBS, AIBN; 2) THF/H2; 3) 
IBX, DMSO, 59% in three steps; D) 1) BF3-THF, 36%, 0 ºC, 15 hrs, 41%; 2) 
methylisoleucine, LiOH, THF/H2O, 0 ºC, 1 d, 83%; E) MnO2, DCM, rt, 40 hrs, 61%.
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3.4.2 O’Doherty Approach69 
 
Synthesis of jadomycin A 163 and the jadomycin B carbasugar analogue 174 was carried 
out by O’Doherty et al. in 2010 as depicted in Scheme 73 and 74 respectively. Here the key 
reaction was a 6-π-electrocyclic ring closure. To commence with the synthesis, Stille 
coupling was employed between benzylated bromojuglone 25 and a suitably substituted 
stannane 181 which was made by directed-ortho metalation of MOM or BOM protected 3-
(1,3-dioxan-2-yl)-5-methylphenol 182. Acetal protection on the resulting tricyclic adduct 183 
was removed to generate an aldehyde 184, which was then condensed with butyl isoleucine 
185 which generated 186 via a 6-π-electrocyclic ring closure. The final steps were the acid 
promoted oxazole ring formation and debenzylation to obtain jadomycin A 163. 
 
88 
 
 
 
Scheme 73: Reagents and conditions: A) For R = MOMCl, DIPEA, DCM, rt, 12 hrs, 60%; 
For R = BOMCl, DIPEA, DCM, rt, 12 hrs, 70%; B) nBuLi, Bu3SnCl3, hexane, 0 ºC, 2 hrs, For 
R = MOM, 68%, For R = BOM, 49%; C) Pd2(dba)3, CHCl3, PPh3, CuI, THF, 75 ºC, 2 hrs, 
73%; D) HCl(aq.), CH3CN, rt, 4-8 mins, 77%; E) Toluene, rt, 24 hrs, 91%; F) TFA, rt, 74%.
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Synthesis of jadomycin B carbasugar analogue 174 was carried out by Stille cross-coupling 
of 2-bromo-5-hydroxynaphthalene-1,4-dione 24 with a suitably substituted stannane 181. On 
the resulting product 187, Mitsunobu reaction was carried out with previously synthesized 
cyclitol donor 188 to lead to the generation of stable product 189 which was then globally 
deprotected to generate 190. Subsequently the condensation of aldehyde 190 with protected 
isoleucine 185 and then a 6-π-electrocyclic ring closure resulted in the formation of the 
desired ring system 191. Finally acid-catalyzed transesterification leads to the formation of 
carbasugar analogue of jadomycin B 174 as described in Scheme 74. 
 
O’Doherty and co-workers successfully demonstrated the synthesis of jadomycin A 130 and 
the jadomycin B carbasugar analogue 174 employing a 6-π-electrocyclic ring closure as the 
key reaction.  
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Scheme 74: Reagents and conditions: A) Pd2(dba)3, CHCl3, PPh3, CuI, THF, 75 ºC, 2 hrs, 
For R = MOM, 76%, For R = BOM, 54%; B) PPh3, DIAD, THF, rt, 30 mins, For R = MOM, 
84%, For R = BOM, 91%; C) 2.4 M HCl/MeCN, 8 mins, For R = MOM, 56%, For R = BOM, 
59%; D) Toluene, rt, 4 hrs; E) TFA, rt, 2 hrs, 55%.69 
 
3.5 Synthesis of Phenanthrovirdin Aglycone 169 
 
As discussed previously, jadomycins, phenanthrovirdin 168 and its aglycone 169 are 
characterized by a common benzo[b]phenanthridine-7,12-dione 162 core. Due to structural 
intricacy and instability linked with jadomycins, mainly with the glycosidic bond, there have 
only been two total syntheses reported thus far. On the other hand, there have been a few 
successful approaches towards the synthesis of the substituted benzo[b]phenanthridine-
7,12-dione which is the common core in all the jadomycins.  
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3.5.1 Gore’s Approach86 
 
The first report on the synthesis of the phenanthrovirdin aglycon 169 came in 1991 authored 
Gore et al. The aglycone was constructed by initially coupling cyanophthalide 192 with 
previously synthesized substituted bromocinnamate 193 which was then followed by air 
oxidation to yield the quinone 194. The resulting molecule 194 was the reduced and 
methylated to generate the aromatic ether 195. Later, the ester was deprotected followed by 
functional group conversion into an amide to give 196. Subsequently, formylation was 
achieved by substitution of bromine to generate 197. Later, employing modified Hoffman 
rearrangement conditions carbamate was obtained 198 which on hydrolysis and cyclization 
generated ring B to give 199. Finally, deprotection and oxidation to quinone gave 
phenanthrovirdin aglycone 169. 
 
 
 
Scheme 75: Reagents and conditions: A) 1) LDA, THF, -78 ºC, 20 hrs, 68%; B) K2CO3/ 
Me2SO4, Na2S2O4, acetone, reflux, 24 hrs, 77%; C) 1) TBAF/THF; 2) Tf2O/pyridine; 3) NH3, 
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83%; D) 1) tBuLi; 2) DMF, 80%; E) NaOMe/Br2, MeOH; F) 1) H2O, reflux, 30 mins, 82% G) 
1) BBr3/ DCM, -78 ºC; 2) aq. NaOH, O2, -78 ºC, rt, quantitative yield.
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3.5.2 Valderrama’s Approach103 
 
Later in 1997, Valderrama  et al. reported the synthesis of the 8-
hydroxybenzo[b]phenanthridine-7,12-dione 200 framework along with minor product 201 by 
using a hetero Diels–Alder reaction as the key step as depicted in Scheme 76. The B ring 
was built by a regioselective [4+2] cycloaddition of N,N-dimethylhydrazone 202 with 5-
hydroxy-1,4-naphthoquinone 129 which was followed by air oxidation and aromatization. The 
remarkable regioselectivity of this cycloaddition reaction was attributed to the polarization of 
the azadiene and the directing effect of the free hydroxyl group present on juglone 129. 
 
 
 
Scheme 76: Reagents and conditions: CH3CN, air, 5 days. 
 
3.5.3 Mohri’s Approach104 
 
Mohri and co-workers also accomplished the synthesis of 1-methoxy-phenanthrovirdin 
aglycone 203 as shown in Scheme 77. Starting from commercially available substituted 
benzyl alcohol 204, oxaborole 205 was synthesized employing a directed orthometallation-
trimethylborate quench protocol. It was then coupled with 5-methoxybromojuglone 138 by 
doing a Suzuki-Miyaura cross-coupling reaction to furnish the biaryl axis 206. The molecule 
obtained was dissolved in aqueous ammonia leading to the generation of hydroquinone 207 
followed by treatment with manganese dioxide facilitated an oxidative cyclization to generate 
208. Later selective cleavage of the methylether was accomplished by using with BBr3 to 
generate the final product, 1-methoxy-phenanthrovirdin aglycone 203. 
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Scheme 77: Reagents and conditions: A) 1) nBuLi/Et2O, 0-25 ºC; 2) B(OMe)3, 42%; B) 
PdCl2, K2PO4, DMF, rt, 42%; C) NH3(aq.), MeCN, 50%; D) MnO2, DCM, 78%; E) BBr3, DCM, 
quantitative yield. 
 
3.5.4 de Frutos’s Approach105 
 
de Frutos et al. described the synthesis of phenanthrovirdin aglycone 169 in 2001 as shown 
in Scheme 78. The key step in this synthesis was a palladium-catalysed Stille coupling of 5-
methoxybromojuglone 138 with a sterically hindered arylstannane 209 which was 
synthesized from 3-hydroxy-5-methylbenzoic acid 210 over seven steps. The biaryl 
compound 211 obtained was treated with aqueous ammonia to afford an intermediate 
hydroquinone which was treated immediately with aqueous acid to facilitate the ring closure 
to afford 212. Lithium iodide in 2,6-lutidine effectively cleaved the MOM protection to yield 
the desired phenanthrovirdin aglycone 169. 
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Scheme 78: Reagents and conditions: A) 1) MeOH, H2SO4 (cat.), 23 °C, 14 hrs, 94%; 2) 
DHP, PPTS (cat.), DCM, 23 °C, 48 hrs, 63%; 3) LiAlH4, THF, 23 °C, 13 hrs, 93%; 4) PCC, 
NaOAc, DCM, 23 °C, 3 hrs, 81%; 5) 1,3-propanediol, TsOH (cat.), toluene, reflux, 3 hrs, 
74%; 6) Chloromethyl methyl etheriPr2EtN, DCM, 40 °C, 24 hrs, 80%; 7) nBuLi, nBu3SnCl, 
hexane, 0 °C, 97%; B) Pd(PPh3)4, CuI, THF, 70 °C, 12 hrs, 65%; C) 1) NH4Cl, NaOAc, 
EtOH, 80 °C, 12 hrs; 2) aq HCl, 3 hrs, 21%; D) LiI, 2,6-lutidine, 140 °C, 6 hrs, 63%.105 
 
3.6 Conclusion 
 
In conclusion, we have discussed the biological importance of jadomycins, their biosynthesis 
and various synthetic approaches towards the total synthesis of jadomycins or the 
benzophenanthridine core, the phenanthrovirdin aglycone 169. These polyketides are known 
for their extensive therapeutic applications and intrinsic structural features. Most of the 
synthetic approaches are known to be long with some harsh reaction conditions and often 
resulting in low yields. This is why developing new synthetic routes has always been a 
challenge for organic chemists. So, as a part of this PhD research programme we wished to 
develop a new methodology to synthesize benzo[b]phenanthridine 162 as found in 
jadomycins using the Suzuki-Miyaura cross coupling reaction as the key step as we had this 
expertise in our laboratories. 
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3.7 Aims 
 
From our previous discussion in this chapter we realized the biological importance and 
therapeutic application of the naphthoquinone molecule jadomycin. The discussion also 
outlined the fact that limited synthetic methods exist for the synthesis of 
benzo[b]phenanthridine-7,12-dione 162 motif and therefore we wished to conduct research 
on this problem. We later plan to extend our methodology to related complex molecules and 
hopefully towards the synthesis of the natural product itself. 
 
As outlined in Scheme 79, we could easily prepare 2-bromo-1,4-dimethoxynaphthalene 97. 
This could be utilized as the substrate for a Suzuki-Miyaura cross-coupling reaction with 2-
cyanophenylboronic acid 213 to generate the biaryl compound 214. Reduction of the nitrile 
214 to an amine 215, followed by re-generation of the quinone 216 by oxidation would allow 
for an intramolecular Michael addition to hopefully afford the desired 
benzo[b]phenanthridine-7,12-dione motif 162. 
 
Once the methodology was successfully tested and established by carrying it out on simple 
aromatic systems, we wish to extend it to more complex starting materials hoping to develop 
a general procedure for the synthesis of this class of compounds. 
 
Scheme 79 
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Chapter 4: Results and Discussion: Synthetic Approaches Towards the 
Benzo[b]phenanthridine-7,12-dione Core of Jadomycin 
 
The following Chapter will concentrate on the synthesis of the benzo[b]phenanthridine-7,12-
dione 129 motif which forms the backbone of important class of secondary metabolites the 
jadomycins known for their potent antibiotic, anti-cancer and enzyme-inhibitory activities.87,106  
 
 
 
Benzo[b]phenanthridine-7,12-dione 162 
 
Figure 28 
 
4.1 Attempted Synthesis Towards Benzo[b]phenanthridine-7,12-dione 162 
 
The synthetic scheme depicted below summarizes how we plan to synthesize the target 
benzo[b]phenanthridine-7,12-dione 162. Starting from the commercially available 1,4-
naphthoquinone 95 we planned to protect the starting material as 1,4-dimethoxynaphthalene 
96 followed by an ortho-bromination to afford 97. With the brominated compound in hand, 
we then wished to couple it with a relevant boronic acid, such as 2-cyanophenylboronic acid 
213 employing the palladium-catalyzed Suzuki-Miyaura cross coupling reaction to generate 
the aromatic compound 214 containing a biaryl axis. Reduction of the nitrile to an amine 215 
followed by oxidation of the 1,4-dimethoxynaphthalene to a naphthoquinone 216 could then 
be carried out. This compound would be an ideal substrate for an intramolecular Michael 
addition reaction leading to the formation of ring B and hence completing the synthesis of the 
benzo[b]phenanthridine-7,12-dione 162 moiety as described in Scheme 79. 
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Scheme 79 
 
The synthesis and characterization of 1,4-dimethoxynaphthalene 96 and 2-bromo-1,4-
dimethoxynaphthalene 97 have been described previously in Chapter 2. We will therefore 
focus on the synthesis of the benzo[b]phenanthridine-7,12-dione core 162 from the 
advanced precursor, 2-bromo-1,4-dimethoxynaphthanlene 97, in this section. 
 
4.1.1 Synthesis of 2-(1,4-Dimethoxynaphthalen-2-yl)benzonitrile 214. 
 
 
 
Scheme 80: Reagents and conditions: 2-Cyanophenylboronic acid, Pd(PPh3)4, 2 M aq. 
Na2CO3, DME, EtOH, reflux, 24 hrs, 51% or 2-cyanophenylboronic acid, Pd(PPh3)4, CsF, 
DME, microwave irradiations, 150 °C, 150 W, 30 mins, 76% 
 
Having 2-bromo-1,4-dimethoxynaphthalene 97 in hand we planned to construct the biaryl 
axis with commercially available 2-cyanophenylboronic 213 acid to obtain the 2-(1,4-
97 
 
dimethoxynaphthalen-2-yl)benzonitrile 214 motif. Initially, the reaction was carried out using 
conventional heating to facilitate the Suzuki-Miyaura cross coupling reaction. In this 
procedure tetrakis(triphenylphosphine)palladium(0) under inert conditions together with 2-
bromo-1,4-dimethoxynaphthalene 97 and 2-cyanophenylboronic acid 213 were dissolved in 
dry dimethoxyethane and ethanol and the reaction was stirred at room temperature for ten 
minutes. After this time, a 2 M aqueous sodium carbonate solution was added and the 
reaction was heated to reflux for twenty four hours. On completion of the reaction, as 
determined by thin layer chromatography, the mixture was quenched with water and the 
crude product was purified by column chromatography to afford the desired product 214 in a 
moderate yield of 51%.  
 
We were not able to improve the yields of this Suzuki-Miyaura cross coupling reaction by 
performing this reaction in the conventional reflux manner, by changing the reaction time and 
also by changing the solvent from dimethoxyethane to dimethyl formamide. In an attempt to 
improve the yield of the reaction, we decided to perform the reaction in a microwave 
reactor.48 2-Bromo-1,4-dimethoxynaphthalene 97, 2-cyanophenylboronic acid 213, palladium 
catalyst and cesium fluoride as the base were suspended in dry dimethoxyethane. The 
reaction mixture was heated up to 150 °C and irradiated at 150 W for thirty minutes after 
which time the reaction appeared to be complete as observed by thin layer chromatography. 
The desired product was isolated as yellow crystalline powder in an improved yield of 76%. 
Modification of the reaction conditions (temperature, power and time of the reaction) did not 
further improve the yield of the product. 
 
One disadvantage with the microwave procedure is that it could only be conducted on a 
small scale, with only 250 mg of starting material used in the reaction owing to the size of the 
microwave vial. The reaction was therefore repeated several times and the crude product 
was combined for purification. 
 
Also it was realized that 2.5 mL solvent was appropriate for the reaction as larger amounts of 
solvent did not stir well. Also this concentrated reaction mixture gave the maximum yield 
(76%) of the product 214. 
 
Characterization by 1H and 13C NMR spectroscopy confirmed the 
formation of the biaryl compound 214. Two peaks arising from the 
methoxy protons were prominent at 4.01 and 3.53 ppm respectively 
in the 1H NMR spectrum with peaks in the 13C NMR spectrum at 
98 
 
61.9 and 55.9 ppm. A key identifying feature came from the 13C NMR spectrum, where a 
peak was observed at 118.5 ppm which corresponded to the carbon of the nitrile group. 
Finally the proton on H-3’ gave rise to a singlet which appears upfield at 6.73 ppm with the 
corresponding carbon signal appearing at 105.4 ppm in the 13C NMR spectrum. On 
analyzing the FTIR spectrum of the product, a very prominent stretching band at 2225 cm-1 
was observed which clearly signifies the presence of a nitrile functionality. HRMS also 
confirmed the molecular formula of the compound. 
 
4.1.2 Synthesis of (2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanamine 215 
 
 
 
Scheme 81: Reagents and conditions: LiAlH4, dry THF, reflux, 6 hrs, 63%. 
 
Having successfully formed the biaryl axis with a nitrile substituent on the aromatic ring, our 
next step was to reduce the nitrile group of 214 to an amine 215. This reduction proved to be 
the most challenging step in our synthesis as the nitrile group was very resistant to reduction 
due to stabilization by conjugation with the aromatic ring. A variety of reducing agents were 
employed in attempts to reduce the nitrile functionality including the borane tetrahydrofuran 
complex, Raney nickel, palladium on carbon, sodium borohydride with nickel chloride and 
lithium aluminium hydride. Unfortunately none of these methods successfully reduced the 
cyanide into an amine functional group. We then attempted the use of lithium aluminium 
hydride in a ten fold excess and performed the reaction by heating under reflux in 
tetrahydrofuran. For this reaction we dissolved 2-(1,4-dimethoxynaphthalen-2-yl)benzonitrile 
214 in dry tetrahydrofuran and cooled the solution to 0 ºC. Lithium aluminium hydride was 
then added and the reaction mixture was allowed to warm up to room temperature before 
being heated at reflux for twelve hours. The progress of the reaction was monitored by thin 
layer chromatography and a new spot of lower Rf compared to the starting material was 
seen to be forming. This was expected as the amine functionality is much more polar than a 
nitrile functional group. 
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On completion of the reaction, purification by silica gel column chromatography was 
attempted. However this was not successful in obtaining the product in pure form. Also 
because of the sticky resinous nature of the product, attempts to purify the product by 
recrystallization were also unsuccessful. Owing to these issues we decided to treat the 
product as an intermediate and conducted the next step of the synthesis without further 
purification. For characterization we relied on FTIR which showed a very prominent broad 
peak characteristic of the amine functionality at 3400-3300 cm-1. A comparison with the FTIR 
of the starting material also showed that the reaction had been a success as no stretching 
band was observed in the region of 2260 cm-1 which is characteristic for the nitrile 
functionality. 
 
4.1.3 Attempted Synthesis of 2-(2-(Aminomethyl)phenyl)naphthalene-1,4-dione 216 
 
 
 
Scheme 82: Reagents and conditions: Ceric Ammonium Nitrate (CAN), CH3CN: H2O (1:1), 4 
hrs, rt, atmospheric condtions. 
 
After having successfully synthesized (2-(1,4-dimethoxynaphthalen-2-
yl)phenyl)methanamine 215 we were now in a position to oxidize the 1,4-
dimethoxynaphthalene system to the quinone 216 to obtain the required substrate for our 
intra-molecular Michael addition reaction. There are reports in the literature for this type of 
oxidation using ceric ammonium nitrate to produce a naphthoquinone from a protected 
hydroquinone.107 We therefore dissolved the starting material 215 in acetonitrile in an open 
vessel at room temperature and then added an aqueous solution of ceric ammonium nitrate. 
The reaction mixture immediately changed colour to bright orange, which was an indication 
that the reaction was proceeding. Analysis by thin layer chromatography showed that the 
starting material 215 had been consumed and a very bright spot of higher Rf than the 
starting material 215 had appeared. Happy with these observations, we isolated the new 
product after work-up and subjected it to purification by column chromatography. 
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To our surprise, the spectroscopic data did not show the expected signals in the 1H and 13C 
NMR spectra. All the peaks observed in the 1H and 13C NMR spectra were in the aromatic 
region. There were signals integrating for nine protons in the aromatic region of the 1H NMR 
spectrum and signals arising from sixteen carbons in 13C NMR spectrum. There were two 
characteristic signals for carbonyl carbons at 182.8 and 179.8 ppm respectively in the 13C 
NMR spectrum, which indicated that oxidation had in fact taken place. Characteristic peaks 
of the methoxy protons and carbons were also absent. 
 
It appeared that during the course of the oxidation facilitated by ceric ammonium nitrate, that 
the Michael addition reaction to afford a benzophenanthridine dione system had taken place. 
Much to our disappointment further characterization confirmed that the formation of 
benzo[c]phenanthridine-11,12-dione 217 and not the desired benzo[b]phenanthridine-7,12-
dione 162 has taken place.  
 
 
Figure 29 
 
Spectroscopic analysis of 217 showed all peaks in the aromatic 
regions of both the 1H and 13C NMR spectra. Two peaks at 182.8 
and 179.8 ppm in the 13C NMR spectrum suggested two aromatic 
carbonyl groups were present in the molecule probably as an ortho 
quinone. Confirmation that 217 was an ortho quinone came from 
HMBC analysis where it was observed that C-12 couples with H-1 as its three bonds away 
while C-11 does not couple with any proton. In case of 162 both the carbonyl carbons should 
show similar coupling pattern in the HMBC spectrum. We also tried to obtain the crystal 
structure of the compound 217 which indicated conclusively the arrangement of the rings as 
in 217 rather than 162. Unfortunately we were not able to obtain a final crystal structure of 
the molecule as the crystals were too thin to reveal the exact structure of the molecule.. 
Additionally, HRMS analysis of the product corresponded with the molecular formula of the 
product 217.  
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By performing column chromatography a second minor product was isolated from the 
reaction mixture and was identified to be 12-methoxybenzo[c]phenanthridine 218. The exact 
mechanism for this process is still not clear but a proposed mechanism for the formation of 
both 217 and 218 is outlined later. 
 
 
Scheme 83 
 
Spectroscopic results were found to be in agreement with 
literature.108 The 1H NMR spectrum of 12-
methoxybenzo[c]phenanthridine 218 shows the presence of a 
methoxy group with a singlet at 4.17 ppm integrating for three 
protons with the corresponding peak at 55.6 ppm in the 13C NMR 
spectrum. A singlet at 7.64 ppm in the 1H NMR spectrum was assigned to the proton H-11 
and correlated with the peak in the 13C NMR spectrum at 95.8 ppm. Carbons, C-12, C-6 and 
C-5 gave rise to the signals 154.7, 149.3 and 137.1 ppm respectively. The FTIR spectrum 
also clearly showed the ether functionality with a sharp peak at 1253 cm-1. HRMS analysis 
confirmed the correct mass for the product. However, structure validation was confirmed by 
single crystal X-ray crystallography (Figure 30). 
 
 
 
Single crystal X-ray of 12-methoxybenzo[c]phenanthridine 218 
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Figure 30 
 
A possible mechanism for the synthesis of benzo[c]phenanthridine-11,12-dione 184 and 185 
is outlined in Scheme 69. A similar mechanism of reaction was proposed by Johnson et 
al.109 The ceric ammonium nitrate -mediated oxidation of 215 is believed to initially afford the 
radical cation 219 Nucleophilic addition of lone pair of electrons of the amine group to the 
aromatic radical cation of 182 will result in the radical intermediate 220, which on elimination 
of methanol provides intermediate 221 which then undergoes aromatization to afford the 
minor product 218. Further oxidation will then allow for the formation of 
benzo[c]phenanthridine-11,12-dione 217 in the presence and oxygen (from atmosphere) but 
the exact mechanism for this step is not very clear (Scheme 84).  
 
 
Scheme 84  
 
Watanabe et al. in 2003 also demonstrated the synthesis of 3,4,13-trimethoxy-5-methyl-5,6-
dihydrobenzo[c][1,3]dioxolo[4,5-j]phenanthridine 222 and 3,4,13 
trimethoxybenzo[c][1,3]dioxolo[4,5-j]phenanthridine 223, which are similar molecules like 
218.110 
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Figure 31 
 
The successful synthesis of the ortho quinone benzo[c]phenanthridine-11,12-dione 218, 
raises the issue of possible important applications of compounds possessing an ortho 
quinone moiety. In the literature there are examples where compounds containing 
precursors to the ortho quinone fragment have very important biological consequences. 
 
For example, dopamine 224 which is responsible for the synthesis of neuromelanin, takes 
place by oxidation of dopamine 224 to its ortho quinone 225, as shown in Scheme 85 
followed by an intramolecular Michael addition type cyclization to form leucochrome 226. 
Leucochrome 226 which gets oxidized into aminochrome 227 and further polymerises into 
neuromelanin, which is a pigment of substantia nigra (Scheme 85). Disregulation of this 
process leads to the ortho quinone 225 binding to DNA and could possibly cause mutations 
that could initiate neuro degradation disorders such as Parkinson’s disease.111 
 
 
Scheme 85  
 
VPQ 229 is another example of an ortho qunone, which is a metabolite of known anti-cancer 
drug etoposide (VP-16) 228. Etoposide 228 constitutes an important class of anti-cancer 
agents and acts by trapping topoisomerase II/DNA complex. This process takes place by 
104 
 
conversion of etoposide 228 to metabolite VPQ 229 which is a powerful inhibitor of 
topoisomerase (Figure 32).112 
 
 
 
Figure 32  
 
Considering the significance as illustrated by these two examples of ortho quinones in 
biology we speculate that the synthesized benzo[c]phenanthridine-11,12-dione 217 could 
have uses in medicinal chemistry and other related fields. The area needs to be explored in 
the future. 
 
4.2 B Ring Formation In Benzo[b]phenanthridine-7,12-dione 162 Skeleton. 
 
It was reported in 2001 by de Frutos et al. that 1,10-dimethoxy-8-methyl-11,12-
dihydrobenzo[c]phenanthridin-12-ol 230 was isolated, when ammonia was added to 3-
methoxy-2-(5-methoxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-5-methylbenzaldehyde 231 
(Scheme 84) in an attempt to use a Michael-type reaction in order to synthesize the 
benzo[b]phenanthridine-7,12-dione 162 framework.105 
 
Scheme 84: Reagents and conditions: NH4OAc, HOAc, 118 °C, 24 hrs. 
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In 2010, O’Doherty and co-workers also suggested that the benzo[c]phenanthridine 
framework would be isolated when trying to synthesize ring B in benzo[b]phenanthridine-
7,12-dione 162. This reaction proceeds via 6-exo-trig cyclization process.69 
 
From all the studies directed either towards the total synthesis of jadomycins or the 
synthesis of the phenanthrovirdin core 168, it can be concluded that, for reasons pertaining 
to stereoelectronics, the B ring should be constructed from the cyclization of a 2-amino-3-
phenyl-naphthoquinone 231.105 rather than onto the 3-position of an anthraquinone 216, 
where 6-exo-trig cyclization takes place to give benzo[c]phenanthridine 232 (Scheme 
84).69,105  
 
 
 
 
 
Scheme 84  
 
The findings by de Frutos et al. and O’Doherty et al. thus demonstrated that the result we 
obtained by having synthesized benzo[c]phenanthridine-11,12-dione 217 and 12-
methoxybenzo[c]phenanthridine 218 was not totally unexpected.  
 
4.3 Attempted Synthesis of Benzo[b]phenanthridine-7,12-dione 162 Using the 
Buchwald-Hartwig Reaction 
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In our quest to synthesize benzo[b]phenanthridine-7,12-dione 162, we had to go back and 
look for an alternative route as our proposed route failed to give us the desired product. As a 
possible option we utilized the previously prepared 2-(1,4-dimethoxynaphthalen-2-
yl)benzonitrile 214 and attempt to brominate the position ortho to the methoxy group of the 
naphthalene as this ring is electron rich. This compound 233 could then be subjected to 
conditions to reduce nitrile 233 into an amine 234. This molecule could then be subjected to 
the conditions of Buchwald-Hartwig amination reaction which would result in cyclization in 
the presence of the palladium catalyst leading to the generation of ring B of 235. Then this 
could then be oxidized to afford the desired benzo[b]phenanthridine-7,12-dione 162 
(Scheme 85). 
 
 
Scheme 85 
 
4.3.1 Synthesis of 2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)benzonitrile 233 
 
 
 
Scheme 86: Reagents and conditions: NBS, CH3COONa, acetic acid, rt, 4 hrs, 83%. 
 
We therefore attempted bromination of the previously prepared 2-(1,4-dimethoxynaphthalen-
2-yl)benzonitrile 214 as it is known that on the electron rich naphthalene ring the methoxy 
group is ortho directing and in this case the C-3’ position is the only electron rich site 
favorable for the desired bromination. The reaction was carried out by dissolving the starting 
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material in acetic acid. N-Bromosuccinimide and sodium acetate were added to this stirred 
solution at room temperature under inert conditions and left to stir for four hours before being 
quenched. The desired product 233 was isolated from the reaction mixture by column 
chromatography purification. 
 
The structure of the product 233 was confirmed by NMR 
spectroscopy by the disappearance of a singlet at 6.73 ppm in the 
1H NMR spectrum, characteristic of the proton ortho to the methoxy 
group. This clearly proved that the substitution reaction has taken 
place. Also, signals occurring for one less proton compared to the 
starting material 2-(1,4-dimethoxynaphthalen-2-yl)benzonitrile 214 were visible in the 
aromatic region of the 1H NMR spectrum. Two methoxy gave rise to signals at 3.99 and 3.58 
ppm in 1H NMR spectrum and at 62.1 and 62.1 ppm in the 13C NMR spectrum. 
 
4.3.2 Synthesis of (2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)phenyl)methanamine 
234 
 
 
 
Scheme 87: Reagents and conditions: LiAlH4, dry THF, 5 hrs, 34% 
 
After the successful introduction of the bromine at the position ortho to the methoxy group, 
the following reduction of the nitrile group to an amine was carried out as described 
previously. Once again, purification of the amine 234 proved difficult and this product 234 
was treated as an intermediate. Progress of the reaction was monitored by thin layer 
chromatography and it was observed that a spot appeared at very low Rf compared to the 
starting material. A prominent broad peak at 3521 cm-1 was observed in the FTIR spectrum 
which indicated the presence of the amine functionality in the molecule. The compound 234 
was used without further purification in the subsequent step. Also, the reaction was low 
yielding (34%) despite several attempts to improve the yield by increasing/decreasing 
reaction time, increasing equivalents of lithium aluminium hydride, but this did not improve 
matters. 
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4.3.3 Attempted Synthesis of 7,12-Dimethoxy-5,6-dihydrobenzo[b]phenanthridine 235 
 
 
Scheme 88: Reagents and conditions: Pd(OAc)2, BINAP, Cs2CO3, toluene, reflux, 3 days, 
inert conditions. 
 
With the desired amine in hand, we wished to apply the Buchwald-Hartwig amination 
reaction conditions on the aromatic bromine 234 to afford the desired ring closed product 
235. There have been examples of this type of coupling reaction reported in the literature for 
both intermolecular and intramolecular Buchwald-Hartwig amination coupling reactions as 
shown in two examples in Scheme 89 and Scheme 90.113,114 
 
 
 
Scheme 89: Reagents and conditions: cat. Pd(OAc)2, BINAP, Cs2CO3, Toluene, reflux, 2 
days, inert conditions. 
 
 
 
Scheme 90: Reagents and conditions: cat. Pd(OAc)2, CuI, K2CO3, 81%. 
 
In order to attempt the synthesis of 7,12-dimethoxy-5,6-dihydrobenzo[b]phenanthridine 235 
we conducted the reaction under Buchwald-Hartwig reaction conditions the with catalytic 
palladium acetate and BINAP in toluene. To this solution, a degassed solution of [2-(3-
bromo-1,4-dimethoxynaphthalen-2-yl)phenyl]methanamine 234 in dry toluene was added. 
109 
 
The solution was stirred at room temperature before adding cesium carbonate to the 
reaction mixture, which was then heated to reflux and left to stir for two days. Unfortunately, 
starting material 234 was not consumed during the reaction. Variations on the procedure 
were attempted including the use of tetrakis(triphenylphosphine)palladium(0) and a range of 
solvents without success. Although disappointed we once again searched the literature for 
alternative procedures. 
 
Reports have been documented where nucleophilic substitution reactions with halogenated 
1,4- quinones have been carried out under aqueous conditions as show in Scheme 
91.115,116,117  
 
 
 
Scheme 91: Reagents and conditions: water, rt, 15 mins, 100% 
 
The reaction is known to proceed by nucleophilic displacement of the halogen atom with a 
nitrogen nucleophile (Scheme 92).114 
 
 
 
Scheme 92 
 
With this information in hand, we decided to see if this approach would be feasible on our 
precursor for the synthesis of benzo[b]phenanthridine-7,12-dione 162. Oxidation of the 1,4-
dimethoxy system of (2-(3-bromo-1,4-dimethoxynaphthalen-2yl)phenyl)methanamine 234 to 
the 1,4-quinone system 236 could give us a substrate 236 for this cyclization reaction, which 
would result in the generation of ring B by nucleophilic substitution in the presence of water 
generating product 237. Oxidation of the secondary amine generated could give us our 
desired product, benzo[b]phenanthridine-7,12-dione 162 (Scheme 78). 
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Scheme 93 
 
4.3.4 Attempted Synthesis of 2-(2-(Aminomethyl)phenyl)-3-bromonaphthalene-1,4-
dione 236 
 
 
 
Scheme 94: Reagents and conditions: PIFA, CH3CN: H2O (1:1), rt, 2 hrs, 56% 
 
The first step in the synthesis of our substrate for the intramolecular nucleophilic substitution 
reaction was the oxidation of (2-(3-bromo-1,4-dimethoxynaphthalen-2-
yl)phenyl)methanamine 234 to the 2-(2-(aminomethyl)phenyl)-3-bromonaphthalene-1,4 
dione 236. To achieve this, we used phenyliodine bis(trifluoroacetate) which has been used 
to oxidize hydroquinones to quinones.107. Using this reagent and the conditions specified in 
the experimental a product was isolated which was bright orange in colour which suggested 
that we may have produced our desired quinone as many quinones are bright orange or 
yellow in colour. However, when we characterized it by NMR spectroscopy, we were happy 
to observe that the product obtained in 56% yield was not 2-(2-(aminomethyl)phenyl)-3-
bromonaphthalene-1,4-dione 236 rather benzo[b]phenanthridine-7,12-dione 162 which was 
further confirmed by X-ray crystallography. 
 
111 
 
In both the 1H and 13C NMR spectra, there were no signals 
observed for benzylic protons or carbons. Also the two protons 
previously observed for the amine group were not present in the 1H 
NMR spectrum. Both 1H and 13C NMR spectra indicated the 
presence of a complete aromatic framework with the two carbonyl 
carbons giving rise to signals at 186.2 and 182.3 ppm for C-12 and C-7 respectively. A 
singlet was observed downfield at 9.58 ppm in the 1H NMR spectrum which could be due to 
proton H-1. 
 
The structure of the product was confirmed by X-ray crystallography (Figure 31). The crystal 
was obtained from slow evaporation in chloroform.  
 
 
Single crystal X-ray of benzo[b]phenanthridine-7,12-dione 162 
 
Figure 31 
 
It appeared, not unexpectedly that during the course of the reaction three reactions took 
place consecutively in one pot. The first reaction was oxidation of the 1,4-
dimethoxynaphthalene 234 into a 1,4-naphthoquinone 236 induced by phenyliodine 
bis(trifluoroacetate). This was followed by an intra-molecular substitution reaction, where the 
nitrogen nucleophile displaced the bromine atom leading to 237. Finally, the secondary 
amine 237 would have been oxidized by phenyliodine bis(trifluoroacetate) to give 162. So, to 
summarize, we managed to isolate our desired product 162 in one step from (2-(3-bromo-
1,4-dimethoxynaphthalen-2-yl)phenyl)methanamine 234 when we were planning to carry out 
three individual reactions namely; oxidation, ring cyclization and re-oxidation. 
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Scheme 95 
 
4.4 Synthesis Towards 8-Hydroxybenzo[b]phenanthridine-7,12-dione 238 
 
Having successfully synthesized the desired framework of the jadomycin antibiotics, we 
wanted to test our methodology on a more complex system. The synthesis of 8-
hydroxybenzo[b]phenanthridine-7,12-dione 238 could be achieved using this methodology 
starting from benzyl protected and 2-brominated juglone 26. Reduction of the quinone and 
subsequent protection with methyl groups affords 5-(benzyloxy)-2-bromo-1,4-
dimethoxynaphthalene 26 as discussed in Chapter 2. We envisaged that 5-(benzyloxy)-2-
bromo-1,4-dimethoxynaphthalene 26 could be subjected to a Suzuki-Miyaura cross coupling 
reaction with 2-cyanophenyl boronic acid 213 to afford 239. This molecule could then be 
subjected to bromination, which we anticipated would afford a product 240 with the bromine 
atom ortho to the methoxy group. The nitrile functional group could then be reduced to afford 
an amine 241. Compound 241 could then be treated with phenyliodine bis(trifluoroacetate) to 
afford the desired 8-(benzyloxy)benzo[b]phenanthridine-7,12-dione 242. Finally, the benzyl 
group could be cleaved to afford the free hydroxyl group as shown in Scheme 96. 
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Scheme 96 
 
4.4.1 Synthesis of 2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzonitrile 239 
 
 
 
Scheme 97: Reagents and conditions: 2-Cyanophenylboronic acid, Pd(PPh3)4, CsF, DME, 
microwave irradiations, 150 °C, 150 W, 30 mins, 95%. 
 
With the advanced substrate for the Suzuki-Miyaura cross coupling reaction in hand, we 
subjected 5-(benzyloxy)-2-bromo-1,4-dimethoxynaphthalene 26 to 2-cyanophenyl boronic 
acid 213 in the presence of palladium(0) catalyst and base under microwave irradiation 
conditions. Under the above mentioned conditions product 239 was furnished as a yellow 
solid in 95% yield. 
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Characterization of the product was easily done using 1H and 13C 
NMR spectroscopy. Notably, four additional protons in the 
aromatic region of 1H NMR spectra were observed, originating 
from the cyanophenyl moiety. Additionally, there are two singlets 
at 3.89 and 3.42 ppm integrating for six protons in total 
accounting for the two methoxy groups and a singlet at 5.16 ppm 
for the two benzylic protons in the 1H NMR spectrum. A singlet at 
6.71 ppm which represents the proton H-3’ was also observed in 
the 1H NMR spectrum. In the 13C NMR spectrum, twenty six peaks are visible which 
accounts for number of carbons expected for the product. Three peaks at 156.3, 153.5 and 
147.1 ppm represent the three aromatic carbons attached directly to oxygen: C-4’, C-1’ and 
C-5’ respectively. Two peaks at 61.7 and 56.7 ppm represent the two methoxy carbons, 
while the benzylic carbon appears as a signal at 71.6 ppm. The nitrile carbon could be seen 
as a signal at 119.2 ppm. 
 
After the successful synthesis of 2-(5-(benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzonitrile 
196, we were now able to attempt brominate at carbon C-3’ using the same procedure as we 
used for 2-(1,4-dimethoxynaphthalen-2-yl)benzonitrile 233. Unfortunately, after a number of 
attempts and variations on the method we never managed to obtain the desired product. It 
was concluded that the addition of an extra electron donating substituent on the other ring of 
the naphthalene was leading to multiple bromination products. It was also possible that the 
benzyl substituent allowed for bromination to take place on this protecting group. 
 
4.5 Synthesis Towards 8-Methoxybenzo[b]phenanthridine-7,12-dione 243 
 
At this point, we decided to abandon the steps described in Scheme 96 and start the 
synthesis with a different protecting group such as a simple methyl which is less bulky and 
would not allow for bromination. The remainder of the synthetic scheme would be carried out 
as before to afford the desired substrate for the coupling reaction, 2-bromo-1,4,5-
trimethoxynaphthalene 80. The synthesis and characterization of 2-bromo-1,4,5-
trimethoxynaphthalene 80 has been previously discussed in Chapter 2. Suzuki-Miyaura 
cross coupling of 2-bromo-1,4,5-trimethoxynaphthalene 80 with 2-cyanophenyl boronic acid 
213 would give us the required biaryl compound 244, which could be subjected to a 
bromination reaction to introduce bromine ortho to the methoxy group to generate 245. 
Reduction of the cyano group to an amine 246 followed by oxidation using phenyliodine 
bis(trifluoroacetate) would afford 243. The methoxy group could be removed in a final 
deprotection step to yield the desired product 238 as shown in Scheme 98. 
115 
 
 
Scheme 98 
 
4.5.1 Synthesis of 2-(1,4,5-Trimethoxynaphthalen-2-yl)benzonitrile 244 
 
 
 
Scheme 99: Reagents and conditions: 2-Cyanophenylboronic acid, Pd(PPh3)4, CsF, DME, 
microwave irradiations, 150 °C, 150 W, 30 mins, 85% 
 
Having 2-bromo-1,4,5-trimethoxynaphthalene 80 in hand, we subjected this to the conditions 
of the Suzuki-Miyaura cross coupling reaction with 2-cyanophenylboronic acid 213 to form 
the biaryl axis found in compound 244. The product 244 was prepared using the microwave 
procedure previously used to afford after work up and purification by column 
chromatography, the product 200 as white solid in 85% yield. 
 
Characterization of the resulting product by NMR spectroscopy 
confirmed that the coupling reaction had been successful. 
Characteristic peaks for methoxy protons as singlets could be seen 
at 4.00, 3.99 and 3.50 ppm in the 1H NMR spectrum with peaks in 
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the 13C NMR spectrum visible at 61.64, 56.98 and 56.63 ppm respectively. The proton H-3’ 
could be identified as a singlet at 6.79 ppm in the 1H NMR spectrum. Carbons C-4’, C-1’ and 
C-5’ gave rise to signals with characteristic chemical shifts of 157.5, 153.4 and 147.2 ppm in 
the 13C NMR spectrum respectively. 
 
4.5.2 Attempted Synthesis of 2-(3-Bromo-1,4,5-trimethoxynaphthalen-2-yl)benzonitrile 
245 
 
 
Scheme 100: Reagents and conditions: NBS, CH3COONa, acetic acid, rt, 4 hrs. 
 
After the successful construction of the biaryl axis of 244, the following step was the 
bromination at the position ortho to the methoxy group to provide us with the substrate 245 
for the intramolecular substitution reaction. The reaction was carried out the same way as 
described previously for the synthesis 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)benzonitrile 
233 by dissolving the starting material in acetic acid followed by the addition of sodium 
acetate and N-bromosuccinimide. The reaction was stirred at room temperature for four 
hours but unfortunately no change was observed by thin layer chromatography. The reaction 
mixture was then heated to reflux, however this led to decomposition of the starting material 
244. At this stage we decided to proceed with the reduction of the nitrile 244 to an amine 247 
and we would then attempt bromination on the reduced compound 247 as shown in Scheme 
101. 
 
4.5.3 Synthesis of (2-(1,4,5-Trimethoxynaphthalen-2-yl)phenyl)methanamine 247 
 
 
 
Scheme 101: Reagents and conditions: LiAlH4, dry THF, reflux, 6 hrs, 58%  
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Having previously reduced the nitrile functionality for example in 2-(1,4-
dimethoxynaphthalen-2-yl)benzonitrile 215 using an excess of lithium aluminium hydride, we 
knew that the reduction of 2-(1,4,5-trimethoxynaphthalen-2-yl)benzonitrile 244 would require 
similar conditions. Therefore, the starting material 244 in tetrahydrofuran and a large excess 
of the lithium aluminium hydride was added and the reaction mixture was heated at reflux for 
six hours. The crude product was isolated by basic work up, but attempts to purify the 
product 247 by column chromatography failed. NMR spectroscopic analysis of the crude 
product 247 confirmed formation of amine by the appearance of signals arising from the 
benzylic carbon and protons in NMR spectra of the product 247. As before, therefore we 
treated the amine as an intermediate and carried the crude product into the next step without 
further purification as all the attempts failed owing to sticky resinous nature of the product 
247. 
 
4.5.4 Attempted Synthesis of (2-(3-Bromo-1,4,5-trimethoxynaphthalen-2-
yl)phenyl)methanamine 246 
 
 
 
Scheme 102: Reagents and conditions: Br2, CCl4, 0 ºC, 15 mins. 
 
As we had been unable to brominate 2-(1,4,5-trimethoxynaphthalen-2-yl)benzonitrile 244, 
we now attempted bromination of the reduced compound (2-(1,4,5-trimethoxynaphthalen-2-
yl)phenyl)methanamine 247. The amine 246 obtained was an extremely polar molecule, and 
was found to be insoluble in most of the organic solvents except for acetic acid. When the 
reaction was carried out under the above mentioned conditions with N-bromosuccinimide 
and sodium acetate in acetic acid the expected product was not formed. Even variations in 
the procedure did not help in the reaction.  
 
We therefore decided to attempt intramolecular nucleophilic substitution reaction on (2-
(1,4,5-trimethoxynaphthalen-2-yl)phenyl)methanamine 247 using phenyliodine 
bis(trifluoroacetate) rather than ceric ammonium nitrate. As phenyliodine bis(trifluoroacetate) 
is much milder oxidizing agent compared to ceric ammonium nitrate, and we were curious to 
know whether this reagent could provide us with the desired product 246.  
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4.5.5 Attempted Synthesis of 8-Methoxybenzo[b]phenanthridine-7,12-dione 243 
 
 
 
Scheme 103: Reagents and conditions: PIFA, CH3CN: H2O (1:1), rt, 4 hrs, 63% 
 
The final reaction leading to ring closure and re-oxidation was attempted on (2-(1,4,5-
trimethoxynaphthalen-2-yl)phenyl)methanamine 247 by dissolving it in acetonitrile and 
adding phenyliodine bis(trifluoroacetate) dissolved in water. The reaction was stirred for four 
hours and progress was monitored by thin layer chromatography. The starting material 247 
was consumed and a new very bright red spot of higher Rf appeared, which was isolated and 
purified by column chromatography to afford a very bright red solid, which we anticipated to 
be a benzophhenanthridine, in 63% yield. 
 
The product obtained was characterized by NMR spectroscopy. It 
was clearly evident that we had formed a quinone as in both 1H and 
13C NMR spectra there were peaks for only one methoxy group 
compared to three in the starting material 247. Furthermore, in the 
13C NMR spectrum signals at 184.1 and 179.7 ppm characteristic of 
carbonyl carbons were visible. Eight protons could be seen in the aromatic region of the 1H 
NMR spectrum with fifteen carbon peaks observed in the aromatic region of the 13C NMR 
spectrum. However, although the NMR spectroscopic evidence indicated that ring cyclization 
had taken place along with oxidation, we were still not very sure of the arrangement of the 
rings in the product, as both 8-methoxybenzo[b]phenanthridine-7,12-dione 243 and 1-
methoxybenzo[c]phenanthridine-11,12-dione 248 could have formed as shown in Figure 32.  
 
 
 
Figure 32 
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A crystal structure was obtained for the product we had isolated and confirmed that the 
actual product that had formed during the reaction was reaction was not unexpected but 
disappointingly 1-methoxybenzo[c]phenanthridine-11,12-dione 248 (Figure 33).  
 
Isolation of the 1-methoxybenzo[c]phenanthridine-11,12-dione 248 and 
benzo[c]phenanthridine-11,12-dione 217 using this method suggested that without the 
bromine substituent, the 6-endo trig cyclization is favored. In order to isolate the desired 
benzo[b]phenanthridine-7,12-dione 162 the presence of a halogen at the position ortho to 
the methoxy group appears to be essential. 
 
 
 
Single crystal X-ray structure of 1-methoxybenzo[c]phenanthridine-11,12-dione 248 
 
Figure 33 
 
4.6 Conclusion 
 
Chapter 4, addressed the synthetic approaches taken towards the benzo[b]phenanthridine-
7,12-dione 162, which constitutes the core of the jadomycin antibiotics using time and cost 
efficient methodology. We also tried to extend the methodology towards the synthesis of 8-
methoxybenzo[b]phenanthridine-7,12-dione 238, but resulted in the synthesis of the 1-
methoxybenzo[c]phenanthridine-11,12-dione 248 framework. The complete synthesis of 1-
methoxybenzo[c]phenanthridine-11,12-dione 248 and benzo[c]phenanthridine-11,12-dione 
217 also sheds some light on the dynamics of the ring closure in the phenanthrovirdin 
aglycone 169. 
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Chapter 5: Introduction, Literature Reviews and Aims: Benzo[i]phenanthridines 
 
5.1 Topoisomerase I-Targeting Activity 
 
The topological state of DNA is regulated by DNA topoisomerases, enzymes that catalyze 
and regulate the breaking and rejoining of DNA strands.118 These enzymes are also involved 
in controlling the template supercoiling during RNA transcription.119 On the basis of 
difference in their initial mechanisms where a single or double-stranded DNA break is 
implicated, there are two major subtypes of this class of nuclear enzymes, topoisomerase I 
(TOP I) and topoisomerase II (TOP II). Both these enzymes are major targets of many anti-
cancer drugs.120 The anticancer activity of topoisomerase targeting agents is based on their 
ability to stabilize the enzyme-DNA cleavable complex. This drug induced stabilization of the 
enzyme-DNA cleavable complex changes these essential components of the replication 
machinery of the cell into a cellular poison.121  
 
Camptothecin 249, an alkaloid, was first isolated from the stem wood of Camptotheca 
acuminata, by Wall et al. in 1966, and was found to exhibit potent antileukemic and 
antitumour activities in animals.122 Later, it was found to be strong inhibitor of nucleic acid 
synthesis in mammalian cells, and a potent inducer of strand breaking in chromosomal DNA. 
It acts by blocking the rejoining step of the breakage-reunion reaction of mammalian DNA 
TOP I which ultimately leads to cell death.123,124 
 
 
 
Camptothecin 207 
 
Figure 34 
 
Camptothecin 249 has been studied extensively and it has resulted in the development of 
structurally related analogues and in the development of two clinical TOP 1-targeting drugs, 
topotecan 250 (hycamptin) and irinotecan 251 (CPT-11/camptosar) (Figure 35).124,125  
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Topotecan 250     Irinotecan 251 
 
Figure 35 
 
These clinical agents, topotecan 250 and irinotecan 251, incorporate the camptothecin ring 
system, which includes the presence of an δ-lactone. During drug metabolism, hydrolysis of 
this lactone takes place which results in an inactive derivative that possesses high affinity for 
human serum albumin. Both topotecan 250 and irinotecan 251 suffer from metabolic 
instability and are substrates for efflux transporters associated with multidrug resistance. 
This disadvantage of these clinical drugs has encouraged further studies on the 
development of novel TOP I-targeting agents.126,127  
 
5.2 Non-camptothecin TOP I-Targeting Agents. 
 
Although camptothecin derivatives are widely used clinically for anti-tumour intervention, 
their drawbacks: lack of chemical stability, toxicity, severe drug resistance and other 
undesirable side effects have paved the way for the generation of non-camptothecin based 
TOP I-targeting agent with better pharamacokinetic and pharmacological profiles.128 
 
The most encouraging scaffolds identified as non-camptothecin TOP I-targeting agents are 
indolocarbazoles, indenoisoquinolines, and phenanthridines 252.129 
 
The phenanthridine skeleton 252 forms a small but important class of a heterocycles found 
in a large number of naturally occurring and bioactive compounds showing widespread 
pharmacological activities and applications.130 
 
122 
 
 
Phenanthridine 252 
 
Figure 36 
 
The phenanthridine ring system forms the basis of ethidium bromide 253 and propidium 
iodide 254, both of which are used extensively in molecular biology laboratories as nucleic 
acid stains and act by binding to double stranded DNA by intercalating between the base 
pairs.131 
 
 
 
   Ethidium bromide 253          Propidium iodide 254 
 
Figure 37 
 
Alkaloids such as nitidine chloride 255, chelerythrine chloride 256 and sanguinarine chloride 
257 also have a phenanthridine ring system fused to a benzene ring or other heterocyclic 
compounds and are known for their high biological importance.130,131  
 
 
Nitidine chloride 255  ….Chelerythrine chloride 256………Sanguinarine chloride 257 
 
Figure 38 
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Nitidine chloride 255 is a benzophenanthridine alkaloid found in species of the genus 
Zanthoxylum, notably in Zanthoxylum nitidum, and is a known TOP I inhibitor as well as a 
potential anti-malarial agent. Its capacity to complex haem and inhibit β-haematin formation 
suggests a mechanism of action similar to that of chloroquine.132,133 
Chelerythrine chloride 256 is a benzophenanthridine alkaloid extracted from greater 
celandine (Chelidonium majus) and is known for its potent, and selective protein kinase C 
inhibition.134  
 
Sanguinarine chloride 257, an alkaloid isolated from bloodroot plant Sanguinaria 
canadensis, possesses remarkable anticancer effects along with antimicrobial, anti-
inflammatory and antioxidant properties.135 
 
Numerous 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones have been recognized as 
active TOP I-targeting agents having exceptionally good anti-tumour activity, including 
dibenzo[c,h][1,6]naphthyridin-6-one (ARC-111, topovale) 258 and the 11-aza analogue of 
ARC-111, isoquino[4,3-c]cinnolin-12-one 259 and related compounds.136 
  
 
 
         ARC-111, topovale 258   Isoquino[4,3-c]cinnolin-12-one 259 
 
Figure 39 
 
Replacing the C-ring of topovale with a phenyl group results in benzo[i]phenanthridine 
containing compounds such as 260 and 261 (Figure 40), which have also shown 
comparable TOP I-targeting activity to camptothecin 249 or topovale 258.128,137 
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   260      261 
 
Figure 40 
 
Substituted benzo[i]phenanthridines have been known to possess TOP I-targeting activity 
and cytotoxicity against a number of human tumour cell lines.138 AR-VIII-83 262, which also 
has a benzo[i]phenanthridine skeleton has the potential to be further developed as a non-
camptothecin TOP I-targeting agent, owing to the promising biological activities associated 
with it. The occurrence of the aminoalkyl group attached to the 12-carboxamide provides the 
much needed hydrophilic character to the compound improving the pharmacokinetics of the 
compound.136 
 
 
 
AR-VIII-83 262 
 
Figure 41 
 
LaVoie and co-workers have explored this fact of, improving pharmacokinetic properties by 
introducing hydrophilic groups, by making numerous analogues of nitidine 255 in the form of 
substituted benzo[i]phenanthridines which have also shown potential TOP I inhibition 
activity.121,124,138,139,140,137  
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A few representatives of the molecules containing a benzo[i]phenanthridine framework that 
were synthesized by LaVoie and co-workers having TOP I inhibitor activity are shown in 
Figure 42. 
 
                 
 
                  
 
Figure 42 
 
5.3 Selected Synthetic Approaches to the Benzo[i]phenanthridine Ring System 
 
The importance of benzo[i]phenanthridine 263 ring system as a TOP I inhibitor prompted us 
to consider the use of a novel approach for the synthesis of this class of compounds. In the 
following section, selected reported synthetic approaches towards the 
benzo[i]phenanthridines 263 will be discussed. 
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Benzo[i]phenanthridine 263 
 
Figure 43 
 
5.3.1 Li et al. Approach Towards the Synthesis of Benzo[i]phenanthridine 
Derivatives.141 
 
Li et al. proposed the use of substituted o-nitrostannanes 264 for the preparation of a variety 
of substituted phenanthridine and benzo[i]phenanthridine derivatives. Reaction of 264 with 
2-bromo-1-naphthaldehyde 265 generated substituted 2-(2-nitrophenyl)-1-naphthaldehydes 
266. Subsequent treatment of these 2-(2-nitrophenyl)-1-naphthaldehydes 266 with zinc dust 
in acetic acid at reflux yielded 8,9-benzo[i]phenanthridines 267 in good yields as shown in 
Scheme 104. 
 
 
 
Scheme 104: Reagents and conditions: A) cat. Pd(PPh3)4, CuBr, reflux, THF, 70-90%; B) Zn 
dust, acetic acid, 60-95%.141 
 
5.3.2 Yanada et al. Approach142 
 
In the synthesis proposed by Yanada et al., an π-acidic metal-catalyzed tandem reaction 
was employed to synthesize the benzo[i]phenanthridine 263 framework. In the synthesis, a 
Lewis acid catalyzed annulation of ortho-alkynylbenzaldehydes 268 with ortho-
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alkynylanilines 269 sequentially proceeds to form one carbon-nitrogen and two carbon-
carbon bonds of benzophenanthridine 263 in one step. 
 
 
 
Scheme 105: Reagents and conditions: In(OTf)3, DMF, 80 °C, 24 hrs, 93%.
142 
 
A proposed mechanism for this indium(III)-catalyzed tandem reaction is shown in Scheme 
106, where coordination of In(OTf)3 with the triple bond of 225 to give 270 enhances the 
electrophilicity of alkyne and subsequent nucleophilic attack of the carbonyl oxygen to the 
electron-deficient alkyne results in the formation of the 6-endo-dig-cyclized pyrylium cation 
intermediate 271. Followed by Diels-Alder-type cycloaddition of 271 with ortho-alkynylaniline 
226 would occur as shown in 272 to give the intermediate 273 with the same high 
regioselectivity. Subsequent bond rearrangement proceeds to afford 274 with regeneration 
of In(OTf)3. Dehydration of 274 produces ring-condensed heteroaromatic compound 220 as 
illustrated in Scheme 106. 
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Scheme 106 
 
5.3.3 Ghosh et al. Approach143 
 
Ghosh et al. have developed an efficient method for the synthesis of benzo[i]phenanthridines 
analogues employing a ligand-free domino Suzuki coupling–Michael addition reaction 
catalyzed by in situ generated palladium nanoparticles in water. The first step was the Wittig 
reaction of 2-bromocarboxaldehydes 275 with 1-(triphenylphosphoranylidene)-2-propanone 
276 which generated β-(2-bromoaryl)-α,β-unsaturated carbonyl intermediate 277. This 
intermediate was treated with 2-aminophenylboronic acid 230 to give rise to 
benzo[i]phenanthridines 263 via a ligand-free domino Suzuki coupling–Michael addition 
reaction with the elimination of acetone molecule as shown in Scheme 106. 
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Scheme 106: Reagents and conditions: A) DCM, 0 °C, rt, 3 hrs, 90%; B) Pd(OAc)2, K3PO4, 
TBAB, H2O, 90 °C, 70%.
143 
 
Due to the biological importance of benzo-fused phenanthridines and the fact that only a few 
synthetic approaches to these compounds have been employed in the past, we planned to 
undertake the synthesis of substituted benzo[i]phenanthridines using a novel approach. 
 
5.4 Proposed Synthesis of Substituted Benzo[i]phenanthridine 
 
The synthetic approach we envisioned for the synthesis of the benzo[i]phenanthridine  263 
skeleton was inspired by a research publication by Ali et al. in 2011, where the authors 
demonstrated the synthesis of functionalized, halogen substituted quinolines using an 
iodine-mediated ring cyclization as the key step.144 The approach employed the treatment of 
suitably substituted aliphatic and aromatic 2-tosylaminophenylprop-1-yn-3-ols 279 with 
molecular iodine leading to iodocyclization in a 6-endo-dig fashion to generate a library of 
substituted 3-iodoquinolones 280 as shown in Scheme 107. 2-Tosylaminophenylprop-1-yn-
3-ols 279 were in turn prepared from suitably substituted 1-(2-aminophenyl)ketones 281, 
which were protected with a tosyl group, and the resulting product 282 was treated with a 
substituted terminal alkyne 283 under basic conditions to yield 279. 
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Scheme 92: Reagents and conditions: A) PTSA, pyridine, rt, 4 hrs, B) C2H5MgBr, THF, 4 
hrs, rt-heating under reflux; C) I2, MeOH, 60 °C, 6 hrs.
144 
 
We envisioned utilizing the aromatic iodine present in the substituted quinolones as 
synthesized by Ali et al. as a handle for the further functionalization in order to synthesize 
substituted benzo[i]phenanthridines.144 
 
To achieve our target we planned to carry out two key reactions: a Suzuki-Miyaura cross 
coupling reaction with a suitably substituted 2-carbonylphenylboronic acid to generate a 
biaryl compound and a potassium t-butoxide and light induced ring cyclization to generate 
the substituted benzo[i]phenanthridine structure. 
 
5.5 Potassium t-butoxide and Light Induced Ring Cyclization  
 
A vast amount of research has been conducted on the synthesis of polyaromatic and poly-
heteroaromatic compounds in the laboratories of the University of the Witwatersrand 
employing potassium t-butoxide and light to induce ring cyclization to form a new aromatic 
ring. 
 
While studying the synthesis of substituted naphthalenes, de Koning et al. demonstrated that 
when 1-(2-allyl-3,4,6-trimethoxyphenyl)ethanone 284 was subjected to potassium t-butoxide 
in presence of dimethylformamide and light from a high pressure mercury lamp (400 W), ring 
cyclization took place to yield 1,2,4-trimethoxy-5-methylnaphthalene 285 as shown in 
Scheme 108.145  
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Scheme 108: Reagents and conditions: KOBut, DMF, hν, 80 °C, 10 mins. 
 
The mechanism of this ring closure reaction was proposed to proceed by photoenolization 
by an initial Norrish type II process. Direct irradiation from a high pressure mercury lamp 
(400 W) leads to the excitation of the carbonyl group of 286 to an excited singlet state 287, 
which, as a result of the inter-system crossing, immediately decays into the triplet state 288. 
This triplet state intermediate 288 abstracts hydrogen to afford the diradical 289 which 
quickly rearranges to photoenol 290. Further a 6π electrocyclic process affords the alcohol 
292 which, after dehydration, yields the naphthalene product 292 (Scheme 109).146 
 
 
 
Scheme 109 
 
This novel light and base-assisted cyclization reaction to form a centrally-positioned aromatic 
ring has been employed extensively and successfully to generate a variety of polyaromatic 
and poly-heteroaromatic molecules. 
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For example, de Koning et al. demonstrated the synthesis of substituted phenanthrenes 293 
using this ring cyclization method.147 The procedure involved subjecting a compound 
possessing a biaryl axis 294 and bearing both a carbonyl group and a methyl group ortho to 
the biaryl axis but on opposite rings, to potassium t-butoxide and light. This led to the 
formation of the phenanthrenes of general structure 293. 
 
 
 R1 = Me, R2 = R3 = R4 = H 
 
Scheme 110: Reagents and conditions: KOBut, DMF, light, 70-80 °C 
 
5.6 Aim of the Project 
 
Based on the findings by Ali et al. and having knowledge of the potassium t-butoxide and 
light induced ring cyclization and Suzuki-Miyaura cross coupling reactions, we envisioned a 
synthesis for the generation of substituted benzo[i]phenanthridines 295, using these key 
reactions.144 We planned to begin with the tosyl protection of suitably substituted 1-(2-
aminophenyl)ethanones 296 to afford tosylated intermediates 297, which could then be 
converted into 298 by treatment with a substituted terminal alkyne 299. The resulting product 
298 could then be subjected to the iodine induced cyclization reported by Ali et al. to yield 
300.144 A Suzuki-Miyaura cross coupling reaction could then follow between 300 and a 
suitably substituted 1-carbonyl boronic acid 301 to generate the biaryl compound 302. 
Compound 302 would then be a suitable substrate for potassium t-butoxide and light 
induced ring cyclization as it possesses the required methyl and carbonyl substituents, to 
finally generate 295 as shown in Scheme 111.  
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R1 = Aryl, alkyl 
R2 = H, Me 
Scheme 111 
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Chapter 6: Results and Discussion: Benzo[i]phenanthridines 
 
The importance of benzo[i]phenanthridines in therapeutics as TOP I inhibitors prompted us 
to synthesize substituted benzo[i]phenanthridines using our novel potassium t-butoxide and 
light induced cyclization reaction as a key step as discussed in Chapter 5. 
 
 
 
Substituted benzo[i]phenanthridines 295 
 
Figure 44 
 
6.1 Approaches Towards the Synthesis of 5-Phenylbenzo[i]phenanthridine 303 
 
To proceed with the synthesis, we first planned to synthesize a simple analogue of the 
benzo[i]phenanthridines, namely, 5-phenylbenzo[i]phenanthridine 303. We envisioned the 
synthesis would commence from 1-(2-aminophenyl)ethanone 304. The primary amine of 304 
would be tosyl protected as the first step to afford 305. Treatment with phenylacetylene 306 
under basic conditions would yield N-(2-(2-hydroxy-4-phenylbut-3-yn-2-yl)phenyl)-4-
methylbenzenesulfonamide 307. The molecular iodine-mediated cyclization would follow as 
the next step to give 3-iodo-4-methyl-2-phenylquinoline 308. Subsequently, a Suzuki-
Miyaura cross coupling reaction with 2-formylphenyl boronic acid 98 would afford 2-(4-
methyl-2-phenylquinolin-3-yl)benzaldehyde 309. Finally, subjecting 309 to the conditions of 
potassium t-butoxide and light would yield 5-phenylbenzo[i]phenanthridine 303 as shown in 
Scheme 112. 
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Scheme 112 
 
6.1.1 Synthesis of N-(2-Acetylphenyl)-4-methylbenzenesulfonamide 305 
 
 
 
Scheme 113: Reagents and conditions: pTsCl, pyridine, rt, 4 hrs, 100% 
 
To carry out the synthesis of N-(2-acetylphenyl)-4-methylbenzenesulfonamide 305, 
commercially available 1-(2-aminophenyl)ethanone 304 was taken up in pyridine and treated 
with tosyl chloride. The reaction was stirred under inert conditions and at room temperature 
for four hours over which time the reaction mixture becomes a white slurry. On completion of 
the reaction, the mixture was quenched with cold water to facilitate the precipitation of the 
product 305 as a white solid, which was then dried and used directly in the following step 
without further characterization.  
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6.1.2 Synthesis of N-(2-(2-Hydroxy-4-phenylbut-3-yn-2-yl)phenyl)-4-
methylbenzenesulfonamide 307 
 
 
Scheme 114: Reagents and conditions: C2H5MgBr, dry THF, 0 ºC-rt- reflux, 4 hrs, 99% 
 
Crude N-(2-acetylphenyl)-4-methylbenzenesulfonamide 305, was then subjected to the next 
step in our synthesis which was the addition of phenylacetylene 306 under basic conditions. 
Initially, generation of phenylacetylene anion was achieved using ethylmagnesium bromide 
as the base. Under inert conditions, phenylacetylene dissolved in dry tetrahydrofuran was 
added to ethylmagnesium bromide in tetrahydrofuran at 0 °C, with the liberation of ethane 
gas clearly evident. After fifteen minutes, starting material 305 dissolved in dry 
tetrahydrofuran was added to the reaction mixture, which was then allowed to warm to room 
temperature, and subsequently heated to reflux for four hours. The progress of the reaction 
was monitored by thin layer chromatography and on completion, isolation of the product 307 
and purification by column chromatography was performed to obtain the product 307 as a 
white solid in 99% yield. 
 
The characterization of the product was done by 1H and 13C NMR 
spectroscopy and the results were found to be in agreement with 
that of the literature.144 The 1H NMR spectrum showed the presence 
of a hydrogen attached to nitrogen, as a singlet visible at 9.21 ppm. 
At 3.22 ppm a broad peak for the proton of the hydroxyl group was 
present, and. two singlets at 2.33 and 1.76 ppm, integrating for 
three protons each, confirmed that the two methyl groups were 
present in the molecule. Signals from the 13C NMR spectrum also 
correlated with the signals present in the 1H NMR spectrum. There were two peaks at 31.3 
and 21.5 ppm which signified the two carbons of the two methyl groups. At 90.8 and 86.5 
ppm were the two peaks for the two carbons of the triple bond C-8 and C-9. Finally, a signal 
at 72.2 ppm confirmed the presence of the quaternary carbon C-7.  
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6.1.3 Synthesis of 3-Iodo-4-methyl-2-phenylquinoline 308 
 
 
Scheme 115: Reagents and conditions: I2, methanol, 60 ºC, 6 hrs, 32%. 
 
To carry out the synthesis of 3-iodo-4-methyl-2-phenylquinoline 308, the starting material 
307 was dissolved in methanol and iodine was added. The reaction was allowed to stir for 
six hours at 60 ºC, after which time the mixture was quenched. The product was isolated and 
then purified by column chromatography to afford 308 as a white powder in a disappointing 
yield of 32%. Despite numerous attempts to improve the yield of the reaction, this was the 
best yield of the product 308 we obtained. We were never able to get complete conversion of 
the starting material 307 into the product 308 in this reaction.144 
 
The mechanism of this iodocyclization reaction of conversion of 307 to 308 has been 
explained by Ali et al. where the reaction involves anti attack of the electrophile and the 
nitrogen of the tosylated amino group on the alkyne moiety of 310 to generate an 
intermediate 311, which then undergoes a proton removal by the iodide present in the 
reaction mixture to give compound 312. In protic solvents 312 loses hydroxyl ion to give 
cation 313 and finally, 313 gains full aromaticity by eliminating a tosyl group to form quinoline 
derivative 308 as illustrated in Scheme 116.144 
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Scheme 116 
 
The spectroscopic results of the product 308 were found to be in 
agreement with the literature.144 A clear singlet at 3.03 ppm 
integrating for three protons in the 1H NMR spectrum referred to the 
methyl group at C-3 in the molecule with the corresponding peak at 
25.9 ppm in the 13C NMR spectrum. The remaining signals in the 
aromatic region of the 1H NMR spectrum integrated for nine protons as expected. 
 
6.1.4 Synthesis of 2-(4-Methyl-2-phenylquinolin-3-yl)benzaldehyde 309 
 
 
Scheme 117: Reagents and conditions: Method 1): 2-Formylphenyl boronic acid, Pd(OAc)2, 
sodium carbonate, DMF:H2O (2:1), reflux, 4 hrs, 79%; Method 2) 2-Formylphenyl boronic 
acid, Pd(PPh3)4, CsF, DME, 15 mins, 120 W, 120 ºC, microwave irradiation, 70%. 
 
After the successful synthesis of 3-iodo-4-methyl-2-phenylquinoline 308, albeit in low yield, 
the next step in our synthesis was the generation of the biaryl axis utilizing the aromatic 
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iodide 308 by employing a Suzuki-Miyaura cross coupling reaction with 2-formylphenyl 
boronic acid 98 to yield 309. Two methods were tested for this reaction, a conventional 
method and the reaction in a microwave reactor.  
 
Method 1: In this classical method for the Suzuki-Miyaura cross coupling reaction, starting 
material 308 was dissolved in dry, degassed dimethylformamide treated with catalytic 
palladium(II)acetate. The reaction was allowed to stir under inert conditions and at room 
temperature for ten minutes, before the addition of 2-formylphenyl boronic acid 98 and 
sodium carbonate. The reaction mixture was then heated to reflux for four hours. The 
product 309 was isolated after work-up and purification by column chromatography as an off-
white solid in 79% yield. 
 
Ali et al. carried out a similar Suzuki-Miyaura cross coupling reaction where the authors 
managed to generate biaryl axis in 2,3,4-triphenylquinoline 314 by coupling 3-iodo-2,4-
diphenylquinoline 315 with phenylboronic acid 316 as shown in Scheme 118.148 
 
 
 
Scheme 118: Reagents and conditions: Pd(OAc)2, Na2CO3, DMF:H2O (2:1), reflux, 4 hrs, 
92%.  
 
Method 2: In the microwave method for the Suzuki-Miyaura cross coupling reaction, all the 
reagents along with starting material 308 and solvent were added to a microwave reaction 
vial and then subjected to microwave irradiation at 120 W, 120 ºC for ten minutes. This was 
followed by work-up and purification by column chromatography to afford the product 309 in 
70% yield. 
 
Although both methods worked very well in terms of isolated yield of the product 309, the 
microwave method proved to be more convenient in terms of time taken for the reaction. 
 
The characterization of the product 309 was done by 1H and 13C 
NMR spectroscopy. The appearance of a singlet at 9.76 ppm in the 
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1H NMR spectrum, integrating for one proton, indicated the presence of the aldehyde 
functional group, with the corresponding peak for the carbonyl carbon present in the 13C 
NMR spectrum at 191.0 ppm. A singlet at 2.48 ppm integrating for three protons in the 1H 
NMR spectrum represented the protons of the methyl group, with the signal for the methyl 
carbon visible at 29.7 ppm in the 13C NMR spectrum. There were thirteen peaks in the 
aromatic region of the 1H NMR spectrum ranging from 8.24-7.17 ppm, along with eighteen 
signals in the aromatic region of the 13C NMR spectrum from 158.6 to 124.1 ppm.  
 
6.1.5 Synthesis of 5-Phenylbenzo[i]phenanthridine 303 
 
  
Scheme 119: Reagents and conditions: KOBut, dry DMF, 80 ºC, Hg-lamp with quartz filter, 
10 mins, 84%. 
 
We were now in a position to test the novel ring cyclization on 309 to hopefully afford 5-
phenylbenzo[i]phenanthridine 303. To this end, 2-(4-methyl-2-phenylquinolin-3-
yl)benzaldehyde 309 was dissolved in dry dimethylformamide and the resulting solution was 
degassed for ten minutes. Potassium t-butoxide was added to the reaction mixture, and the 
solution immediately turned dark black in colour. Then reaction mixture was allowed to stir 
for ten minutes at 80 ºC and was continuously irradiated with a high pressure Hg-lamp 
through a quartz filter. On completion of the reaction as monitored by thin layer 
chromatography, the mixture was quenched, and pure product 303 was isolated after work-
up and purification by column chromatography as a yellow solid in 84% yield. The product 
was re-crystallized from chloroform/hexane by slow evaporation. 
 
The mechanism of this ring closure reaction has already been mentioned in Chapter 5, 
which suggests that the reaction proceeds by photoenolization by an initial Norrish type II 
process. Direct irradiation from a high pressure mercury lamp (400 W) leads to the excitation 
of the carbonyl group of 309 to an excited singlet state 317, which, as a result of the inter-
system crossing, immediately decays into the triplet state 318. This triplet state intermediate 
318 abstracts hydrogen to afford the diradical 319 which quickly rearranges to photoenol 
320. Then a 6π electrocyclic process affords the alcohol 321 which, after dehydration, yields 
the desired heterocycle as illustrated in Scheme 120.146 
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Scheme 120 
 
The spectroscopic data for both the 1H and 13C NMR spectra was 
found to be in accordance with literature.149 There were signals 
integrating for fifteen protons in the aromatic region of the 1H NMR 
spectrum as expected. Finally, the single crystal X-ray structure 
confirmed that we had synthesized 5-phenylbenzo[i]phenanthridine 
303 
 
 
Single crystal X-ray structure of 5-phenylbenzo[i]phenanthridine 303 
 
Figure 45 
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6.2 Approaches Towards Synthesis of Related Substituted Benzo[i]phenanthridines 
 
As a result of the success of this synthetic sequence we now wished to extend the synthesis 
to the use of other acetylenes. As shown in Scheme 121, two other acetylenes were tested. 
 
 
Scheme 121: Reagents and conditions: C2H5MgBr, dry THF, 1-ethynyl-4-methylbenzene 
and 1-ethynyl-4-methoxybenzene, 0 ºC-rt- reflux, 4 hrs. 
 
We anticipated the synthesis of 322 and 323 to be the same as that of N-(2-(2-hydroxy-4-
phenylbut-3-yn-2-yl)phenyl)-4-methylbenzenesulfonamide 307, with the only difference being 
the use of different acetylenes in these cases. Instead of using phenylacetylene, as for the 
synthesis of 303, we used 1-ethynyl-4-methylbenzene or 1-ethynyl-4-methoxybenzene. 
However, both of these reactions were unsuccessful, even after a number of trials using the 
same procedure as before. The problem appeared to be the generation of the anion at the 
terminal acetylene.  
 
Therefore we decided to test other bases to abstract the proton from the terminal acetylene. 
We decided to use lithium diisopropylamide as base for the reaction and managed to obtain 
the products 322 and 323, but in very low yields. Unfortunately, due to time constrains we 
were not able to continue with this work. We are however, confident that the yields for these 
reactions could be improved, and this will be considered for future work. 
 
6.3 Conclusion 
 
In summary, we were pleased with the results obtained for the synthesis of 5-
phenylbenzo[i]phenanthridine 303. Although we were unsuccessful in the synthesis of 
analogues of 295, we are hopeful that variations in the procedure could lead to the synthesis 
of a library of benzo[i]phenanthridines 295 in the near future. 
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Chapter 7: Introduction, Literature Reviews and Aims: Quinoline[2,3-a]carbazoles 
 
7.1 Carbazoles 
 
Carbazole 324 is an aromatic, heterocyclic organic compound with a tricyclic structure 
containing two six membered benzene rings fused on each side of a five membered nitrogen 
containing ring (Figure 46). Naturally occurring carbazoles form a small part of nitrogen 
containing compounds called the alkaloids.150  
 
 
Carbazole 324 
 
Figure 46 
 
Carbazole 324 was isolated for the first time in 1872 from the anthracene fraction of coal tar 
by Graebe and Glazer in 1872.151 A century later, Chowdhury et al. reported the isolation of 
carbazole for the first time from a plant source -Glycosmis pentaphylla.152,153  
 
7.1.1 Simple Functionalized Carbazoles: Isolation and Biological Importance 
 
3-Methylcarbazole 325 was isolated independently by Roy et al., Joshi et al. and Ngadjui et 
al. from the roots of a variety of Clausena species such as Clausena heptaphylla, Arn 
Clausena indica Oliv., and Clausena anisata.154,155,156 Later in 1987, Chowdhury et al. 
described the isolation of 3-methylcarbazole 325 from the root bark of Glycosmis 
pentaphylla.157 Almost a decade later, 3-methylcarbazole 325 was isolated by Chakrabarty 
et al. from the roots of Murraya koenigii and the following year Wu et al. isolated 3-
methylcarbazole 325 from the root bark of Murraya euchrestifolia.158,159  
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3-Methylcarbazole 325 
 
Figure 47 
 
3-Formylcarbazole 326 was isolated for the first time in 1988 by Wu et al. from the root bark 
of Murraya euchrestifolia and three years later by Li et al., along with the ester methyl 
carbazole-3-carboxylate 327, from the roots of Clausena lansium.160,161 Diverse parts of this 
plant are used in traditional medicine in China, Taiwan, and the Philippines for the treatment 
of a number of conditions including, bronchitis, malaria, asthma, gastrointestinal 
inflammation, ulcers, influenza, colds and colic pains.162. 3-Formylcarbazole 326 was also 
isolated from Glycosmis pentaphylla in 1992 by Jash et al.163 (Figure 48) 
 
 
  3-Formylcarbazole 326   Methyl carbazole-3-carboxylate 327 
 
Figure 48 
 
9-Carbonyl-substituted carbazoles, 9-carbethoxy-3-methylcarbazole 328 and 9-formyl-3-
methylcarbazole 329, were isolated by Chakrabarty et al., from the roots of Murraya 
koenigii.158 These compounds show weak cytotoxicity against mouse melanoma B16 and 
adriamycin-resistant P388 mouse leukemia cell lines (Figure 49).158 
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          9- Carbethoxy-3-methylcarbazole 328               9-Formyl-3-methylcarbazole 329 
 
Figure 49 
 
The first time a carbazole alkaloid was isolated from a mammalian source was in 1983 by 
Luk et al., when they isolated 3-chlorocarbazole 330 from female bovine urine.164 Lee and 
co-workers reported the isolation of the dibromocarbazole alkaloids, 3,6-dibromocarbazole 
331, 2,7-dibromocarbazole 332 and 3,6-diiodocarbazole 333 from the cyanobacterium 
Kyrtuthrix maculans in 1999.165 2,7-Dibromocarbazole 332 is reported as neuroprotective 
compound P7C3. In 2005, Zhu et al. reported the isolation of 1,3,6,8-tetrabromocarbazole 
334 from the sediment cores of lake Michigan (Figure 50).166 
 
 
3-Chlorocarbazole 330 3,6-Dibromocarbazole 331            2,7-Dibromocarbazole 332 
 
 
  3,6-Diiodocarbazole 333 1,3,6,8-Tetrabromocarbazole 334 
 
Figure 50 
 
Extracts of the leaves and bark of shrubs of the genus Murraya (family Rutaceae), 
flourishing in Southern Asia, are used as traditional medicine for the treatment of eczema, 
rheumatism, and dropsy. This class represents the chief source for 1-oxygenated carbazole 
alkaloids. The earliest reports of the isolation of oxygenated carbazoles were in 1969 and 
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1971, when mukoeic acid 335 and the corresponding methyl ester, mukonine 336 were 
isolated from the stem bark of Murraya koenigii (Figure 51).167 In 1983, Wu et al. and 
Furukawa et al. reported the isolation of murrayafoline-A 337 from the root bark of Murraya 
euchrestifolia while Cuong et al. isolated the same alkaloid 337 from Glycosmis stenocarpa 
Guillaumin in 2004.168,169,170 Koenoline 338, a carbazole alkaloid known for its cytotoxic 
properties was isolated from Murraya koenigii and Clausena heptaphylla both of the 
Rutaceae family.171 Cuong et al. isolated murrayanine 339, which is known for its 
antimicrobial activity against human pathogenic fungi, from another genus of the Rutaceae 
family, Glycosmis stenocarpa Guillaumin.170 
 
 
 
Murrayafoline-A 337    Koenoline 338  Murrayanine 339              
 
 
 
      Mukoeic acid 335     Mukonine 336 
 
Figure 51 
 
Ito et al. in 2000, isolated peroxygenated carbazole alkaloids: clausamine D 340, clausamine 
E 341 and clausamine G 342 from the branches of Clausena anisata. These alkaloids 
displayed anti-tumour activity (Figure 52).172 
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 Clausamine D 340  Clausamine E 341      Clausamine G 342 
 
Figure 52 
 
From the plant Clausena excavata, clauzoline-I 343 was isolated by Ito et al. and clausine D 
344 and mukonidine 345were isolated by Wu et al.173,174 These alkaloids are known for their 
platelet aggregation inhibition property (Figure 53). 
 
 
        Clauzoline-I 343           Clausine D 344   Mukonidine 345 
 
Figure 53 
 
The first carbazole-1,4-quinone alkaloid identified, murrayaquinone B 346, was isolated from 
the root bark of Murraya euchrestifolia.168,169 This was followed by the reported isolation of 
murrayaquinone A 347, which was seen to exhibit significant cytotoxicity against SK-MEL-5 
and Colo-205 cells, along with cardiotonic activity. Murrayaquinone B 346 was shown to 
inhibit the leukemia cell line CCRF-CEM. Clausenaquinone A 348, isolated from Clausena 
excavata exhibited powerful inhibitory activity towards rabbit platelet aggregation induced by 
arachidonic acid, along with cytotoxicity toward HCT-8, RPMI-7951, and TE671 tumour cells 
(Figure 54).175 
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Murrayaquinone B 346  Murrayaquinone A 347 Clausenaquinone A 348 
 
Figure 54 
 
7.1.2 Fused Carbazoles: Isolation and Biological Importance 
 
Frequently, naturally occurring alkaloids are observed where the carbazole ring 324 is fused 
with other aromatic, heteroaromatic or heterocyclic rings, with girinimbine 349 being the first 
pyranocarbazole alkaloid isolated from Murraya koenigii and Clausena hepataphylla.153,176 
Murrayanine 350 was isolated in 2003 by Hao et al. from Murraya koenigii which in addition 
to a pyran ring fused to the carbazole nucleus, also contains an annulated furan ring.177 
(Figure 55). 
 
Girinimbine 349   Murrayanine 350 
 
Figure 55 
 
Furostifoline 351 was the first furo[3,2-a]carbazole alkaloid collected from the root bark of 
Murraya euchrestifolia Hayata by Ito et al. Various parts of this plant are used in Chinese folk 
medicine.178 Later, Wu et al. described the isolation of two other furocarbazole alkaloids, 
furoclausine-A 352 and furoclausine-B 353 from Clausena excavata.159  
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 Furostifoline 351 Furoclausine A 352    Furoclausine B 353 
 
Figure 56 
 
An interesting class of imidazo-pyrrolocarbazoles has been found in extracts isolated from 
various natural sources and include the compounds granulatimide 354, isogranulatimide 355 
and 6-bromo granulatimide 356 (Figure 57). These molecules represent a new class of 
inhibitors of the cell division cycle.179,180  
 
 
 
 Granulatimide 354  Isogranulatimide 355      6-Bromo granulatimide 356 
 
Figure 57 
 
Pyridocarbazole containing alkaloids have attracted widespread interest since the first 
isolation of ellipticine 357 and its analogues, 10-hydroxyellipticine 358 and 5-formylellipticine 
359 from various natural sources (Figure 58). These molecules have been shown to exhibit 
potent antineoplastic activity in a number of human tumour systems, by DNA intercalation 
and/or inhibition of topoisomerase.181,182,183  
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  Ellipticine 357  9-Hydroxyellipticine 358  5-Formylellipticine 359 
 
Figure 58 
 
Two quinolino[4,3-b]carbazole-1,4-quinones, calothrixin A 360 and B 361 were isolated from 
the blue green algae Calothrix cyanobacteria. These quinoline fused carbazoles have been 
shown to prevent the growth of a chloroquine resistant strain of the malaria parasite 
Plasmodium falciparum and human HeLa cancer cells.184 Later it was reported that 
calothrixin A 360 is redox-active and induces the intracellular formation of reactive oxygen 
species. Hecht and co-workers reported calothrixin A 360 and B 361 and their O- and N-
methylated derivatives which act as human DNA topoisomerase I poisons, capable of 
stabilizing the enzyme−DNA covalent binary complex and leading to topoisomerase I-
dependent cell death (Figure 59).185,186 
 
 
 
        Calothrixin A 360    Calothrixin B 361 
 
Figure 59 
 
In 2012 Lyakhova reported the isolation of a bromoindolophenanthridine 362 from marine 
sponge Penaras sp. in the South China Sea. The biological importance of the molecule is 
yet to be explored Figure 60.187 
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362 
 
Figure 60 
 
Indolocarbazoles are another well-studied class of biologically active carbazole alkaloids that 
contain a fused indole moiety. Representatives from this class of carbazole alkaloids are 
known to possess a wide range of biological activities such as anti-tumour, antifungal, 
hypotensive, antimicrobial, protein kinase C (PKC) inhibition and antiplatelet aggregation 
activity. Presently, several indolo[2,3-a]-carbazole alkaloids are in clinical trials for their 
potential use in cancer therapy.188 These naturally occurring indolo-pyrrolocarbazole have 
been isolated from a wide diversity of natural sources. Rebeccamycin 363 and related 
compounds are known to bind to DNA and exhibit antitumour properties.177 Kojiri et al. 
reported the isolation of BE-13793C 364, from the culture broth of Streptoverticillium 
mobaraense strain BA13793. This indolo-pyrrolocarbazole showed significant inhibitory 
activity against topoisomerases I and II and inhibited the growth of doxorubicin or vincristine-
resistant P388 murine leukemia cell lines (Figure 61.177,189  
 
 
 
 
Rebeccamycin 363    BE-13793C 364 
 
Figure 61 
 
The first indolo[2,3-a]pyrrolo[3,4-c]carbazole alkaloid to be isolated was staurosporine 365, 
which was isolated in 1977 from a culture of Streptomyces strain by Omura et al. Since then, 
a number of analogues of the same skeleton have been isolated and are known for their 
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intresting bioactive properties.177,190 Staurosporine 365 exhibits promising biological activities 
including antimicrobial, antihypertensive and cytotoxic properties, nanomolar inhibition of 
protein serine/threonine kinases (such as PKC and protein tyrosine kinase), and inhibition of 
platelet aggregation.191 11-Hydroxystaurosporine 366 and 3,11-dihydroxystaurosporine 367 
are active against human nasopharyngeal cancer cells and 11-hydroxystaurosporine 366 is 
more potent than staurosporine 365 in protein kinase C (PKC) inhibition. Staurosporinone 
368 has shown cytotoxicity against HeLa, jurkat, and vincristineresistant KB/VJ300 cells, 
along with the inhibition of protein tyrosine kinase, whereas 6-hydroxystaurosporinone 369 
has demonstrated protein tyrosine kinase inhibition (Figure 62).192 
 
 
 
Staurosporine 365   11-Hydroxystaurosporine 366        3,11-Hydroxystaurosporine 367 
 
 
 
  Staurosporinone 368   6-Hydroxystaurosporinone 369  
 
Figure 62 
 
7.2 Quinoline Fused Carbazoles: Synthetic Approaches 
 
As discussed earlier in this Chapter, the carbazole 234 skeleton is widely present in nature 
either alone or fused with other heterocycles. One such class of fused heterocycles is the 
carbazole fused quinolones, in which we are specifically interested. To date, only three 
molecules of this class are known in the nature, calothrixin A 360 and B 361, quinolino[4,3-
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b]carbazole-1,4-quinones.184,185,186 and the non-quinone containing dibromo-quinolino[4,3-
a]carbazole 362, isolated recently from a marine sponge source (Figures 59 and 60). 
 
There are a number of reported synthetic approaches directed to calothrixin A 360 and 
calothrixin B 361, but no synthesis has been reported for the recently isolated dibromo-
quinolino[4,3-a]carbazole 362 framework as yet. 
 
7.2.1 Approaches Towards the Synthesis of Quinolino[4,3-b]carbazole-1,4-quinones 
 
7.2.1.1 Bernardo’s Approach Towards the Synthesis of Calothrixin A 360 and B 
361193,194 
 
In 2002, Bernardo et al. reported a simple and brief synthetic route to calothrixin B 361 
starting from readily available indole 370 and quinoline-3,4-dicarboxylic anhydride 371. The 
quinoline-3,4-dicarboxylic anhydride 310 was converted into the acid chloride 372 which was 
then used in the Friedel Crafts acylation reaction with indole 370 to give 373. The free 
nitrogen of 373 was protected to yield 374, followed by lithation and intramolecular 
nucleophilic substitution of the ester leading to the generation of N-MOM-calothrixin B 375. 
Cleavage of the protecting group was done finally to afford calothrixin B 361 in five steps 
starting from 361. Transformation of calothrixin B 361 to calothrixin A 360 was achieved by 
using m-perchlorobenzoic acid as oxidant and refluxing the reaction in dichloromethane as 
shown in Scheme 122. 
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Scheme 122: Reagents and conditions: A) 1) Methanol, reflux; 2) SOCl2 (neat), 70%; B) 
ZnCl2, CH3MgBr, 90%; C) NaH, MOMCl, THF, 0 °C, 90%; D) LiHMDS, TMEDA, THF, -78 °C, 
92%; E) HCl, DMSO, 100 °C, 83%; F) mCPBA, DCM, reflux, 70%.193,194 
 
7.2.1.2 Bernardo’s Palladium Catalyzed Approach Towards the Synthesis of 
Calothrixin B 361195 
 
Bernardo et al. again in 2007 reported an efficient palladium-catalyzed route for the 
synthesis of calothrixin B 361, using the phenanthridinone 376 and 2-nitrophenylboronic acid 
377 as the precursors of Suzuki-Miyaura cross coupling reaction (Scheme 123). The 
synthesis was started with the transformation of 3-bromo-2,5-dimethoxybenzoic acid 378 
into an acid chloride, which was then coupled with 2-iodoaniline 379 leading to the 
generation of the amide 380. The free secondary nitrogen of the amide 380 was then 
protected to yield 381 and this was followed by a palladium-catalyzed Heck cyclization 
reaction generating the phenanthridinone 376. Another palladium catalyzed reaction, a 
Suzuki−Miyaura coupling of the bromophenanthridinone 376 with 2-nitrophenylboronic acid 
377 was carried out to synthesize o-nitrophenylphenanthridinone 382. Cadogan cyclization 
of o-nitrophenylphenanthridinone 382 provided the indolophenanthridinone 383. Later, the 
reduction of the amide group followed by an acidic work-up afforded the 
dimethoxyindolophenanthridine 384. Finally, oxidative demethylation and quenching of the 
reaction with anhydrous methanol in the presence of air led to the synthesis of calothrixin B 
361. 
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Scheme 123: Reagents and conditions: A) 1) SOCl2, reflux; 2) 2-Iodoaniline, K2CO3, THF, rt, 
91%; B) NaH, MOMCl, THF, 30 °C, 98%; C) Cat. Pd(OAc)2, cat. PPh3, K2CO3, DMF, 100 °C, 
92%; D) Cat. Pd(OAc)2, cat. PPh3, K2CO3, DMF, 150 °C; E) P(OEt)3, 174 °C, 89%; F) 1) 
LiAlH4, THF, rt; 2) 6 N HCl, rt; G) 1) BBr3, DCM, rt; 2) Air, methanol, rt, 97%.
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7.2.1.3 Sissouma’s Approach Towards the Synthesis of Calothrixin B 361. 196,197 
 
Sissouma et al. have also described a new synthetic route for the assembly of calothrixin B 
361 as shown in Scheme 124. The dehydrogenation of tetrahydro-4H-carbazol-4-one 385 
using palladium on activated carbon gave 4-hydroxy-9H-carbazole 386, which, after bis-
protection with a carboxybenzyl protecting group, led to 387. Chemoselective 
monodeprotection of 387 using aqueous sodium hydroxide gave the N-Cbz-protected 4-
hydroxy-9H-carbazole 388, which was brominated to afford the 3-bromocarbazole derivative 
389. Oxidation of 389 with diacetoxyiodobenzene provided the quinone dienophile 390, 
which was used in the Diels Alder cycloaddition with 2-azadiene 391 affording the 
cycloadduct 391, along with in situ removal of the Cbz group. Deprotonation of cycloadduct 
392 followed by treatment with N-phenyl-bis-(trifluoromethanesulfonimide) afforded aryl 
triflate 393. Finally, a palladium(0)-catalyzed defunctionalization led to the generation of 
calothrixin B 361.196,197 
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Scheme 124: Reagents and conditions: A) 10% Pd/C, Ph2O, 1,2,3-trimethylbenzene, 250 
°C, 90%; B) NaH, CbzCl, DMF, 0 °C-rt, 91%; C) NaOH, dioxane/H2O, 40 °C, 90%; D) NBS, 
MeCN, rt, 94%; E) PhI(OAc)2, methanol, TFA, rt, 83%; F) MeCN, 40 °C, 80%; G) 1) 
LiHMDS, THF, HMPA, -78 °C; 2) PHNTf2, THF, -78 °C; H) Pd(PPh3)4, Et3N, 
HCOOH/dioxane, reflux, 75%.196,197 
 
7.2.1.4 Tohyama’s Approach Towards the Synthesis of Calothrixin B 361198 
 
In 2005, Tohyama et al. reported a new synthesis of calothrixin B 361 with an allene-
mediated electrocyclic reaction of a 6π-electron system as shown in Scheme 125. Wittig 
olefination of 2-formyl-N-benzenesulfonylindole 394 with (2-
nitrobenzyl)triphenylphosphonium bromide 395 gave the trans-styrylindole 395 which on 
reaction with 1,1- dichloromethyl methyl ether and aluminium chloride afforded 397. The next 
step was the Grignard reaction of 397 with ethynylmagnesium bromide leading to the 
generation of corresponding propargyl alcohol, which was then protected as the 
methoxymethyl ether 398. This intermediate was then subjected to an allene-mediated 
electrocyclic reaction with potassium t-butoxide to afford the desired 4-oxygenated carbazole 
399. Oxidation of this product with DDQ followed by the removal of the protecting group 
generated the 3-formyl-4-hydroxy-carbazole 400. Finally, reduction of the nitro group of 400 
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followed by intramolecular condensation and then oxidation to a quinone provided calothrixin 
B 361.198 
 
 
 
Scheme 125: Reagents and conditions: A) nBuLi, THF, 0 °C, 96%; B) MeOCHCl2, AlCl3, 
DCM, -78 °C, 96%; C) 1) THF, 0 °C; 2) MOMCl, i-Pr2NEt, DCM, 86%; D) KOBut, 
HOBut/THF, 90 °C, 29%; E) 1) DDQ, LiClO4, DCM/H2O, rt; 2) 6 N HCl, ethylene glycol, THF, 
60 °C, 70%; F) 1) H2, Pd/C, HOEt, rt; 2) CAN, MeCN/H2O, 0 °C, 67%.
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7.2.1.5 Yamabuki’s Approach for Synthesis of Calothrixin B 361199 
 
Later in 2006, Yamabuki et al. described a biomimetic approach towards the synthesis of 
calothrixin B 361 with the key step involving an electrocyclic reaction (Scheme 126). The 
synthesis started with a Suzuki−Miyaura coupling of 401 with indol-2-ylboronic acid 402 
generating 2,2-bisindole derivative 403. Cleavage of the N-Boc protecting group followed by 
the protection of both nitrogen atoms with methoxymethyl chloride led to the di-protected 
bisindole 404. This was followed by a Grignard reaction of 404 with ethynylmagnesium 
bromide, which yielded the corresponding propargyl alcohol 405, which was then protected 
as the methoxymethylether 406. An allene-mediated electrocyclic reaction of 406 provided 
the desired indolocarbazole 407. Subsequent oxidation of the 6-methylindolocarbazole 407 
afforded 6-formylindolocarbazole 408 which was subjected to another oxidation reaction 
mediated by DDQ. This resulted in the formation of N-protected-calothrixin B 409, via 
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quinone imine 410 and quinone 411 as intermediates. Final deprotection of the 
methoxymethyl protecting group gave calothrixin B 361. 
 
 
Scheme 126: Reagents and conditions: A) PdCl3, 2 M Na2CO3, toluene, 80 °C, 99%; B) 1) 
TFA, 0 °C; 2) NaH, MOMCl, DMF, rt, 83%; C) THF, 0 °C, 93%; D) MOMCl, i-Pr2NEt, DCM, 
50 °C, 93%; E) KOBut, HOBut, THF, 90 °C, 93%; F) DDQ, DMF, rt, 74%; G) CAN, 
methanol/H2O, 0 °C, 40%; H) HCl, THF, 50-55 °C, 48 hrs, 65%.
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7.2.1.6 Sperry’s Approach for the Synthesis of Calothrixin B 361200, 201 
 
Sperry et al. reported their synthesis of calothrixin B 361 in 2007. In their synthetic scheme, 
cis-chlorohydrin 412 was obtained from Indigo 413 using a literature procedure.202 Reduction 
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of the cis-chlorohydrin 412 led to the synthesis of 5-hydroxyindolo[2,3-a]carbazole 414, 
which, on subsequent Vilsmeier formylation provided 5-hydroxyindolo-[2,3-a]carbazole-6-
carboxaldehyde 415. Protection of the free NH and OH groups using excess of 
methoxymethylchloride, gave the highly protected product 416. This product could be 
converted over two steps using the method provided by Hibino et al. in to calothrixin B 361 
(Scheme 127). 200, 201 
 
 
Scheme 127: Reagents and conditions: A) Zn, NH4Cl, THF/Methanol, rt, 55%; B) POCl3, 
DMF, 0 °C, 82%; C) NaH, MOMCl, DMF, 44%. 
 
7.3 Synthesis of Quinolino[2,3-a]carbazoles 417 
 
There are a number of reported approaches to the synthesis of the quinolino[4,3-b]carbazole 
417 framework which have been directed towards the synthesis of calothrixin A 360 and B 
361 as discussed in the preceding section. The quinolino[2,3-a]carbazole 417 skeleton or it 
could also be referred to as indolo[3,2-c]acridines 417 is another arrangement of a carbazole 
fused to a quinoline, and to the best of our knowledge, only a few procedures have been 
reported for the synthesis of these ring-fused systems.203  
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        Quinolino[2,3-a]carbazoles 417 
 
Figure 63 
 
Prabakarana et al. reported the synthesis of quinolino[2,3-a]carbazoles (13H-indolo[3,2-
c]acridines) 417 in 2010. The synthesis began with generation of 7-chloro-5,6-dihydro-13H-
indolo[3,2-c]acridine 418, by reacting 2,3,4,9-tetrahydro-1H-carbazol-1-ones 419 with 
anthranilic acid 420 in the presence of phosphorus oxychloride at 130-140 °C for sixteen 
hours. This was followed by treatment of 418 with Pd/C in diphenyl ether under reflux to 
obtain the quinolino[2,3-a]carbazoles (13H-indolo[3,2-c]acridines) 417 (Scheme 127). 
 
 
R   R’   R’’ 
a CH3  H  H  
b H  CH3  H  
c H  H  CH3  
d H  H  H 
e Cl  H  H  
 
Scheme 127: Reagents and conditions: A) POCl3, 130-140 °C, 16 hrs; B) Pd/C, diphenyl 
ether. 
 
An alternative method was also outlined in the same report directed towards the synthesis of 
quinolino[2,3-a]carbazoles 417, where 2,3,4,9-tetrahydro-1H-carbazol-1-ones 421 and isatin 
422 were reacted under Pfitzinger conditions to obtain 5,6-dihydro-13H-indolo[3,2-c]acridine-
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7-carboxylic acids 423.203 The carboxylic acids 423 were dehydrogenated and 
decarboxylated to afford the quinolino[2,3-a]carbazoles 417 (Scheme 128). 
 
 
R   R’   R’’ 
a CH3  H  H  
b H  CH3  H  
c H  H  CH3  
d H  H  H 
e Cl  H  H  
 
Scheme 128: Reagents and conditions: A) NaOH/KOH, ethanol-H2O; B) Pd/C, diphenyl 
ether. 
 
The same research group published numerous reports where they managed to synthesize 
substituted quinolino[2,3-a]carbazoles (13H-indolo[3,2-c]acridines) 417. 
 
Prasad and co-workers in 2006, accomplished the synthesis of 12,13-dihydro-5-oxo-9-
methylquinolino[2,3-a]-carbazole 424 by stirring 1-hydroxy-6-methylcarbazole 425 and 
anthranilic acid 420 in zinc chloride and phosphorous oxychloride at room temperature as 
shown in Scheme 129.204 
 
 
 
Scheme 129: Reagents and conditions: Anthranilic acid, ZnCl2, POCl3, 30%. 
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The same authors also carried out synthesis of similar kind of quinolino[2,3-a]carbazole 
(indolo[3,2-c]acridines) framework 417. 9-Nitro-7-phenyl-5,6-dihydro-indolo[3,2-c]acridines 
426 have been synthesized by refluxing a mixture of 2,3,4,9-tetrahydro-1H-carbazole-1-one 
421 and 2-amino-5-nitro-benzophenone 427 in acetic acid and a few drops of sulfuric acid. 
The product obtained was treated with palladium on carbon in diphenyl ether afforded 1-
methyl-9-nitro-7-phenyl-indolo[3,2-c]acridine 428 as shown in Scheme 130.205 
 
 
 
Scheme 130: Reagents and conditions: A) AcOH/H2SO4, reflux, 426 a) = 42%, 426 b) = 
38%, 426 c) = 39%, 426 d) = 36%; B) Pd/C, diphenyl ether, 428) = 42%. 
 
Synthesis of quinocarbazoles 429 which are also known as substituted pyridocarbazole 
derivatives were also synthesized by Prasad and co-workers from condensation of 8-methyl-
2,3,4,9-tetrahydro-1H-carbazol-1-one 430 with o-aminobenzonitrile 431 under acidic 
condition as illustrated in Scheme 131.206 The product 429 obtained exists in its keto-enol 
form with 432 in 1:1 ratio. 
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Scheme 131: Reagents and conditions: A) p-TsOH, dry toluene, 6 hrs, 75%. 
 
As little research has been done on the synthesis of quinolino[2,3-a]carbazoles such as 417. 
We were interested in the synthesis of these heteroaromatic compounds as they mimic the 
framework of the indolocarbazoles and could be seen as an analogue of the aromatic 
framework of staurosporine 365 or rebeccamycin 363 (Figure 64). 
 
 
 
        Quinoline[2,3-a]carbazoles 356 
 
Figure 64 
 
Furthermore, this specific carbazole would provide a rigid framework which could be suitable 
for metal chelation. Meggers et al. have employed this type of approach to synthesize 
staurosporine 365 and related analogues which resulted in molecules which could bind to 
the specific active site of the GSK-3 protein.207,208,209 In this case, ruthenium complexes, 
compound A 433 and compound B 434 (Figure 65) were assembled as the metal chelates 
and were completely inert biologically, resulting in no toxicity issues. 
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   Compound A 433  Compound B 434 
 
Figure 65 
 
7.4 Synthesis of Carbazole Ring – The Wits Approach 
 
For this PhD a strategy towards the synthesis of quinolino[2,3-a]carbazoles 417, was 
developed based on the work done previously in the organic chemistry research laboratories 
of the University of the Witwatersrand. The synthesis of polyaromatic and 
polyheteroaromatic systems including carbazole and fused carbazole system, has been 
accomplished in our laboratories using the potassium t-butoxide and light mediated ring 
cyclization. This novel potassium t-butoxide and light mediated ring cyclization reaction has 
been described extensively in Chapter 5. 
 
Employing this potassium t-butoxide and light mediated ring cyclization approach, the 
synthesis of benzo[a]carbazoles 435 have been demonstrated by de Koning and co-
workers.147 For the synthesis of benzo[a]carbazoles 435, 2-bromoindole-3-carbaldehyde 436 
or its N-methyl analogue were subjected to Suzuki-Miyaura cross coupling with a variety of 
boronic acids 437 to afford the biaryl compounds. The free indole nitrogen was protected at 
this point by treatment of potassium(bistrimethylsilyl)amide (KHMDS) and then methyl 
iodide, to afford the N-methyl precursor 438. Treatment of the 2-arylindoles 438 with 
potassium t-butoxide as described previously afforded the desired benzo[a]carbazoles 435 
in good yields as shown in Scheme 132. 
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Scheme 132: Reagents and conditions: A) Pd(PPh3)4, aq. Na2CO3, DME; B) 1) For R = H, 
KHDMS, MeI, 0 °C, DCM; 2) KOBut, DMF, hν, 70-80 °C.147 
 
Using the same ring closing methodology, de Koning et al. published another report in 2000 
demonstrating the synthesis of substituted pyrido[2,3-a]carbazoles 439.210 The synthetic 
scheme was initiated by a palladium catalysed Suzuki-Miyaura cross coupling reaction 
taking place between N-Boc protected indole-2-boronic acid 440 and 2-bromo-3-
methylpyridine 441. Carbon-carbon bond formation between C-2 of the indole nucleus and 
the pyridine subunit to give 442 is often problematic in the synthesis of carbazoles and this 
method proved to be a very efficient for this purpose.210,211 Having generated the biaryl 
compound 442, the Boc protecting group was removed followed by formylation to yield 443. 
Before proceeding to the key potassium t-butoxide induced ring closure step, the free indole 
nitrogen was again protected to afford 444. The desired ring closed product 445 was then 
produced using potassium t-butoxide in the presence of light. A final deprotection reaction 
was performed to afford the pyrido[2,3-a]carbazoles 439 (Scheme 133). 
 
 
Scheme 133: Reagents and conditions: A) 1) LiTMP, -78 °C, THF; 2) B(OPr)3; 3) H
+, 100%; 
B) 10% Pd(PPh3)4, aq. Na2CO3, DME, 99%; C) SiO2, microwave oven, 3 mins, 96%; D) 
POCl3, DMF, 91%; E) KHDMS, MeI, THF for R = Me, 99%; BnBr, KHDMS, THF for R = 
Benzyl 84%; F) KOBut, DMF, hν, 70-80 °C; G) AlCl3, 0 °C, benzene, 80%.
210 
 
In 2003, de Koning et al., reported the synthesis of naphtho[a]carbazoles and 
benzo[c]carbazoles from indole precursors using the standardised key reaction for the ring 
closure employing the use of potassium t-butoxide and light.212 For the generation of 
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naphtho[1,2-a]carbazole 446, naphtho[2,1-a]carbazole 447 and naphtho[2,3-a]carbazole 448 
commercially available N-methyl-2-bromoindole-3-carbaldehyde 449 was used as a common 
substrate. 449 was treated with three different boronic acids (450, 451 and 452) under 
Suzuki coupling reaction conditions to generate the desired biaryl compounds 453, 454 and 
455. Each of these compounds were subjected to the ring closing reaction conditions using 
potassium t-butoxide and light to afford the desired naphtho-fused carbazoles 446, 447 and 
448 as shown in Scheme 134. 
 
 
 
Scheme 134: Reagents and conditions: A) 10 mol% Pd(PPh3)4, DME/EtOH, 2 M aq 
Na2CO3, reflux 48 hrs; 60-99%; B) KOBut, DMF, hν, 10 mins; 56-86%. 
 
Formation of benzo[c]carbazole 456 was also achieved by first generating the bromo indole 
precursor 457 by the reaction of 2-substituted indoles 458 with molecular bromine or N-
bromosuccinimide, followed by protection of the free nitrogen by N-methylation afforded 457. 
Subsequent treatment with 2-formylphenyl boronic acid 98 under Suzuki coupling conditions 
generated the desired biaryl compound 459 which was lastly exposed to potassium t-
butoxide in the presence of light to result in the desired benzo[c]carbazole 456 (Scheme 
135). 212  
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Scheme 135: Reagents and conditions: A) 1) For R = H, Br2, DMF, rt, 83%; For R = OMe, 
NBS, DCM, cat. SiO2, 30 min, 99%; 2) (MeO)2SO2, NaH, THF, For R = H, 18 hrs, 99%, For 
R = OMe, 48 hrs, 94%;  B) 20 mol% Pd(PPh3)4, DMF, K3PO4, 100 °C, 65 hrs, For R = H, 
83%; For R = OMe, 80%.; C) KOBut, DMF, hν, 10 min, R = H, 80%; For R = OMe, 70%. 
 
7.5 Aims of this Section 
 
Having seen the large variety of carbazole nuclei in nature and the importance of these in 
nature, synthetic organic chemists are inspired to assemble this framework. There are many 
new methods directed towards the synthesis of functionalized carbazoles or carbazole nuclei 
embedded in more complex molecules fused with other cyclic, aromatic or heteroaromatic 
rings.  
 
With the knowledge gained about carbazoles from research previously done in our 
laboratories previously, we decided to use this same methodology and direct it towards the 
synthesis of the quinolino[2,3-a]carbazole 417 skeleton employing what we hoped would be 
the potassium t-butoxide and light induced ring closure reaction as the key step, as shown in 
Scheme 136. 
 
 
Scheme 136 
 
The aim of this section is therefore to synthesize quinolino[2,3-a]carbazole 417 framework 
employing potassium t-butoxide and light induced ring closure reaction as the key step. 
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Chapter 8: Results and Discussion: Base and Light Mediated Approach Towards the 
Synthesis of Quinolino[2,3-a]carbazoles 
 
8.1 Introduction 
 
We have discussed in the previous Chapter the abundance of carbazoles in nature and their 
wide range of applications as therapeutics.213 Carbazoles fused with quinolines are rare in 
nature, but possess a wide range of biological activities. Only three compounds are known in 
nature being a quinoline fused with the carbazole skeleton, and these are are: calothrixins A 
360 and B 361 with a quinolino[4,3-b]carbazole-1,4-quinone arrangement, and the recently 
isolated dibromo-quinolino[4,5-a]carbazole 362. There are a number of reports describing 
the synthesis of calothrixin A 360 and B 361 in literature. But, to the best of our knowledge, 
to date only a few studies has been reported for the synthesis the of quinolino[2,3-
a]carbazole 417 framework. For these reasons, we wished to explore new approaches to the 
synthesis of quinolino[2,3-a]carbazoles such as 417 (Figure 66).203 
 
 
417 
 
Figure 66 
 
The two nitrogens in quinolino[2,3-a]carbazole 417, we believed in theory could bind with 
metals to form metal complexes, a property of quinolino[2,3-a]carbazoles 417 that is not yet 
explored. 
 
With all the necessary background regarding carbazole fused quinolines, we decided to start 
with two targets in mind: quinolino[2,3-a]carbazole 417 and 7-methoxy-quinolino[2,3-
a]carbazole 460 (Figure 59). 
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Figure 67 
 
The first step towards our synthetic targets was to do a retrosynthetic analysis. Having our 
preliminary knowledge of the synthesis of pyrido[2,3-a] carbazoles 439 which was published 
previously by our group (Scheme 137), we envisioned that our synthesis could be 
accomplished in a similar manner, with two fragments coming from indole 370 and 3-methyl 
quinoline 461 rather than the 2-bromo-3-methylpyridine 441 used as was reported. These 
two fragments could be coupled using Suzuki-Miyaura cross coupling reaction and later a 
potassium t-butoxide and light induced reaction could be carried out to form the final 
aromatic ring.210 
 
 
Scheme 137: Reagents and conditions: A) 1) LiTMP, -78 °C, THF; 2) B(OiPr)3; 3) H
+, 100%; 
B) 10% Pd(PPh3)4, aq. Na2CO3, DME, 87%; C) SiO2, microwave oven, 3 mins, 100%; D) 
POCl3, DMF, 91%; E) KHDMS, MeI, THF for R = Me; BnBr, KHDMS, THF for R = Benzyl, 
77%; F) KOBut, DMF, hv, 70-80 °C, 75%; G) AlCl3, 0 °C, benzene, 80%.
210 
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8.2 An Envisaged Retro Synthesis of Substituted Quinoline[2,3-a]carbazoles 
 
Based on the results published by de Koning et al. for the synthesis of pyrido[2,3-
a]carbazoles (Scheme 137) we envisioned synthesizing quinoline[2,3-a]carbazole 417 
skeleton as shown in Scheme 138.210 
 
 
R = H 
R = OMe 
R’ = Boc 
Scheme 138 
 
Specifically we wished to couple 1H-indol-2-ylboronic acid 462 and 2-bromo-3-
methylquinoline 461. These two fragments could be synthesized from indole 370 (5-
methoxyindole 463) and 3-methyl quinoline 464 respectively, both of which are available 
commercially.  
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Scheme 139 
 
Once we have synthesized the fragments 462 and 461 we hoped, they could be coupled 
employing Suzuki-Miyaura cross coupling reaction methodology.  
 
To commence with our synthetic scheme we wanted to first synthesize both the fragments 
which could be coupled using the palladium catalyzed Suzuki-Miyaura cross coupling 
reaction. 
 
8.3 Synthetic Approaches towards Quinolino[2,3-a]carbazole 417 and 7-Methoxy-
quinolino[2,3-a]carbazole 460 
 
8.3.1 Syntheses of Fragment A 462 
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Scheme 140: Reagents and conditions: A) Di-t-butyl dicarbonate, DMAP, dry THF, rt, 18 
hrs, For R = H, 98%, For R = OMe, 100%; B) DIPA, nBuLi, trimethyl borate, dry THF, 5 hrs, -
78 ºC-0 ºC-rt, For R = H, 95%, For R = OMe, 93%. 
 
The Boc protection of commercially available indole 370 and 5-methoxy-1H-indole 463 was 
carried out by stirring the two starting materials separately, in freshly distilled and dry 
tetrahydrofuran. Dimethylaminopyridine and di-t-butyl dicarbonate were added to the 
reaction mixture which, was allowed to stir for eighteen hours under inert conditions and at 
room temperature before being quenched. Work up and column chromatography followed to 
afford the product in each case in quantitative yields. Thin layer chromatography showed 
that the products (465 and 466) in both cases had much higher Rf values as compared to the 
starting materials (370 and 463). Examination of the NMR spectra showed that there was 
some residue from the di-t-butyl dicarbonate present even after purification by the column 
chromatography in both the products (465 and 466). Fortunately, this did not pose any 
problems for future steps and we were able to purify the products after the next reaction. The 
spectral data was found to be in agreement with that observed in the literature.214 One 
reason for using Boc protection at this point of the synthesis was that the Boc group is that it 
will allow for directed ortho metalation (DOM) which will be useful in the next step of our 
scheme: synthesis of the required boronic acid as shown in Scheme 141. 
 
 
 
Scheme 141 
 
We were now in a position to introduce a boronic acid substituent in the 2-position of the two 
Boc protected indoles 465 and 466 in order to couple them with 2-bromo-3-methylquinoline 
461 through the Suzuki-Miyaura cross coupling reaction. The first synthesis of these two 
boronic acids, 440 and 467, was reported by de Koning et al. of the organic chemistry 
laboratories of University of the Witwatersrand.210 The Boc group in each compound 
facilitates directed  ortho lithation which, when quenched, with trimethyl borate, leads to the 
formation of the borate ester. The addition of dilute hydrochloric acid during work-up of each 
reaction leads cleavage of each ester to afford the two boronic acids 440 and 467. 
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To carry out the reaction, diisopropylamide was added to dry tetrahydrofuran under inert 
conditions and the solution was cooled to -78 ºC. nButyllithium was added dropwise to the 
stirred solution and the reaction was allowed to warm up to 0 ºC for another thirty minutes. 
 
After the in situ preparation of lithium di-isopropylamine, the 
reaction mixture was cooled again to -78 ºC and N-boc-indole 
dissolved in tetrahydrofuran was added dropwise to the reaction 
mixture. Triisopropyl borate was added and on completion of the 
reaction, the mixture was quenched by the careful addition of ice 
cold water and 2 M hydrochloric acid. Subsequent to work up, solvent was removed under 
reduced pressure to one fourth of its original volume. At this stage, the thick slurry obtained 
was stirred vigorously at 0 ºC and ice cold hexane was added to facilitate precipitation of the 
boronic acid, which was filtered, dried and stored in the freezer. These boronic acids are 
stable if stored at low temperature, and could even be characterized by NMR spectroscopy. 
The spectroscopic data of 1-(t-butoxycarbonyl)-1H-indol-2-ylboronic acid 440 was found to 
be in agreement with that reported in the literature.215,216 Similarly, the spectroscopic data of 
t-butyl 5-methoxy-1H-indole-1-carboxylate 467 was found to be in accordance with that 
reported in the literature.210, 217  
 
8.3.2 Synthesis of Fragment B 
 
We now wished to tackle the synthesis of fragment B: 2-bromo-3-methylquinoline 461. A 
literature search unearthed a paper where the synthesis of this quinoline has been 
demonstrated. The procedure involved a Pfitzinger reaction on isatin 422 with propionic 
anhydride to yield 1-propionylisatin 468, which was later heated with sodium hydroxide to 
obtain 3-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylic acid 469. Further treatment with 
copper powder led to decarboxylation to afford 470. Finally, reaction with phosphoryl 
bromide gave the heteroaromatic bromide 461 as shown in Scheme 142.218 
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Scheme 142: Conditions and reagents: A) (EtCO)2O, reflux, 2.5 hrs, 81%; B) NaOH, heat, 1 
hr, 81%; C) Cu powder, quinoline, reflux, 5 hrs; D) POBr3, 140 °C. 
 
In our hands, we were able to synthesize 3-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylic 
acid 469 using the reported literature procedure.218 Conversion of 468 to 469 proceeds by 
Halberkann variation of Pfitzinger reaction where 469 is converted into the keto acid 471 in 
the presence of sodium hydroxide, which then undergoes cyclization through the CO and 
CH2 groups to give quinolone 469 as illustrated in Scheme 143.
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Scheme 143 
 
The decarboxylation of 469 using copper powder never yielded the desired product 470. We 
recovered starting material 469 from this reaction with no trace of product. Alternative 
methods for decarboxylation were also tested but these also failed to afford the desired 
product 470. 
 
As this synthetic route for the synthesis of fragment B 461 was unsuccessful, we attempted 
alternative procedures. In the literature search, we found a procedure which involved the 
rearrangement of 3-methylquinoline-1-oxide 472 as the key step.220 Here, treatment of 
commercially available 3-methylquinoline 464 with a peroxide source leads to 3-
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methylquinoline-1-oxide 472. A rearrangement with p-tosylchloride in the presence of base 
generates 3-methylquinolin-2(1H)-one 473, which can be converted to fragment B 461 by 
reaction with phosphoryl bromide, as described in Scheme 143. 
 
 
Scheme 143: Reagents and conditions: A) mCPBA, dry DCM, atmospheric conditions, 0 ºC-
rt, 45 mins, 87%; B) pTSA, K2CO3, CHCl3:H2O, rt, inert conditions, 5 hrs, 83%; C) POBr3, 
neat reaction, 140 ºC, 3 hrs, 83%. 
 
We therefore embarked on this synthesis of fragment B 461 with commercially available 3-
methyl quinoline 464 by dissolving it in dry dichloromethane cooled down to 0 ºC. m-
Chloroperbenzoic acid was added in portions, and the reaction started to bubble vigorously. 
When all of the starting material 464 had been consumed, the reaction was quenched, and 
the product isolated after work-up and purification by column chromatography. The product 
472 was obtained as a light yellow solid and was characterized by NMR spectroscopy. The 
data obtained was found to be in agreement with that reported in the literature.220 
 
1H and 13C NMR spectroscopy showed the correct number of signals as 
expected in the product 472. A singlet for the methyl protons was seen at 
2.46 ppm in the 1H NMR spectrum, with the corresponding peak at 13.5 
ppm in the 13C NMR spectrum. There were two singlets observed in the 1H 
NMR spectrum at 8.45 ppm and 7.55 ppm which are likely to be due to protons H-1 and H-3 
respectively. 
 
After the successful synthesis of 3-methyl quinoline oxide 472, the next step in the synthesis 
of fragment B 461 was the rearrangement of 472 to form 3-methylquinolin-2(1H)-one 473, 
This was achieved by dissolving the starting material 472 in chloroform and treating it with p-
toluene sulfonic acid and potassium hydroxide in water. The solution was stirred for five 
hours at room temperature and under inert conditions. Thin layer chromatography showed 
the emergence of a new product at higher Rf than the starting material 472. On completion 
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of the reaction, work up and column chromatography were performed to obtain the product 
as an off-white solid in 83% yield. Analysis by 1H and 13C NMR spectroscopy confirmed the 
formation of the desired product, and the spectroscopic data was found to be in agreement 
with that reported in the literature.221 
 
The most characteristic feature came from the 13C NMR spectrum with a 
peak at 164.5 ppm indicating the presence of a carbonyl carbon. In the 1H 
NMR spectrum, a singlet integrating for one proton at 11.80 ppm, 
characteristic of an NH group was observed. The other singlet arising from proton H-1 was 
seen at 7.65 ppm in the 1H NMR spectrum. The three protons of the methyl group gave rise 
to a signal at 2.31 ppm in the 1H NMR spectrum, and the corresponding peak in the 13C 
NMR spectrum could be observed at 16.8 ppm. 
 
The final step in the synthesis of fragment B 461 was the functional group interconversion to 
allow for the formation of bromide which could later be utilized in the Suzuki Miyaura cross 
coupling reaction. The product 461 was obtained by heating 3-methylquinolin-2(1H)-one 473 
with phosphoryl bromide at 140 ºC for three hours, during which time the formation of the 
new spot of higher Rf than the starting material 473 was observed by thin layer 
chromatography. Work up and purification by column chromatography gave the desired 
product 461 as a light brown solid in 83% yield. The spectroscopic data was found to be in 
agreement with that reported in the literature.222 
 
Disappearance of the singlet at 11.80 ppm in the 1H NMR spectrum due to 
the secondary amine was major indication of product formation. 
Furthermore, in the 13C NMR spectrum the signal for the carbonyl carbon 
at 164.5 ppm was no longer visible indicating that the carbonyl group was no longer present. 
A singlet for proton H-1 could be seen at 7.93 ppm in the 1H NMR spectrum and the 
corresponding peak in the 13C NMR spectrum could be seen at 22.4 ppm. 
 
8.3.3 Suzuki Miyaura Cross Coupling Reaction to Couple Fragment A 462 and B 461 
 
On having successfully synthesized both of the required fragments, we were now able to 
attempt the formation of a biaryl axis using the Suzuki Miyaura cross coupling reaction 
(Scheme 123). 
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R = H 440, OMe 467       R = H 474, OMe 475 
 
Scheme 144: Reagents and condition: Pd(PPh3)4, aq. 2 M Na2CO3, DME, rt-reflux, inert 
conditions, 18 hrs, For R = H, 95%, For R = OMe, 80%. 
 
The same synthetic procedure was followed for the preparation of 474 and 475, gave the 
desired products in excellent yields in both cases. However, care was taken to degas all 
solvent and water, used in the reaction and all glassware used were thoroughly dried prior to 
use. The starting materials, 440 or 467 in dry dimethoxyethane were added to the palladium 
catalyst and the resulting solution was stirred for ten minutes at room temperature and under 
inert conditions. An aqueous solution of the base was then added to the resulting mixture 
and was allowed to stir at reflux for eighteen hours. After work-up and purification by column 
chromatography, the products 474 and 475 in both cases were obtained as solids in very 
good yields. 
 
Significantly, if the reaction was carried out too dilute, then reaction took much longer and 
resulted in lower yields of the product. Also the concentration of the aqueous solution of 
base had a profound impact on the yield of the product obtained, where concentrations 
higher than 2 M substantially decreased the yield of product. 
 
We also tested the reaction in the microwave reactor using tetrakis(triphenylphosphine) 
palladium(0) as catalyst, cesium fluoride as base and dimethoxyethane as solvent. The 
reaction mixture was subjected to microwave irradiation at 150 ºC and 150 W. On 
spectroscopic analysis of the product we isolated revealed that the Suzuki-Miyaura cross 
coupling reaction had taken place along with deprotection of the Boc group. Although 
deprotection of the Boc group was planned as the following step in our synthesis, we 
decided not to pursue this approach as the yields obtained were significantly lower than 
when conventional heating was used in the reaction.  
 
Keyari et al. in 2013 reported a similar type of Suzuki-Miyaura cross coupling reaction for the 
synthesis of biaryl axis in 7-aminoquinoline quinones 476 under microwave irradiation.223 
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Scheme 145: Reagents and conditions: Pd(PPh3)4, DME/Na2CO3, 110 °C, 25 mins, 73%. 
 
To our surprise, the Boc group stayed intact during the microwave conditions as reported by 
Keyari et al. contrary to our results of the Suzuki-Miyaura cross coupling reaction under 
microwave conditions.223 Using slightly milder conditions might  have helped in this case but 
we decided to stick to the conventional procedure of Suzuki-Miyaura cross coupling reaction 
as the yields were good. 
 
Identification of t-butyl 2-(3-methylquinolin-2-yl)-1H-indole-1-
carboxylate 474 was done by 1H and 13 C NMR spectroscopy, 
where peaks from both fragment A 341 and B 390 were visible in 
the spectrum. Signals arising from the Boc protecting group viz, a 
singlet at 1.12 ppm integrating for nine protons in the 1H NMR 
spectrum and the corresponding peak at 27.4 ppm in the 13C 
NMR spectrum were observed. The carbonyl group from the Boc was seen as a signal at 
154.9 ppm in the 13C NMR spectrum. The methyl protons on carbon C-7’ were observed at 
2.35 ppm as a singlet integrating for three protons in the 1H NMR spectrum with the 
corresponding peak in the 13C NMR spectrum at 19.3 ppm Two singlets were visible at 7.93 
ppm for proton H-6’ and at 6.71 ppm for proton H-1 respectively in the 1H NMR spectrum. 
FTIR spectral analysis depicted characteristic peaks for the Boc group with a peak at 1721 
cm-1 for the carbonyl group and one at 1328 cm-1 for a C-O stretch. Additionally, at 1258 cm-1 
a peak was observed which is characteristic of a C=N group. The molecular ion peak for 
C22H22N2O2 (M
++H) was observed at 359.1750 in the HRMS analysis, and correlated with 
the expected value. 
t-Butyl 5-methoxy-2-(3-methylquinolin-2-yl)-1H-indole-1-
carboxylate 475 was also easily identified by 1H and 13C NMR 
spectroscopy. Peaks pertaining to the Boc protecting group 
could be seen in both 13C and 1H NMR spectra. A singlet for 
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the methyl group was visible in the 1H NMR spectrum at 2.37 ppm, with the corresponding 
peak in the 13C NMR spectrum at 19.4 ppm. The three methoxy protons were observed at 
3.88 ppm in the 1H NMR spectrum with the corresponding signal at 55.7 ppm in the 13C NMR 
spectrum. Two singlets in the 1H NMR spectrum at 7.97 ppm and 6.64 ppm corresponded to 
the protons H-6’ and H-1. Proton H-6 appeared as a doublet at 7.06 ppm in the 
1H NMR 
spectrum with a coupling constant of 2.5 Hz due to meta coupling with H-4. Apart from NMR 
spectroscopic analysis, FTIR and HRMS analysis further confirmed the formation of the 
product. In the FTIR spectrum, a peak at 1725 cm-1 due to the carbonyl group and a C-O 
stretch at 1320 cm-1 further confirmed the presence of product 475. Peaks at 1272-1259 cm-
1 due to the C=N bond were also visible in the FTIR spectrum. HRMS analysis of the product 
gave the molecular ion as 389.1848 for C24H24N2O3 (M
++H), which correlated with the 
calculated value.  
 
8.3.4 Deprotection Reaction of the Boc Group 
 
 
R = H 474, OMe 475     R = H 476, OMe 477 
 
Scheme 146: Reagents and conditions: AlCl3, DCM, 0 ºC-rt, 1 hr, For R = H, 68%, For R = 
OMe, 69% 
 
The formylation reaction of indoles usually occurs in the more reactive 3-position of the 
indole molecules as it is the most nucleophilic site. To ensure that the next step in our 
synthesis, formylation occurs at the desired position, we decided to deprotect the indole 
nitrogen to render the 3-position more nucleophilic and most suitable for formylation. 
Therefore, we carried out deprotection of the Boc groups from our two compounds, t-butyl 2-
(3-methylquinolin-2-yl)-1H-indole-1-carboxylate 474 and t-butyl 5-methoxy-2-(3-
methylquinolin-2-yl)-1H-indole-1-carboxylate 475. 
 
The deprotection reaction was carried out by dissolving the starting materials separately in 
dichloromethane and cooling down the solution to 0 ºC. The Lewis acid, aluminium chloride 
was added carefully in portions, and the reaction mixture was stirred for one hour at room 
temperature under inert conditions. The progress of the reaction was monitored every fifteen 
180 
 
minutes by thin layer chromatography. If the reaction was left for extended periods of time 
some decomposition occurred which was seen by the emergence of multiple spots on the 
thin layer chromatography plate. Surprisingly the Rf value of the product was higher than that 
of the starting material in both cases, when we were expecting the opposite. However, 
intramolecular hydrogen bonding between the hydrogens of the indole moiety with the 
nitrogen of quinoline moiety could be an explanation for this as shown in Figure 60. 
 
 
Figure 68 
 
After completion of the reaction, the mixture was quenched and the product isolated after 
work-up and column chromatography. The product in each case was obtained as a bright 
yellow solid and in moderate yields: 68% for 476 and 69% for 477. 
 
The characteristic signals of the Boc group were absent from the 
1H and 13C NMR spectra of 2-(1H-indol-2-yl)-3-methylquinoline 
476. Also, a singlet appeared at 10.13 ppm in the 1H NMR 
spectrum integrating for one proton which is characteristic of the 
free hydrogen of the secondary amine. The signal for the methyl 
group could be seen at 2.80 ppm in the 1H NMR spectrum with 
the corresponding peak at 21.8 ppm in the 13C NMR spectrum. Two singlets could be seen 
at 7.94 ppm and 7.15 ppm for protons H-7’ and H-1 respectively in the 1H NMR spectrum. A 
characteristic peak for the amine group was observed at 3289 cm-1 in the FTIR spectrum, 
which further confirmed the absence of the Boc group. Finally, the molecular ion for C18H14N2 
(M++H) was observed at m/z 259.1230 in the HRMS. 
 
2-(5-Methoxy-1H-indol-2-yl)-3-methylquinoline 477 was also 
identified easily from the 1H and 13C NMR spectra. At 10.05 
ppm in the 1H NMR spectrum a singlet due to the free 
hydrogen of the indole nucleus was visible. A singlet for H-6’ 
was seen at 7.90 ppm, and singlets for the three protons of 
each of the methoxy group and for the methyl group were 
observed at 3.86 ppm and 2.76 ppm respectively. In the 13C NMR spectrum, a signal for C-5 
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was observed at 154.2 ppm. A broad N-H stretch was observed in the FTIR spectrum at 
3147 cm-1. HRMS gave the expected mass with m/z 289.1331  
 
8.3.5 Formylation of 3-Position on Indole Moiety 
 
 
R = H 476, OMe 477    R = H 478, OMe 479 
 
Scheme 147: Conditions and reagents: Dichloromethyl methyl ether, SnCl4, 
dichloromethane, -70 ºC-0 ºC, 3 hrs, For R = H, 75%, For R = OMe, 65%. 
 
After successfully preparing 2-(1H-indol-2-yl)-3-methylquinoline 476 and 2-(5-methoxy-1H-
indol-2-yl)-3-methylquinoline 477 we wanted to introduce a formyl substituent at the 3-
position of the indole moiety of each of these molecules which would be used later for the 
potassium t-butoxide induced ring closure reaction. To proceed with the synthesis, a 
classical Vilsmeier reaction was employed, which involved the use of phosphoryl chloride, 
dimethyl formamide and toluene as solvent. Unfortunately, this method was not successful 
on either substrate 476 or 477, even after multiple attempts. 
 
While searching for an alternative procedure we came across a reaction which uses 
dichloromethyl methyl ether as the formylating agent.224 We decided to test this method on 
our substrate 2-(1H-indol-2-yl)-3-methylquinoline 476. To proceed with the reaction starting 
material 476 was added to dry dichloromethane under argon and at room temperature. 
Dichloromethyl methyl ether was then added to the stirred reaction mixture and reaction 
mass turned bright yellow. After that, the reaction mixture was cooled to -70 ºC and treated 
with tin(IV)chloride. The reaction mixture was then allowed to warm to 0 ºC and was stirred 
at the same temperature for three hours under inert conditions. 
 
The progress of the reaction was monitored by thin layer chromatography and after three 
hours all of the starting material 476 had been consumed and a new spot, which had higher 
Rf value compared to the starting material, appeared. After work up and column 
chromatography, the product 478 was obtained as a yellow solid. However the product was 
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particularly unstable, possibly due to the presence of both the free secondary amine and the 
formyl group. Similar problems were encountered in the synthesis of 5-methoxy-2-(3-
methylquinolin-2-yl)-1H-indole-3-carbaldehyde 479, with the more electron rich indole ring 
making this compound even more unstable.  
 
Due to the instability of these products, we were only able to obtain a 1H NMR spectrum for 
2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 478. 5-Methoxy-2-(3-methylquinolin-2-
yl)-1H-indole-3-carbaldehyde 479 was treated as an intermediate and used in the next step 
without any further characterization. 
 
The 1H NMR spectrum of 478 showed, a clear peak at the 
chemical shift of 9.80 ppm, integrating for one proton 
characteristic of an aldehyde group. At 12.50 ppm, a singlet 
indicating the presence of the free indole amine was visible and 
another singlet at 8.41 ppm, integrating for one proton was 
characteristic of the proton at C-6’. A singlet at 3.32 ppm 
confirmed the presence of three protons of the methyl group. Although we were unable to 
fully characterize this compound, the presence of a signal in the 1H NMR spectrum indicating 
an aldehyde clearly showed that we had successfully introduced the formyl group to afford 
the carbaldehyde 478. 
 
8.3.6 Reprotection of the Indole Nitrogen 
 
Following the successful formylation of the indole moiety of the molecule to obtain 478 and 
479, it was necessary to protect the indole nitrogen, before performing the potassium t-
butoxide mediated ring closure reaction, as the free NH group would hinder the formation of 
the final aromatic ring. We decided to use a benzyl protecting group as the benzyl group can 
also be removed at the end of the synthesis if necessary.  
 
 
R = H 478,OMe 479    R = H 480,OMe 481 
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Scheme 148 Reagents and conditions: NaH, BnBr, DMF, rt, 1 hr, For R = H, 93%, For R = 
OMe, 97%. 
 
To carry out the reaction on both aldehydes, 478 and 479 were treated separately with 
sodium hydride in dimethylformamide. Each reaction was allowed to stir at room temperature 
under inert conditions for one hour, after which benzyl bromide was added. Purification of 
the products was achieved by column chromatography of the products. 480 and 481 were 
isolated as off white solids. Analysis of the products was done by 1H and 13C NMR 
spectroscopy. 
 
The most diagnostic signal in the 1H NMR spectrum was the 
appearance of a peak representing the two benzylic protons at 
5.29 ppm, with the corresponding peak in the 13C NMR spectrum 
visible at 47.9 ppm. The total number of aromatic signals in 
the`1H-NMR had increased by five protons which clearly shows 
that a benzyl substituent was present. The characteristic peak for 
the carbonyl group was also seen in the FTIR spectrum at 1708 cm-1. The HRMS gave the 
expected mass for C26H22N2O (M
++H), 377.1646 further corroborating the result obtained.  
 
In the NMR spectroscopic analysis of 1-benzyl-5-methoxy-2-
(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 481 we 
were also able to identify all of the required signals. A peak at 
5.59 ppm in the 1H NMR spectrum and at 56.9 ppm in the 13C 
NMR spectrum indicated the presence of the benzylic protons 
and carbon respectively. In both the 1H and 13C NMR spectra 
there was an increase the integration of the signals in the aromatic region due to the 
introduction of the benzyl group. The characteristic peak for the aldehyde functional group in 
the FTIR spectrum was observed at 1718 cm-1. Also the HRMS gave the molecular ion for 
C27H22N2O2, (M
++H) at 407.1752, which corresponded well with the calculated value. 
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8.3.7 Potassium t-butoxide and Light Induced Ring Closure Reaction 
 
 
R = H 480, OMe 481    R = H 482,OMe 483 
 
Scheme 149: Conditions and reagents: KOBut, hv, DMF, 80 ºC, 10 mins, For R = H, 80%; 
For R = OMe, no reaction.  
 
Having previous knowledge of the ring closing reaction induced by base and a source of 
light, we tested the reaction on each substrate 480 and 481 in dimethylformamide at 80 ºC 
with potassium t-butoxide. Starting with 480, the reaction mixture was analyzed by thin layer 
chromatography and a spot with much higher Rf value compared to the starting material 480 
was observed. The product 482 was isolated and purified by column chromatography. 
Unfortunately, even after numerous attempts we failed to isolate the desired product 483 
when we did the same reaction on 1-benzyl-5-methoxy-2-(3-methylquinolin-2-yl)-1H-indole-
3-carbaldehyde 481. 
 
 
 
Scheme 150 
 
The presence of the methoxy group, which renders the substrate 481 more electron rich, 
may play a role in this. We were not in a position to optimize this reaction at this stage and it 
will be considered for the future work. 
 
For the product 482, there were sixteen protons observed in the 
aromatic region of the 1H NMR spectrum which corresponded 
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with the structure expected. There was one singlet seen at 8.79 ppm which is most likely due 
to proton H-3 as it does not couple to any other protons. Interestingly in the 1H NMR 
spectrum, the signal from the two benzylic protons shifted downfield to 6.86 ppm as 
compared to 5.59 ppm in the starting material. This could be attributed to the fact that due to 
the ring closure, the compound is fully aromatic and rigid. The 13C NMR spectrum also 
depicted the correct number of signals in the aromatic region as we were expecting twenty 
two peaks in total. In the FTIR spectrum, there was no carbonyl peak to be seen, which 
indicated conversion of the starting material to the product. Also HRMS gave m/z of 
359.1542 for C26H18N2 (M
++H), which correlated well with what we were expecting. Final 
confirmation came from the single crystal X-ray structure obtained for our product 
corroborated our result as shown in Figure 69.  
 
 
Single X-ray crystal structure of quinolino[2,3-a]carbazole 482 
 
Figure 69 
 
8.3.8 Benzylic Deprotection to form Quinolino[2,3-a]carbazole 417 
 
 
 
Scheme 151: Conditions and reagents: AlCl3, benzene, 0 °C-rt, 2 hrs, 79%. 
 
We were very happy to isolate quinolino[2,3-a]carbazole 482 using the potassium t-butoxide 
and light induced cyclization reaction, which was the key step in our synthetic scheme. 
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Having synthesized the desired quinoline fused carbazole 482 the final step was the benzyl 
deprotection from the indole nitrogen. The reaction was carried out using a literature 
reported procedure in which a strong Lewis acid in a non-polar solvent was used. Starting 
material 482 was dissolved in benzene and aluminium chloride was added to the reaction 
mixture at 0 °C.210 The reaction mass was slowly allowed to warm to room temperature and 
was stirred at this temperature for two hours. During the course of the reaction a colour 
change of the solution was observed from yellow to bright red. Progress of the reaction was 
monitored by thin layer chromatography and a new spot was observed just below the 
starting material 482. Subsequent to work-up and column chromatography product 417 was 
isolated as a yellow solid in 79% yield. 
 
NMR spectroscopic studies were carried out to confirm the 
structure and were found to be in accordance with the 
literature.203The proton of the free indole nitrogen could be seen 
as a singlet in the 1H NMR spectrum downfield at 10.61 ppm. 
Signals from eleven protons could be seen in the aromatic 
region in the 1H NMR spectrum. Nineteen signals could be seen in the 13C NMR spectrum, 
all in the aromatic region which complies well with the expected structure. Also, it was clear 
that we had successfully deprotected the nitrogen as there were no peaks for the benzylic 
group in either the 1H or the 13C NMR spectrum. In the FTIR spectrum, a broad peak at 3216 
cm-1 which is characteristic of the free secondary amine, could be observed. HRMS result 
was also found to be in agreement with that of the expected product. 
 
8.4 Conclusion 
 
In this part of the PhD, we were successful in synthesizing quinolino[2,3-a]carbazole 482, 
demonstrating a further use of the light and potassium t-butoxide mediated ring closure 
reaction. Unfortunately we were not able to isolate 7-methoxy-quinolino[2,3-a]carbazole 460, 
by the same process but this would be considered for the future work. 
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Chapter 9: Experimental Procedures 
 
9.1. General Experimental Procedures 
 
9.1.1. Purification of Solvents and Reagents 
 
Solvents utilized for chromatographic techniques (ethyl acetate and n-hexane) were distilled 
preceding use by means of conventional distillation processes. The solvents employed in 
reactions were first dried over the suitable drying agent, followed by distillation under an inert 
atmosphere (argon or nitrogen gas). Acetonitrile and dichloromethane were distilled over 
calcium hydride, whereas tetrahydrofuran was distilled over sodium with benzophenone as 
an indicator. All the required chemicals or reagents were obtained from FLUKA, SIGMA 
ALDRICH or MERCK and were used without further purification. 
 
9.1.2. Chromatography Procedures 
 
Normal chromatography was performed with silica gel 60 (Macherey-Nagel, particle size 
0.063-0.200 mm) adsorbent, with both isocratic and gradient eluent systems being 
employed. Thin layer chromatography (TLC) of the compounds was executed on Macherey-
Nagel Alugram Sil G/UV254 plates pre-coated with 0.25 mm silica gel 60. The TLC plates 
were viewed under UV light (254 nm and 366 nm). 
 
9.1.3. Spectroscopic and Physical Data 
 
Nuclear magnetic resonance (NMR) spectra were recorded on either a Bruker AVANCE 300 
MHz or a Bruker AVANCE III 500 MHz spectrometer. All spectra were recorded in 
chloroform-d or dimethylsulfoxide-d6. All chemical shift values are reported in parts per 
million referenced against trimethylsilane which is given an assignment of zero parts per 
million. Coupling constants (J-values) are given in Hertz (Hz).  
 
The infra-red spectra were recorded on a Bruker Tensor 27 standard system spectrometer. 
Measurements were made by loading the sample directly onto a diamond cell. The 
measurements are reported on the wavenumber scale (/cm-1).  
 
Melting points were determined on a Reichert hot-stage microscope, and remain 
uncorrected. All crystalline compounds were recrystallized in the appropriate solvents prior 
to melting point determination. 
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High resolution mass spectra were obtained with a Waters-LCT-Premier mass spectrometer. 
The sample was dissolved in methanol to a concentration of 2 ng/μl and introduced by direct 
infusion. The ionization mode was electrospray positive with a capillary voltage of 2500 V 
and a desolvation temperature of 250 °C using nitrogen gas at 250 L/hr. 
 
The intensity data was recorded on a Bruker APEX II CCD area detector diffractometer with 
graphite monochromated Mo K3 radiation (50 kV, 30 mA) with temperature of measurement 
at 173(2) K, using the APEX 2 data collection software. The collection method involved 4-
scans of width 0.5 and 512×512 bit data frames. The data reduction was achieved by means 
of the program SAINT+ and face indexed absorption corrections were made using XPRE. 
 
Crystal structures were solved employing direct methods using SHELXTL. Nonhydrogen 
atoms were first refined isotropically followed by anisotropic refinement by full matrix least-
squares calculations based on F2 using SHELXTL. The hydrogen atoms were first located in 
the difference map then positioned geometrically and allowed to ride on their respective 
precursor atoms. Diagrams and publication material were generated using SHELXTL, 
PLATON151 and ORTEP-3. 
 
9.1.4. Other General Procedures 
 
All the glass reaction vessels were dried in an oven. The term “in vacuo” refers to the 
removal of solvent by use of a rotary evaporator. The residual solvent of purified material 
was removed by utilizing a high vacuum pump (ca.0.1 mm Hg) at ambient temperature until 
constant mass was achieved. 
 
9.2 Preparation of 1,4-Dimethoxynaphthalene58 96 
 
Commercially available 1,4-naphthoquinone 95 (1eq., 4.00g, 25.31mmoles) in diethyl ether 
(150mL) was added to a vigorously stirring solution of sodium dithionite (10eq., 36.00g, 
0.25moles) in water (200mL) for a period of one hour. The colour of the solution changes 
from dark orange to pale yellow which indicates reduction of quinone. The solution was 
transferred to a separating funnel and organic layer was collected, washed with brine 
(200mL×2), dried over anhydrous magnesium sulfate, filtered and organic solvent was 
removed in vacuo to obtain crude naphthalene-1,4-diol 93 as a brown solid, which is an 
unstable intermediate and was used in the next reaction without any characterization. 
Naphthalene-1,4-diol 93 was dissolve in dry acetone (100mL) and potassium carbonate 
(4eq., 14.00g, 50.00mmoles) was added to it. The reaction was allowed to stir for thirty 
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minutes at room temperature under inert conditions. The reaction mixture changes color 
from light brown to very dark brown which indicates the generation of an anion. Dimethyl 
sulfate (7eq., 44.00g, 16.6mL, 35.00mmoles) was added to the reaction mixture and the 
reaction was allowed to stir at reflux for eighteen hours. The reaction was allowed to cool to 
room temperature and the potassium carbonate was filtered off. The acetone was removed 
in vacuo to obtain a brown oil which was dissolved in diethyl ether (200mL). Aqueous 
ammonia (100mL) was then added to this solution in portions with stirring till the evolution of 
bubbles stops. The solution was transferred to a separating funnel and organic layer was 
collected which was washed with aqueous 10% hydrochloric acid (100mL), water (100×2mL) 
and brine (100mL). The organic layer was collected, dried over anhydrous magnesium 
sulfate, filtered and organic solvent removed in vacuo to obtain 1,4-dimethoxynaphthalene 
89 as a brown solid which was purified by column chromatography (10% EtOAc-Hexane) to 
obtain product as a white solid (4.10g, 21.60mmoles, 85%). 
 
Rf 0.44(20% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 8.21 (2H, 
dd, J = 6.4, 3.3 Hz, ArH), 7.50 (2H, dd, J = 6.4, 3.3 Hz, ArH), 6.68 (2H, s, 
ArH-2,3), 3.94 (6H, s, OMe×2); 13C NMR (75 MHz, Chloroform-d) δ 
149.5(ArC-1,4), 126.3(ArC), 125.9(ArC), 121.8(ArC), 103.1(ArC), 
55.8(OMe×2).58  
 
9.3 Preparation of 2-Bromo-1,4-dimethoxynaphthalene59 97 
 
1,4-dimethoxynaphthalene 96 (1eq., 1.00g, 5.31moles) was dissolved in 25mL dry 
dichloromethane in a 50mL round bottom flask and N-bromosuccinimide (1eq., 1.00g, 
5.31moles) was added to it. The reaction was stirred under inert conditions at room 
temperature for eighteen hours. After that time aqueous sodium sulfite (20mL) was added to 
it to quench the reaction and solution was transferred to a separating funnel. The organic 
material was extracted into dichloromethane (20mL×3). The combined organic phases were 
collected and washed subsequently with water (30mL) and brine (30mL), dried over 
anhydrous magnesium sulfate, filtered and organic solvent was removed in vacuo which was 
purified by column chromatography (10% EtOAc-Hexane) to obtain 2-bromo-1,4-
dimethoxynaphthalene 90 as a pale yellow solid (1.20g, 4.47mmoles, 84%).  
 
Rf 0.28 (20% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 8.23 – 
8.18 (1H, m, ArH), 8.09 – 8.03 (1H, m, ArH), 7.60 – 7.47 (2H, m, ArH), 
6.88 (1H, s, ArH-3), 3.97 (3H, s, OMe), 3.95 (3H, s, OMe); 13C NMR (75 
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MHz, Chloroform-d) δ 152.3(ArC-1), 146.9(ArC-4), 129.0(ArC), 127.3(ArC), 125.9(ArC), 
125.8(ArC), 122.7(ArC), 121.9(ArC), 112.0(ArC), 108.0(ArC), 61.4(OMe), 55.9(OMe).59 
 
9.4 Preparation of 2-(1,4-Dimethoxynaphthalen-2-yl)benzaldehyde 99 
 
2-Bromo-1,4-dimethoxynaphthalene 97 (1eq., 200mg, 0.751mmoles), 2-formylphenylboronic 
acid 98 (1.5eq., 169mg, 1.13mmoles), tetrakis(triphenylphosphine)palladium(0) (0.4eq., 
47.0mg, 0.302mmoles) and cesium fluoride (2.5eq., 285mg, 1.877mmoles) were added to a 
microwave vial and freshly degassed dimethoxy ethane (2mL) was added to the mixture. 
The reaction was set up in a microwave reactor at 150 °C and 150 W power with high 
stirring for thirty minutes. On completion, the reaction mass was filtered off, adsorbed on 
silica and subjected to column chromatography (5% EtOAc/Hexane) to obtain the product 99 
as an off-white solid (166mg, 0.572mmoles, 76%).  
 
Rf 0.51 (20% EtOAc/Hexane); mp. 190-192 ºC (C2H5)2O; 
FTIR(ν/cm-1): 2935 (C-H), 1726 (C=O), 1625-1469 (C=C), 1263-
1224 (C-O); 1H NMR (500 MHz, Chloroform-d) δ 9.90 (1H, s, CHO), 
8.30 (1H, dd, J = 8.0, 1.5 Hz, ArH), 8.17-8.11 (1H, m, ArH), 8.08 
(1H, dd, J = 8.1, 1.5 Hz, ArH), 7.71 (1H, td, J = 7.5, 1.5 Hz, ArH), 
7.64-7.50 (4H, m, ArH), 6.74 (1H, s, ArH-3’), 4.01 (3H, s, OMe), 3.40 (3H, s, OMe); 13C NMR 
(75 MHz, Chloroform-d) δ 192.4 (C=O), 152.0 (ArC-4’), 147.0 (ArC-1’), 141.9 (ArC), 
133.8(ArC), 133.5 (ArC), 131.0 (ArC), 128.4 (ArC), 127.9 (ArC), 127.2 (ArC), 127.1, 
126.64(ArC), 126.2 (ArC), 125.4(ArC), 122.4(ArC), 122.3(ArC), 105.9(ArC-3’), 60.9 (OMe), 
55.8 (OMe); HRMS (ESI+): Found M++ H 293.1169, C19H17O3 (M
++ H) requires 293.1178, 
m/z 293.1169(100%), 292.1092(50%). 
 
9.5 Preparation of (2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanol 86 
 
2-(1,4-Dimethoxynaphthalen-2-yl)benzaldehyde 99 (1eq., 657mg, 2.25mmoles) was 
dissolved in 10mL of freshly distilled dry tetrahydrofuran under inert conditions in a 25mL 
round bottom flask. Lithium aluminium hydride (3eq., 255mg, 6.75mmoles) was added to the 
mixture carefully. The reaction was allowed to stir at room temperature under inert conditions 
for two hours. When completed, the reaction was cooled down to 0 °C and a 2% aqueous 
sodium hydroxide (10mL) was added dropwise to quench the unreacted lithium aluminium 
hydride and then diluted with ice-cold water (25mL). The organic material was the extracted 
into ethyl acetate (20mL×3) and combined organic phases were washed with brine (50mL), 
dried over anhydrous magnesium sulfate, filtered and the solvent was removed in vacuum to 
191 
 
obtain crude product which was then subjected to column chromatography (40% 
EtOAc/Hexane) to obtain product 79 as a white solid (638mg, 2.17mmoles, 96%). 
 
Rf 0.38 (50% EtOAc/Hexane); mp. 114-115 ºC (C2H5)2O; 
FTIR(ν/cm-1): 3442 (OH), 2930 (C-H), 1625-1454 (C=C), 1273-1229 
(C-O); 1H NMR (300 MHz, Chloroform-d) δ 8.34-8.22 (1H, m, ArH), 
8.16-8.05 (1H, m, ArH), 7.65-7.32 (6H, m, ArH), 6.62 (1H, s, ArH-
3’), 4.44 (1H, d, J = 11.1 Hz, one of CH2OH), 4.37 (1H, d, J = 11.1 
Hz, one of CH2OH), 3.93 (3H, s, OMe), 3.61 (1H, s, OH), 3.47 (3H, s, OMe);
 13C NMR (75 
MHz, Chloroform-d) δ 152.0(ArC-4’), 146.2(ArC-1’), 139.5(ArC), 137.9(ArC), 130.1(ArC), 
129.9(ArC), 129.1(ArC), 128.4(ArC), 128.3 (ArC), 127.8(ArC), 127.1(ArC), 126.2(ArC), 
125.8(ArC), 122.4(ArC), 122.1(ArC), 106.4(ArC-3’), 64.1(CH2OH), 61.6 (OMe), 55.7 (OMe); 
HRMS (ESI-): Found M+-OH 277.1240, C19H17O2 (M
+-OH) requires 277.1240, m/z 
277.124(100%), 294.1244(30%). 
 
9.6 Preparation of 12-Methoxy-6H-dibenzo[c,h]chromen-6-one38 65 
 
(2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanol 86 (1eq., 265mg, 0.903 mmoles) was 
dissolved in dichloromethane (10mL) and to this stirring solution was added N-
bromosuccinimide (2eq., 320mg, 1.80mmoles) and the reaction mass was allowed to stir at 
room temperature and under atmospheric conditions for eight hours. On completion of the 
reaction aqueous saturated solution of sodium sulfite (10mL) was added to quench the 
reaction. The organic layer was collected and washed with water (10mL) and brine (10mL), 
dried over anhydrous magnesium sulfate, filtered and the organic solvent was removed 
under reduced pressure to obtain the crude product which was purified by column 
chromatography (10% EtOAc-Hexane) to isolate 12-methoxy-6H-dibenzo[c,h]chromen-6-one 
65 as light tan solid (129mg, 0.474mmoles, 53%). The spectroscopic data was found to be in 
agreement with that of Jones and Qabaja.38 
 
Rf 0.88 (20% EtOAc/Hexane); mp. 228-230 °C (C2H5)2O; FTIR(ν/cm
-
1): 2935 (C-H), 1722 (C=O), 1664-1418 (C=C), 1277-1225 (C-O); 1H 
NMR (300 MHz, Chloroform-d) δ 8.58-8.43 (2H, m, ArH), 8.26 (1H., 
d, J = 7.7 Hz, ArH), 8.12 (1H, d, J = 8.1 Hz, ArH), 7.95-7.82 (1H, m, 
ArH), 7.63 (3H, ddd, J = 9.9, 7.3, 1.4 Hz, ArH), 7.24 (1H, s, ArH-11), 
4.12 (3H, s, OMe); 13C NMR (75 MHz, Chloroform-d) δ 161.4(ArC-6), 
152.4(ArC), 141.8 (ArC), 135.5(ArC), 134.7(ArC), 130.7(ArC), 128.4(ArC), 127.7(ArC), 127.3 
(ArC), 126.8(ArC), 124.8(ArC), 122.1(ArC), 122.1(ArC), 121.8(ArC), 121.4(ArC), 112.6 
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(ArC), 95.8(ArC-11), 55.79(OMe), HRMS (ESI+): Found M++H 277.0865, C18,H12,O3 (M
++ H) 
requires 277.0865, m/z 277.0865(100%), 278.0694(20%).38 
 
9.7 Preparation of 2-Bromo-1,4-dimethoxybenzene59 112 
 
N-bromosuccinimide (1eq., 2.57g, 14.40 mmoles) was added to a stirring solution of 1,5-
dimethoxybenzene 111 (1eq., 2.00g, 14.40mmoles) in dichloromethane (20mL) under inert 
conditions at room temperature. The reaction was allowed to stir under the same conditions 
for seventy two hours. After this time an aqueous saturated solution of sodium sulfite (20mL) 
was added and then washed with dichloromethane (20mL×3). The combined organic phases 
were collected and washed with water (30mL) and then with brine (30mL), dried over 
anhydrous magnesium sulfate. The resulting solution was filtered and the organic solvent 
was removed under reduced pressure to isolate the product 112 as a clear oil (2.82g, 12.98 
mmoles, 90%). 
 
Rf 0.66 (20% EtOAc/Hexane) 
1H NMR (500 MHz, Chloroform-d) δ 7.11 (1H, d, 
J = 2.6 Hz, ArH-3), 6.84-6.81 (1H, m, ArH-5), 6.81 (1H, d, J = 2.6 Hz, Ar-6H), 
3.82 (3H, s, OMe), 3.74 (3H, s, OMe); 13C NMR (126 MHz, Chloroform-d) δ 
154.0(ArC-1), 150.3(ArC-4), 119.0(ArC), 113.6(ArC), 112.9(ArC), 112.0(ArC-2), 
56.8(OMe), 55.9(OMe).59 
 
9.8 Preparation of 2',5'-Dimethoxybiphenyl-2-carbaldehyde64 114 
 
2-Bromo-1,4-dimethoxynaphthalene 112 (1eq., 250mg, 1.15mmoles), 2-formylphenylboronic 
acid 98 (1.5eq., 207mg, 1.38mmoles.), tetrakis(triphenylphosphine)palladium(0) (0.1eq., 
133mg, 0.29mmoles) and cesium fluoride (2.5eq., 437mg, 2.88mmoles) were added to a 
microwave vial in dimethoxy ethane (2mL) as solvent and the solution was degassed for two 
minutes. The reaction mixture was transferred to a microwave reactor at 150 °C and 150 W 
power with vigorous stirring for thirty minutes. On completion, the reaction mass was filtered 
off, adsorbed on silica and subjected to column chromatography (5% EtOAc/Hexane) to 
obtain the product 114 as white low melting solid (246mg, 1.02mmoles, 88%) 
 
Rf 0.40 (20% EtOAc/Hexane); 
1H NMR (500 MHz, Chloroform-d) δ 9.79 
(1H, s, CHO), 8.01-7.97 (1H, m, ArH), 7.64 (1H, td, J = 7.5, 1.2 Hz, ArH), 
7.48 (1H, t, J = 7.6 Hz, ArH), 7.38-7.34 (1H, m, ArH), 6.94 (1H, dd, J = 
8.9, 3.0 Hz, ArH), 6.90 (1H, d, J = 8.9 Hz, ArH), 6.87 (1H, d, J = 3.0 Hz, 
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ArH), 3.81 (3H, s, OMe), 3.67 (3H, s, OMe); 13C NMR (126 MHz, Chloroform-d) δ 
192.5(C=O), 153.8(ArC), 150.7(ArC), 141.6(ArC), 134.0(ArC), 133.7(ArC), 131.0(ArC), 
127.8(ArC), 127.7 (ArC), 126.6(ArC), 117.3(ArC), 114.4(ArC), 111.8(ArC), 55.9(OMe), 
55.8(OMe).64 
 
9.9 Preparation of (2',5'-Dimethoxybiphenyl-2-yl)methanol 115 
 
2',5'-dimethoxybiphenyl-2-carbaldehyde 114 (1eq., 200mg, 0.826mmoles) was taken up in 
tetrahydrofuran (20mL) and lithium aluminium hydride (2eq., 63.0mg, 1.65 mmoles) was 
added to it at 0 ºC under inert conditions. The reaction mixture was allowed to warm up to 
room temperature and reaction was stirred under inert conditions for one hour. On 
completion the temperature was again reduced to 0 ºC and an ice cold aqueous 2 M sodium 
hydroxide solution (10mL) was added to it dropwise to quench the unreacted lithium 
aluminium hydride. The mixture was then transferred to a separating funnel and washed 
repeatedly with diethyl ether (30mL×3). The combined organic phases were washed with 
water (20mL) and brine (20mL), dried over anhydrous magnesium sulfate, filtered and 
solvent was removed in vacuum to isolate crude product which was purified using column 
chromatography (20% EtOAc/Hexane) to isolate the product 97 as a clear oil (244mg, 
0.821mmoles, 100%). 
 
Rf 0.30(20% EtOAc/Hexane); FTIR(ν/cm
-1): 3422 (O-H), 2999-2835 (C-
H), 1600-1439 (C=C), 1274-1210 (C-O); 1H NMR (300 MHz, Chloroform-
d) δ 7.55 (1H, d, J = 7.5 Hz, ArH), 7.44-7.34 (2H, m, ArH), 7.25-7.20 
(1H, m, ArH), 6.95-6.87 (2H, m, ArH), 6.76 (1H, d, J = 2.9 Hz, ArH), 4.44 
(1H, d, J = 6.6 Hz, one of CH2OH), 4.40 (1H, d, J = 6.6 Hz, one of 
CH2OH), 3.79 (3H, s, OMe), 3.68 (3H, s, OMe), 2.42 (1H, s, OH); 
13C NMR (75 MHz, 
Chloroform-d) δ 153.9(ArC-3’), 150.6(ArC-1’), 139.3(ArC), 137.4(ArC), 131.1(ArC), 
130.1(ArC), 128.8(ArC), 28.1(ArC), 127.7(ArC), 117.0(ArC), 113.6(ArC), 112.8(ArC), 
63.8(CH2OH), 56.7(OMe), 55.7(OMe); HRMS (ESI-): Found M
+-OH 227.2784, C15H15O2 (M
+-
OH) requires 227.2784, m/z 227.1065(100%), 244.1091(15%). 
 
9.10 Preparation of 2-Methoxy-6H-benzo[c]chromen-6-one 110 
 
(2',5'-Dimethoxybiphenyl-2-yl)methanol 115 (1eq., 50.0mg, 0.204mmoles) was taken up in 
carbontetrachloride (5mL) and N-bromosuccinimide (1.5eq., 54.0mg, 0.307mmoles) was 
added. AIBN (0.01eq., 0.5mg, 0.002mmoles) was added to this stirring mixture and the 
reaction was allowed to stir under reflux for eighteen hours. After this time an aqueous 
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sodium sulfite solution (5mL) was added to the reaction mass to quench unreacted N-
bromosuccinimide and the solution was transferred to a separating funnel containing water 
(10mL). The organic phase was separated and the aqueous phase was washed repeatedly 
with dichloromethane (10mL×3). The combined organic phases were washed with brine 
(20mL), dried over anhydrous magnesium sulfate, filtered and solvent was reduced under 
removed pressure to afford the crude product which was purified by column chromatography 
(10% EtOAc/Hexane) to isolate the product 110 as a white solid (23.0mg, 0.100mmoles, 
49%). 
 
Rf 0.45(20% EtOAc/Hexane); mp. 117-119 ºC CH2Cl2; FTIR(ν/cm
-1): 2938 
(C-H), 1722 (C=O), 1664-1420 (C=C), 1277-1225 (C-O); 1H NMR (300 
MHz, Chloroform-d) δ 8.41 (1H, dd, J = 7.9, 1.0 Hz, ArH), 8.07 (1H, d, J = 
8.1 Hz, ArH), 7.83 (1H, td, J = 7.8, 1.4 Hz, ArH), 7.64-7.55 (1H, m, ArH), 
7.50 (1H, d, J = 2.9 Hz, ArH), 7.31 (1H, d, J = 9.0 Hz, ArH), 7.05 (1H, dd, 
J = 9.0, 2.9 Hz, ArH), 3.91 (3H, s, OMe); 13C NMR (75 MHz, Chloroform-
d) δ 161.3(C=O), 156.4(ArC), 145.7(ArC), 134.7(ArC), 134.7(ArC), 130.7(ArC), 129.0(ArC), 
121.7(ArC), 121.4(ArC), 118.7(ArC), 118.6(ArC), 117.1(ArC), 106.4(ArC), 55.9(OMe); HRMS 
(ESI+):  Found M++ H 227.0701, C14H11O3 (M
++H) requires 227.0709, m/z 227.0701(100%), 
226.0625(30%). 
 
9.11 Preparation of 12-hydroxy-6H-dibenzo[c,h]chromen-6-one 120 
 
2-(1,4-Dimethoxynaphthalen-2-yl)benzaldehyde 99 (1eq., 50.0mg, 0.171mmoles), N-
bromosuccinimide (2eq., 61.0mg, 0.342mmoles) and 5mL of dichloromethane were added to 
a round bottom flask. The reaction was allowed to stir at room temperature under 
atmospheric conditions for eighteen hours over which time the colour changed from yellow to 
bright red. On completion, an aqueous saturated solution of sodium sulfite (10mL) was 
added to quench unreacted N-bromosuccinimide and then the organic material was 
extracted into dichloromethane (5mL×3). The organic phases were collected and washed 
with brine (20mL), dried on anhydrous magnesium sulfate, filtered and solvent was removed 
under reduced pressure to obtain a residue which was subjected to column chromatography 
(20% EtOAc/ Hexane) to obtain the product 120 as yellow solid (26.2mg, 0.099mmoles, 
57%).  
 
Rf 0.80 (20% EtOAc/Hexane); mp. 99-101 ºC CH2Cl2; 
1H NMR (300 
MHz, Chloroform-d) δ 9.95 (1H, s, OH), 8.26 (1H, dd, J = 5.5, 3.4 
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Hz, ArH), 8.12 (1H, dd, J = 5.5, 3.5 Hz, ArH), 8.02 – 7.94 (1H, m, ArH), 7.85-7.67 (5H, m, 
ArH), 7.38 (1H, d, J = 7.2 Hz, ArH); 13C NMR (75 MHz, Chloroform-d) δ 191.3(ArC), 
181.0(ArC), 177.8(ArC), 150.9(ArC), 136.8(ArC), 135.1(ArC), 134.3(ArC), 134.1(ArC), 
134.0(ArC), 133.9(ArC), 133.6(ArC), 131.9(ArC), 131.3(ArC), 130.2(ArC), 129.8(ArC), 
127.7(ArC), 127.4(ArC); HRMS (ESI-):  Found M+- H 261.0545, C17H10O3 (M
+- H) requires 
261.06, m/z 261.0545(100%), 262.0620(55%). 
 
9.12 Preparation of 4'-Bromo-2',5'-dimethoxybiphenyl-2-carbaldehyde 121 
 
N-bromosuccinimide (1.5eq., 54.0mg, 0.307mmoles) was added to a stirring solution of 
(2',5'-dimethoxybiphenyl-2-yl)methanol 115 (1eq., 50.0mg, 0.204mmoles) in chloroform 
(5mL) and then AIBN (0.01eq., 0.5mg, 0.002mmoles) was added to this stirring mixture. The 
reaction was allowed to stir under reflux for eighteen hours. On completion an aqueous 
sodium sulfite solution (5mL) was added to the reaction mass to quench the unreacted N-
bromosuccinimide and the solution was transferred to a separating funnel containing water 
(10mL). The organic phase was separated and aqueous phase was washed repeatedly with 
dichloromethane (10mL×3). The combined organic phases were washed with brine (20mL), 
dried over anhydrous magnesium sulfate, filtered and then the solvent was removed under 
reduced pressure to isolate the crude product which was purified by column chromatography 
(10% EtOAc/Hexane) to furnish the product 121 as a low melting white solid (41.2mg, 
0.127mmoles, 63%). 
 
Rf 0.61(20% EtOAc/Hexane); FTIR(ν/cm
-1): 2934-2748(C-H), 
1691(CHO), 1596(C=C), 1208(C-O), 656(C-Br); 1H NMR (500 MHz, 
Chloroform-d) δ 9.78 (1H, s, CHO), 8.02-7.97 (1H, m, ArH), 7.65 (1H, 
d, J = 1.2 Hz, ArH), 7.51 (1H, s, ArH), 7.34 (1H, d, J = 7.6 Hz, ArH-3), 
7.18 (1H, s, ArH-5’), 6.86 (1H, s, ArH-2’), 3.88 (3H, s, OMe), 3.69 (3H, 
s, OMe); 13C NMR (126 MHz, Chloroform-d) δ 192.1 (C=O), 150.8 (ArC-3’), 150.4(ArC-6’), 
140.7(ArC), 134.0(ArC), 133.7(ArC), 130.9(ArC), 128.2(ArC), 126.9(ArC), 126.7(ArC-4’), 
116.3(ArC), 115.2(ArC), 112.1(ArC), 57.0(OMe), 56.2(OMe); HRMS (ESI+): Found M++H 
321.0120, C15H14BrO3 (M
++H) requires 321.0127, m/z 320.0043(100%), 322.0043(97%). 
 
9.13 Preparation of 2-(2-(Bromomethyl)phenyl)-1,4-dimethoxynaphthalene 123 
 
(2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanol 86 (1eq., 100mg, 0.340mmoles) was 
dissolved in dry dichloromethane (10mL). Triphenyl phosphine (5eq., 446mg, 1.70mmoles) 
and carbontetrabromide (5eq., 563mg, 1.70mmoles) were added to it and the reaction was 
196 
 
allowed to stir at room temperature and under an argon atmosphere for three hours after 
which time the reaction mixture goes from clear to bright orange in color. On completion of 
the reaction the dichloromethane was removed under vacuum and the resulting orange 
residue was subjected to column chromatography (10% EtOAc/Hexane) to obtain product 
105 as a yellow oil (85.0mg, 0.237mmoles, 67%). 
 
Rf 0.35 (20% EtOAc/Hexane); FTIR(ν/cm
-1): 3056(C-H), 1591(C=C), 
1365(C-O), 690(C-Br); 1H NMR (300 MHz, Chloroform-d) δ 8.29 (1H, 
d, J = 7.7 Hz, ArH), 8.13 (1H, d, J = 8.3 Hz, ArH), 7.56 (3H, ddd, J = 
15.1, 11.3, 5.8 Hz, ArH), 7.39 (3H, s, ArH), 6.76 (1H, s, ArH-3), 4.55 
(1H, d, J = 10.2 Hz, one of CH2Brr), 4.47 (1H, d, J = 10.2 Hz, one of 
CH2Br), 3.99 (3H, s, OMe), 3.49 (3H, s, OMe); 
13C NMR (75 MHz, Chloroform-d) δ 
151.5(ArC-4), 146.5(ArC-1), 138.6(ArC), 136.2(ArC), 130.9(ArC), 130.7(ArC), 128.7(ArC), 
128.3(ArC), 128.2(ArC), 127.9(ArC), 126.9(ArC), 126.3(ArC), 125.8(ArC), 122.3(ArC), 
122.2(ArC), 106.3(ArC), 61.5(OMe), 55.8(OMe), 32.5(CH2Br). 
 
9.14 Preparation of 5-(Benzyloxy)naphthalene-1,4-dione68 40 
 
Commercially available juglone 129 (1eq., 2.50g, 14.30mmoles) was dissolved in 
carbontetrachloride (50mL) in a 100mL round bottom flask. To this solution benzyl bromide 
(2q, 4.91g, 3.4mL, 28.00mmoles) and silver oxide (2eq., 6.65g, 28.00mmoles) were added. 
The reaction mixture was then heated under reflux and inert conditions for seventy two 
hours. The reaction was allowed cooled to room temperature and was filtered through celite 
to get rid of the solid silver oxide. Water was then added to the crude mixture and the 
mixture was transferred to a separating funnel. The crude mixture obtained was washed with 
chloroform (50mL×3). The combined organic phases were washed with brine (100mL), dried 
over anhydrous magnesium sulfate, filtered and then the solvent was removed in vacuo to 
obtain 5-(benzyloxy)naphthalene-1,4-dione 40 as yellow solid (3.10g, 12.40mmoles, 88%). 
 
Rf 0.68 (20% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) 7.74 
(1H, dd, J=7.6, 0.9 Hz, ArH), 7.65 (1H, dd, J=8.0, 7.5 Hz, ArH), 7.58 (2H, 
d, J=7.3 Hz, ArH), 7.42 (2H, t, J= 7.3 Hz, ArH), 7.33–7.37 (2H, m, ArH), 
6.89 (2H, s, ArH-2,3), 5.30 (2H, s, CH2); 
13C NMR (75 MHz, Chloroform-d) 
185.2(ArC-1), 184.1(ArC-4), 158.5(ArC-5), 136.0(ArC), 140.9 (ArC), 
136.2(ArC), 134.8(ArC), 134.1 (ArC), 130.2(ArC), 128.7 (ArC), 128.0 
(ArC), 126.6 (ArC), 119.6 (ArC), 119.5(ArC), 70.9(CH2).
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9.15 Preparation of 5-(Benzyloxy)-2-bromonaphthalene-1,4-dione69 25 
 
Bromine (1.09eq., 35.0mg, 0.01mL, 0.436mmoles) in dichloromethane (5mL) maintained at 
0 °C was added dropwise to a stirring solution of 5-(benzyloxy)naphthalene-1,4-dione 40 
(1eq., 100mg, 0.400mmoles) in dichloromethane (5mL) also at 0 °C and reaction was 
allowed to stir for fifteen minutes at 0 °C under inert conditions. After that the reaction was 
allowed to warm up and solvent and unreacted bromine was removed in vacuo until most of 
dichloromethane evaporated. To this residue 10% aqueous acetic acid (1mL) was added 
and the mixture was again subjected to vacuum to leave behind an oily residue. Ethanol 
(10mL) was added to the thick mixture and the reaction was stirred under reflux for fifteen 
minutes after which it was allowed to cool down to room temperature. Water (10mL) was 
added and the mixture transferred to a separating funnel and solution was then extracted 
with dichloromethane (10mL×3). The organic phase was combined and washed with 
aqueous saturated solution of sodium bicarbonate (10mL) and brine (10mL) respectively, 
dried over anhydrous magnesium sulfate, filtered and solvent was removed in vacuo to 
obtain 5-(benzyloxy)-2-bromonaphthalene-1,4-dione 25 as a crude product which was 
further purified by column chromatography (20% EtOAc/hexane) to obtain the product 25 as 
a bright yellow solid (97.0mg, 0.282mmoles, 74%).  
 
Rf 0.75 (15% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 
7.87-7.80 (1H, m, ArH), 7.64 (1H, t, J = 8.1 Hz, ArH), 7.56 (2H, d, J = 
7.2 Hz, ArH), 7.38 (5H, dt, J = 17.9, 7.1 Hz, ArH), 5.31 (2H, s, CH2); 
13C 
NMR (75 MHz, Chloroform-d) δ 181.3(ArC-4), 178.3(ArC-1), 158.8(ArC-
5), 142.3(ArC), 136.9(ArC), 135.8(ArC), 134.9(ArC), 133.1(ArC), 
128.7(ArC), 128.1(ArC), 126.7(ArC), 120.9(ArC), 120.1(ArC), 
119.8(ArC), 72.0(CH2).
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9.16 Preparation of 5-(Benzyloxy)-2-bromo-1,4-dimethoxynaphthalene70 26 
 
5-(Benzyloxy)-2-bromonaphthalene-1,4-dione 25 (1eq., 1.24g, 3.79moles) was dissolved in 
diethyl ether (100mL) and the solution was vigorously stirred. To this, sodium dithionite 
(10eq., 5.39g, 37.90moles) dissolved in water (100mL) was added slowly. The mixture was 
allowed to stir for thirty minutes over which time the solution changed colour from dark brown 
to almost clear pale yellow solution. The reaction mixture was transferred to a separating 
funnel and organic phase was collected and washed with brine (100mL), dried over 
anhydrous magnesium sulfate, filtered and solvent was removed in vacuo to obtain 5-
(benzyloxy)-2-bromonaphthalene-1,4-diol as dark brown oil which was an unstable 
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intermediate. Immediately 50mL of dry acetone was added to the flask containing 5-
(benzyloxy)-2-bromonaphthalene-1,4-diol under inert conditions and the solution was stirred 
vigorously. To this solution, potassium carbonate (12eq., 6.24g, 45.28moles) was added 
followed by dimethyl sulfate (7eq., 3.33g, 2.5mL, 26.40moles) and the reaction was allowed 
to stir under inert conditions at reflux for eighteen hours. After this time the reaction was 
allowed to cool down to room temperature, was filtered through celite to remove potassium 
carbonate and the solvent was removed in vacuo to obtain a dark brown oil which was 
dissolved in stirring diethyl ether (100mL). Aqueous ammonia was slowly added to this 
stirring solution in portions (5mL) until bubbling stopped. The solution was transferred to a 
separating funnel and organic layer was collected which was washed with 15% hydrochloric 
acid (50mL), water (50mL) and brine (50mL) respectively. The organic layer was collected, 
dried over anhydrous magnesium sulfate, filtered and solvent was removed in vacuo to 
obtain a as light brown solid which was further purified by column chromatography (5% 
EtOAc/Hexane) to yield the product 26 as a white solid (960mg, 2.5moles, 74%). 
 
Rf 0.65 (20% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 7.70 
(1H, d, J = 8.4 Hz, ArH), 7.56 (2H, d, J = 7.5 Hz, ArH), 7.47-7.27 (4H, 
m, ArH), 6.95 (1H, d, J = 7.8 Hz, ArH), 6.90 (1H, s, ArH-3), 5.17 (2H, s, 
CH2), 3.91 (3H, s, OMe), 3.89 (3H, s, OMe); 
13C NMR (75 MHz, 
Chloroform-d) δ 156.6(ArC-1), 154.0(ArC-4), 146.6(ArC-5), 137.3(ArC), 
131.8(ArC), 128.4(ArC), 127.6(ArC), 127.6(ArC), 126.9(ArC), 
118.1(ArC), 115.1(ArC), 112.7(ArC), 109.7(ArC), 109.2(ArC-3), 
71.4(CH2), 61.2(OMe), 56.6(OMe).
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9.17 Preparation of 2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 131 
 
5-(Benzyloxy)-2-bromo-1,4-dimethoxynaphthalene 26 (1eq., 250mg, 0.669mmoles), 2-
formylphenylboronic acid 98 (1.5eq., 151mg, 1.004moles), 
tetrakis(triphenylphosphine)palladium(0) (0.1eq., 77mg, 0.067mmoles) and cesium fluoride 
(2.5eq., 253mg, 1.67mmoles) were transferred to a microwave vial using dimethoxy ethane 
(2mL) as the solvent. The resulting solution was degassed for two minutes and then 
subjected to a microwave reactor at 150 °C and 150 W with vigorous stirring for thirty 
minutes. On completion, the reaction mass was filtered, adsorbed on silica and then 
subjected to column chromatography (5% EtOAc/Hexane) to obtain the product 131 as a 
yellow solid (249mg, 0.625mmoles, 93%) 
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Rf 0.35 (30% EtOAc/Hexane); mp.
 117-118 ºC (C2H5)2O;
 
FTIR(ν/cm-1): 2925(C-H), 1700(CHO), 1596(C=C), 1127(C-O); 
1H NMR (300 MHz, Chloroform-d) δ 9.90 (1H, s, CHO), 8.09 
(1H, d, J = 7.7 Hz, ArH), 7.80 (1H, d, J = 8.3 Hz, ArH), 7.71 (1H, 
t, J = 7.3 Hz, ArH), 7.62 (2H, d, J = 7.3 Hz, ArH), 7.59-7.52 (2H, 
m, ArH), 7.45 (3H, dt, J = 13.5, 7.7 Hz, ArH), 7.35 (1H, d, J = 7.1 
Hz, ArH), 7.03 (1H, d, J = 7.6 Hz, ArH), 6.79 (1H, s, ArH-3’), 
5.25 (2H, s, CH2), 3.96 (3H, s, OMe), 3.38 (3H, s, OMe); 
13C 
NMR (75 MHz, Chloroform-d) δ 192.4 (C=O), 156.4(ArC), 153.8(ArC), 146.9(ArC), 
141.6(ArC), 137.4(ArC), 133.7(ArC), 133.5(ArC), 131.3(ArC), 130.9(ArC), 128.4(ArC), 
128.0(ArC), 127.6(ArC), 127.4(ArC), 127.1(ArC), 127.0(ArC), 126.1(ArC), 119.0(ArC), 
115.6(ArC), 109.6(ArC), 108.1(ArC-3’), 71.5(CH2), 60.7(OMe), 56.7(OMe). 
 
9.18 Preparation of (2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)phenyl)methanol 
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2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 131 (1eq., 260mg, 
0.634mmoles) was dissolved in freshly distilled dry tetrahydrofuran (20mL) in a 50mL round 
bottom flask under inert conditions. To this stirring solution was added sodium borohydride 
(3eq., 72.0mg, 1.90mmoles) and the reaction mass was allowed to stir at room temperature 
for twelve hours over which time the reaction changes its color from a yellow to a clear 
solution. On completion of the reaction, ice cold water (10mL) was added drop wise to the 
reaction mass to quench the unreacted sodium borohydride. The solution was transferred to 
a separating funnel and organic material was extracted into diethyl ether (20mL×3). The 
combined organic phases were washed with brine (30mL), dried over anhydrous magnesium 
sulfate, filtered and the solvent was removed in vacuo to afford a residue which was purified 
by means of column chromatography (30% EtOAc/Hexane) to furnish pure product 109 as a 
white solid (260mg, 0.631mmoles, 99%,). 
 
Rf 0.44 (50% EtOAc/Hexane); mp. 115-117 ºC (C2H5)2O; 
FTIR(ν/cm-1):  3489(OH), 2934(C-H), 1573(C=C), 1257(C-O); 1H 
NMR (300 MHz, Chloroform-d) δ 7.82-7.72 (1H, m, ArH), 7.67-
7.57 (3H, m, ArH), 7.51-7.28 (7H, m, ArH), 6.99 (1H, d, J = 7.4 
Hz, ArH), 6.66 (1H, s, ArH-3’), 5.23 (2H, s, CH2), 4.43 (1H, d, J 
= 10.5 Hz, one of CH2OH), 4.37 (1H, d, J = 10.5 Hz, one of 
CH2OH), 3.90 (3H, s, OMe 3.46 (3H, s, OMe); 
13C NMR (300 
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MHz, CDCl3) δ 156.5(ArC-4’), 153.7(ArC-1), 146.1(ArC), 139.4(ArC), 137.7(ArC), 
137.5(ArC), 131.3(ArC), 130.0(ArC), 129.9(ArC), 129.8(ArC), 128.4(ArC), 128.3(ArC), 
127.9(ArC), 127.6(ArC), 127.2(ArC), 127.0(ArC), 118.5(ArC), 115.4(ArC), 109.2(ArC), 
108.4(ArC-3’), 71.5(CH2), 64.1(OMe), 61.5(OMe), 56.6(CH2OH); HRMS (ESI+): Found M
++H 
401.1732, C26H23O3 (M
++H) requires 401.2469, m/z 383.1635(100%), 401.1732(20%). 
 
9.19 Preparation of 5-Methoxynaphthalene-1,4-dione71 137 
 
9.19.1 Method 1 
 
4,8-Dimethoxynaphthalen-1-ol 145 (1eq., 1.40g, 6.82mmoles) was transferred in to a 100mL 
round bottom flask containing 20mL acetonitrile at room temperature under atmospheric 
conditions. When this stirring solution became clear, ceric ammonium nitrate (2.5eq., 9.34g, 
17.05mmoles) dissolved in 20mL of water was added dropwise. The color of reaction 
changes immediately from brown to very bright yellow and was allowed to stir at the same 
conditions for another five minutes after which time the reaction mixture was filtered through 
a pad of celite, and then transferred to a beaker carrying a 100mL aqueous saturated 
solution of sodium bicarbonate stirring at room temperature. The solution bubbled vigorously 
and once the bubbling ceased the solution was transferred to a separating funnel and was 
extracted with dichloromethane (50mL×3). The organic phases were combined and washed 
with brine (100mL), dried over anhydrous magnesium sulfate, filtered and then the solvent 
was removed in vacuo to obtain a residue which was subjected to column chromatography 
(15% EtOAc/Hexane) to obtain pure 5-methoxynaphthalene-1,4-dione 137 (1.27g, 
6.75mmoles, 98%).71 
 
9.19.2 Method 2 
 
Commercially available juglone 129 (1eq., 2.50g, 14.36mmoles) was dissolved in 50mL of 
dichloromethane in a 100mL round bottom flask. To this mixture, methyl iodide (2eq., 4.08g, 
1.78mL, 28.73mmoles) and silver oxide (2eq, 6.65g, 28.73mmoles) were added and the 
reaction was allowed to stir at room temperature and under inert conditions for forty eight 
hours. On completion the reaction mixture was filtered through a pad of celite and after 
evaporation of the solvent it was purified by means of column chromatography to obtain 5-
methoxynaphthalene-1,4-dione 137 as off-white powder (1.98g, 10.52mmoles, 73%). 
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Rf 0.57 (30% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 7.78-
7.66 (2H, m, ArH), 7.32 (1H, dd, J = 8.0, 1.4 Hz, ArH), 6.88 (2H, s, ArH-2,3), 
4.02 (3H, s, OMe); 13C NMR (75 MHz, Chloroform-d) δ 185.2(ArC-4), 
184.7(ArC-1), 159.6(ArC-5), 140.9(ArC), 136.2(ArC), 135.0(ArC), 
134.1(ArC), 119.7(ArC), 119.2(ArC), 117.9(ArC), 77.4(ArC-2,3), 56.5(OMe). 71 
 
9.20 Preparation of 2-Bromo-5-methoxynaphthalene-1,4-dione67 138 
 
9.20.1 Method 1 
 
Bromine (1.09eq., 230mg, 0.074mL, 1.44.mmoles) dissolved in chloroform (10mL) was 
added dropwise to 5-methoxynaphthalene-1,4-dione 137 (1eq., 250mg, 1.32mmoles) in 
chloroform (25mL) while stirring at 0 °C under argon. The reaction mixture was allowed to 
stir at the same temperature for fifteen minutes. After this time, chloroform and unreacted 
bromine were removed in vacuum, until a few mLs of solvent were left. Aqueous 10% acetic 
acid (2mL) was added and the thick residue was again subjected to vacuum until it became 
a thick moist mass. Ethanol (25mL) was added to it and the reaction mass was allowed to 
stir under reflux for fifteen minutes. The reaction was allowed to cool down to room 
temperature and 50mL of aq. saturated solution of sodium bicarbonate was added. The 
solution was transferred to a separating funnel and extracted with dichloromethane 
(25mL×3). The combined organic phases were washed with brine (100mL) and dried over 
anhydrous magnesium sulfate, then filtered through a pad of celite and solvent was removed 
in vacuum to afford the crude product as dark brown oil which was purified through column 
chromatography (20% EtOAc/Hexane) to procure 2-bromo-5-methoxynaphthalene-1,4-dione 
138 as bright orange solid in 73% yield (259mg, 0.969mmoles). 
 
9.20.2 Method 2 
 
2-Bromo-5-hydroxynaphthalene-1,4-dione 23 (1eq., 758mg, 3.01mmoles) was taken up in a 
100mL round bottom flask with 50mL of dichloromethane under inert conditions and at room 
temperature. To this solution, methyl iodide (2eq., 858mg, 0.38mL, 6.03mmoles) and silver 
oxide (2eq., 1.37g, 6.03mmoles) were added and the reaction was allowed to stir at the 
above mentioned reaction conditions for seventy two hours. On completion, the reaction 
mass was filtered through a pad of celite and then immediately subjected to column 
chromatography (20% EtOAc/Hexane) to obtain 2-bromo-5-methoxynaphthalene-1,4-dione 
138 as a bright orange solid (698mg, 2.61mmoles, 87%). 
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Rf 0.52(30% EtOAc/Hexa) 
1H NMR (300 MHz, Chloroform-d) δ 7.83 (1H, 
d, J = 7.6 Hz, ArH), 7.70 (1H, t, J = 8.1 Hz, ArH), 7.40 (1H, d, J = 1.3 Hz, 
ArH-3), 7.35 (1H, d, J = 8.5 Hz, ArH), 4.02 (3H, s, OMe); 13C NMR (75 
MHz, Chloroform-d) δ 181.4(ArC-1), 178.2(ArC-4), 160.0(ArC-5), 
142.3(ArC), 136.8(ArC), 135.1(ArC), 133.1(ArC), 120.6(ArC), 119.3(ArC), 118.5(ArC), 
56.6(OMe). 67 
 
9.21 Preparation of 1,5-Dimethoxynaphthalene72 143 
 
Naphthalene-1,5-diol 142 (1eq., 10.00g, 62.50mmoles) was dissolved in dry acetone 
(400mL) in a 1L round bottom and the solution was stirred until all of the naphthalene-1,5-
diol 142 dissolved. Potassium carbonate (3eq., 25.80g, 18.72mmoles) and dimethyl sulfate 
(3eq., 23.60g, 17.7mL, 18.72mmoles) were added to the stirring solution before the reaction 
was allowed to stir under reflux for twelve hours. The progress of reaction was monitored by 
thin layer chromatography over which time it changes color from black to reddish brown. On 
completion, the reaction was allowed to cool down to room temperature and filtered through 
a pad of celite to remove potassium carbonate. The solution was cooled down to 0 °C and 
aqueous ammonia was added slowly in portions (5mL) to obtain a brown precipitate which 
were washed with acetone (50mL×3), filtered off and dried in vacuo to obtain 1,5-
dimethoxynaphthalene 143 as a light brown solid (10.05g, 53.40mmoles, 86%). 
 
Rf 0.35 (20% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 7.83 (2h, 
d, J = 8.5 Hz, ArH), 7.37 (2H, t, J = 8.0 Hz, ArH), 6.83 (2H, d, J = 7.7 Hz, 
ArH), 3.98 (6H, s, OMe×2); 13C NMR (75 MHz, Chloroform-d) δ 155.2(ArC-
1,5), 126.6(ArC), 125.2(ArC), 114.2(ArC), 104.5(ArC), 55.5(OMe×2). 72 
 
9.22 Preparation of 4,8-Dimethoxy-1-naphthaldehyde73 144 
 
Toluene (18mL) and dimethylformamide (2.4eq., 6.70g, 7.10mL, 91.80mmoles) were added 
to a 100mL round bottom flask containing 1,5-dimethoxynaphthalene 143 (1eq., 7.20g, 
38.25mmoles) under argon while the temperature was maintained at 0 °C. At the same 
temperature phosphoryl chloride (1.6eq., 9.38g, 5.60mL, 61.20mmoles) was added 
dropwise. The reaction mixture was allowed to stir for thirty minutes at 0 °C after which it 
was allowed to reach room temperature and then was refluxed for three hours over which 
time the reaction changes its colour from dark brown to dark red. On completion, the 
reaction was allowed to cool down to room temperature and ethyl acetate (100mL) was 
added. Then this solution was poured over stirring aqueous 10% sodium hydroxide (100mL) 
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in a 250mL beaker and stirred for five minutes. Later the solution was transferred to a 
separating funnel and the organic layer was collected. The aqueous phase was washed with 
ethyl acetate (25mL×3) and the combined organic phases were washed with brine (100mL), 
dried on anhydrous magnesium sulfate, filtered through a pad of celite and solvent removed 
in vacuo to obtain product 120 as a brown powder (6.57g, 30.25mmoles, 79%).  
 
Rf 0.73 (15% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 11.04 
(1H, s, CHO), 8.07 (1H, d, J = 8.3 Hz, ArH), 7.95 (1H, dd, J = 8.5, 0.8 Hz, 
ArH), 7.44 (1H, t, J = 8.1 Hz, ArH), 7.03 (1H, d, J = 7.7 Hz, ArH), 6.89 (1H, 
d, J = 8.3 Hz, ArH), 4.05 (3H, s, OMe), 4.00 (3H, s, OMe); 13C NMR (75 
MHz, Chloroform-d) δ 194.6(C=O), 159.5(ArC-4), 156.4(ArC-1), 129.4(ArC), 
127.7(ArC), 127.1(ArC), 125.8(ArC), 124.7(ArC), 115.3(ArC), 107.8(ArC), 103.9(ArC), 
55.9(OMe), 55.6(OMe). 73 
 
9.23 Preparation of 4,8-Dimethoxynaphthalen-1-ol74 145 
 
At 0 °C, 4,8-dimethoxy-1-naphthaldehyde 144 (1eq., 1.00g, 4.60mmoles) was dissolved in 
methanol (10mL) in a 100mL round bottom flask and stirred vigorously. To this hydrogen 
peroxide (1.3eq., 203mg, 0.18mL, 5.90mmoles) was added followed by addition of sulfuric 
acid (0.1mL). The resulting thick mass was stirred vigorously and eventually everything 
dissolves. The reaction was allowed to stir for another twelve hours at room temperature 
under atmospheric conditions. On completion, the reaction mixture was poured onto a 
stirring solution of aqueous saturated solution of sodium bicarbonate (50mL) maintained at a 
temperature of 0 °C and was then immediately extracted in ethyl acetate. (50mL×3). The 
combined organic phases were collected and washed with brine (100mL), dried over 
anhydrous magnesium sulfate, filtered and then solvent was removed in vacuo to obtain the 
crude product which was then purified through column chromatography (10% 
EtOAc/Hexane) to yield the product 121 as light brown solid (769mg, 3.76mmoles, 80%). 
 
Rf 0.29 (30% EtOAc/Hexane);
1H NMR (300 MHz, Chloroform-d) δ 8.94 (1H, 
s, OH), 7.85 (1H, dd, J = 0.8, 8.5 Hz, ArH), 7.33 (1H, dd, J = 8.0, 8.1 Hz, 
ArH), 6.84 (1H, d, J = 7.7 Hz, ArH), 6.77 (1H, d, J = 8.4 Hz, ArH-2) 6.75 
(2H, J = 8.4 Hz ArH-3), 4.05 (3H, s, OMe), 3.93 (3H, s, OMe); 13C NMR (75 
MHz, Chloroform-d) δ 155.9(ArC-4), 148.1(ArC-5), 147.9(ArC-1), 
127.9(ArC), 125.1(ArC), 115.9(ArC), 115.6(ArC), 109.0(ArC), 106.28(ArC), 104.9(ArC), 
56.1(OMe), 56.0(OMe). 74 
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9.24 Preparation of Naphthalene-1,5-diyl diacetate75 22 
 
Commercially available naphthalene-1,5-diol 142 (1eq., 10.00g, 62.40mmol), acetic 
anhydride (5eq., 57.36g, 53mL, 56.19mmol) and pyridine (10eq., 49.35g, 50.4mL, 
62.40mmol) were added to a 250mL round bottom flask and stirred at room temperature 
under argon for twelve hours. On completion, water (1000mL) was added to the reaction to 
quench unreached acetic anhydride and reaction was cooled down to 0 °C, by doing so the 
product precipitated out of solution which was then filtered and dried to obtain naphthalene-
1,5-diyl diacetate 22 as a light brown powder (14.98g, 61.33mmoles, 98%). 
 
1H NMR (300 MHz, Chloroform-d) δ 7.77 (2H, d, J = 8.5 Hz, ArH), 7.49 
(2H, t, J = 8.0 Hz, ArH), 7.28 (2H, d, J = 7.5 Hz, ArH), 2.44 (6H, s,CH3×2); 
13C NMR (75 MHz, Chloroform-d) δ 169.3(C=O×2), 146.7(ArC-1,5), 
128.1(ArC), 126.0(ArC), 119.3(ArC), 118.8(ArC), 21.0(CH3×2).
 75 
 
 
 
 
9.25 Preparation of 6-Bromo-5,8-dioxo-5,8-dihydronaphthalen-1-yl acetate75 146 
 
Naphthalene-1,5-diyl diacetate 22 (1eq., 2.40g, 10.00mmol) was dissolved in 100mL of 
warm acetic acid in a 500mL round bottom flask and to the stirring solution was added 
dropwise a solution of N-bromosuccinimide (4eq., 7.20g, 40.00mmol) in 200mL acetic acid 
and 100mL water maintained at a temperature of 65 °C. This reaction was then stirred under 
inert conditions and a temperature of 65 °C for forty five minutes. After which time, the 
reaction was allowed to warm up to room temperature and then 200mL of water was added 
and transferred to a separating funnel where it was extracted with chloroform (250mL×3). 
The organic phases were combined and washed with brine (500mL), dried over anhydrous 
magnesium sulfate, filtered through a pad of celite and then the chloroform was removed in 
vacuo to provide the crude product which was further recrystallized from ethanol to obtain 
pure 6-bromo-5,8-dioxo-5,8-dihydronaphthalen-1-yl acetate as a bright orange powder 
(2.30g, 77.70mmoles, 79%). 
 
Rf 0.71 (30% EtOAc/Hexane);
1H NMR (300 MHz, Chloroform-d) δ 8.09 
(1H, dd, J = 7.6, 1.6 Hz, ArH), 7.96 (1H, s, ArH-3), 7.62 (1H, d, J = 7.6 
Hz, ArH), 7.57 (1H, dd, J = 8.1, 1.6 Hz, ArH), 2.52 (3H, s, CH3); 
13C NMR 
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(75 MHz, Chloroform-d) δ 174.9(ArC-1), 167.9(C=O), 148.8(ArC-4), 148.7(ArC-5), 
134.1(ArC), 131.0(ArC), 130.0(ArC), 126.8(ArC), 124.9(ArC), 120.0(ArC), 41.8(ArC-3), 
21.6(CH3).
75 
 
9.26 Preparation of 2-Bromo-5-hydroxynaphthalene-1,4-dione70 23 
 
6-Bromo-5,8-dioxo-5,8-dihydronaphthalen-1-yl acetate 146 (1eq., 2.00g, 6.70mmoles) was 
stirred in a 200mL round bottom flask with 75mL ethanol. To this stirring solution, 22.5mL of 
3 N sulfuric acid was added dropwise and the reaction mixture was stirred under reflux for 
two hours. After which, the reaction was allowed to cool down to room temperature and 
solvent was removed in vacuo. The residue left was dissolved in water (50mL) and extracted 
with chloroform (25mL×3). The combined organic phases were washed with brine (100mL), 
dried over anhydrous magnesium sulfate, filtered and then concentrated in vacuo to obtain 
crude product which was later purified by column chromatography to furnish pure product 23 
as a bright orange solid (1.66g, 6.53mmoles, 98%). 
 
Rf 0.28 (30% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 11.81 
(1H, s, OH), 7.73 (1H, d, J = 7.4 Hz, ArH), 7.67 (1H, d, J = 8.2 Hz, ArH), 
7.32 (1H, d, J = 8.3 Hz, ArH), 7.20 (1H, s, ArH-3); 13C NMR (75 MHz, 
Chloroform-d) δ 187.9(ArC-1), 161.7(ArC-5), 147.1(ArC-4), 136.5(ArC), 
135.8(ArC), 131.1(ArC), 125.3(ArC), 120.7(ArC), 114.6(ArC).70 
 
9.27 Preparation of 2-Bromo-1,4,5-trimethoxynaphthalene75 80 
 
9.27.1 Method 1 
 
2-Bromo-5-methoxynaphthalene-1,4-dione 138 (1eq., 2.00g, 7.46mmoles) was dissolved in 
diethyl ether (200mL) and then transferred to a 1L round bottom flask carrying a solution of 
water (200mL) and sodium dithionite (10eq., 10.05g, 74.69mmoles). The solution was 
allowed to stir at room temperature and under atmospheric conditions for thirty minutes over 
which time it changed colour from bright orange to pale yellow. The organic layer was 
collected and washed with brine (250mL), dried over anhydrous magnesium sulfate, filtered 
and concentrated in vacuo to get 2-bromo-5-methoxynaphthalene-1,4-diol as light brown 
solid which being unstable was immediately dissolved in dry acetone (100mL) in a 200mL 
round bottom flask stirring under argon. Potassium carbonate (7eq., 7.21g, 52.28mmoles) 
and dimethyl sulfate (7eq., 6.58g, 4.90mL, 52.28mmoles) were then added. The reaction 
was allowed to stir under reflux for eighteen hours. On completion, the reaction mass was 
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allowed to cool down to room temperature and was filtered through a pad of celite. The 
solvent was removed in vacuo and diethyl ether (100mL) was added. Aqueous ammonia 
was slowly added in portions (5mL) with stirring until the bubbling stopped. The solution was 
then transferred to a separating funnel and the organic layer was collected. The aqueous 
layer was washed with diethyl ether (50mL×3). The combined organic layers were washed 
with aqueous 10% hydrochloric acid (150mL), water (150mL) and brine (150mL) 
respectively. The organic layer was collected, dried on anhydrous magnesium sulfate, filtered 
and concentrated in vacuo to obtain crude product as a brown solid which was subjected to 
column chromatography (10% EtOAc/Hexane) to obtain 2-bromo-1,4,5-
trimethoxynaphthalene 80 (1.65g, 5.60mmoles, 75%). 
 
9.27.2 Method 2 
 
2-Bromo-5-methoxynaphthalene-1,4-dione 138 (1eq., 504mg, 1.88mmoles) was dissolved in 
tetrahydrofuran (25mL) in a 100mL round bottom flask at room temperature under an argon 
atmosphere. To this stirring solution was added sodium dithionite (6eq., 1.97g, 1.13mmoles) 
dissolved in water (10mL) and tetrabutyl ammonium iodide (0.09eq., 62.0mg, 0.169mmoles). 
Fifteen minutes later potassium hydroxide (23eq., 2.43g, 43.42mmoles) dissolved in water 
(10mL) was added which immediately changes the colour of reaction from light orange to 
dark brown. The reaction was allowed to stir at the above mentioned conditions for one hour 
after which time dimethyl sulfate (21eq., 5.00g, 3.75mL, 39.64mmoles) was added and it 
was allowed to stir for six hours under the same conditions. The reaction mixture slowly 
changes its colour from dark brown to pale yellow. On completion, the reaction mass was 
transferred to a 250mL round bottom flask carrying ethyl acetate (50mL) stirring at room 
temperature and under atmospheric conditions. Aqueous ammonia was added in portions 
(5mL) until effervescence ceased. The solution was then transferred to a separating funnel 
and extracted with diethyl ether (50mL×3). The organic phases were combined and washed 
with aqueous 10% hydrochloric acid (50mL), water (50mL) and brine (50mL), dried over 
anhydrous magnesium sulfate, filtered and then the solvent removed in vacuo to obtain 
crude product as a brown solid which was purified by column chromatography (10% 
EtOAc/Hexane) to obtain 2-bromo-1,4,5-trimethoxynaphthalene 80 as a white solid (496g, 
1.67mmoles, 89%). 
 
Rf 0.53 (20% EtOAc/Hexane);
1H NMR (300 MHz, Chloroform-d) δ 7.68 
(1H, dd, J = 8.4, 0.8 Hz, ArH), 7.44 (1H, t, J = 8.1 Hz, ArH), 6.89 (2H, d, J 
= 8.0 Hz, ArH), 3.96 (3H, s, OMe), 3.94 (3H, s, OMe), 3.92 (3H, s, OMe); 
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13C NMR (75 MHz, Chloroform-d) δ 157.5(ArC-1), 153.9(ArC-4), 146.7(ArC-5), 131.7(ArC), 
127.5(ArC), 117.6(ArC), 114.6(ArC), 112.6(ArC), 109.8(ArC), 106.9(ArC), 61.2(OMe), 
56.8(OMe), 56.4(OMe).75 
 
9.28 Preparation of 2-(1,4,5-Trimethoxynaphthalen-2-yl)benzaldehyde 139 
 
2-Bromo-1,4,5-trimethoxynaphthalene 80 (1eq., 50.0mg, 0.185mmoles), 2-
formylphenylboronic acid 98 (1.5eq., 42.0mg, 0.277mmoles), 
tetrakis(triphenylphosphine)palladium(0) (0.5eq., 107mg, 0.092mmoles) and cesium fluoride 
(2.5eq., 70.0mg, 0.462mmoles) were added to a microwave vial together with dimethoxy 
ethane (2mL) and then the solution was degassed for nearly two minutes. The reaction was 
transferred to a microwave reactor and heated at 150 °C and 150 W with vigorous stirring for 
thirty minutes. On completion, the reaction mass was filtered, adsorbed on silica and 
subjected to column chromatography (10% EtOAc/Hexane) to obtain the product 139 as an 
off-white solid (35.2mg, 0.118mmoles, 64%). 
 
Rf 0.77 (20% EtOAc/Hexane); mp. 98-100 ºC CH2Cl2; FTIR (ν/cm
-1): 
2837(C-H), 1687(CHO), 1583(C=C), 1263(C-O); 1H NMR (300 MHz, 
Chloroform-d) δ 9.89 (1H, s, CHO), 8.08 (1H, dd, J = 8.1, 1.5 Hz, 
ArH), 7.78 (1H, dd, J = 8.5, 1.0 Hz, ArH), 7.71 (1H, d, J = 1.5 Hz, 
ArH), 7.55 (2H, dd, J = 5.5, 2.2 Hz, ArH), 7.49 (1H, t, J = 8.1 Hz, 
ArH), 6.96 (1H, dd, J = 7.8, 1.0 Hz, ArH), 6.78 (1H, s, ArH-3’), 4.01 (3H, s, OMe), 3.98 (3H, 
s, OMe), 3.37 (3H, s, OMe); 13C NMR (75 MHz, Chloroform-d) δ 192.4(C=O), 157.4(ArC-4’), 
153.7(ArC-1’), 147.0(ArC-5’), 141.6(ArC), 133.7(ArC), 133.5(ArC), 131.3(ArC), 130.9(ArC), 
128.0(ArC), 127.4(ArC), 127.1(ArC), 126.1(ArC), 115.2(ArC), 108.2(ArC), 107.4(ArC-3’), 
60.7(OMe), 56.9(OMe), 56.6(OMe); HRMS (ESI+): Found M++H 323.1268, C20H19O4 (M
++H) 
requires 323.1284, m/z 323.1268(100%), 322.1193(40%). 
 
9.29 Preparation of (2-(1,4,5-Trimethoxynaphthalen-2-yl)phenyl)methanol 134 
 
2-(1,4,5-Trimethoxynaphthalen-2-yl)benzaldehyde 139 (1eq., 34.2mg, 0.117mmoles) was 
dissolved in freshly distilled, dry tetrahydrofuran (10mL) under argon in a 25mL round bottom 
flask and sodium borohydride (3eq., 13.4mg, 0.350) was added carefully. The reaction was 
allowed to stir at room temperature for twelve hours over which time it changes its colour 
from bright yellow to hazy white solution. On completion, the reaction was cooled down to 0 
°C and ice cold water (10mL) was added carefully to quench any unreacted sodium 
borohydride. The solution was then transferred to a separating funnel and the organic 
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material was extracted in diethyl ether (10mL×3). The combined organic phases were 
washed with brine, dried over anhydrous magnesium sulfate, filtered and solvent was 
removed under reduced pressure to obtain the crude product which was then subjected to 
column chromatography (30% EtOAc/ Hexane) to obtain the product as a white solid 134 
(34.7mg, 0.107mmoles, 100%). 
 
Rf 0.47 (50% EtOAc/Hexane); mp 118-120 ºC CH2Cl2; FTIR (ν/cm
-1) 
3384(OH), 2930(C-H), 1584(C=C), 1237(C-O); 1H NMR (300 MHz, 
Chloroform-d) δ 7.66 (1H, d, J = 8.4 Hz, ArH), 7.52 (1H, dd, J = 6.7, 
2.1 Hz, ArH), 7.43-7.24 (4H, m, ArH), 6.85 (1H, d, J = 7.7 Hz, ArH), 
6.58 (1H, s, ArH-3’), 4.34 (1H, d, J = 11.1 Hz, one of CH2OH), 4.29 
(1H, d, J = 11.1 Hz, one of CH2OH), 3.92 (3H, s, OMe), 3.85 (3H, s, OMe), 3.38 (3H, s, 
OMe), 0.85 – 0.71 (1H, m, OH). 
 
9.30 Preparation of 1,4-Dimethoxynaphthalen-2-ylboronic acid 157 
 
2-Bromo-1,4-dimethoxynaphthalene 97 (1eq., 500mg, 1.88mmoles) together with freshly 
distilled, dry tetrahydrofuran (30mL) in a two neck round bottom flask was degassed for 
nearly ten minutes. The reaction mixture was then cooled down to -78 °C and nbutyllithium 
(1.1eq., 1.89mL, 1.1 M/THF, 132mg) was added slowly via a syringe and the resulting 
solution was stirred at -78 °C and under inert conditions for one hour. Triisopropyl borate 
(1.2eq., 424mg, 0.518mL) was then added slowly. The reaction was stirred at -78 °C for 
another one hour and then was slowly allowed to warm up to room temperature and then 
stirred for another two hours before being quenched with 10% aqueous hydrochloric acid 
(50mL). The organic material was extracted with diethyl ether (30mL×3). The organic phases 
were combined and washed with brine (50mL), dried over anhydrous magnesium sulfate, 
filtered and solvent was then removed under reduced pressure till only a few mLs were left. 
This thick residue was cooled down to 0 °C and cold acetone (20mL) was added to it with 
vigorous stirring. While doing so, the product precipitates as a white 
solid which was immediately filtered off and was washed with cold 
acetone to isolate crude product 157 (94%, 408mg, 1.76mmoles).The 
product 157 was not characterized due to solubility and stability 
problems and was used as such in the next step.  
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9.31 Preparation of 2-(1,4-Dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 159 
 
1,4-Dimethoxynaphthalen-2-ylboronic acid 157 (1eq., 200mg, 0.866mmoles), 2-bromo-5-
fluorobenzaldehyde 158 (1.5eq., 264mg, 1.30mmoles), tetrakis(triphenylphosphine) 
palladium (0.08eq., 80.0mg, 0.069mmoles) and cesium fluoride (2.5eq., 329mg, 
2.17mmoles) were transferred to a microwave vial in dimethoxyethane (2mL). The resulting 
solution was degassed for two minutes before being subjected to reaction in a microwave 
reactor at 150 °C, 150 W and vigorous stirring for thirty minutes. On completion, the reaction 
mass was filtered, adsorbed onto silica and subjected to column chromatography (5% 
EtOAc/Hexane) to obtain 2-(1,4-dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde as a 
yellow solid 159 (165mg, 0.530mmoles, 62%). 
 
Rf 0.51 (20% EtOAc/Hexane); mp. 132-134 ºC (C2H5)2O; FTIR 
(ν/cm-1): 2938(C-H), 1687(CHO), 1589(C=C), 1213(C-O), 1102(C-
F); 1H NMR (300 MHz, Chloroform-d) δ 9.83 (1H, d, J = 3.3 Hz, 
CHO), 8.30 (1H, dd, J = 7.7, 2.0 Hz, ArH), 8.18-8.07 (1H, m, ArH), 
7.75 (1H, dd, J = 8.9, 2.8 Hz, ArH), 7.65-7.50 (3H, m, ArH), 7.40 
(1H, td, J = 8.2, 2.8 Hz, ArH), 6.71 (1H, s, ArH-3’), 4.01 (3H, s, OMe), 3.40 (3H, s, OMe); 13C 
NMR (75 MHz, Chloroform-d) δ 191.1(C=O), 162.3(d, JCF = 249 Hz, ArC), 155.2(ArC), 
147.0(ArC), 137.8(ArC), 135.6(ArC), 135.5(ArC), 132.9(d, JCF = 7.3 Hz, ArC), 128.4(ArC), 
126.8(ArC), 126.7(ArC), 124.5(ArC), 122.4(ArC), 122.3(ArC), 120.7(d, JCF = 22.1 Hz, ArC), 
114.0(d, JCF = 22.3 Hz, ArC), 105.7(ArC-3’), 60.9(OMe), 55.8(OMe); HRMS (ESI+): Found 
M++ H 311.1083, C19H16FO3 (M
++ H) requires 311.1084, m/z 311.0995(100%), 
311.1062(60%), 279.0622(20%). 
 
9.32 Preparation of 2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 
161 
 
2-(1,4-Dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 159 (1eq., 50.0mg, 0.161mmoles) 
and N-bromosuccinimide (1eq., 57.0mg, 0.322mmoles) were transferred to a 10mL round 
bottom flask and 5mL dichloromethane was added. The reaction was allowed to stir for 
eighteen hours under atmospheric conditions and room temperature. On completion, the 
reaction was quenched with aqueous saturated solution of sodium sulfite (10mL) and the 
mixture was transferred to a separating funnel where it was extracted into dichloromethane 
(10mL×3). The organic phases were combined, washed with brine (20mL), dried over 
anhydrous magnesium sulfate, filtered and solvent was removed under reduced pressure to 
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obtain 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)-5-fluorobenzaldehyde 161 as a yellow 
solid (28.0mg, 0.073mmoles, 45%). 
Rf 0.62(20% EtOAc/Hexane); mp 118-120 °C (C2H5)2O; FTIR 
(ν/cm-1): 2929(C-H), 1690(CHO), 1585(C=C), 1239(C-O), 
1143(CHO); 1H NMR (300 MHz, Chloroform-d) δ 9.74 (1H, d, J = 
3.1 Hz, CHO), 8.23-8.15 (1H, m, ArH), 8.15-8.08 (1H, m, ArH), 
7.78 (1H, d, J = 8.7 Hz, ArH), 7.63 (2H, dd, J = 6.5, 2.7 Hz, ArH), 
7.47-7.38 (2H, m, ArH), 4.03 (3H, s, OMe), 3.48 (3H, s, OMe); 13C NMR (75 MHz, 
Chloroform-d) δ 190.3(C=O), 162.6 (d, JCF = 250.1 Hz, ArC), 151.1(ArC-4’), 150.6(ArC-1’), 
136.3(ArC), 136.2(ArC) 136.0(ArC), 135.9(ArC), 134.1(d, JCF = 7.3 Hz, ArC), 129.1(ArC), 
127.9(ArC), 127.3(ArC), 127.0(ArC), 123.1(ArC), 122.7(ArC), 120.7 (d, JCF = 22.1 Hz, ArC), 
113.7(d, JCF = 22.5 Hz, ArC), 61.6(OMe), 61.5(OMe); HRMS (ESI+): Found M
++H 388.0095, 
C19H15BrFO3 (M
++ H) requires 389.0184, m/z 388.0095(100%), 390.0072(95%), 
391.0128(30%). 
 
9.33 Preparation of 2-(1,4-Dimethoxynaphthalen-2-yl)benzonitrile 214 
 
2-Bromo-1,4-dimethoxynaphthalene 97 (1eq., 250mg, 0.939mmoles), 2-cyanophenylboronic 
acid 213 (1.5eq., 207mg, 1.41mmoles), tetrakis(triphenylphosphine)palladium(0) (0.2eq., 
217mg, 0.188mmoles) and cesium fluoride (2.5eq., 356mg, 2.35mmoles) were transferred to 
a microwave reactor vial. Dimethoxyethane (2mL) which was previously degassed for ten 
minutes was added to the reaction. The reaction mixture was placed in a microwave reactor 
at 150 °C and 150 W for thirty minutes. After that time reaction mixture was filtered to get rid 
of the solid palladium and then purified by column chromatography (5% EtOAc/Hexane) to 
obtain product 181 as a yellow solid (207mg, 0.716mmoles, 76%).  
 
Rf = 0.44(20% EtOAc/Hexane); mp. 166-168 °C (C2H5)2O; FTIR 
(ν/cm-1) 2966-2842(C-H), 2225(CN), 1624-1591(C=C), 1266-
1227(C-O);  1H NMR (300 MHz,) δ 8.33-8.26 (1H, m, ArH), 8.21-
8.14 (1H, m, ArH), 7.82 (1H, d, J = 7.7 Hz, ArH), 7.68 (2H, d, J = 3.9 
Hz, ArH), 7.63-7.45 (5H, m, ArH), 6.73 (1H, s, ArH-3’), 4.01 (s, 
OMe), 3.53 (s, OMe); 13C NMR (75 MHz, Chloroform-d) δ 151.8(ArC-1’), 147.3(ArC-4’), 
142.9(ArC), 133.2(ArC), 132.4(ArC), 131.4(ArC), 128.8(ArC), 127.7(ArC), 127.0(ArC), 
126.9(ArC), 126.3(ArC), 126.2(ArC), 122.5(ArC), 122.4(ArC), 118.5(ArCN), 113.0(ArC), 
105.4(ArC-3’), 61.9(OMe), 55.8(OMe); HRMS (ESI+): Found M++H 290.1068, C19H16NO2 
(M++H) requires 290.1182, m/z 290.1068 (M++H, 100%), 289.1086(50%)  
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9.34 Preparation of (2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanamine 215 
 
2-(1,4-Dimethoxynaphthalen-2-yl)benzonitrile 214 (1eq., 276mg, 0.957mmoles,) was 
dissolved in freshly distilled tetrahydrofuran (25mL) in a 50 mL round bottom flask and the 
temperature of the solution was maintained at 0 °C. Lithium aluminium hydride (10eq., 
361mg, 9.57mmoles) was added in portions under inert conditions at 0 °C. Slowly the 
temperature of the reaction was allowed to rise to room temperature and followed by heating 
the reaction under reflux and inert conditions for twelve hours after which the reaction was 
allowed to cool down to room temperature. The temperature of the reaction mass was 
reduced to 0 °C and a 4% aqueous sodium hydroxide was added drop wise to quench the 
unreacted lithium aluminium hydride. After the bubbling stopped, ice cold water was added 
and the crude mixture was transferred to a separating funnel where organic material was 
extracted into diethyl ether (20mL×3). The organic phases were then combined and washed 
with brine (30mL), dried over anhydrous magnesium sulfate, filtered and then the solvent 
was removed under vacuo. The crude product was purified by column chromatography 
(EtOAc and 2% of triethylamine) after which to afford the product 215 was obtained as a 
brown sticky resin (177mg, 0.606mmoles, 63%). 
 
Rf = 0.80(10% MeOH/DCM); mp. 73-75 °C (C2H5)2O; FTIR (ν/cm
-1): 
3400-3330(N-H2), 2928-2848(C-H), 1625-1592(C=C), 1268-1225(C-
O); HRMS (ESI+): Found M++H 294.1480, C19H20NO2 (M
++H) 
requires 294.1495, m/z 294.1480 (M++H, 40%), 295.1517 (10%) 
 
9.35 Preparation of Benzo[c]phenanthridine-11,12-dione 217 and 6-
Methoxybenzo[c]phenanthridin-12(11H)-one108 218 
  
(2-(1,4-Dimethoxynaphthalen-2-yl)phenyl)methanamine 215 (1eq., 164mg, 0.559mmoles) 
was added to acetonitrile (2mL) in a 10mL round bottom flask at room temperature and was 
allowed to dissolve completely under atmospheric conditions. Ceric ammonium nitrate (3eq., 
920mg, 1.68mmoles) was dissolved in water (2mL) and added drop wise to the stirring 
mixture. The reaction immediately turned orange in colour. The reaction was allowed to stir 
under the same conditions further for four hours. Water (5mL) was added and the mixture 
was transferred to a separating funnel, washed with dichloromethane (10mL×3). The 
combined organic phases were washed with brine (20mL), dried over anhydrous magnesium 
sulfate, filtered and the solvent was removed under vacuo to obtain crude product which was 
purified by column chromatography (20% EtOAc/Hexane) to obtain 217 and 218. 
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Bright orange solid of 217. (59.5mg, 0.227mmoles, 41%); Rf = 
0.48(30% EtOAc/Hexane); mp. 101-103 °C CHCl3; FTIR (ν/cm
-1): 
2922(C-H); 1662(C=O), 1637(C=C), 1333(ArC-N); UV absorption 
    
    nm(ε): 205.0(3.550), 215.1(4.206), 290.0(0.686), 440.0(0.275); 
1H NMR (300 MHz, Chloroform-d) δ 9.35 (2H, d, J = 7.0 Hz, ArH), 
8.75 (1H, d, J = 7.9 Hz, ArH), 8.12(1H, d, J = 7.5 Hz, ArH), 7.98 (1H, d, J = 8.1 Hz, ArH), 
7.88 (1H, t, J = 7.8 Hz, ArH), 7.75 (1H, t, J = 7.6 Hz, ArH), 7.66 (1H, t, J = 7.5 Hz, ArH), 7.52 
(1H, t, J = 7.5 Hz, ArH); 13C NMR (75 MHz, Chloroform-d) δ 182.8(ArC-11), 179.8(ArC-12), 
158.9(ArC), 151.3(ArC), 137.4(ArC), 136.2(ArC), 134.7(ArC), 134.0(ArC), 130.8(ArC), 
130.5(ArC), 129.5(ArC), 128.8(ArC), 128.6(ArC), 127.6(ArC), 126.3(ArC), 119.4(ArC); 
HRMS (ESI+): Found M++H 260.0699, C17H10NO2 (M
++H) requires 260.0721, m/z 260.0699 
(M++H, 100%), 262.0875 (30%) 
 
 Pale yellow solid of 218 (17.4mg, 0.066mmoles, 39%); Rf = 
0.71(30% EtOAc/Hexane); mp. 132-134 °C CHCl3;
 FTIR (ν/cm-1): 
2850(C-H), 1707(C=N), 1253(C-O); 1H NMR (300 MHz, Chloroform-
d) δ 9.39 – 9.25 (2H, m, ArH), 8.52 (1H, d, J = 8.3 Hz, ArH), 8.37 
(1H, d, J = 8.0 Hz, ArH), 8.07 (1H, d, J = 7.8 Hz, ArH), 7.80 (2H, dt, J 
= 13.4, 7.6 Hz, ArH), 7.74 – 7.67 (1H, m, ArH), 7.64 (1H, s, ArH), 4.17 (3H, s, OMe); 13C 
NMR (75 MHz, Chloroform-d) δ 154.71(ArC-12), 149.28(ArC), 137.09(ArC), 132.769(ArC), 
132.29(ArC), 130.25(ArC), 128.67(ArC), 127.58(ArC), 127.09(ArC), 127.03(ArC), 
126.98(ArC), 126.82(ArC), 124.57(ArC), 122.09(ArC), 121.94(ArC), 121.87(ArC), 
95.79(ArC), 55.61(OMe); HRMS (ESI+): Found M++H 260.1071, C18H14NO (M
++H) requires 
260.1076, m/z 260.1071 (M++H, 100%), 261.1104 (20%). 
 
9.36 Preparation of 2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)benzonitrile 233 
 
2-(1,4-Dimethoxynaphthalen-2-yl)benzonitrile 214 (1eq., 195mg, 0.675mmoles) was 
dissolved in acetic acid (20mL) in a 50mL round bottom flask. Sodium acetate (1.2eq., 
67.2mg, 0.896mmoles) was added followed by N-bromosuccinimide (1.2eq., 144mg, 
0.896mmoles). The reaction was allowed to stir at room temperature under inert conditions 
for four hours. On completion, an aqueous saturated solution of sodium sulfite (20mL) was 
added and the solution was transferred to a separating funnel and then washed with 
dichloromethane (20mL×3). The organic phases were collected, washed with brine (50mL), 
dried over anhydrous magnesium sulfate, and then the solvent was removed in vacuo. The 
crude product obtained was purified by column chromatography (10% EtOac/Hexane) to 
yield the product 233 as an off-white solid (206mg, 0.568mmoles, 83%). 
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Rf 0.76(20% EtOAc/Hexane); mp. 184-186 °C CH2Cl2; FTIR (ν/cm
-1) 
2967-2841(C-H), 2228(CN), 1625-1570(C=C), 1285-1251(C-O), 
690-655 (C-Br); 1H NMR (300 MHz, Chloroform-d) δ 8.21-8.14 (2H, 
m, ArH), 7.81 (1H, dd, J = 7.9, 1.4 Hz, ArH), 7.70 – 7.64 (1H, m, 
ArH), 7.63 – 7.48 (4H, m, ArH), 3.99 (3H, s, OMe), 3.58 (3H, s, 
OMe); 13C NMR (75 MHz, Chloroform-d) δ 150.6(ArC-4’), 143.9(ArC-1’), 137.6(ArC), 
137.4(ArC), 132.6(ArC), 132.3(ArC), 131.8(ArC), 129.4(ArC), 128.3(ArC), 127.4(ArC), 
127.2(ArC), 126.5(ArC), 123.3(ArC), 123.0(ArC), 122.4(ArC), 117.9(ArC), 114.3(ArC), 
62.1(OMe), 62.1(OMe); HRMS(ESI-): Found M+-H 365.1497, C19H15NO2Br(M-H) requires 
366.0128, m/z 365.1497 (M++H, 100%), 371.1081 (10%). 
 
9.37 Preparation of (2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)phenyl)methanamine 
234 
 
2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)benzonitrile 233 (1eq, 172mg, 0.466mmoles) was 
dissolved in 10mL dry tetrahydrofuran in a 25mL round bottom flask and lithium aluminium 
hydride (10eq., 176mg, 4.66mmoles) was added. The reaction was refluxed for five hours. 
On completion, the reaction was cooled down to 0 °C and 2% sodium hydroxide (10mL) was 
added drop wise to quench the reaction. The solution was transferred to a separating funnel 
and washed with dichloromethane (20mL×3). The combined organic phases were washed 
with brine (20mL), dried over anhydrous magnesium sulfate and then the solvent was 
removed under reduced pressure and then purified by flash chromatography (20% 
MeOH/DCM) to obtain the intermediate 234 as a brown resinous solid (59.1mg, 
0.159mmoles, 34%). 
 
Rf: 0.52 (20% MeOH/DCM); mp. 102-104 °C CH2Cl2; FTIR (ν/cm
-1) 
3521(N-H), 2934-2840(C-H), 1608-1541(C=C), 1270-1256(C-O), 
681-657 (C-Br). 
 
 
9.38 Preparation of Benzo[b]phenanthridine-7,12-dione 162 
 
(2-(3-Bromo-1,4-dimethoxynaphthalen-2-yl)phenyl)methanamine 234 (1eq., 59.4mg, 
0.158mmoles) was dissolved in acetonitrile (2mL) in a 10mL round bottom flask and 
phenyliodine bis(trifluoroacetate) (2eq., 137mg, 0.318mmoles) already dissolved in water 
(2mL) was added. The solution changed its color from light yellow to red immediately. The 
reaction was stirred at room temperature, under atmospheric conditions for two hours before 
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it was quenched by adding an aqueous saturated solution of sodium bicarbonate (10mL) and 
then the organic material was extracted into ethyl acetate (15mL×3). The organic phases 
were combined and washed with brine (20mL), dried over anhydrous magnesium sulfate, 
filtered and organic solvent was removed in vacuo. The crude residue was purified by 
column chromatography (20% EtOAc/Hexane) to afford benzo[b]phenanthridine-7,12-dione 
162 as a bright yellow solid (23.0mg, 0.089mmoles, 56%). 
 
Rf 0.77(50% EtOAc/Hexane); mp. 167-170 °C CHCl3; FTIR (ν/cm
-1) 
2923(C-H), 1667(C=N), 1660(C=O), 1587-1588(C=C); 1H NMR 
(300 MHz, Chloroform-d) δ 9.67 (1H, d, J = 8.7 Hz, ArH), 9.58 (1H, 
s, ArH-1), 8.36 (1H, d, J = 9.0 Hz, ArH), 8.29 (1H, d, J = 9.0 Hz, 
ArH), 8.11 (1H, d, J = 8.1 Hz, ArH), 7.98 (1H, ddd, J = 8.6, 7.0, 1.4 
Hz, ArH), 7.87 – 7.79 (3H, m, ArH); 13C NMR (75 MHz, Chloroform-d) δ 186.2(ArC-12), 
182.3(ArC-7), 158.4(ArC), 145.5(ArC), 134.4(ArC), 134.1(ArC), 134.1(ArC), 134.0(ArC), 
132.8(ArC), 132.2(ArC), 130.6(ArC), 130.2(ArC), 128.7(ArC), 127.9(ArC), 127.2(ArC), 
127.1(ArC), 124.5(ArC); HRMS (ESI+): Found M++H 260.0713, C17H10NO2 (M
++H) requires 
260.0712, m/z 260.0703 (M++H, 100%), 261.0744 (20%). 
 
9.39 Preparation of 2-(5-(Benzyloxy)-1,4-dimethoxynaphthalen-2-yl)benzonitrile 239 
 
5-(Benzyloxy)-2-bromo-1,4-dimethoxynaphthalene 26 (1eq., 388mg, 0.981mmoles), (2-
cyanophenyl)boronic acid 213 (1.5eq., 216mg, 1.47mmoles), cesium fluoride (2.5eq., 
370mg, 2.45mmoles) and tetrakis(triphenylphosphine)palladium(0) (0.08eq., 86.2mg, 
0.078mmoles) were transferred to a microwave vial, dimethoxy ethane (2mL) was added 
and the reaction was allowed to run in a microwave reactor at 150 °C and 150 W with high 
stirring for thirty minutes. After completion solution was filtered and purified by column 
chromatography to obtain the product 239 as a yellow solid (390mg, 0.986mmoles, 95%). 
 
Rf 0.32 (20% EtOAc/Hexane); mp. 135-137 °C CH2Cl2; FTIR 
(ν/cm-1) 2951-2843(C-H), 2225(CN), 1595-1578 (C=C), 1258-
1241( C=O); 1H NMR (300 MHz, Chloroform-d) δ 7.75 (2H, t, J = 
6.5 Hz, ArH), 7.65 – 7.50 (4H, m, ArH), 7.37 (5H, dd, J = 19.4, 
7.6 Hz, ArH), 6.95 (1H, d, J = 7.4 Hz, ArCH), 6.71 (1H, s, ArH-
3’), 5.16 (2H, s, OCH2), 3.89 (3H, s, OMe), 3.42 (3H, s, OMe); 
13C NMR (75MHz, Chloroform-d) δ 156.4(ArC-4’), 153.5(ArC-1’), 
147.1(ArC-5’) 142.5(ArC), 137.5(ArC), 133.2(ArC), 132.4(ArC), 
131.7(ArC), 131.3(ArC), 128.4(ArC), 127.8(ArC), 127.6(ArC), 127.2(ArC), 127.0(ArC), 
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126.9(ArC), 119.3(ArC), 118.5(CN), 115.8(ArC), 112.9(ArC), 109.9(ArC), 107.7(ArC), 
71.6(OCH2), 61.7(OMe), 56.7(OMe); HRMS (ESI+): Found M
++H 396.1585, C26H22NO3 
(M++H) requires 396.1600, m/z 396.1585 (M++H, 100%), 397.1612 (25%). 
 
9.40 Preparation of 2-(1,4,5-Trimethoxynaphthalen-2-yl)benzonitrile 244 
 
2-Bromo-1,4,5-trimethoxynaphthalene 80 (1eq., 200mg, 0.673mmoles), (2-
cyanophenyl)boronic acid 213 (1.5eq., 148mg, 1.00mmoles), 
tetrakis(triphenylphosphine)palladium(0) (0.2eq., 155mg, 0.135mmoles) and cesium fluoride 
(2.5eq., 255mg, 1.68mmoles) were added to a microwave vial together with dimethoxy 
ethane (2mL). The reaction was set in the microwave reactor under conditions of vigorous 
stirring, 150 °C and 150 W. On completion the reaction mixture was filtered, washed with 
ethyl acetate and the residue obtained after evaporation of the organic solvent was 
adsorbed onto silica and subjected to column chromatography (15% EtOAc/Hexane) to 
procure the pure product 244 as a yellow solid (182mg, 0.570mmoles, 85%). 
 
Rf 0.30 (20% EtOAc/Hexane); mp. 95-97 °C CH2Cl2; 
1H NMR (300 
MHz, Chloroform-d) δ 7.81 (2H, dd, J = 8.5, 1.0 Hz, ArH), 7.72 – 
7.64 (2H, m, ArH), 7.48 (2H, t, J = 8.1 Hz, ArH), 6.95 (1H, d, J = 7.7 
Hz, ArH), 6.79 (1H, s, ArH-3’), 4.00 (3H, s, OMe), 3.99 (3H, s, OMe), 
3.50 (3H, s, OMe). 13C NMR (75 MHz, Chloroform-d) δ 157.5(ArC-
4’), 153.4(ArC-1’), 147.2(ArC-5’), 142.5(ArC), 133.2(ArC), 132.4(ArC), 131.6(ArC), 
131.3(ArC), 127.7(ArC), 127.2(ArC), 126.8(ArC), 118.8(ArC), 118.4(ArC), 115.3(ArC), 
112.9(ArC), 107.9(ArC), 107.6(ArC), 61.6(OMe), 57.0(OMe), 56.6(OMe); HRMS (ESI+): 
Found M++H 320.1281, C20H18NO3 (M
++H) requires 320.1287, m/z 320.1281 (M++H, 100%), 
321.1312 (20%). 
 
9.41 Preparation of (2-(1,4,5-Trimethoxynaphthalen-2-yl)phenyl)methanamine 247 
 
2-(1,4,5-Trimethoxynaphthalen-2-yl)benzonitrile 244 (1eq., 100mg, 0.313mmoles) was 
transferred to a 25mL round bottom flask in freshly distilled dry tetrahydrofuran (10mL) and 
the temperature of the solution was maintained at 0 °C. Lithium aluminium hydride (10eq., 
119mg, 3.15mmoles) was added carefully and in portions at the same temperature. The 
temperature of the reaction mixture was allowed to rise up to room temperature slowly and 
then stirred under reflux for six hours. On completion the reaction mixture was allowed to 
cool down to room temperature and the temperature was further maintained at 0 °C. An 
aqueous 2% sodium hydroxide was added drop wise until all of unreacted lithium aluminium 
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hydride was quenched. Ice cold water (20mL) was added and the solution was extracted in 
diethyl ether (25mL×3). The organic phases were collected and washed with brine (30mL) 
and then dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo to 
obtain a residue which was subjected to column chromatography (10% MeOH/DCM) to 
afford (2-(1,4,5-trimethoxynaphthalen-2-yl)phenyl)methanamine 247 (59.0mg, 0.182mmoles, 
58%) as a brown resinous solid. Due to solubility and polarities issues the product was 
considered as an intermediate as was used as such in the next step without further 
characterization. 
Rf: 0.44 (20% MeOH/DCM). 
 
 
 
 
 
9.42 Preparation of 1-Methoxybenzo[c]phenanthridine-11,12-dione 248 
 
(2-(1,4,5-Trimethoxynaphthalen-2-yl)phenyl)methanamine 247 (1eq., 50.0mg, 0.154mmoles) 
was transferred to a 10mL round bottom flask containing acetonitrile (2mL) which was stirred 
at room temperature and under atmospheric conditions. Phenyliodine bis(trifluoroacetate) 
(3.5eq., 232mg, 0.539mmoles) dissolved in water (2mL) was added drop wise to the stirring 
mixture. The reaction was allowed to stir under the same conditions for four hours. Water 
(5mL) was added and the mixture was transferred to a separating funnel where the organic 
material was extracted into dichloromethane (10mL×3). The combined organic phases were 
washed with brine (20mL), dried over anhydrous magnesium sulfate, filtered and then the 
solvent was removed under vacuo to obtain the crude product which was purified using 
column chromatography (15% EtOAc/Hexane) to obtain product 248 as a bright red solid 
(28.2mg, 0.096mmoles, 63%). 
 
Rf: 0.50(30% EtOAc/Hexane); mp. 114-116 °C CHCl3; 
1H NMR (500 
MHz, Chloroform-d) δ 9.44 (1H, s, ArH-6), 9.34 (1H, d, J = 8.5 Hz, 
ArH), 8.52 (1H, d, J = 7.6 Hz, ArH), 8.05 (1H, d, J = 7.9 Hz, ArH), 
7.91 (1H, t, J = 7.4 Hz, ArH), 7.73 (2H, dt, J = 19.6, 7.6 Hz, ArH), 
7.15 (1H, d, J = 8.3 Hz, ArH), 4.04 (3H, s, OMe); 13C NMR (126 MHz, 
Chloroform-d) δ 184.1(ArC-12), 179.7(ArC-11), 162.3(ArC-1), 158.5(ArC), 151.2(ArC), 
139.2(ArC), 137.2(ArC), 134.4(ArC), 133.6(ArC), 128.7(ArC), 128.6(ArC), 128.5(ArC), 
126.1(ArC), 120.4(ArC), 119.2(ArC), 118.9(ArC), 114.6(ArC), 56.4(OMe); HRMS (ESI+): 
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Found M++H 290.0807, C18H12NO3 (M
++H) requires 290.0818, m/z 290.0807 (M++H, 100%), 
290.2681 (30%). 
 
9.43 Preparation of N-(2-Acetylphenyl)-4-methylbenzenesulfonamide144 305 
 
Commercially available 1-(2-aminophenyl)ethanone 255 (1eq., 250mg, 
1.85mmoles) was added to pyridine (1mL) and p-toluenesulfonyl chloride 
(5eq., 529mg, 2.77mmoles) under an argon atmosphere. The thick solution 
obtained was stirred at room temperature for four hours. When completed, the 
reaction mixture was quenched with the addition of water (20mL). The 
precipitate was filtered off and dried in vacuum to afford N-(2-acetylphenyl)-4-
methylbenzenesulfonamide as a white powder in 100% yield (289mg, 
1.83mmoles). The known product was not characterized and immediately used 
in the next step. 
 
9.44 Preparation of N-(2-(2-Hydroxy-4-phenylbut-3-yn-2-yl)phenyl)-4-
methylbenzenesulfonamide144 307 
 
Ethyl magnesium bromide (3eq., 691mg, 1.73mL(3M in THF), 5.18mmol) was added to dry 
distilled tetrahydrofuran (10mL) at room temperature under an argon atmosphere. To this 
stirring solution was added phenyl acetylene 306 (3eq., 529mg, 5.60mL, 5.18mmol) drop 
wise and the resulting solution was stirred at the same conditions for fifteen hours. To this 
solution, N-(2-acetylphenyl)-4-methylbenzenesulfonamide (1eq., 500mg, 1.73mmoles) 
dissolved in dry tetrahydrofuran (10mL) was added drop wise using a syringe. The reaction 
was then refluxed for four hours. On completion, reaction was allowed to cool down to room 
temperature and was quenched by addition of an aqueous saturated solution of ammonium 
chloride (25mL). The resultant mixture was then was extracted with diethyl ether (25mL×3). 
The combined organic phases were washed with brine (100mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated to obtain the crude product which was purified 
by column chromatography (15% EtOAc/Hexane) to furnish the product 307 as an off-white 
solid in 99% yield (672mg, 1.71mmoles). 
 
Rf: 0.41(30% EtOAc/Hexane);
 1H NMR (300 MHz, Chloroform-d) δ 
9.21 (1H, s, NH), 7.77 (2H, d, J = 8.3 Hz, ArH), 7.66-7.53 (2H, m, 
ArH), 7.50-7.42 (2H, m, ArH), 7.37-7.30 (3H, m, ArH), 7.26-7.14 
(3H, m, ArH), 7.06-6.98 (1H, m, ArH), 3.22 (1H, s, OH), 2.33 (3H, s, 
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CH3), 1.76 (3H, s, CH3); 
13C NMR (75 MHz, Chloroform-d) δ 143.7(ArC), 137.1(ArC), 
135.7(ArC), 131.8(ArC), 131.3(ArC), 129.6(ArC), 129.0(ArC), 128.9(ArC), 128.4(ArC), 
127.3(ArC), 123.4(ArC), 121.9(ArC), 119.8(ArC), 90.8(C-8), 86.5(C-9), 72.2(C-7), 31.3(CH3), 
21.5(CH3).
144 
 
9.45 Preparation of 3-Iodo-4-methyl-2-phenylquinoline144 308 
 
N-(2-(2-Hydroxy-4-phenylbut-3-yn-2-yl)phenyl)-4-methylbenzenesulfonamide 307 (1eq., 
114mg, 0.198mmoles) was added to dry methanol (5mL) in a 25mL round bottom flask and 
iodine (1.5eq., 76.0mg, 0.289mmoles) was added to it under inert conditions. The reaction 
mixture was stirred at 60 °C for six hours. On completion, the reaction was quenched by 
addition of an aqueous saturated solution of sodium dithionite (20mL) and was extracted 
with diethyl ether (20mL×3). The combined organic phases were transferred to a separating 
funnel and washed with aqueous sodium bicarbonate (50mL) and brine (50mL) respectively, 
dried over anhydrous magnesium sulfate, filtered off and evaporation of the solvent afforded 
the crude product which was then purified by column chromatography (4% EtOAc/Hexane) 
to obtain the pure product 308 as a light yellow solid (35.0mg, 0.101mmoles, 32%). 
 
Rf 0.62 (30% EtOAc/Hexane);
1H NMR (300 MHz, Chloroform-d) δ 
8.15 (2H, t, J = 7.1 Hz, ArH), 7.78 (1H, t, J = 7.4 Hz, ArH), 7.61 (3H, 
d, J = 19.3 Hz, ArH), 7.51 (3H, d, J = 6.8 Hz, ArH), 3.03 (3H, s, CH3); 
13C NMR (75 MHz, Chloroform-d) δ 162.0(ArC), 149.1(ArC), 146.5 
(ArC), 144.2(ArC), 130.1(ArC), 129.8(ArC), 129.1(ArC), 128.4 (ArC), 
127.2(ArC), 127.1(ArC), 124.2(ArC), 100.4(ArC), 25.9(CH3).
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9.46 Preparation of 2-(4-Methyl-2-phenylquinolin-3-yl)benzaldehyde 260 
 
3-Iodo-4-methyl-2-phenylquinoline 259 (1eq., 23.0mg, 0.070mmoles), (2-
formylphenyl)boronic acid 98 (2eq., 21.0mg, 0.141mmoles), cesium fluoride (2.5eq., 25.0mg, 
0.175mmoles) and tetrakis(triphenylphosphine)palladium(0)  (0.1eq., 80.0mg, 0.070mmoles) 
were transferred to a microwave vial and 2mL of freshly degassed dimethoxy ethane was 
added to it. The mixture was then set up in a microwave reactor for reaction with vigorous 
stirring and temperature and power of 150 °C and 150 W respectively. On completion the 
reaction was filtered off then subjected to column chromatography (10% EtOAc/Hexane) to 
obtain pure 2-(4-methyl-2-phenylquinolin-3-yl)benzaldehyde 260 (15.1mg, 0.046mmoles, 
70%) as a yellow powder. 
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Rf 0.48 (30% EtOAc/Hexane); mp. 94
°C (C2H5)2O melting point? 
1H 
NMR (500 MHz, Chloroform-d) δ 9.76 (1H, s, CHO), 8.24 (1H, d, J = 
8.4 Hz, ArH), 8.10 (1H, d, J = 8.4 Hz, ArH), 7.87 (1H, d, J = 7.8 Hz, 
ArH), 7.81-7.76 (1H, m, ArH), 7.65 (1H, t, J = 7.6 Hz, ArH), 7.58-
7.54 (1H, m, ArH), 7.45 (1H, t, J = 7.6 Hz, ArH), 7.26-7.21 (3H, m, 
ArH), 7.17 (3H, dd, J = 5.2, 1.6 Hz, ArH), 2.48 (3H, s, CH3); 
13C NMR (126 MHz, Chloroform-
d) δ 191.0(C=O), 158.6(ArC), 147.2(ArC), 143.1(ArC), 142.3(ArC), 140.7(ArC), 134.4(ArC), 
133.5(ArC), 132.4(ArC), 130.4(ArC), 130.0(ArC), 129.7(ArC), 129.4(ArC), 128.4(ArC), 
128.2(ArC), 127.9(ArC), 127.8(ArC), 127.0(ArC), 124.1(ArC), 29.7(CH3). 
 
9.47 Preparation of 5-Phenylbenzo[i]phenanthridine149 303 
 
2-(4-Methyl-2-phenylquinolin-3-yl)benzaldehyde 309 (1eq., 13.0mg, 0.039mmoles) was 
added to dry dimethylformamide (2mL) in a 10mL round bottom flask and the solution was 
degassed for two minutes. To this was added potassium t-butoxide and the reaction was 
stirred at 80 °C under argon and the flask was irradiated with a high pressure mercury lamp 
through a quartz filter in a dark room. On completion, the reaction was allowed to cool down 
to room temperature and diluted with water (10mL) and then extracted in diethyl ether 
(15mL×3) before being dried over anhydrous magnesium sulfate. The reaction mixture was 
filtered and then the solvent removed in vacuo to yield the crude product which was then 
purified by column chromatography (10% EtOAc/Hexane) to obtain the product as a yellow 
solid (12.0mg, 0.039mmoles, 84%). 
 
Rf 0.40
 (30% EtOAc/Hexane); 1H NMR (500 MHz, Chloroform-d) δ 
8.68 (2H, dd, J = 8.5, 4.6 Hz, ArH), 8.31 (1H, d, J = 7.9 Hz, ArH), 
8.20 (1H, d, J = 9.0 Hz, ArH), 7.95 (1H, d, J = 7.9 Hz, ArH), 7.80 (2H, 
dd, J = 7.6, 6.1 Hz, ArH), 7.75-7.69 (1H, m, ArH), 7.66-7.62 (2H, m, 
ArH), 7.54-7.48 (4H, m, ArH), 7.21 (1H, ddd, J = 8.5, 6.9, 1.4 Hz, 
ArH).149 
 
9.48 Preparation of t-Butyl 1H-indole-1-carboxylate210 465 
 
Indole 370 (1eq., 2.00g, 17∙07mmoles) was dissolved in dry tetrahydrofuran (45mL) in a 100mL 
round bottom flask under inert conditions. To this stirring solution, 4-dimethylaminopyridine 
(0∙015eq, 31.0mg, 0∙256mmol) and di-t-butyl dicarbonate (1.5eq., 5.58g, 25∙60mmoles) were 
added at room temperature. The reaction was stirred under the same conditions for eighteen 
hours. On completion, the reaction mixture was quenched using water (50mL) and neutralized by 
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adding an aqueous sodium bicarbonate solution (50mL). The organic material was extracted into 
ethyl acetate (100mL×3), separated and organic layer was washed with water (100mL×2). The 
organic phases were combined and washed with brine (100mL), dried over anhydrous magnesium 
sulfate and the solvent was removed under vacuum to obtain the residue which was purified by 
column chromatography (20% EtOAc/Hexane) to obtain t-butyl 1H-indole-1-carboxylate 465 as a 
pale yellow oil (3.62g, 16.66mmoles, 98%). 
 
Rf 0.19 (30% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 8.17 (1H, d, J 
= 8.2 Hz, H-1), 7.54 (1H, d, J = 3.7 Hz, ArH), 7.49 (1H, d, J = 7.7 Hz, ArH), 7.35-
7.21 (1H, m, ArH), 7.22-7.10 (1H, m, ArH), 6.49 (1H, d, J = 3.7 Hz, H-2), 1.60 (9H, 
s, CH3×3);
 13C NMR (75 MHz, Chloroform-d) δ 149.6(C=O), 146.8(ArC), 
130.6(ArC), 125.8(ArC), 124.1(ArC), 122.6(ArC), 120.9(ArC), 115.2(ArC), 
107.2(ArC), 83.4(C-7), 28.0(CH3×3).
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9.49 Preparation of t-Butyl 5-methoxy-1H-indole-1-carboxylate210 466 
 
5-Methoxy-1H-indole 463 (1eq., 2.00g, 13.59mmoles) was dissolved in dry tetrahydrofuran (45mL) 
in a 100mL round bottom flask under inert conditions. To this solution, 4-dimethylaminopyridine 
(0.015eq., 25.0mg, 0.203mmoles) and di-t-butyl dicarbonate (1.5eq., 4.40g, 20.25mmoles) was 
added. The resulting solution was stirred at room temperature and under argon for eighteen hours. 
On completion, the reaction was quenched by the addition of water (50L) and then the mixture was 
neutralized by addition of an aqueous saturated solution of sodium bicarbonate (50mL). The 
solution was transferred to a separating funnel and the organic material was extracted into ethyl 
acetate (100mL×3). The combined organic phases were then washed with brine (100mL), dried 
over anhydrous magnesium sulfate, filtered and the solvent was removed under reduced pressure 
to furnish crude product which was purified by column chromatography to obtain the pure product 
466 as a light pink solid in 100% yield (3.30g, 13.55mmoles). 
 
Rf 0.21 (30% EtOAc/Hexane); 
1H NMR (300 MHz, Chloroform-d) δ 8.02 (1H, 
d, J = 8.8 Hz, ArH), 7.56 (1H, d, J = 3.6 Hz, ArH), 7.02 (1H, d, J = 2.5 Hz, 
ArH), 6.92 (1H, d, J = 9.0 Hz, ArH), 6.66-6.37 (1H, m, ArH), 3.84 (3H, s, 
OMe), 1.52 (9H, s, CH3×3); 
13C NMR (75 MHz, Chloroform-d) δ 155.9(ArC-
4), 149.7(C=O), 146.8(ArC), 131.4(ArC), 126.5(ArC), 115.8(ArC), 
113.0(ArC), 107.1(ArC), 103.5(ArC), 85.1(C-7), 55.7(OMe), 28.2(CH3×3).
 210 
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9.50 Preparation of (1-(t-Butoxycarbonyl)-1H-indol-2-yl)boronic acid210, 215, 216 440 
 
In a 50mL flame dried two neck round bottom flask, 30mL of tetrahydrofuran was added under inert 
conditions. Diisopropyl amine (2.5eq., 3∙14g, 4∙30mL, 28∙76mmoles) was added to it and the 
solution was cooled down to -78 °C. nButyllithium (2.4eq., 1∙15 M in THF, 27∙60mmoles, 1.70g, 
23.89mL) was added drop wise to the stirring solution at the same temperature. The reaction was 
warmed up to 0 °C and stirred for thirty minutes. The solution turned slightly yellowish which 
indicated the generation of lithium diisopropylamide. The reaction was again cooled down to -78 °C 
and 2.80g of t-butyl 1H-indole-1-carboxylate 465 (11.50mmoles) dissolved in tetrahydrofuran 
(10mL) was added drop wise to the reaction and was allowed to stir at same temperature for two 
hours. Reaction changes colour from pale yellow to bright orange. Triisopropyl borate (2.5eq., 
5∙40g, 13.25mL, 28.76mmoles) was added drop wise to the reaction and the reaction was slowly 
warmed up to room temperature over two hours. By this time the reaction becomes cloudy light 
orange in color. The reaction mixture was quenched by adding ice cold water drop wise and 2 M 
hydrochloric acid carefully to hydrolyze borate ester. The organic material was extracted using 
diethyl ether (50mL×3). The organic phases were then combined and washed with brine (50mL), 
dried over anhydrous magnesium sulfate and solvent was removed under vacuum, till a few mLs of 
solvent was left. Cold hexane (25mLs) was added to it and stirred vigorously at 0 °C which resulted 
in precipitation of the expected boronic acid. The solid was filtered and dried under reduced 
pressure to obtain (1-(t-butoxycarbonyl)-1H-indol-2-yl)boronic acid 440 as a white solid (2.84g, 
10.87mmoles, 95%)  
 
1H NMR (300 MHz, Dimethylsulphoxide-d6) δ 8.19 (2H, s, B(OH)2), 8.10 
(1H, d, J = 8.2 Hz, ArH), 7.57 (1H, d, J = 7.7 Hz, ArH), 7.29 (1H, t, J = 7.6 
Hz, ArH), 7.21 (1H, t, J = 7.4 Hz, ArH), 6.64 (1H, s, ArH-3), 1.62 (9H, s, 
CH3×3); 
13C NMR (75 MHz, Dimethylsulphoxide-d6) δ 150.3(C=O), 
136.6(ArC), 131.1(ArC), 124.3(ArC), 122.9(ArC), 121.0(ArC), 114.9(ArC), 
112.5(ArC), 84.4(C-8), 28.0(CH3×3).
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9.51 Preparation of 1-(t-Butoxycarbonyl)-5-methoxy-1H-indol-2-ylboronic acid210, 217 467 
 
Diisopropyl amine (2.5eq., 2.20g, 3mL, 20.30mmoles) was added in a 50mL flame dried two neck 
round bottom flask and 30mL of freshly distilled, dry tetrahydrofuran was added and the solution 
was cooled to -78 °C. nButyllithium. (2.4eq., 1∙5 M in THF, 1.24g, 12.90mL, 19.40mmoles) was 
added drop wise to the stirring solution at the same temperature under inert conditions. The 
reaction was warmed up to 0 °C and stirred for thirty minutes. The solution turned slight yellowish 
which indicated generation of lithium diisopropylamide. The reaction was again cooled down to -78 
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°C and t-butyl 5-methoxy-1H-indole-1-carboxylate 466 (1eq., 2.00g, 8.12mmoles) dissolved in 
tetrahydrofuran (10mL) was added drop wise to the reaction and allowed to stir at same 
temperature for two hours. The reaction changes colour from pale yellow to bright orange which 
indicated the generation of anion. Trimethyl borate (2.5eq., 2.10g, 2.20mL, 20.30mmoles) was 
added drop wise to the stirring solution and the reaction was slowly warmed up to room 
temperature over two hours. By this time the reaction becomes cloudy light orange in color. The 
reaction mixture was quenched by adding ice cold water drop wise and 2 M hydrochloric acid 
carefully to hydrolyse borate ester. The organic material was extracted using diethyl ether 
(50mL×3). The organic phases were combined and washed with brine, dried over anhydrous 
magnesium sulfate and solvent was removed under vacuum, till a few mL of solvent was left. Cold 
hexane (25mLs) was added to it and stirred vigorously at 0 °C which resulted in precipitation of the 
expected boronic acid. The solid was filtered and dried under reduced pressure to obtain (1-(t-
butoxycarbonyl)-1H-indol-2-yl)boronic acid 467 as a white solid (2.15g, 7.38mmoles, 93%). 
 
1H NMR (300 MHz, Dimethylsulphoxide-d6) δ 8.18 (2H, s, B(OH)2), 7.96 
(1H, d, J = 9.0 Hz, ArH), 7.09 (1H, d, J = 2.1 Hz, ArH), 6.89 (1H, dd, J = 
8.9, 2.2 Hz, ArH), 6.56 (1H, s, ArH-3), 3.78 (3H, s, OMe), 1.60 (9H, s, 
CH3×3); 
13C NMR (75 MHz, Dimethylsulphoxide-d6) δ 155.8(ArC-5), 
150.3(C=O), 132.0(ArC), 131.2(ArC), 115.6(ArC), 113.0(ArC), 
112.5(ArC), 103.5(ArC-3), 84.2(C-8), 55.7(OMe), 28.1(CH3×3).
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9.52 Preparation of 3-Methylquinoline 1-oxide220 472 
 
3-Methylquinoline 464 (1eq., 2.50g, 17.45moles) was dissolved in freshly distilled 
dichloromethane (20mL) and m-chloroperbenzoic acid (2eq., 6.02g, 34.91mmoles) was 
added to the stirring reaction solution in portions. The reaction mixture bubbled and changed 
color from very light yellow to dark yellow. The reaction was then allowed to stir at room 
temperature under air for forty five minutes after which time reaction goes very hazy dark 
yellow. An aqueous saturated solution of sodium bicarbonate (20mL) was added to quench 
the excess m-chloroperbenzoic at 0 °C and then the solution was transferred to separating 
funnel and washed with dichloromethane (50mL×3). The organic phase were combined and 
washed with brine (100mL), dried over magnesium sulfate and purified using column 
chromatography (5% MeOH/DCM) to afford the product 472 as light a yellow solid (2.40g, 
15mmoles, 87% yield)  
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Rf 0.86 (EtOAc); 
1H NMR (300 MHz, Chloroform-d) δ 8.69 (1H, d, J = 8.6 
Hz, ArH), 8.45 (1H, s, ArH-3), 7.79 (1H, d, J = 8.1 Hz, ArH), 7.70 (1H, t, J = 
7.2 Hz, ArH), 7.66-7.57 (1H, m, ArH), 7.55 (1H, s, ArH-1), 2.46 (3H, s, 
CH3).; 
13C NMR (75 MHz, Dimethylsulphoxide-d6) δ 134.5(ArC), 
131.8(ArC), 126.0(ArC), 125.0(ArC), 124.1(ArC), 123.5(ArC), 122.2(ArC), 120.3(ArC), 
114.3(ArC), 13.5(CH3).
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9.53 Preparation of 3-Methylquinolin-2(1H)-one221 473 
 
3-Methylquinoline 1-oxide 472 (1eq., 2.40g, 15.00mmoles) was dissolved in chloroform 
(50mL) in a 100mL round bottom flask and p-toluene sulfonic acid (1.2eq., 3.45g, 
18.11mmoles) was added. Potassium carbonate (3.5eq., 7.29g, 52.81mmoles) was 
dissolved in water (25mL) and added to the reaction mixture. The reaction was allowed to 
stir for five hours at room temperature under inert conditions. On completion the reaction 
mixture was cooled to 0 °C, and an aqueous saturated solution of sodium bicarbonate 
(100mL) was added to it slowly and carefully to quench unreacted p-toluene sulfonic acid. 
While doing so, reaction mixture bubbled vigorously. When bubbling ceased the solution was 
transferred to a separating funnel and extracted with chloroform (50mL×3). The organic 
layers were collected together, dried over anhydrous magnesium sulfate, filtered off and 
solvent was then removed in vacuo to obtain the crude product which was then purified by 
column chromatography (30% EtOAc/Hexane) to furnish pure 3-methylquinolin-2(1H)-one 
473 as an off-white solid (2.00g, 12.00mmoles, 83%). 
 
Rf 0.48 (EtOAc); 
1H NMR (300 MHz, Chloroform-d) δ 11.80 (1H, s, NH), 
7.65 (1H, s, ArH), 7.44 (3H, dt, J = 22.8, 7.9 Hz, ArH), 7.19 (1H, t, J = 7.3 
Hz, ArH), 2.31 (3H, s, CH3); 
13C NMR (75 MHz, Chloroform-d) δ 
164.5(C=O), 137.5(ArC), 130.1(ArC), 129.3(ArC), 126.8(ArC), 122.4(ArC), 
120.32(ArC), 115.6(ArC), 16.8(CH3).
221 
 
9.54 Preparation of 2-Bromo-3-methylquinoline222 461 
 
3-Methylquinolin-2(1H)-one 473 (1eq., 93.0mg, 0.657mmoles) and phosphorus oxybromide 
(1.5eq., 274mg, 0.954mmoles) were transferred to a 10mL round bottom flask and stirred at 
140 °C for three hours. On completion, the reaction mixture was immediately poured in a 
beaker carrying ice cold water (20mL) and was transferred to a separating funnel and was 
then extracted in dichloromethane (20mL×3). The combined organic phases were washed 
with brine (50mL) and dried over anhydrous magnesium sulfate, filtered and the solvent was 
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removed in vacuo to obtain crude product. Column chromatography (20% EtOAc/Hexane) 
was performed to obtain product 461 in pure form as a light brown powder (101mg, 
0.454mmoles, 83%). 
 
Rf 0.31 (EtOAc); 
1H NMR (300 MHz, Chloroform-d) δ 8.01 (1H, d, J = 8.4 
Hz, ArH), 7.93 (1H, s, ArH-1), 7.73 (1H, d, J = 8.1 Hz, ArH), 7.70-7.62 (1H, 
m, ArH), 7.58-7.49 (1H, m, ArH), 2.58-2.50 (3H, s, CH3); 
13C NMR (75 
MHz, Chloroform-d) δ 147.0(ArC), 145.5(ArC), 137.0(ArC), 132.3(ArC), 
129.5(ArC), 128.3(ArC), 127.7(ArC), 127.0(ArC), 126.9(ArC), 22.4(CH3).
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9.55 Preparation of t-Butyl 2-(3-methylquinolin-2-yl)-1H-indole-1-carboxylate 474 
 
A flame dried 2-neck 50mL round bottom flask was charged with tetrakis(triphenylphosphine) 
palladium(0) (0.1eq., 442mg, 0∙38mmoles) under inert conditions and at room temperature. 1.00g 
(3.88mmoles) of (1-(tbutoxycarbonyl)-1H-indol-2-yl)boronic acid 440 and 2-bromo-3-
methylquinoline 473 (1eq., 850mg, 3.83mmoles) were added to 20mL of dimethoxyethane. The 
solution was degassed for ten minutes and transferred to the flask from a dropping funnel. Mixture 
was allowed to stir for ten minutes at room temperature. An 2 M aqueous sodium carbonate (4mL) 
was degassed for ten minutes and transferred to the reaction flask via a dropping funnel. The 
reaction was allowed to stir at reflux for eighteen hours under inert conditions, over which time 
reaction turns from milky yellow to clear brown solution. The reaction was cooled and quenched 
using water (20mL) and the solution was transferred to a separating funnel and organic material 
was extracted using ethyl acetate (50mL×3). The organic phases were combined, washed with 
brine (50mL), dried over anhydrous magnesium sulfate and the solvent was removed under 
vacuum to obtain the crude product, which was then purified by column chromatography (10% 
EtOAc/Hexane) to obtain t-butyl 2-(3-methylquinolin-2-yl)-1H-indole-1-carboxylate 474 as a pale 
yellow solid (1∙30g, 36∙26 mmoles, 95%). 
 
Mp. 45 °C (C2H5)2O; Rf 0.50 (30% EtOAc/Hexane); FTIR (ν/cm
-1): 2978-
2930(C-H), 1721(CO2O), 1601-1560(ArC=C), 1328(C-O), 1258(C=N), 
1226(C-N); 1H NMR (300 MHz, Chloroform-d) δ 8.31 (1H, d, J = 8.0 Hz, 
ArH), 8.11 (1H, d, J = 8.3 Hz, ArH), 7.93 (1H, s, ArH-6’), 7.75 (1H, d, J = 
8.0 Hz, ArH), 7.61 (2H, dd, J = 13.2, 7.8 Hz, ArH), 7.51 (1H, d, J = 7.4 
Hz, ArH), 7.35 (1H, d, J = 7.7 Hz, ArH), 7.27 (1H, d, J = 7.4 Hz, ArH), 
6.71 (1H, s, ArH-1), 2.35 (3H, s, CH3), 1.12 (9H, s, CH3×3); 
13C NMR (75MHz, Chloroform-d) δ 
154.9(C=O), 149.7(ArC), 146.0(ArC), 137.8(ArC), 136.7(ArC), 135.3(ArC), 130.8(ArC), 129.3(ArC), 
129.2(ArC), 128.8(ArC), 127.8(ArC), 126.7(ArC), 124.7(ArC), 123.0(ArC), 120.9(ArC), 115.5(ArC), 
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110.4(ArC), 83.3(O-C-(CH3)3), 27.4(CH3×3), 19.4(CH3); HRMS (ESI+): Found M
++H 359.1750, 
C22H23N2O2 (M
++H) requires 359.1750, m/z 359.1750 (M++H, 100%), 360.1778 (25%). 
 
9.56 Preparation of t-Butyl 5-methoxy-2-(3-methylquinolin-2-yl)-1H-indole-1-carboxylate 475 
 
In a flame dried 2-neck 50mL round bottom flask tetrakis(triphenylphosphine) palladium(0) (0.1eq., 
198mg, 0∙172mmoles) was added under inert conditions and at room temperature. 1-(t-
Butoxycarbonyl)-5-methoxy-1H-indol-2-ylboronic acid 467 (1eq., 500mg, 1.72mmoles) and 2-
bromo-3-methylquinoline 473 (1eq., 381mg, 1.72mmoles) were added to 10mL of dimethoxy 
ethane and the solution was degassed for ten minutes and then transferred to the flask from a 
dropping funnel. The resulting mixture was allowed to stir for ten minutes at room temperature and 
an aqueous 2 M sodium carbonate (3mL) was degassed for ten minutes and transferred to the 
reaction flask via a dropping funnel. The reaction was allowed to stir at reflux for eighteen hours 
under inert conditions, over which time reaction turns from milky yellow to clear brown solution. 
The reaction was cooled and quenched using water (10mL). The mixture was then transferred to a 
separating funnel and organic material was extracted using ethyl acetate (15mL×3). The organic 
phases were combined, washed with brine (50mL), dried over anhydrous magnesium sulfate and 
the solvent was removed in vacuum to obtain the crude product, which was purified by column 
chromatography (10% EtOAc/Hexane) to obtain t-butyl 2-(3-methylquinolin-2-yl)-1H-indole-1-
carboxylate as yellow solid 475 (536mg, 1.37 mmoles, 80%). 
 
Mp. 49 °C (C2H5)2O; Rf 0.43 (30% EtOAc/Hexane); FTIR (ν/cm
-1): 
2920-2850(C-H), 1725(CO2R), 1602-1560(ArC=C), 1320(C-O), 
1272-1259(C=N), 1219(C-N); 1H NMR (300 MHz, Chloroform-d) δ 
8.14 (2H, dd, J = 17.7, 8.7 Hz, ArH), 7.97 (1H, s, ArH), 7.79 (1H, d, 
J = 8.0 Hz, ArH), 7.66 (1H, dd, J = 8.4, 1.3 Hz, ArH), 7.60-7.49 (1H, 
m, ArH), 7.06 (1H, d, J = 2.5 Hz, ArH), 6.99 (1H, dd, J = 9.0, 2.5 Hz, 
ArH), 6.64 (1H, s, ArH), 3.88 (3H, s, OMe), 2.37 (3H, s, CH3), 1.14 (9H, s, CH3×3); 
13C NMR (75 
MHz, Chloroform-d) δ 156.1(ArC-5), 155.0(C=O), 149.7(ArC), 146.1(ArC), 138.4(ArC), 135.3(ArC), 
131.45(ArC), 130.9(ArC), 130.1(ArC), 129.3(ArC), 128.8(ArC), 127.9(ArC), 126.8(ArC), 
126.7(ArC), 116.4(ArC), 113.6(ArC), 110.2(ArC), 103.3(ArC), 83.3(O-C-(CH3)3), 55.7(OMe), 
27.5(CH3×3), 19.4(CH3); HRMS (ESI+): Found M
++H 389.1848, C24H25N2O3 (M
++H) requires 
389.1866, m/z 389.1848 (M++H, 100%), 390.1896 (25%). 
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9.57 Preparation of 2-(1H-Indol-2-yl)-3-methylquinoline 476 
 
t-Butyl 2-(3-methylquinolin-2-yl)-1H-indole-1-carboxylate 474 (1eq., 1.00g, 2∙79mmoles) was 
dissolved in dry dichloromethane (20mL) in a 50mL round bottom flask under inert conditions and 
the temperature was cooled down to 0 °C. Aluminium chloride (1.3eq., 484mg, 3∙63mmoles) was 
added to the reaction in one portion. The reaction immediately changed color from light yellow to 
bright red. The reaction was allowed to stir for one hour under the same conditions. The reaction 
was quenched using ice cold water and red colour disappears immediately and changed to yellow. 
The organic material was extracted in to dichloromethane (20mL×3). The organic phases were 
combined, washed with brine (50mL), dried over anhydrous sodium sulfate and the solvent was 
removed in vacuum to obtain the crude product, which was purified by flash column 
chromatography (5% EtOAc/Hexane) to obtain 2-(1H-indol-2-yl)-3-methylquinoline 476 as a yellow 
solid (480mg, 36∙26 mmoles, 68%). 
 
Mp. 155-157 °C (C2H5)2O; Rf 0.35 (30% EtOAc/Hexane); FTIR (ν/cm
-1): 
3289(N-H), 3046-2972(C-H), 1616-1559(ArC=C), 1240(C=N); 1H NMR 
(300 MHz, Chloroform-d) δ 10.13 (1H, s, NH), 8.06 (1H, d, J = 8.4 Hz, 
ArH), 7.94 (1H, s, ArH), 7.71 (2H, t, J = 7.5 Hz, ArH), 7.64 (1H, t, J = 7.6 
Hz, ArH), 7.48-7.43 (2H, m, ArH), 7.26 (1H, t, J = 7.5 Hz, ArH), 7.15 
(1H, s, ArH), 7.12 (1H, t, J = 7.5 Hz, ArH), 2.80 (3H, s, CH3); 
13C NMR 
(75 MHz, Chloroform-d) δ 149.5(ArC), 146.2(ArC), 137.6(ArC), 136.2(ArC), 135.8(ArC), 
129.4(ArC), 129.0(ArC), 129.0(ArC), 128.6(ArC), 127.2(ArC), 126.7(ArC), 126.2(ArC), 123.7(ArC), 
121.54(ArC), 119.9(ArC), 111.2(ArC), 105.3(ArC), 21.8(CH3); HRMS (ESI+): Found M
++H 
259.1230, C18H14N2 (M
++H) requires 259.1236, m/z 259.1230 (M++H, 100%), 260.1259 (20%). 
 
9.58 Preparation of 2-(5-Methoxy-1H-indol-2-yl)-3-methylquinoline 477 
 
t-Butyl 5-methoxy-2-(3-methylquinolin-2-yl)-1H-indole-1-carboxylate 475 (1eq., 1.08g, 2∙79mmoles) 
was dissolved in dry dichloromethane (20mL) under an argon atmosphere and temperature was 
cooled down to 0 °C. Aluminium chloride (1.3eq., 0.481mg, 3.61mmoles) was added to the 
reaction in one portion. The reaction immediately changed color from light yellow to bright red and 
was allowed to stir for one hour under the same conditions. On completion, reaction was quenched 
using ice cold water (30mL), the red colour disappeared immediately turning to yellow. The organic 
material was extracted in dichloromethane (30mL×3). Organic phases were combined, washed 
with brine (50mL), dried over anhydrous sodium sulfate and solvent was removed in vacuum to 
obtain the crude product, which was purified using flash column (5% EtOAc/Hexane) to obtain 2-
(1H-indol-2-yl)-3-methylquinoline 405 as a yellow solid (553mg, 1.91 mmoles, 69%). 
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Mp. 175-177 °C (C2H5)2O; Rf 0.64 (30% EtOAc/Hexane); FTIR 
(ν/cm-1): 3147(N-H), 3069-2934(C-H), 1622-1594(ArC=C), 1322(C-
O), 1292(C+n); 1H NMR (300 MHz, Chloroform-d) δ 10.05 (1H, s, 
NH), 8.04 (1H, d, J = 8.4 Hz, ArH), 7.90 (1H, s, ArH), 7.74-7.58 (2H, 
m, ArH), 7.49-7.39 (1H, m, ArH), 7.30 (1H, d, J = 8.8 Hz, ArH), 7.12 
(1H, d, J = 2.3 Hz, ArH), 7.05 (1H, d, J = 1.4 Hz, ArH), 6.93 (1H, dd, 
J = 8.8, 2.4 Hz, ArH), 3.86 (3H, s, OMe), 2.76 (3H, s, CH3); 
13C NMR (75 MHz, Chloroform-d) δ 
154.2(ArC-5), 149.5(ArC),  146.2(ArC), 137.6(ArC), 136.7(ArC), 131.2(ArC), 129.7(ArC), 
129.0(ArC), 128.9(ArC), 128.6(ArC), 127.2(ArC), 126.7(ArC), 126.1(ArC), 114.5(ArC), 112.0(ArC), 
105.0(ArC), 102.6(ArC), 55.8(OMe), 21.8(CH3); HRMS (ESI+): Found M
++H 289.1331, C19H16N2O 
(M++H) requires 289.1342, m/z 289.1331 (M++H, 100%), 290.1364 (20%). 
 
9.59 Preparation of 2-(3-Methylquinolin-2-yl)-1H-indole-3-carbaldehyde 478 
 
2-(1H-Indol-2-yl)-3-methylquinoline 476 (1eq., 430mg, 1.66mmoles) was transferred to a 50mL 
round bottom flask carrying 20mL dichloromethane and to this stirring solution was added 
dichloromethyl methyl ether (2eq., 383mg, 0.30mL, 3.33mmol) at room temperature and under 
argon. The solution was then cooled down to -70 °C and tin(IV)chloride (1.5eq., 650mg, 0.29mL, 
2.49mmoles) was added carefully to the reaction mixture. The reaction mass was allowed to warm 
up to 0 °C and then was stirred for three hours at 0 °C under argon. On completion, the reaction 
was quenched using water (50mL) and then an aqueous saturated solution of sodium bicarbonate 
(20mL) was added. The solution was then transferred to a separating funnel and was washed with 
dichloromethane (25mL×3). The organic phases were combined, dried over anhydrous sodium 
sulfate, filtered off and the solvent was removed under reduced pressure to obtain crude product 
which was subjected to column chromatography (25% EtOAc/Hexane) to yield 2-(3-methylquinolin-
2-yl)-1H-indole-3-carbaldehyde 478 as a yellow solid (358mg, 1.25mmoles, 75%). 
 
Rf 0.53 (50% EtOAc/Hexane); 
1H NMR (500 MHz, DMSO-d6) δ 12.55 
(1H, s, NH), 9.81 (1H, s, C=O), 8.41 (1H, s, ArH), 8.23 (1H, d, J = 7.7 
Hz, ArH), 8.08 (1H, d, J = 8.4 Hz, ArH), 8.02 (1H, d, J = 8.1 Hz, ArH), 
7.79 (1H, t, J = 7.6 Hz, ArH), 7.68 (1H, t, J = 7.5 Hz, ArH), 7.57 (1H, d, J 
= 7.9 Hz, ArH), 7.32 (2H, dt, J = 21.9, 7.2 Hz, ArH), 3.32 (3H, s, CH3).  
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9.60 Preparation of 5-Methoxy-2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 479 
 
2-(5-Methoxy-1H-indol-2-yl)-3-methylquinoline 477 (1eq., 123mg, 0.429mmoles) was added to a 
20mL round bottom flask and dichloromethane (5mL) was added. To this solution dichloromethyl 
methyl ether (2eq., 98.0mg, 0.08mL, 0.858mmol) was added at room temperature under inert 
conditions. The reaction mixture was then cooled down to -70 °C and tin(IV)chloride (1.5eq., 
176mg, 0.07mL, 0.643mmoles) was added carefully. The reaction mixture was allowed to warm up 
to 0 °C and under these conditions stirred for another three hours. On completion, the reaction was 
quenched using water (10mL) and an aqueous saturated solution of sodium bicarbonate (10mL) 
was added. The solution was then transferred to a separating funnel and the organic material was 
extracted with dichloromethane (10mL×3). The organic phases were combined, dried over 
anhydrous sodium sulfate, filtered off and solvent was removed under reduced pressure to procure 
crude product which was subjected to column chromatography (25% EtOAc/Hexane) to obtain 5-
methoxy-2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 479 as a dark yellow solid (88.0mg, 
0.279mmoles, 65%-crude yield). 
 
Rf 0.39 (30% EtOAc/Hexane). Due to stability and solubility 
problems this product was considered as an intermediate 
and was used in the following step without any 
characterization. 
 
 
 
9.61 Preparation of 1-Benzyl-2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 480 
 
2-(3-Methylquinolin-2-yl)-1H-indole-3-carbaldehyde 478 (1eq., 188mg, 0.657mmoles) 
together with dimethylformamide (2mL) under argon was added to a 10mL round bottom 
flask. Sodium hydride (2eq., 53.0mg of 60%, 1.31mmoles) was added and the reaction 
mixture was allowed to stir for ten minutes. Benzyl bromide (2eq., 225mg, 0.156mL. 
1.31mmoles) was added and the reaction mixture was allowed to stir under argon and at 
room temperature for one hour. On completion, the reaction was cooled down to 0 °C and 
was quenched by adding ice cold water (10mL) carefully and then was transferred to a 
separating funnel where it was washed with dichloromethane (10mL×3). The combined 
organic phases were washed with brine (25mL), dried over anhydrous magnesium sulfate, 
filtered off through a pad of celite and then solvent was removed in vacuo to obtain the crude 
product which was purified by column chromatography (20% EtOAc/ Hexane) to obtain pure 
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1-benzyl-2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 480 as an off-white solid 
(230mg, 0.610mmoles, 93%). 
 
Mp. 67-70 °C (C2H5)2O; Rf 0.39 (50% EtOAc/Hexane); FTIR 
(ν/cm-1): 3030-2922(C-H), 1708(CHO), -1661-1598(ArC-C), 
1237(C=N), 1202(C-N); 1H NMR (300 MHz, Chloroform-d) δ 9.73 
(1H, s, CHO), 8.43 (1H, dd, J = 5.6, 3.0 Hz, ArH), 8.12 (1H, d, J 
= 8.4 Hz, ArH), 8.03 (1H, s, ArH-6’), 7.84 (1H, d, J = 8.1 Hz, 
ArH), 7.74 (1H, t, J = 7.2 Hz, ArH), 7.62 (1H, t, J = 7.5 Hz, ArH), 
7.44 (1H, dd, J = 5.9, 3.0 Hz, ArH), 7.41-7.33 (2H, m, ArH), 7.14 (3H, q, J = 5.9 Hz, ArH), 
6.91 (2H, d, J = 6.4 Hz, ArH), 5.30 (2H, s, CH2), 2.14 (3H, s, CH3); 
13C NMR (75 MHz, 
Chloroform-d) δ 185.3(C=O), 150.1(ArC-1), 147.5(ArC), 146.5(ArC), 137.3(ArC), 136.8(ArC), 
136.0(ArC), 131.6(ArC), 129.6(ArC), 129.5(ArC), 128.6(ArC), 128.2(ArC), 127.9(ArC), 
127.8(ArC), 127.0(ArC), 127.0(ArC), 125.3(ArC), 124.3(ArC), 123.4(ArC), 122.3(ArC), 
116.5(ArC), 110.6(ArC), 47.9(CH2), 19.3(CH3); HRMS (ESI+): Found M
++H 377.1646, 
C26H21N2O (M
++H) requires 377.1655, m/z 377.1646 (M++H, 100%), 378.1678 (30%); 
 
9.62 Preparation of 1-Benzyl-5-methoxy-2-(3-methylquinolin-2-yl)-1H-indole-3-
carbaldehyde 481 
 
5-Methoxy-2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 479 (1eq., 38.0mg, 
0.122mmoles) was dissolved in dry dimethylformamide (2mL) under inert conditions and the 
temperature of the solution was reduced to 0 °C. To this solution was added sodium hydride 
(2eq., 6.0mg, 0.244mmoles) and the reaction mixture was allowed to stir for ten minutes and 
slowly the temperature was allowed to rise to room temperature when benzyl bromide (2eq., 
0.02mL, 42.0mg, 0.244mmoles) was added. The reaction was allowed to stir for another one 
hour at this temperature. On completion, the reaction was again cooled down to 0 °C and 
ice-cold water (10mL) was added carefully to quench the reaction. The solution was 
transferred to a separating funnel and extracted with dichloromethane (10mL×3). The 
organic phases were combined and washed with brine (25mL), dried over anhydrous 
magnesium sulfate, filtered off through a pad of celite and then the solvent was removed in 
vacuo to obtain the crude product which was purified by column chromatography (20% 
EtOAc/ Hexane) to obtain pure 1-benzyl-5-methoxy-2-(3-methylquinolin-2-yl)-1H-indole-3-
carbaldehyde 481 as a white solid (48.0mg, 0.118mmol, 97%). 
 
Mp 79-81 °C (C2H5)2O; Rf 0.50 (30% EtOAc/Hexane); FTIR (ν/cm
-1): 2920-2850(C-H), 
1718(CHO), 1660(ArC-C), 1230(C=N), 1175(C-N), 1341(C-O); 1H NMR (300 MHz, 
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Chloroform-d) δ 10.75 (1H, s, CHO), 8.04-7.98 (2H, m, ArH), 
7.76 (1H, d, J = 8.1 Hz, ArH), 7.68 (1H, s, ArH-5), 7.65 (1H, 
s, ArH-6’), 7.58-7.50 (2H, m, ArH), 7.13-7.09 (3H, m, ArH), 
6.91 (1H, d, J = 9.0 Hz, ArH), 6.84 (2H, dd, J = 6.5, 2.7 Hz, 
ArH), 5.59 (2H, s, CH2), 3.96 (3H, s, OMe), 2.48 (3H, s, CH3); 
13C NMR (75 MHz, Chloroform-d) δ 190.7(C=O), 159.5(ArC-
5), 152.1(ArC-1), 146.3(ArC), 141.6(ArC), 138.1(ArC), 137.0(ArC), 133.4(ArC), 131.0(ArC), 
129.2(ArC), 128.9(ArC), 128.4(ArC), 127.5(ArC), 127.2(ArC), 127.0(ArC), 126.8(ArC), 
126.4(ArC), 126.2(ArC), 118.0(ArC), 115.8(ArC), 107.6(ArC), 106.2(ArC), 56.9(CH2), 
47.7(OMe), 20.5(CH3); HRMS (ESI+): Found M
++H 407.1752, C27H23N2O2, (M
++H) requires 
407.1760, m/z 407.1752 (M++H, 100%), 406.1787(30%). 
 
9.63 Preparation of 13-Benzyl-13H-indolo[3,2-c]acridine 482 
 
1-Benzyl-2-(3-methylquinolin-2-yl)-1H-indole-3-carbaldehyde 480 (1eq., 148mg, 
0.394mmoles) was dissolved in dimethylformamide (2mL) and the solution was degassed for 
two minutes To this solution, potassium t-butoxide (4eq., 176mg, 1.57mmoles) was added 
and the reaction mixture was allowed stirred at 80 °C under argon while the flask was 
irradiated with a high pressure mercury lamp through a quartz filter under dark for ten 
minutes. When completed, the reaction was allowed to cool down to room temperature and 
then diluted with water (10mL) and the organic material was extracted in diethyl ether 
(10mL×3). The combined organic phases were washed with brine (25mL), dried over 
anhydrous magnesium sulfate, filtered and solvent was removed in vacuum to obtain the 
crude product which was purified by column chromatography (5% EtOAc/Hexane) to obtain 
13-benzyl-13H-indolo[3,2-c]acridine 482 as a bright yellow solid (113mg, 0.316mmoles, 
80%).  
 
Mp. 183-185 °C CHCl3; Rf 0.21 (30% EtOAc/Hexane); FTIR 
(ν/cm-1): 3055-2919(C-H), 1604(ArC-C), 1256(C=N), 1197(C-N); 
1H NMR (300 MHz, Chloroform-d) δ 8.79 (1H, s, ArH-3), 8.19 
(3H, t, J = 7.3 Hz, ArH), 7.99 (1H, d, J = 8.3 Hz, ArH), 7.70 (2H, 
d, J = 8.5 Hz, ArH), 7.61 (1H, d, J = 8.2 Hz, ArH), 7.55-7.44 (2H, 
m, ArH), 7.33 (3H, d, J = 7.6 Hz, ArH), 7.23-7.12 (3H, m, ArH), 6.86 (2H, s, CH2); 
13C NMR 
(75 MHz, Chloroform-d) δ 147.1(ArC), 141.4(ArC), 140.4(ArC), 139.4(ArC), 135.5(ArC), 
133.1(ArC), 129.5(ArC), 129.3(ArC), 128.4(ArC), 127.9(ArC), 127.0(ArC), 126.8(ArC), 
126.8(ArC), 125.7(ArC), 125.3(ArC), 123.4(ArC), 120.6(ArC), 120.1(ArC), 120.1(ArC), 
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119.9(ArC), 119.7(ArC), 110.5(ArC), 49.3(CH2); HRMS (ESI+): Found M
++H 359.1542, 
C26H19N2 (M
++H) requires 359.1549, m/z 359.1542 (M++H, 100%), 360.1569 (25%) 
 
9.64 Preparation of 13H-indolo[3,2-c]acridine203 417 
 
13-Benzyl-13H-indolo[3,2-c]acridine 482 (1eq., 50.0mg, 0.139mmoles) was dissolved in 3mL 
of benzene under inert conditions and to the resulting solution was added aluminium chloride 
(4eq., 37.0mg, 0.558mmoles) at 0 °C. The resulting reaction mixture was allowed to warm 
up to room temperature and was stirred at this temperature under inert conditions for two 
hours. After this time, the reaction was quenched using water (10mL) and then the organic 
material was extracted into ethyl acetate (10mL×3). The combined organic phases were 
washed with an aqueous saturated solution of sodium bicarbonate (20mL), followed by brine 
(20mL). The organic phases were collected, dried over anhydrous magnesium sulfate, 
filtered and solvent was removed under reduced pressure to obtain the crude product. Later 
column chromatography (10% EtOAc/Hexane) was carried out to isolate pure product 417 
as a yellow solid (29.0mg, 0.110mmoles, 79%). 
 
Mp. 107-109 °C (C2H5)2O (lit. 110 °C); Rf 0.39 (30% 
EtOAc/Hexane); FTIR (ν/cm-1): 3216(N-H), 3046-2921(ArC-C), 
1242(C=N); 1H NMR (300 MHz, Chloroform-d) δ 10.61 (1H, s, 
NH), 8.85 (1H, d, J = 10.0 Hz, ArH), 8.28 (1H, t, J = 7.8 Hz, 
ArH), 8.20-8.10 (1H, m, ArH), 8.08-8.00 (1H, m, ArH), 7.80-7.67 
(2H, m, ArH), 7.58-7.51 (1H, m, ArH), 7.49-7.38 (1H, m, ArH), 7.33-7.26 (2H, m, ArH), 7.24-
7.18 (1H, m, ArH); 13C NMR (75 MHz, Chloroform-d) δ 147.5(ArC), 138.5(ArC), 136.3(ArC), 
130.0(ArC), 128.9(ArC), 128.5(ArC), 128.4(ArC), 128.4(ArC), 126.4(ArC), 126.0(ArC), 
126.0(ArC), 125.4(ArC), 125.3(ArC), 124.0(ArC), 120.5(ArC), 120.1(ArC), 120.1(ArC), 
119.3(ArC), 111.8(ArC); HRMS (ESI+): Found M++H 269.1073, C19H13N2 (M
++H) requires 
269.1079, m/z 269.1073 (M++H, 100%), 270.1104 (20%). 
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Appendix A: Selected NMR spectra 
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Appendix B: Single Crystal X-ray Differection Data 
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Crystal Structure Data for 12-methoxy-6H-dibenzo[c,h]chromen-6-one 64 
 
Table 1: Crystal data and structure refinement for compound 64 
 
Empirical formula      C18 H12 O3  
Formula weight      276.28  
Temperature       173(2) K  
Wavelength       0.71069 Å  
Crystal system      Triclinic  
Space group       P-1  
Unit cell dimensions      a = 7.1970(7) Å α=103.237(3)°.  
b = 9.0700(9) Å β=105.722(3)°.  
c = 10.8400(11) Å γ=104.026(3)°.  
Volume      627.07(11) Å3  
Z       2  
Density (calculated)      1.463 Mg/m3  
Absorption coefficient     0.100 mm-1  
F(000)       288  
Crystal size       0.62 x 0.14 x 0.04 mm3  
Theta range for data collection    2.06 to 27.00°.  
Index ranges      -9≤h≤9, -11≤k≤10, -13≤l≤13  
Reflections collected      6387  
Independent reflections     2743 [R(int) = 0.0758]  
Completeness to theta = 27.00°    100.0 %  
Absorption correction     None  
Max. and min. transmission     0.9960 and 0.9409  
Refinement method     Full-matrix least-squares on F2  
Data / restraints / parameters    2743 / 0 / 191  
Goodness-of-fit on F2      0.874  
Final R indices [I>2sigma(I)]     R1 = 0.0479, wR2 = 0.1016  
R indices (all data)      R1 = 0.0902, wR2 = 0.1190  
Largest diff. peak and hole     0.229 and -0.271 e.Å-3  
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Crystal Structure Data for 2-methoxy-6H-benzo[c]chromen-6-one 98 
 
Table 2: Crystal data and structure refinement for compound 98 
 
 
Empirical formula C14H10O3 
Formula weight 226.22 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 7.4581(8) Å α = 83.115(4)° 
  b = 10.7427(12) Å β =  
  83.963(4) 
  c = 13.7087(15) Å γ  =  
  73.844(4) 
Volume 1044.4(2) Å3 
Z  4 
Density (calculated) 1.439 Mg/m3 
Absorption coefficient 0.101 mm-1 
F(000) 472 
Crystal size 0.50 x 0.16 x 0.06 mm3  
Theta range for data collection 2.85 to 28.00° 
Index ranges -9<=h<=9, -14<=k<=14, - 
  18<=l<=18 
Reflections collected 44613 
Independent reflections 5037 [R(int) = 0.0294] 
Completeness to theta = 28.00 99.8% 
Absorption correction Semi-empirical from 
  equivalents 
Max. and min. transmission 0.9937 and 0.9506 
Refinement method Full-matrix least-squares on F2 
279 
 
Data/restraints/parameters 5037/0/309 
Goodness-of-fit on F2 1.017 
Final R indices [I>2sigma(I)] R1 = 0.0381, wR2 = 0.1033 
R indices (all data) R1 = 0.0481, wR2 = 0.1115 
Largest diff. peak and hole 0.328 and -0.227 e.Å-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
280 
 
Crystal Structure Data for 12-methoxybenzo[c]phenanthridine 185 
 
Table 3: Crystal data and structure refinement for 185 
 
 
Empirical formula C18H13NO 
Formula weight 259.29 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group P2(1) 
Unit cell dimensions a = 18.0958(19) Å α = 90° 
  b = 8.9270(11) Å β = 90° 
  c = 15.7941(19) Å γ = 90° 
Volume 2551.4(5) Å3 
Z  8 
Density (calculated) 1.350 Mg/m3 
Absorption coefficient 0.084 mm-1 
F(000)\tab 1088\par 
Crystal size 0.22 x 0.17 x 0.16 mm3  
Theta range for data collection 3.46 to 27.99° 
Index ranges  -22<=h<=23, -11<=k<=11, - 
  20<=l<=20 
Reflections collected 18478 
Independent reflections 3176 [R(int) = 0.0333] 
Completeness to theta = 27.99 99.6% 
Absorption correction Semi-empirical from 
  equivalents 
Max. and min. transmission 0.9866 and 0.9818 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 3176/1/363 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0389, wR2 = 0.0967 
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R indices (all data) R1 = 0.0503, wR2 = 0.1040 
Absolute structure parameter 10(10) 
Largest diff. peak and hole 0.247 and -0.142 e.Å-3 
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Crystal Structure Data for benzo[b]phenanthridine-7,12-dione 129 
 
Table 4: Crystal data and structure refinement for compound 129 
 
 
Empirical formula      C17 H9 N O2 
Formula weight      259.25 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group       C2/c 
Unit cell dimensions     a = 10.5737(6) Å α = 90°. 
        b = 11.0912(6) Å β = 98.998(2)°. 
        c = 20.0250(11) Å γ = 90°. 
Volume      2319.5(2) Å3 
Z        8 
Density (calculated)     1.485 Mg/m3 
Absorption coefficient     0.099 mm-1 
F(000)       1072 
Crystal size      0.40 x 0.38 x 0.31 mm3 
Theta range for data collection   3.56 to 25.50°. 
Index ranges      -12<=h<=12, -13<=k<=13, -19<=l<=24 
Reflections collected     8630 
Independent reflections    2020 [R(int) = 0.0264] 
Completeness to theta = 25.50°   93.6 %  
Absorption correction     Semi-empirical from equivalents 
Max. and min. transmission    0.9699 and 0.9620 
Refinement method     Full-matrix least-squares on F2 
Data / restraints / parameters    2020 / 0 / 181 
Goodness-of-fit on F2     1.072 
Final R indices [I>2sigma(I)]    R1 = 0.0485, wR2 = 0.1212 
R indices (all data)     R1 = 0.0620, wR2 = 0.1312 
Largest diff. peak and hole    0.286 and -0.152 e.Å-3 
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Crystal Structure Data for 1-methoxybenzo[c]phenanthridine-11,12-dione 205 
 
Table 5: Crystal data and structure refinement for compound 205 
 
 
 
Empirical formula  C18H11NO3 
Formula weight  289.28 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 17.5504(8) Å α = 90°. 
  b = 7.1638(3) Å β = 96.459(2)°. 
  c = 20.5142(9) Å γ = 90°. 
Volume 2562.83(19) Å3 
Z  8 
Density (calculated) 1.499 Mg/m3 
Absorption coefficient 0.103 mm-1 
F(000) 1200 
Crystal size 0.36 x 0.26 x 0.16 mm3 
Theta range for data collection 3.60 to 28.00°. 
Index ranges -20<=h<=23, -9<=k<=9, -27<=l<=27 
Reflections collected 17130 
Independent reflections 3089 [R(int) = 0.0296] 
Completeness to theta = 28.00° 99.7%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9837 and 0.9638 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3089 / 0 / 200 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0487, wR2 = 0.1356 
R indices (all data) R1 = 0.0546, wR2 = 0.1417 
Largest diff. peak and hole 0.568 and -0.523 e.Å-3 
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Crystal Structure Data for 5-phenylbenzo[i]phenanthridine 254 
 
Table 6: Crystal data and structure refinement for 254 
 
 
Empirical formula  C23H15N 
Formula weight  305.36 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 5.7490(5) Å α = 90°. 
  b = 11.6180(11) Å β = 90°. 
  c = 22.756(2) Å γ = 90°. 
Volume 1519.9(2) Å3 
Z  4 
Density (calculated) 1.334 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 640 
Crystal size 0.268 x 0.068 x 0.052 mm3 
Theta range for data collection 3.62 to 25.50°. 
Index ranges -6<=h<=6, -14<=k<=14, -26<=l<=27 
Reflections collected 19610 
Independent reflections 1605 [R(int) = 0.0581] 
Completeness to theta = 25.50° 96.8%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.99 and 0.98 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1605 / 0 / 217 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0404, wR2 = 0.0823 
R indices (all data) R1 = 0.0562, wR2 = 0.0879 
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Absolute structure parameter 10(10) 
Largest diff. peak and hole 0.154 and -0.154 e.Å-3 
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Crystal Structure Data for 13-benzyl-13H-indolo[3,2-c]acridine  410 
 
Table 7: Crystal data and structure refinement for 410 
 
 
Empirical formula    C26H18N2 
Formula weight    358.42 
Temperature     173(2) K 
Wavelength     0.71073 Å  
Crystal system    Monoclinic 
Space group     P2(1) 
Unit cell dimensions    a = 18.7377(12) Å α = 90° 
b = 4.3336(3) Å β = 105.903(2)° 
c = 22.6892(15) Å γ = 90° 
Volume     1771.9(2) Å3 
Z       4 
Density (calculated)    1.344 Mg/m3 
Absorption coefficient    0.079 mm-1 
F(000)      752 
Crystal size     0.64 x 0.06 x 0.04 mm3 
Theta range for data collection  3.30 to 25.50° 
Index ranges     -22<=h<=22, -5<=k<=4, -27<=l<=27 
Reflections collected    24135 
Independent reflections   3289 [R(int) = 0.0600] 
Completeness to theta = 25.50{\'b0}  99.8%  
Absorption correction    Semi-empirical from equivalents 
Max. and min. transmission   0.9969 and 0.9512 
Refinement method    Full-matrix least-squares on F2 
Data/restraints/parameters   3289/0/253 
Goodness-of-fit on F2    01.030 
Final R indices [I>2sigma(I)]   R1 = 0.0455, wR2 = 0.0932 
R indices (all data)    R1 = 0.0789, wR2 = 0.1076 
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Largest diff. peak and hole   0.182 and -0.210 e Å-3 
 
 
